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Abstract 
Non-typhoidal Salmonella is an important bacterial pathogen causing worldwide 
morbidity and mortality. Early interactions between Salmonella Typhimurium and 
intestinal epithelium have been demonstrated in animal models, but little is known in 
humans. The aims of this thesis were to a) establish in vitro and ex vivo models to study 
such interactions, b) seek evidence of Salmonella invasion in human tissues in vivo, and 
c) identify virulence genes responsible for Salmonella adherence, invasiveness, and 
intracellular growth using a high throughput screening model based on transposon 
mediated differential hybridisation (TMDH). 
 
HEp-2 cell cultures were validated as a reproducible in vitro model at different early 
stages and for investigating host cell cytokine responses and signalling pathways. The 
model discriminated between different wild-type and characterised mutant strains; it 
also demonstrated the ability of probiotic lactobacilli to inhibit IL-8 expression in IL-
1β-pretreated and Salmonella-co-treated cells. This was not via IκBα degradation, 
phosphorylation of NF-κB p65 or its nuclear translocation. Lactobacilli did not post-
infectiously affect intracellular Salmonella proliferation or IL-8 production.  
 
Polarised Caco-2 cells were employed to investigate host responses to various bacterial 
pathogen associated molecular patterns (PAMPs). Exposure to Salmonella Typhimurium 
DNA triggered IL-8/hBD-2 mRNA expression and infection with its FliC-deficient 
mutant ∆fliM stimulated IL-8 mRNA expression. Thus, both flagellin and bacterial 
DNA could elicit pro-inflammatory responses. Histology and immunohistochemistry of 
in vivo and ex vivo human tissues showed bacterial/Salmonella invasion in epithelial 
cells, macrophages, and neutrophils. 
 
After HEp-2 cell infection and extraction of genomic DNA using 1,440 transposon 
mutants of Salmonella Typhimurium, Transposon Directed Insertion-site Sequencing 
(TraDIS) identified 47 genes responsible for bacterial colonisation, among which 5 
genes (intergenic sucD-cydA, glyA, yqiC, wzxE, and rfaI) account for bacteria-cell 
association. Furthermore, we discovered that speG is responsible for intracellular 
replication. Selected mutants will be re-characterised for pathophysiology investigations 
and prospective adaptation to prevention/treatment in non-typhoidal salmonellosis. 
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1.1. Foodborne diseases, bacterial diarrhoea, and Enterobacteriaceae in man 
Foodborne diseases are causing tremendous health hazards and public health burden 
worldwide. They annually cause approximately 76 million illnesses, 325,000 
hospitalisations, and 5,000 deaths in the United States (Mead et al. 1999). More than 
200 known diseases can be transmitted through foods and they can manifest from mild 
gastroenteritis to life-threatening complications. In the United States, 80% of the more 
than 5.2 million cases of bacterial diarrhoea each year originate from foodborne 
transmission (Mead et al. 1999). Foodborne bacterial diarrhoea has become an emerging 
health challenge not only because of personal hygiene and environmental contamination, 
but also from the growing importation of foods from developing countries where the 
infections are common, the increased consumption of fresh vegetables and fruits, the 
trend in producing vast amounts of low-cost foods, and the growing habit of consuming 
foods in public restaurants (Dupont 2007). 
 
The word diarrhoea derives from Greek words 'dia' (through) and 'rhein' (to flow). The 
current definition of diarrhoea, 'the abnormal frequency and liquidity of faecal 
discharge', was coined by Hippocrates over 2,000 years ago (Butzner 1996). Since then 
acute diarrhoea due to enteric infection has remained an important cause of infant 
morbidity and mortality throughout the world. Nowadays, diarrhoea annually causes 1.3 
million deaths in children younger than 5 years and is still one of the three most 
common single causes of death in this age range (Black et al. 2010). Acute diarrhoea, 
defined as an increased frequency of defecation with three or more times per day or at 
least 200 g of stool per day (or >10 g stool/kg body weight/day for infants and children) 
lasting less than 14 days; it may be accompanied by abdominal cramping, nausea, 
vomiting, malnutrition, or systemic symptoms (Kliegman et al. 2007;Thielman and 
Guerrant 2004). If it persists for more than 14 days it is termed chronic diarrhoea. 
Although aetiologies of diarrhoeal diseases can be infectious or non-infectious, acute 
diarrhoea mostly originates from enteric infections. Causative agents of infectious 
diarrhoea vary worldwide, including viral, bacterial, and parasitic pathogens. Although 
most of the cases with diarrhoea are caused by viral pathogens in Europe, North 
America, and other industrialised countries, bacterial pathogens can be more prevalent 
in developing countries (Podewils et al. 2004). Furthermore, bacterial pathogens tend to 
develop more severe clinical features and longer hospital stay than viral pathogens in 
hospitalised children (Chen et al. 2006). 
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Bacterial enteropathogens are dreadful human killers in food-related illness and cause 
considerable social burdens. Nontyphoidal Salmonella, Listeria, and Toxoplasma 
account for 1,500 deaths each year, more than 75% of the mortalities caused by known 
pathogens in the United States (Mead et al. 1999). Among the three pathogens, 
nontyphoidal Salmonella is constantly ranked as one of the top three known pathogens 
in the estimated bacterial illnesses, the hospitalisations, and the deaths in foodborne 
infections (Mead et al. 1999). The four most commonly reported bacterial 
enteropathogens in the United States – Campylobacter, non-typhoidal Salmonella, 
Shiga toxin–producing Escherichia coli (E. coli), and Shigella – are responsible for an 
estimated cost of 7 billion US dollars annually (Allos et al. 2004). The first three of 
these bacteria can enter the human food chain from infected or colonised animals and 
spread to humans from animal reservoirs. Contamination with these pathogens in food 
animals is threatening global food supply and becoming a major public health burden.  
 
Most of the bacterial enteropathogens such as diarrhoeagenic E. coli, Salmonella, 
Shigella, and Yersinia are classified as members of the family Enterobacteriaceae 
(MacFaddin 1980). Genetic studies place these bacteria among the phylum 
Proteobacteria, the class Gammaproteobacteria, and their own order Enterobacteriales. 
Enterobacteriaceae are a big family of Gram-negative, facultatively anaerobic, rod-
shaped bacteria typically 1–5 μm in length, which are usually flagellated and motile. 
They can be found in soil, water, plants, and animals from insects to humans. Most 
bacteria of Enterobacteriaceae are oxidase negative because they generally lack 
cytochrome C oxidase and therefore cannot utilise oxygen for energy production with 
an electron transfer chain (Farmer, III et al. 1981). Some Enterobacteriaceae species 
can cause human diseases but the others not normally associated with disease are often 
opportunistic pathogens. They have been responsible for as many as half of the 
nosocomial infections reported annually in the United States, most frequently by species 
of Escherichia, Klebsiella, Enterobacter, Proteus, Serratia, and Providencia (Dorland 
2003).  
 
Similarities are present in the family of Enterobacteriaceae. For example, most 
members of Enterobacteriaceae have type 1 fimbriae involved in the D-mannose-
sensitive binding to their host cells and tissue tropism (Adegbola and Old 1987;Stahlhut 
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et al. 2009). Meanwhile, many potentially pathogenic members of Enterobacteriaceae 
often produce type 3 fimbriae (Adegbola and Old 1983;Allen et al. 1991;Old and 
Adegbola 1985) and their expression is strongly associated with biofilm growth (Ong et 
al. 2010). Different members of Enterobacteriaceae can similarly express a transferable 
conjugate plasmid encoding adhesive fimbriae and a multidrug efflux pump (Burmolle 
et al. 2008), suggesting that these related bacteria may adopt a common strategy for 
increasing their fitness and virulence to the host cells. Furthermore, RNA-specific 
nucleotide sequences are conserved among most enterobacteria and certain members of 
this family have close DNA relationships (Brenner et al. 1969). This is indicated by 
genetic homology values that can be as high as 80% in certain chromosomal regions of 
E. coli and Salmonella (Middleton 1971).   
 
Enteric infections occur when microbial virulence factors can subdue host defence 
factors during pathogen-host interactions. Microbial virulence factors include 
enterotoxicn or cytotoxin elaboration, invasiveness, and mucosal adherence. Host 
defence factors include gastric acidity, intestinal motility, indigenous gut microbiota, 
mucous secretion, and specific mucosal and systemic immune defences (Cohen 1991). 
Pathogenic enterobacteria cause infectious diarrhoea by four major mechanisms or by 
combination of these mechanisms which are classified into noninflammatory, 
inflammatory, invasive, and systemic (Cohen 1996;Navaneethan and Giannella 2008). 
Non-inflammatory diarrhoea is caused by elaboration of a bacterial enterotoxin prior to 
entry into the human hosts to cause food poisoning (e.g. Staphylococcus aureus), or by 
enterotoxin-producing organisms (e.g. enterotoxigenic E. coli and Vibrio cholerae) that 
adhere to the mucosa, secrete toxins within the intestinal lumen, and alter absorption 
and/or secretion of the enterocytes without causing mucosal damage. Inflammatory 
diarrhoea is caused by cytotoxin-producing non-invasive bacteria (e.g. 
enterohaemorrhagic E. coli [EHEC], enteroaggregative E. coli [EAggEC], and 
Clostridium difficile), non-toxin secreting non-invasive bacteria (e.g. enteropathogenic 
E. coli [EPEC]), or by invasive microbes (e.g. Salmonella, Shigella, and 
Campylobacter). The cytotoxin-producing bacteria attach to the mucosa, induce 
cytokines, and stimulate the intestinal mucosa to release inflammatory mediators. The 
non-toxin secreting non-invasive bacteria EPEC non-intimately bind to host cells by 
bundle-forming pili, and then intimately attach to the host cells by formation of 
attaching/effacing (A/E) lesions to activate cellular cytoskeletal rearrangement and 
 32
signal transduction associated with tyrosine kinases. These events lead to disappearance 
of cellular microvilli with subsequent loss of absorptive surface, dysregulation of 
electrolyte and water transport, which are further amplified by disruption of the 
intestinal epithelial barrier structure/function and activation of the host inflammatory 
responses (Lapointe et al. 2009). Invasive microbes, which can also produce cytotoxins, 
invade and destruct the intestinal mucosa to activate acute inflammation with 
involvement of the elicited cytokines and inflammatory mediators. Systemic infections 
are characterised by enteric fever which is the major manifestation of Salmonella 
enterica serovar Typhi or Paratyphi although they can also develop in the patients with 
immunocompromised status or underlying diseases after infection of non-typhoidal 
Salmonella serovars (Dhanoa and Fatt 2009). Typhoidal Salmonella mainly translocate 
across the intestinal epithelium into the host circulation or disseminate via the 
reticuloendothelial system within CD18 expressing phagocytes that clinically manifests 
as septicaemia with absence or mild involvement of slowly developed mononuclear-
infiltrating intestinal inflammation. In contrast, non-typhoidal Salmonella usually 
colonise and invade the intestinal epithelium and lamina propria presenting clinically as 
enterocolitis with development of neutrophil-dominated intestinal inflammation 
(Coburn et al. 2007;Hapfelmeier and Hardt 2005), without dissemination via the 
systemic circulation. Taken together, the ultimate purpose of using these underlying 
mechanisms for these bacteria is to evade and modulate the host defence systems for 
successful establishment of the enteric infection. 
 
1.2. Epidemiology and impact of non-typhoidal salmonellosis 
1.2.1. Non-typhoidal salmonellosis in UK and other countries. 
Non-typhoidal Salmonella is one of the commonest bacterial pathogens in humans and 
animals worldwide (Hohmann 2001). For the past century, prevalence of Salmonella 
serotypes in humans dramatically increased in England and Wales and in the United 
States (Baumler et al. 2000). There are over 1.3 billion human cases of acute 
gastroenteritis annually worldwide, with 3 million deaths (Pang et al. 1995). In the 
United States, non-typhoidal Salmonella affect approximately 1–3 million people 
estimated from 45,000 reported cases, cause 500–2,000 deaths, and result in 168,000 
visits to physicians and 15,000 hospitalisations annually (Altekruse et al. 
1997;Hohmann 2001;World Health Organization 2008). There are few data on the 
incidence in the developing countries, where only l–10% of cases are reported, and 
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where the disease is more severe, often being associated with 20–30% mortality (Pang 
et al. 1995). Non-typhoidal Salmonella carries considerable morbidity and mortality 
particularly diarrhoea and septicaemia in children (Tsai et al. 2007) and 
immunocompromised patients (Gordon 2008;Molyneux 2004). Under certain 
circumstances, it causes serious complications such as toxic megacolon, bowel 
perforation (Chao et al. 2000;Chiu et al. 2002), meningitis, septic arthritis (Graham 
2002), osteomyelitis (Chi et al. 2001), endovasculitis, and septicaemia (Graham 
2002;Hohmann 2001).  
 
Moreover, non-typhoidal salmonellosis constitutes heavy socioeconomic burden and 
threat to public health because of characteristic bacterial faecal shedding from carriers 
(Gordon 2008) and increasing antibiotic resistance rates (Rabsch et al. 2001;Randall et 
al. 2004;Su et al. 2004;Su et al. 2008). Not only are Salmonella infections in humans 
often food borne but they can be acquired through contact with infected animals. Food 
products from farm animals, especially from poultry, pigs, and cattle, are a main source 
of human Salmonella infections. 
 
1.2.2. Non-typhoidal salmonellosis in Taiwan 
In Taiwan, tremendous challenges have been arising from non-typhoidal Salmonella. 
Hospital-based studies indicate that non-typhoidal Salmonella remains the leading cause 
of bacterial enteric infections in children (Chen et al. 2006;Chi et al. 2001), with 
bacteraemia in 4.5% to 15.1% of paediatric in-patients (Chi et al. 2001;Huang et al. 
2004). Similarly, bacteraemia complicates the infection in ~8% of the 
immunocompetent patients with non-typhoidal salmonellosis in the United States 
(Dupont 2009). In contrast, the rate of non-typhoidal Salmonella septicaemia was less 
than 2% in England and Wales (Threlfall et al. 1992).  
 
Recent reports in Taiwan warn of the emergence of ceftriaxone and ciprofloxacin 
resistance, mainly from invasive Salmonella Cholerasuis (Chiu et al. 2004b;Huang et al. 
2004), and fluoroquinolone resistance from Salmonella Schwarzengrund (Baucheron et 
al. 2005) and Salmonella Cholerasuis (Chiu et al. 2004c). Since a five antimicrobial-
resistant strain of Salmonella Typhimurium DT104 was isolated in the early 1990s 
(Molbak et al. 1999), multidrug resistance rates have been increasing and expanding 
worldwide (Su et al. 2004;Su et al. 2008;Weinberger and Keller 2005). Multiple drug 
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resistance of Salmonella in England and Wales had soared from 5% in 1981 to 12% in 
1988 (Ward et al. 1990), but decreased in certain serotypes in 1999 (Threlfall et al. 
2000). Unfortunately, Salmonella Typhimurium, Salmonella Cholerasuis, and 
Salmonella Schwarzengrund rank as the three most frequently isolated serotypes from 
human sources in Taiwan (Chiu et al. 2004a), and the antibiotic resistance rates of 
Salmonella serotypes in Taiwan, such as 98% in Salmonella Cholerasuis, appear higher 
than those in other countries (Su et al. 2004).  
 
Non-typhoidal Salmonella infections in Taiwan reveal high risks of hospitalisation, 
bacteraemia in children, emerging antibiotic resistance, and pathogen spreading 
between humans and animals. All of these problems urge further investigations into 
epidemiology, pathogenesis, prevention, and management of non-typhoidal Salmonella 
in Taiwan. 
 
1.3. Characteristics of non-typhoid Salmonella infection in man and animals 
1.3.1. Isolation, classification, and nomenclature of Salmonella species 
Salmonella are flagellated, gram-negative, facultatively anaerobic rod-shaped bacteria. 
In the family of Enterobacteriaceae that are generally oxidase negative, Salmonella are 
lactase-negative bacteria which can be distinguished from lactase-positive bacteria (e.g. 
Klebsiella, E. coli, and Enterobacter) and lactase-slow/weak (e.g. Serratia and 
Citrobacter) by the MacConkey agar that can detect low pH values created by bacterial 
lactose fermentation (MacFaddin 1980). Furthermore, Salmonella can utilise ferrous 
sulfate and convert it to hydrogen sulfide. Therefore, growth on Bismuth sulfite agar 
will discriminate from the other lactase-negative bacteria (e.g. Shigella, Proteus, and 
Yershinia) which cannot produce hydrogen sulfide. 
 
To date, over 2,500 serovars have been subdivided from Salmonella subspecies 
according to flagellar, carbohydrate, and lipopolysaccharide structures on the cell 
surface (Brenner et al. 2000;Coburn et al. 2007;Fierer and Guiney 2001). The antigenic 
classification system of Salmonella serovars has been established by Kauffman and 
White over one century ago. All antigenic formulae of recognised Salmonella serotypes 
are listed in the Kauffmann-White scheme (Popoff 2001), which is regularly updated for 
newly recognised serovars by the WHO Collaborating Centre for Reference and 
Research on Salmonella at the Pasteur Institute in Paris, France. In the latest report 
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published in 2004, there were totally 2,541 serovars in the genus Salmonella (Table 1.1) 
(Popoff et al. 2004). 
 
The nomenclature system of Salmonella has long been complicated and confusing until 
2005, when Salmonella enterica were officially approved as the type species of the 
genus Salmonella (Judicial Commission of the International Committee on Systematics 
of Prokaryotes. 2005). In addition, the genus Salmonella also comprises the species 
Salmonella bongori and a new species Salmonella subterranea (Shelobolina et al. 2004), 
which was approved in 2005. The current nomenclature system used by the Centers for 
Disease Control and Prevention (CDC) is based on the recommendations from the 
WHO Collaborating Centre, and taxonomically classify Salmonella into three species: 
Salmonella enterica, Salmonella bongori, and Salmonella substerranea (Table 1.1) (Su 
and Chiu 2007). Salmonella enterica is further classified into six subspecies and only 
one subspecies, Salmonella enterica subsp. enterica, can colonise warm-blooded 
animals (Baumler et al. 1998). Most of the serovars belonging to this subspecies are 
named after the geographical places where they were first isolated (Popoff et al. 2004). 
To avoid confusion between serovars and species, the serovar name is written in 
unitalicised Roman letters with its first letter capitalised. When first cited, the genus 
name is given followed by the species name, the subspecies name, the word 'serotype' 
(or abbreviation 'ser.'), and then the serotype name, e.g., Salmonella enterica subsp. 
enterica serovar Typhimurium, which may be later shortened to Salmonella 
Typhimurium or S. Typhimurium in order to shorten reports (Brenner et al. 2000;Popoff 
et al. 2004). 
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Table 1.1 Current Salmonella nomenclature (Su and Chiu 2007). 
Taxonomic position (writing format) and nomenclature 
 
Genus 
(capitalised, 
italic) 
Species 
(italic) 
Subspecies (italic) Serotypes (or serovars) 
(capitalised, not italic)* 
No of 
serotypes or 
subserotypes 
in each 
species+ 
Salmonella enterica enterica (or subspecies I) Choleraesuis, 
Enteritidis, Paratyphi, 
Typhi, Typhimurium 
1504 
  salamae (or subspecies II) 9,46:z:z39 502 
  arizonae (or subspecies IIIa) 43:z29:- 95 
  diarizonae (or subspecies IIIb) 6,7:l,v:1,5,7 333 
  houtenae (or subspecies IV) 21:m,t:- 72 
  indica (or subspecies VI) 59:z36:- 13 
 bongori subspecies V 13,22:z39:- 22 
 subterranea#    
* Some selected serotypes (serovars) are listed as examples. 
+  (Popoff et al. 2004) 
# (Shelobolina et al. 2004) 
 
1.3.2. Clinical features of human non-typhoidal Salmonella infection 
Typically, Salmonella enterica are orally acquired to cause enteric fever (typhoid fever), 
enterocolitis/diarrhoea, bacteraemia, and chronic asymptomatic carriage (Coburn et al. 
2007). After a latent period of 6 to 72 hours following oral ingestion of >50,000 
bacteria, clinical manifestations may develop including acute onset cramping abdominal 
pain, diarrhoea with or without blood, and/or extra-intestinal involvements for 5 to 7 
days. Risks of increased inflammatory severity, prolonged duration of illness, and 
severe complications are higher in young children and elderly than immunocompetent 
adults (Chao et al. 2000;Chao et al. 2006;Chi et al. 2001;Chiu et al. 2002;Coburn et al. 
2007;Huang et al. 2004). Age-specific differences in host defence mechanisms may 
account for the increased susceptibility to and severity of salmonellosis in infants 
(Cohen 1991). Treatment is basically supportive for dehydration, but antibiotic therapy 
is indicated in patients with toxic, invasive or systemic diseases, immunocompromised 
status, inflammatory bowel disease, haemoglobinopathy, and extremes of age at 
younger than 3 months and older than 65 years (Dupont 2009). Only very few serovars 
such as Salmonella Typhi, Salmonella Paratyphi, and Salmonella Sendai can cause 
typhoid fever in humans. Most of the other serovars causing clinical diagnoses other 
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than typhoid fever are defined as non-typhoidal Salmonella (Coburn et al. 2007;Gordon 
2008).  
 
1.3.3. Host specificity of non-typhoidal Salmonella 
Disease manifestation depends on host susceptibility and the infectious Salmonella 
serovar (Coburn et al. 2007;Fierer and Guiney 2001). Salmonella Typhimurium, 
Salmonella Enteritidis, Salmonella Choleraesuis, and Salmonella Dublin can cause 
diseases in both humans and animals. Salmonella Dublin usually causes intestinal 
inflammation, bacteraemia, and abortion in cows, but it causes diarrhoea and can be 
associated with bacteraemia in humans. Salmonella Choleraesuis always causes 
septicaemia in pigs, but can lead to diarrhoea and associated septicaemia in humans. 
Both Salmonella Typhimurium and Salmonella Enteritidis infect multiple hosts 
including humans, cattle, rodents, sheep, and poultry. However, Salmonella 
Typhimurium induces typhoid-like systemic disease in mice, but never results in 
typhoid fever in humans. Because Salmonella serovars may behave similarly or 
differently in different host species, better understanding of host susceptibility of 
Salmonella serovars can facilitate selection of appropriate infection models to simulate 
Salmonella human infections for studying pathogenesis. 
 
Diverse host range of Salmonella serovars and their degree of host adaptation can be 
attributed to evolution of host adaptation in Salmonella enterica. It has been postulated 
that in the genus Salmonella virulence evolved in three phases (Baumler et al. 1998). In 
the first phase, acquisition of Salmonella pathogenicity island-1 (SPI-1) by plasmid- or 
phage-mediated horizontal gene transfer diverted Salmonella from E. coli and other 
organisms. In the second phase, acquisition of genes necessary for colonisation of 
deeper tissues led to possession of SPI-2 in Salmonella enterica but not in Salmonella 
bongori serovars. In the third phase, Salmonella enterica subsp. enterica involved an 
expansion in host range to include warm-blooded vertebrates whilst the other 
Salmonella enterica subspecies and Salmonella bongori are mainly associated with 
cold-blooded vertebrates. Using a molecular evolution and phylogenetics based 
approach, analysis of known functions of the differentially evolved genes shows that the 
encoded proteins of the genes in SPI-1 and SPI-2 directly interact with the host cell and 
manipulate its function at different stages of the infection process to decide the host 
specificity of Salmonella enterica serovars in a complex way (Eswarappa et al. 2008a). 
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These genes encode translocon proteins (SipD, SseC and SseD), SptP to inhibit the 
cellular mitogen-activated protein kinase (MAPK) pathway that activates NF-κB, and 
effector proteins (SseF and SifA) necessary for maintaining the Salmonella-containing 
vacuole (SCV) in a juxtanuclear position (Eswarappa et al. 2008a).  
 
Salmonella virulence genes and their encoded proteins are involved with host range and 
specificity. For example, the type 3 secretion systems (T3SS) encoded by SPI-1 and 
SPI-2 play an important role in intestinal colonisation of Salmonella Typhimurium in 
cattle, but only a minor role in chicks; SPI-4 is essential for Salmonella Typhimurium 
colonisation of cattle, but not chicks (Morgan et al. 2004). Comparative screening of 
signature-tagged Salmonella Typhimurium mutants in two animal species revealed that 
the slrP mutant defective for colonisation of Peyer’s patches in mice can colonise 
Peyer’s patches in calves at the wild-type level (Tsolis et al. 1999b). Moreover, FimH 
adhesin plays an important role in host specificity of FimH-expressing pathogens as the 
allelic variants of the FimH adhesin from Salmonella enterica render differential 
bacterial binding to various types of mammalian cells and chicken leucocytes (Guo et al. 
2009).  
 
1.3.4. Structure of the human alimentary tract and tissue tropism of non-
typhoidal Salmonella 
The alimentary tract is anatomically comprised of the oral cavity, pharynx, oesophagus, 
stomach, small intestine, and large intestine (Ross and Reith 1985a). Although located 
within the human body, the alimentary tract contains a huge surface area to serve as the 
main interface between external and internal environments. It is not only the first line 
frontier for interactions between foreign substances and host immunity, but also the 
important organ for digestion, absorption and microbiota habitation (DeSesso and 
Jacobson 2001). The oesophagus is a long muscular conduit in the thoracic cavity which 
connects the pharynx and the stomach. The stomach is an expanded portion of the 
digestive tube directly under the diaphragm to receive the bolus from the oesophagus. 
Within the stomach, the food can be thoroughly mixed with digestive juices into chyme 
which enters the small and large intestines for further digestion and absorption. The 
small intestine is the major site of digestion and absorption for nutrients, water, and 
electrolytes. It is a long tubular structure of the alimentary canal that is divided into 
three parts: duodenum, jejunum, and ileum. The large intestine connects to the terminal 
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ileum via the ileocaecal valve and comprises the caecum, appendix (which is suspended 
from the caecum), ascending colon, transverse colon, descending colon, sigmoid colon, 
rectum, and anal canal (Laberge 1996;Ross and Reith 1985a). Although the large 
intestine can also absorb water and electrolytes, most nutrient processing in the colon is 
due to bacteria and little processing derives from intestinal mucosal/secretory activity 
(DeSesso and Jacobson 2001). 
 
From the view point of cross sections, the wall of the alimentary canal from the 
oesophagus to the rectum is comprised of four layers designated as the mucosa, the 
submucosa, the muscularis externa, and the serosa, from the inner side facing the 
intestinal lumen towards the outer side connecting the mesentery or adventitia. The 
mesentery serve as a route for blood vessels, lymphatic vessels, and nerves; the 
adventitia adheres the intestinal tube to the posterior abdominal wall or other organs 
(Ross and Reith 1985a). 
 
The patterns of the mucosal lining cells from oesophagus to the anus vary in different 
topographical regions of the alimentary tract. The oesophageal mucosa is covered by 
non-keratinised, stratified squamous epithelium and the gastric mucosa is lined by 
simple columnar epithelium. The lining epithelium of the small and large intestines 
consist of simple columnar absorptive cells. The anorectal junction constitutes a 
transition zone with the stratified columnar or cuboidal epithelium in gradient to the 
stratified squamous epithelium between the columnar epithelium of the proximal 
intestinal mucosa and the keratinised stratified squamous epithelium of the distal skin. 
Finally, the thickened circular smooth muscle of the anal canal serves as an internal anal 
sphincter (Ross and Reith 1985a). The four characteristic layers are present throughout 
the alimentary canal. However, they are lined with the characteristically differentiated 
epithelium in different locations for adaptation of the intraluminal environments. 
 
Distinctive histological and functional characteristics of intestinal mucosa exist in 
different regions of the small and large intestines. Circular folds and tiny projections of 
the intestinal core submucosa covered with mucosa, termed plicae circulares and villi 
respectively, create an extensive mucosal surface area for absorption in the small 
intestine; however, no similar structures are present in the large intestine. In addition, 
another unique structure in the gut is Peyer’s patch that comprises transmucosal clusters 
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of organised lymphoid follicles overlaid with a specialised epithelium as the inductive 
site of immune responses. Peyer’s patch numbers vary between species, but studies in 
humans showed the highest density of Peyer’s patches in the ileum (Makala et al. 2002), 
particularly in the terminal ileum (Keita et al. 2006;Van Kruiningen et al. 2002). 
Furthermore, postoperative findings also demonstrated topographical differences in the 
gut. Ileal adaptation is far more efficient than that of the jejunum or colon after surgical 
resection; ileal resection with more than 15 cm in length may be associated with vitamin 
B12 malabsorption (Laberge 1996).  
 
Intriguingly, more questions are raised about in which location(s) of the human gut non-
typhoidal Salmonella prefer to invade the intestinal epithelium, and whether the host 
response varies in different topographical areas of the gut. Most of the existing clinical 
reports indicate that the lower intestinal tract could be the favourite niche of non-
typhoidal Salmonella in human infection. Some studies showed ileum and proximal 
colon are more commonly involved than jejunum, duodenum, and stomach (Boyd 
1985;Coburn et al. 2007;McGovern and Slavutin 1979), whilst non-typhoidal 
salmonellosis is also described to be primarily involved in the jejunum and colon 
(Cohen 1996), or in the distal colon (Mandal and Mani 1976). Such controversies 
require systemic investigations for elucidation of the real situations in tissue tropism, 
their mechanisms, and the parallel host immune responses during non-typhoidal 
Salmonella human infections. 
 
1.3.5. Cell types of the human intestinal epithelium and cell tropism of 
non-typhoidal Salmonella 
The lining intestinal epithelium is the front barrier of host defence for non-typhoidal 
Salmonella to breach at the early stage prior to establishment of a human infection. The 
intestinal epithelium is mainly comprised of absorptive intestinal cells, goblet cells, 
enteroendocrine cells, Paneth cells (Figure 1.1), undifferentiated cells (Figure 1.2), and 
M cells (Figure 1.3) (Jang et al. 2004;Jepson and Clark 2001;Ross and Reith 1985a;van 
der Flier and Clevers 2009).  
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Figure 1.1 Different cell types of the intestinal epithelium. (a) H&E staining shows the 
morphology of the mouse intestine which is lined with a single layer of epithelial cells 
with pocket-like intrusions called the crypts of Lieberkühn and finger-like protrusions 
called villi. Immunohistochemical analysis illustrated the four differentiated cell types 
present in the intestinal epithelium: (b) periodic acid–Schiff (PAS) to stain goblet cells, 
(c) anti-synaptophysin to stain enteroendocrine cells, (d) lysozyme to stain Paneth cells, 
and (e) alkaline phosphatase to stain the enterocyte brush border; adapted from (van der 
Flier and Clevers 2009). 
 
1.3.5.1. Absorptive intestinal cells 
The absorptive intestinal cells, termed enterocytes in the small intestine and colonocytes 
in the large intestine, comprise the major population (>80%) in the intestinal epithelium 
which form a polarised lining with brush borders on the apical surface, bearing 
microvilli and glycocalyx on their tops, and nuclei in the basal region of the cytoplasm 
(Massey-Harroche 2000;Ross and Reith 1985a;van der Flier and Clevers 2009). The 
cells join together to form a physical barrier to separate the intercellular space from the 
intestinal lumen by a junctional complex consisting of zonula occudens (tight junction), 
zonula adherens, and macula adherens (desmosome) which can be observed under 
 42
electron microscopy (Ross and Reith 1985b). Villi are formed by enterocytes (Figure 
1.1a) but not by colonocytes. The absorptive intestinal cells are not only responsible for 
absorption of nutrients, electrolytes, and water (Ross and Reith 1985a), but also are 
serving as an immune barrier by production and secretion of antimicrobial peptides 
(Dommett et al. 2005). 
 
1.3.5.2. Goblet cells 
Goblet cells interlace with absorptive intestinal cells in the intestinal epithelium (Figure 
1.1b) and the proportion of goblet cells among all intestinal cell types range between 
~4% (duodenum) and ~16% (descending colon) (Ross and Reith 1985a;van der Flier 
and Clevers 2009). They produce and secrete mucin glycoproteins into the mucus layer 
which covers the intestinal mucosal surface (Deplancke and Gaskins 2001). The mesh-
like structure of mucus gel can impede the diffusion of irritating macromolecules, form 
a barrier to harmful substances, lubricate the passage of intraluminal particles, maintain 
a hydrated layer over the epithelium, intermediate uptake of nutrients and electrolytes, 
and create a permeable layer for gas exchange with the underlying epithelium 
(Dharmani et al. 2009). The mucus layer, as thick as ~150 to ~350 µm in human gut 
(Fyderek et al. 2009), is the first acellular barrier that should be penetrated by motile 
pathogenic bacteria before they reach the first cellular barrier, intestinal epithelium. It 
provides a microenvironment in formation of gut mucosal biofilms that facilitate 
colonisation of pathogenic bacteria on the apical surfaces of intestinal epithelium. 
However, gut mucosal biofilms may be modulated by consumption of inulin-type 
fructans favouring health-promoting non-pathogenic commensal strains to prevent 
invasion of pathogens (Kleessen and Blaut 2005). Moreover, the mucus layer can 
maintain adequate concentration of secretory IgA to protect against enteric pathogens 
(Kleessen and Blaut 2005). This localised mucus surface layer can retain the secreted 
antimicrobial peptides to create their high local concentrations for preventing bacterial 
entry that still allows the presence of commensal flora (Meyer-Hoffert et al. 2008). 
 
1.3.5.3. Enteroendocrine cells 
Enteroendocrine cells, also known as neuroendocrine or enterochromaffin cells (Figure 
1.1c), are part of a larger group of cells designated as amine precursor uptake 
decarboxylase (APUD) cells which produce not only gastrointestinal hormones (e.g. 
secretin, gastrin, and cholecystokinin) to influence remote target cells, but also secrete 
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paracrine substances (e.g. somatostatin) that diffuse locally to affect their neighbouring 
cells (Andrew 1982;Ross and Reith 1985a). The change in enteroendocrine cells or their 
products can regulate gut physiology, including motility and secretion. Some secreted 
gut endocrines, such as serotonin (5-hydroxytryptamine) and chromogranins, play an 
important role in modulation of immune activation and gut inflammation that may be 
closely related to host innate immunity (Khan and Ghia 2010).  
 
1.3.5.4. Paneth cells 
Paneth cells are located at the base of the epithelial crypts (Figure 1.1d) in the small 
intestine and contain eosinophilic secretory granules in their apical cytoplasm (Ross and 
Reith 1985a). Metaplastic Paneth cells can be found ectopically during episodes of 
inflammation such as Barret’s oesophagus, gastritis, Crohn’s disease, and ulcerative 
colitis (Ouellette and Bevins 2001). Paneth cells secret antimicrobial peptides such as 
lysozyme, secretory phospholipidase A2, angiogenin-4, and α-defensins that can 
provide innate biochemical protection against enteric infection but also protect the 
adjacent mitotically active crypt cells from colonisation by potential pathogens (Khan 
and Ghia 2010;Ouellette 2005). The action of antimicrobial peptides and the phagocytic 
activity of Paneth cells facilitate modulation of the gut flora (Ross and Reith 1985a). 
Reduced Paneth cell defensin expression may play a key role in regulation of the 
composition of commensal microbiota that is hypothetically involved in the 
pathogenesis of necrotising enterocolitis in premature neonates and inflammatory bowel 
disease (Salzman et al. 2007). 
 
1.3.5.5. Undifferentiated cells 
Undifferentiated intestinal cells, also referred to as intestinal stem cells, are located in 
the bottom half of the crypts (Ross and Reith 1985a). Recent mitochondrial DNA 
mutation studies more specifically show that the human stem cell niche is located above 
the Paneth cell zone in the small intestine and at the base of colonic crypts where Paneth 
cells are absent, in parallel to dynamic cell kinetic studies in animals (Fellous et al. 
2009). The new cells divide within the crypts and differentiate into absorptive lineage 
cells and secretory cells; the former are enterocytes or colonocytes and the latter include 
goblet cells, enteroendocrine cells, or Paneth cells. The new cells, except for Paneth 
cells, take several days to reach the villus tip where apoptosis occurs and then the cells 
are shed. The migration of these cells towards the villus tip could be driven by basement 
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membrane flow, mitotic pressure, or active movement of epithelium (Heath 
1996;Radtke and Clevers 2005). However, the newly differentiated Paneth cells migrate 
to the base of the small intestinal crypts where they reside directly beneath the stem 
cells (Heath 1996;Radtke and Clevers 2005). 
 
1.3.5.6. M cells 
M cells, as referred to microfold cells or membranous cells, are specialised intestinal 
epithelial cells which reside in the follicle-associated epithelium (FAE) overlaying 
organised gut-associated lymphoid tissue (GALT) such as the intestinal Peyer’s patches 
in the gastrointestinal tract (Figure 1.2a) (Jepson and Clark 2001). They are 
characterised morphologically having sparse, irregular microvilli on their apical surface, 
with a basolateral cytoplasmic invagination harbouring lymphocytes and macrophages, 
and by function in higher transcytotic capacity of specific particles such as antigens to 
the underlying immune cells than other enterocytes (Figure 1.2b). These unique 
characteristics facilitate M cells to be an efficient route across the intestinal epithelial 
barrier in antigen sampling and immune stimulation, but also allow them vulnerable to 
infection by pathogens. In humans, Peyer’s patches distribute at their highest density in 
the ileum (Cornes 1965); however, M cells can also be observed in the FAE of the 
human colon (Jacob et al. 1987). The FAE of Peyer’s patches are not the only residential 
locations for M cells in the gastrointestinal tract. Non-FAE intestinal villous M cells 
(Jang et al. 2004) or solitary intestinal lymphoid tissue (SILT) can be a major site for 
bacterial invasion because they comprises small lymphoid cell clusters in the entire 
intestinal mucosa in parallel to M cells in Peyer’s patches to induce a strong 
inflammatory response and ensuing mucosal pathology (Halle et al. 2007). 
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Figure 1.2 Illustration of Peyer’s patch, follicle-associated epithelium and M cell. (a) 
Schematic transverse section of a Peyer’s patch lymphoid follicle and associated 
structures. (b) Illustration of the follicle-associated epithelium, which is characterised by 
the presence of specialised M cells that can translocate antigens to immune cells in their 
basolateral invaginations for induction of immune responses; adapted from (Clark et al. 
2000). 
 
1.3.5.7. Cell tropism of non-typhoidal Salmonella 
Cell tropism may occur during early or late interactions between non-typhoidal 
Salmonella and host cells. Limited evidence showed that Salmonella Typhimurium 
predominantly bound to the mucus layer during the first 4 hours and in small foci of 
epithelial attachment and invasion of the enterocytes from 4 to 8 hours of inoculation in 
human intestinal in vitro organ culture (Haque et al. 2004). Pathogens utilise various 
bacterial enzymes to degrade mucin glycopeptides in the mucus coat to reach the 
epithelial surface (Deplancke and Gaskins 2001). In such microbial mucolysis, the 
glycoconjugate-cleavage machinery of the respective organisms appears to correlate 
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with the preferential binding of microbes to the specific type of glycoconjugate 
corresponding to the complexity of the oligosaccharide chains in mucin glycopeptides, 
such as differences in size, degree of branching, type of linkage, and the presence of 
terminal sialic acid or sulfate groups. For example, Salmonella Typhimurium possesses 
a sialidase and binds preferentially to a glycoprotein containing sialic acid (Vimal et al. 
2000) and that may be the initial specific binding site of Salmonella Typhimurium on 
the mucosa before bacterial invasion into the epithelium. 
 
Preferential invasion of Salmonella in different cell types has rarely been investigated in 
humans. Intriguingly, Salmonella Typhimurium preferably invade M cells located in the 
FAE of Peyer’s patches in mice (Jones et al. 1994) and swine (Meyerholz et al. 2002). 
Such tropism of M cells may be related to expression of adhesins (Santos and Baumler 
2004). However, Salmonella Typhimurium can invade both M cells and enterocytes 
without predilection in cattle (Santos et al. 2002). Whether Salmonella infection in 
humans preferentially adopts M cells as an invasion route rather than enterocytes is 
obscure. Supposing that M cell tropism was present in human Salmonella infection, it 
would be further questioned if such M cell tropism would be similarly exhibited in the 
M cells of the follicle-associated epithelium (FAE) (Jepson and Clark 2001) and in the 
villous M cells of the non-FAE (Jang et al. 2004). 
 
Dendritic cells may play an early but active role in antigen sampling of Salmonella 
within the intestinal lumen before bacterial attachment and invasion to the intestinal 
epithelium. Dendritic cells can extend long dendrites into the gut lumen to directly seize 
the pathogen (Maric et al. 1996) although they can also reside in the underlying 
lymphoid follicle of the Peyer’s patches to uptake antigens sampled and translocated by 
M cells (Biedzka-Sarek and El 2006). In addition to early contact in these two situations, 
dendritic cells can also be encountered in the deeper tissues such as in the lamina 
propria and lymph nodes, or in the distant organs such as liver and spleen after the 
epithelial barrier has been breached by Salmonella. Wherever they interact with 
pathogens, dendritic cells serve as antigen-presenting cells to activate naïve T cells for 
Salmonella-specific adaptive immunity (Biedzka-Sarek and El 2006). 
 
In vivo animal studies highlight that Salmonella are internalised intracellullarly by 
neutrophils or by dendritic cells and/or macrophages after reaching the basal side of the 
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intestinal epithelium, but they are not found in fibroblasts or other mesenchymal cells 
(Santos and Baumler 2004). Neutrophils can internalise extracellular Salmonella to kill 
the bacteria. In contrast, dendritic cells serve as vehicles for dissemination in the initial 
stage of infection but they are not suitable as ultimate reservoirs of Salmonella as they 
allow bacterial survival but not intracellular replication. In some host species, 
Salmonella can find a safe niche within macrophages to escape from humoural defence 
and neutrophils, and replicate intracellularly for developing a systemic infection (Santos 
and Baumler 2004). Whether these findings are parallel to the phenomena in humans 
remains questionable and requires to be elucidated. 
 
1.4. Host responses of human intestinal epithelium during early interactions 
with non-typhoidal Salmonella 
Basically, establishing a Salmonella infection involves bacterial virulence, host-
pathogen interactions, and host responses. The early interactions between non-typhoidal 
Salmonella serovars and intestinal epithelium have been morphologically and 
histologically demonstrated in animal models using fixed ileal loops in calves (Frost et 
al. 1997), ligated ileal loops (Meyerholz et al. 2002;Meyerholz and Stabel 2003), or 
small intestinal segment perfusion (Niewold et al. 2007) in pigs, but little is known in 
humans (Haque et al. 2004). In the swine ileum, both Salmonella Typhimurium and 
Salmonella Cholerasuis exhibited non-cell-specific invasion as early as 10 minutes 
postinoculation (Meyerholz et al. 2002). In the bovine ligated ileal loop, Salmonella 
Typhimurium attach to and invade the apical side of the intestinal epithelium within 10–
15 minutes after infection; most bacteria within epithelial cells are located at the basal 
side of the epithelium and can be detected in the lamina propria after one hour 
postinfection (Santos et al. 2002). This means that epithelial transmigration occurs 
rapidly in vivo.  
 
Membrane ruffling and intracellular SCV are two characteristic responses of host cells 
to Salmonella infection. During Salmonella infection in vitro and in vivo, bacterial entry 
can trigger actin rearrangements that results in membrane ruffling (Francis et al. 
1993;Santos et al. 2002) and subsequent internalisation of the bacteria inside an 
endocytic vesicle, called SCV, in which bacteria multiply whilst cell surface returns to 
normal (Salyers and Whitt 2002b). Invasive bacteria may reside in two different 
compartments within the cells: inside phagosomes or in the cytosol but outside 
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phagosomes. Listeria monocytogenes and Shigella flexneri which invade non-
phagocytic cells can escape from the vacuole and proliferate within the cytosol of host 
cells (Ray et al. 2009). However, Salmonella mainly reside in the phagosomes called 
SCVs, which divide along with Salmonella that results in a single bacterium per SCV. 
The increasing number of SCVs reduces the occurrence of SCVs in phagosome-
lysosome fusion, depletes lysosomes, and finally causes insufficiency in lysosomes. 
Therefore, the Salmonella within SCVs are more likely to avoid lysosomal degradation 
and survive from intracellular defences of host cells (Eswarappa et al. 2010). A 
subpopulation of Salmonella escape from SCV and hyperreplicate in the cytosol to 
serve as a reservoir for dissemination. These cytosolic invasion-primed and -competent 
bacteria are extruded by the epithelial cells that undergo an inflammatory-inducing cell 
death characterised by activation of caspase-1 and apical IL-18 secretion (Figure 1.3) 
(Knodler et al. 2010). Whether Salmonella could laterally enter adjacent epithelial cells 
via their lateral membranes remains unknown. 
 
1.4.1. Histopathophysiology and host chemokine/cytokine responses 
The pathophysiology of human non-typhoidal Salmonella infection is not fully 
understood despite existing evidence from in vitro cell culture and in vivo animal 
models. Studies have demonstrated that recruitment of neutrophils to the infected 
intestinal epithelium is the histopathological hallmark of salmonellosis (McCormick et 
al. 1993). Migration of neutrophils from the microvasculature to the interstitial space in 
the submucosa is initially driven by interleukin-8 (IL-8) primarily via NF-κB activation 
and coordination with at least one or two MAPK pathways (Hoffmann et al. 2002) after 
binding of flagellin to the transmembranous Toll-like receptor (TLR)-5 and/or via 
caspase-1 activation after recognition of flagellin and virulence factors through IL-1β-
converting enzyme protease-activating factor (IPAF) (Figure 1.3), which is one Nod-
like receptor (NLR) (Hurley and McCormick 2003;Miao et al. 2007;Steiner 2007). To 
further drive neutrophils across the epithelial barrier into the intestinal lumen, apical 
secretion of the chemoattractant pathogen-elicited epithelial chemokine (PEEC) is 
elicited via binding of the Salmonella effector protein SipA to the GTPase ADP-
ribosylation factor 6 (ARF6) that leads to translocation of phospholipase D (PLD) and 
subsequent activation of apical surface protein kinase C (PKC) (Figure 1.3) (Criss et al. 
2001;Lee et al. 2000;McCormick et al. 1998). The orchestration of chemokines, 
proinflammatory, and inflammatory/anti-inflammatory cytokines results in the 
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subsequent inflammatory responses which proceed with crypt abscesses, epithelial 
necrosis, oedema, and fluid retention to cause secretory exudates and diarrhoea (Coburn 
et al. 2007).  
 
 
Figure 1.3 Recruitment of neutrophils by IL-8 and PEEC and their signalling pathways 
involving TLR5, caspase-1 (IPAF and NAIP5), and protein kinase C, as well as 
extrusion of cytosolic bacteria with activation of caspase-1 and apical IL-18 secretion 
after Salmonella infection; modified from (Akira and Takeda 2004;Carneiro et al. 
2008;Hurley and McCormick 2003;Knodler et al. 2010;Miao et al. 2007). 
 
IL-8 is a major CXC chemokine, which is one kind of cytokine that can direct and drive 
migration of immune/inflammatory cells. Two subfamilies of chemokines are CXC 
chemokines (e.g. IL-8, GROα, GROβ, GROγ, NAP-2, and ENA-78) and CC 
chemokines (e.g. MCP-1, MCP-2, MCP-3, RANTES, MIP-1α, and MIP-1β) (Baggiolini 
et al. 1995). Both groups are distinguished by the arrangement of the first two of four 
conserved cysteines, with separation by one amino acid in the former (CXC) and 
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adjacent cysteines in the latter (CC). IL-8 and the other CXC chemokines preferentially 
attract neutrophils, whilst the CC chemokines drive basophil and eosinophil 
granulocytes, and T-lymphocytes (Baggiolini et al. 1995). Non-typhoidal Salmonella 
infection not only induces IL-8 but also affect profiling of other chemokines/cytokines. 
For example, infection of bovine ligated ileal loops with Salmonella Typhimurium leads 
to an acute neutrophilic inflammatory response in association with the upregulation of 
CXC chemokines (IL-8, GROα and γ, and GCP2), and some cytokines (IL-1β, IL-1Ra, 
and IL-4) (Santos et al. 2002).  
 
Cytokines are key communication mediators between host cells in the defence against 
Salmonella. In animal models, protective roles have been shown for IL-1α, TNFα, IFN-
γ, IL-12, IL-18, and IL-15, whilst IL-4 and IL-10 inhibit host defences against 
Salmonella (Eckmann and Kagnoff 2001). In addition to the three major groups of 
cytokines including the classical pro-inflammatory cytokines (IL-1 and TNFα), the IL-
18/IFN-γ axis of cytokines (IFN-γ, IL-12, and IL-18), and the anti-inflammatory 
cytokines (IL-4, IL-10, and TGFβ1), recent in vivo studies showed the IL-23/IL-17 axis 
of cytokines (IL-23, IL-22, and IL-17) can amplify inflammatory responses induced by 
Salmonella Typhimurium in the intestinal mucosa against bacterial dissemination to 
suppress disease development (Godinez et al. 2008;Godinez et al. 2009;Siegemund et al. 
2009). The discovery of chemokines/cytokines and their roles in non-typhoidal 
salmonellosis provides clear insights of immune cell recruitment, counterbalance in 
inflammation, and crosstalk between pathogens and host cells. 
 
1.4.2. Recognition of Salmonella pathogen-associated molecular patterns 
by pattern recognition receptors 
The mammalian cells utilise sensors, termed pattern recognition receptors (PRRs), to 
recognise pathogen-associated molecular patterns (PAMPs) expressed in pathogens but 
not in host cells for discrimination between self and non-self that can subsequently 
induce host immune cascades against microbes. PRRs comprise toll-like receptors 
(TLRs), nucleotide-binding oligomerisation domain (NOD)-like receptors (NLRs), 
retinoic acid-inducible gene (RIG)-I-like receptors (RLRs), and C-type lectin receptors 
(CLRs) (Table 1.2) (Kawai and Akira 2009). Bacterial PAMPs are mainly recognised by 
TLRs and NLRs, but can potentially be sensed by CLRs which are primarily expressed 
by myeloid cells such as dendritic cells (Huysamen and Brown 2009;Zhang et al. 2006). 
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Table 1.2 PRRs and PAMPs (Kawai and Akira 2009).  
 PRRs (structure) Adaptors (structure) PAMPs/Activators Species 
TLR TLR1-TLR2 (LRR-TIR) MyD88 (TIR-DD), 
TIRAP (TIR) 
Triacyl lipopeptides 
Curli amyloid fibrils  
Bacteria 
Bacteria (Tukel et al. 2010) 
 TLR2-TLR6 (LRR-TIR) MyD88 TIRAP Diacyl lipopeptides 
LTA 
Zymosan 
Mycoplasma 
Bacteria 
Fungus 
 TLR2 (LRR-TIR) MyD88 TIRAP PGN 
Lipoarabinomannan 
Porins 
t-GPI-mucin 
HA protein 
Bacteria 
Mycoplasma 
Bacteria (Neiserria) 
Parasites (Trypanosoma) 
Virus (Measles virus) 
 TLR3 (LRR-TIR) TRIF (TIR) dsRNA Virus 
 TLR4 (LRR-TIR) MyD88, TIRAP, 
TRIF, TRAM (TIR) 
LPS 
Envelope proteins 
Bacteria 
Virus (RSV, MMTV) 
 TLR5 (LRR-TIR) MyD88 Flagellin Bacteria 
 TLR7 (LRR-TIR) MyD88 ssRNA RNA virus 
 hTLR8 (LRR-TIR) MyD88 ssRNA RNA virus 
 TLR9 (LRR-TIR) MyD88 CpG DNA 
DNA 
Malaria hemozoin 
Bacteria 
DNA virus 
Parasites 
 mTLR11 (LRR-TIR) MyD88 Not determined 
Profilin-like molecule 
Bacteria (Uropathogenic bacteria) 
Parasites (Toxoplasma gondii) 
RLR RIG-I (CARD×2-heliase) IPS-1 (CARD) RNA (5'-PPP ssRNA, 
short ds RNA) 
Virus 
 MDA5 (CARD×2-heliase) IPS-1 RNA (poly IC, long ds 
RNA) 
Virus 
 LGP2 (heliase)  RNA Virus 
NLR NOD1/NLRC1 (CARD-
NBD-LRR) 
RICK (CARD), 
CARD9 (CARD) 
iE-DAP Bacteria 
 NOD2/NLRC2 (CARD-
NBD-LRR) 
RICK, CARD9 MDP Bacteria 
 NALP3/NLRP3 (PYD-
NBD-LRR) 
ASC (PYD-CARD) 
CARDINAL (PYD-
FIND) 
MDP 
RNA 
ATP 
Toxins 
Uric acids, CPPD, 
amyloid-β 
Bacteria 
Bacteria, Virus 
Bacteria? Host? 
Bacteria 
Host 
 NALP1/NLRP1 (CARD-
FIIND-NBD-LRR-PYD) 
ASC Antrax lethal toxin Bacteria 
 IPAF/NLRC4 (CARD-
NBD-LRR) 
 Flagellin Bacteria 
 NAIP5  (BIR×3-NBD-
LRR) 
 Flagellin Bacteria 
CLR Dectin-1 (lectin-ITAM) 
 
LOX-1 
 β-Glucan 
Macobacterial ligand 
? 
Fungi 
Mycobacteria  
Bacteria (Huysamen and Brown 2009) 
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Abbreviations:   
5'-PPP  5'-triphosphorylated MDA5 melanoma differentiation associated gene 5 
ASC apoptosis-associated speck-like protein containing MDP muramyl dipeptide 
 a CARD MMTV mouse mammary tumour virus 
BIR baculovirus inhibitor of apoptosis protein repeat MyD88 myeloid differentiation primary response gene 88 
CARD caspase recruitment domain NAIP neuronal apoptosis inhibitory protein 
CARDINAL CARD8, DACAR, NDPP1 and TUCAN NALP NACHT-LRR-PYD-containing protein 
CLR C-type lectin receptor NBD nuclear binding domain 
CpG cytidine-phosphate-guanosine NOD nucleotide-binding oligomerisation domain 
CPPD calcium pyrophosphate dihydrate NLR NOD-like receptor 
DD dominant negative and deletion-constructs PAMPs pathogen-associated molecular patterns 
dsDNA double-stranded DNA PGN peptidoglycan 
dsRNA double-stranded RNA PRR pattern recognition receptor 
FIIND function to find PYD pyrin domain 
GPI glycosylphosphatidylinositol RICK RIP-like interacting caspase-like apoptosis  
HA haemagglutinin  regulatory protein kinase 
IPAF IL-1β-converting enzyme protease-activating factor RIG-I retinoic acid-inducible gene-I  
ITAM immunoreceptor tyrosine-based activation motif RIP receptor-interacting protein 
iE-DAP γ-D-glutamyl-meso-diaminopimelic acid RLR RIG-I-like receptor 
IPS-1 IFNβ promoter stimulator-1 RSV Respiratory syncytial virus 
LGP2 laboratory of genetics and physiology 2 TIR Toll/IL-1R 
LOX-1 Lectin-like oxidised LDL receptor TIRAP TIR domain-containing adaptor protein 
LPS lipopolysaccharide TRAM TRIF-related adaptor molecule 
LRR leucine-rich repeats TRIF TIR-containing adaptor inducing IFN-β 
LTA lipoteichoic acid   
 
The TLR family are a group of membrane-anchored receptors which are located either 
on the cell surface or the lumen of intracellular vesicles such as endosomes or 
lysosomes. TLRs detect a wide range of PAMPs including lipids, lipoproteins, proteins, 
glycans, and nucleic acids from diverse pathogenic microorganisms (Table 1.2). To date, 
the mammalian TLR family consists of more than 12 members. TLR1–TLR9 are 
conserved between humans and mice, TLR10 is not functional in mice and 
undetermined in man, and TLR11–TLR13 are lost in humans (Kawai and Akira 2009). 
TLRs confer the same cytoplasmic Toll/IL-1R (TIR) domain as IL-1R signalling for 
recruitment of downstream molecules. After ligand binding of TIR, most TLRs 
associate with the myeloid differentiation primary-response protein 88 (MyD88) and 
TIR-domain-containing adaptor protein (TIRAP) to subsequently trigger IL-1 receptor-
associated kinases (IRAKs), TNF receptor-associated factor 6 (TRAF6), and TGFβ-
activated kinase 1 (TAK1) for activation of NF-κB signalling, whilst some TLRs also 
utilises TIR-containing adaptor inducing IFN-β (TRIF) (e.g. TLR3 and TLR4) or with 
TRIF-related adaptor molecule (TRAM) (e.g. TLR4) for MyD88-indendent/TRIF-
dependent signalling to induce IFN-β (Akira and Takeda 2004;Kawai and Akira 2009), 
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which links to the maturation of dendritic cells and induction of adaptive immunity. 
These signals induce gene transcription and translation of chemokines/cytokines which 
orchestrate host immune responses to counteract microbial virulence during infection. 
 
As far as we know, Salmonella confer five reported PAMPs to be recognised by TLRs, 
including triacyl lipopeptides or curli amyloid fibrils (TLR1/TLR2), bacterial 
lipoproteins (TLR2), lipopolysaccharide (TLR4), flagellin (TLR5), and CpG DNA 
(TLR9) (Balaram et al. 2009;Tukel et al. 2010) (Table 1.2). The distribution and 
function of TLR expression in human intestinal epithelium may vary dynamically and 
topographically at different stages of microbial infection. In normal healthy colonic 
epithelium, TLR2 and TLR4 are only expressed in the crypt cells but expression is lost 
with maturation and migration of the cells towards the epithelial villi (Furrie et al. 2005). 
At the subcellular levels, TLR5 is expressed on both apical and basolateral epithelial 
surfaces in the normal human gastric, duodenal, and colonic tissues; and, the expression 
patterns remains unchanged in the EPEC-infected human polarised duodenal mucosa ex 
vivo (Schuller et al. 2009), but becomes exclusively localised at the basolateral pole of 
the intestinal epithelium in patients with chronic active Helicobacter pylori 
(Schmausser et al. 2004); there is more pronounced expression on the apical and 
basolateral epithelial surface in EHEC flagellin-stimulated human colon xenografts 
(Miyamoto et al. 2006). TLR4 expression is barely detectable in the normal human 
terminal ileum and colon (Cario and Podolsky 2000), but is clearly shown at the apical 
and at the basolateral poles of the noninflammed gastric epithelium (Schmausser et al. 
2004); this pattern appears unaltered but with stronger intensity in the Helicobacter 
pylori-infected gastric epithelium. The expression pattern of TLR9 was identical to that 
of TLR4 in non-inflammed gastric epithelium, but became exclusively polarised with 
stronger intensity at the basolateral pole of the gastric epithelium in chronic active 
Helicobacter pylori gastritis. Similarly, TLR9 is expressed on both apical and 
basolateral membranes of human colonic epithelial cells (Lee et al. 2006). In isolated 
human duodenal and colonic epithelial cells, TLR4/MD2 mRNA expression remains 
contradictory (Abreu et al. 2002;Naik et al. 2001;Otte et al. 2004). All of these 
observations show that the TLR expression patterns might change or remain unchanged 
in the different sites of gut after infection by distinctive pathogenic bacteria. 
 
Meanwhile, the subcellular distribution of the expressed TLRs in human intestinal 
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epithelium does not necessarily reflect a parallel polarity in their functional expression. 
TLR5 has been confirmed to respond to basolaterally but not apically applied flagellin 
in a IL-8 response using Ussing chambers in the human colonic mucosa ex vivo (Rhee et 
al. 2005). The related studies in Salmonella are rare. Hence, the questions arise as to 
how these TLRs react and whether they function with polarity in the human intestinal 
epithelium before and after Salmonella infection.    
 
The NLR family comprises several groups of PRRs located in the cytosol to detect the 
intracellular presence of microbial components and endogenous molecules (Table 1.2). 
They can be divided into two categories: (i) NOD1 and NOD2 which detect 
peptidoglycans in the bacterial cell wall, and (ii) inflammasomes (NALP3, NALP1, 
IPAF, and NAIP5) which involve caspase-1-activating complexes for processing of IL-
1β and IL-18 as well as apoptosis (Hruz and Eckmann 2008;Lamkanfi and Dixit 2009). 
These NLRs are characterised by three structural domains: a C-terminal leucine-rich 
repeat domain involved in ligand recognition, a central NOD domain responsible for 
oligomerisation and activation, and an N-terminal effector domain. The N-terminal 
domain can comprise a pyrin domain (e.g. PYD in NALP3, Table 1.2), a caspase 
recruitment domain (e.g. CARD in NOD1/NOD2 and IPAF, Table 1.2), or a baculovirus 
inhibitor-of-apoptosis repeat domain (e.g. BIR×3 in NAIP5, Table 1.2) to introduce 
protein–protein interactions and signalling cascades for expression of inflammation-
associated genes (Hruz and Eckmann 2008).  
 
NOD1 detects the peptidoglycan derived peptide γ-D-glutamyl-meso-diaminopimelic 
acid (iE-DAP) mainly from Gram-negative bacteria, whilst NOD2 senses muramyl 
dipeptide (MDP), a ubiquitous motif in a wide range of both Gram-positive and Gram-
negative bacteria (Table 1.2) (Hruz and Eckmann 2008). NOD1 is expressed in the 
epithelial cells from the upper to lower gastrointestinal tract, whilst NOD2 is expressed 
predominantly in Paneth cells of the small intestine (Lala et al. 2003;Ogura et al. 2003). 
Localisation of NOD2 expression in Paneth cells (Ogura et al. 2003) and the association 
of NOD2 mutation with increased susceptibility to Crohn’s disease (Hugot et al. 2001) 
suggest that NOD2 plays a regulatory role in host immunity to intraluminal bacteria. 
 
A number of enteropathogens can be sensed by NOD1 or NOD2 in the cytosol. The 
invasive cytosolic pathogens such as Listeria monocytogenes (Corr and O'Neill 2009) 
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and Shigella flexneri (Girardin et al. 2001) can proliferate and gain access to NOD1 or 
NOD2 within the host cell cytosol. However, the minimally invasive Helicobacter 
pylori (Allison et al. 2009) or the other invasive bacteria such as Campylobacter jejuni 
(Zilbauer et al. 2007) and Salmonella Typhimurium (Geddes et al. 2010;Hisamatsu et al. 
2003;Le et al. 2009) which are not known to enter the cytoplasm can also be sensed by 
NOD1 or NOD2. Upon activation, NOD1 and NOD2 associate with a common adptor 
protein call RICK (or RIP2) or NF-κB-inducing kinase (NIK) (Figure 1.4) that leads to 
activation of NF-κB and MAPK for secretion of proinflammatory cytokines (Inohara et 
al. 1999;Ogura et al. 2001;Pan et al. 2006). A recent in vivo study using the 
streptomycin-pretreated mice model showed that NOD1 and NOD2 can SPI-2-
dependently modulate inflammation to eliminate bacteria during Salmonella colitis 
(Geddes et al. 2010). Furthermore, intracellular Salmonella Typhimurium and 
Legionella pneumophila may release flagellins from their vacuoles into the host cytosol 
to trigger signalling via inflammasome NLRs such as IPAF and NAIP5 (Figures 1.3 
and 1.4, Table 1.2) (Steiner 2007;Sun et al. 2007b). 
 
Taken together, Salmonella are sensed by host cells in the human gut via diverse routes. 
Not only can specific TLRs on the plasma membranes or the endosomal membranes of 
the host cells detect Salmonella PAMPs, but also NOD NLRs and inflammasome NLRs 
respectively sense cytosolic peptidoglycans and flagellin to induce cell signalling and 
subsequent immune responses. Additional routes are potentially present for validation of 
the complex interactions between Salmonella and human intestinal epithelial cells. 
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Figure 1.4  General overview of Salmonella sensing in a mammalian cell and the 
detection of specific PAMPs by their cognate PRRs; modified from (Carneiro et al. 
2008;Kufer and Sansonetti 2007). 
 
1.4.3. Human gut defence against non-typhoidal Salmonella 
Orally ingested Salmonella need to survive in, pass through, and overwhelm multiple 
host defence barriers in the human gut for establishment of colonisation. First of all, 
Salmonella need to cope with multiple stresses such as gastric acid pH, activity of bile, 
decreasing oxygen availability, and increasing osmotic pressure in the gut before 
reaching their preferential niche for developing pathology (Merritt and Donaldson 
2009;Rychlik et al. 2006).  
 
To survive in the gut, Salmonella have to overcome competition and antibacterial 
activities of endogenous commensal flora that is in symbiosis with the host (Guarner 
and Malagelada 2003). Thereafter, the pathogenic bacteria need to get through the 
physical and chemical barrier functions of the mucus layer, which can be modulated by 
goblet cells in responsive to microbe-activated bioactive factors from gut microbiota or 
from intestinal epithelial or underlying lamina propria cells (Deplancke and Gaskins 
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2001), to keep sufficient surviving bacteria for efficient attachment to and invasion of 
the intestinal epithelium.  
 
The intestinal mucosal barrier, an important part in the gut defence system, is based on 
the tight junctions that seal the paracellular space between the intestinal epithelial cells. 
The entire barrier function is composed of the paracellular tight junctions and 
transcellular barrier across the enterocytes. The tight junction permeability is regulated 
through the cytoskeleton by immune stimuli and coordinates with transcellular transport 
via apical Na+–nutrient co–transport through activation of intracellular signalling events 
(Turner 2009). Dysfunction in the coordination of transcellular and paracellular 
transport lead to diarrhoea. In addition, the integrity of the intestinal barrier, indirectly 
reflected by the degree of the intestinal epithelial permeability, can be quantitatively 
measured in vitro and expressed as transepithelial electrical resistance (TEER) values to 
manifest the barrier properties of the intestinal epithelial layer (Hidalgo et al. 1989). 
 
Secreted from intestinal epithelial cells or migrating immune cells in the human gut, 
antimicrobial peptides (AMPs) including cathelicidin, defensins, and lysozyme play a 
vital role in host innate defence against pathogenic microbes (Dommett et al. 2005), 
directly via their antibacterial activities (Jenssen et al. 2006) or indirectly by modulating 
the microbiota composition (Salzman et al. 2010). The main functions of intestinal 
AMPs are to defend the host against pathogens, to shape microbiota, and to protect stem 
cells (Underwood and Bevins 2010). These AMPs differ in their localisation in the gut. 
Human α-defensins are expressed in Paneth cells and neutrophils, whilst β-defensins 
(hBDs) are expressed in enterocytes with constitutive expression in hBD-1 and strong 
inducible expression by microbial or inflammatory stimulation in hBD-2, hBD-3, and 
hBD-4 (Dommett et al. 2005;Eckmann 2006). Cathelicidin LL-37/hCAP18 is expressed 
in the epithelium of the stomach and colon (Hase et al. 2003;Hase et al. 2002). 
Lysozyme is constitutively expressed in the upper GI tract, including gastric and pyloric 
glands, Brunner’s glands of the duodenum, the Paneth cells, crypts of Lieberkühn, and 
villous tips of the small intestine (Montero and Erlandsen 1978). 
 
Cathelicidin, defensins, and lysozyme are cationic peptides which displace the lipids, 
weaken the membrane, and create pores in bacterial membrane to cause cell death 
(Bugla-Ploskonska et al. 2009;Zasloff 2002). Bacteria have a number of efficient 
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resistance mechanisms to minimise the effectiveness of human AMPs, such as efflux 
pumps, secreted proteases, altered membrane fluidity, and modification of the bacterial 
cell surface in anionic molecules (e.g. teichoic acids, phospholipids, and lipid A) (Otto 
2009;Peschel 2002).  
 
Salmonella is sensitive and responsive to human intestinal defensins. Transgenic mice 
expressing human α-defensin 5 (HD5) in their Paneth cells have been proven to be 
resistant to Salmonella Typhimurium enteric infections (Salzman et al. 2003b). Another 
two in vitro studies demonstrated that Salmonella flagellin is the major ligand to induce 
human hBD-2 expression in Caco-2 cells via NF-κB activation (Ogushi et al. 
2001;Takahashi et al. 2001). Conversely, enteric Salmonella Typhimurium 
downregulate expression of α-defensins and lysozyme in mice to evade host defences 
(Salzman et al. 2003a). The ability to resist the killing effect of AMPs is necessary for 
bacterial virulence in Salmonella Typhimurium, which has developed resistance 
mechanisms regulated by the PhoP/PhoQ two-component regulation system or yejABEF 
operon (Eswarappa et al. 2008b;Groisman et al. 1992). 
 
Not only being regulated by host AMPs, shaping the enteric microbiota is also 
influenced by innate bacterial signalling pathways, secretory IgA in adaptive immunity, 
host genetics, and environmental factors including diet, intake of antibiotics/probiotics, 
and bacterial exposure early in life (Hansen et al. 2010). Competent pathogens are 
supposed to disrupt the ecology of gut flora, either directly through pathogen-
commensal interactions, indirectly via the pathogen-induced host mucosal immunity, or 
by a combination of these factors. In a mouse model of gastroenteritis, Salmonella 
Typhimurium caused transient changes in the microbiota throughout the intestinal tract 
in a partially SPI-2-dependent manner during the host inflammatory response to 
infection. These findings raise the question as to how the gut flora is changed during 
infection, and provide a new insight into which commensal microbial populations are 
crucial in maintaining intestinal homeostasis against salmonellosis. A recent in vivo 
study demonstrated that the microbiota generates colonisation resistance and mediates 
pathogen clearance in primary Salmonella Typhimurium infection (Endt et al. 2010). 
Therefore, the intervention of probiotics to manipulate the composition of commensal 
microbiota appears to have the potential for prevention and treatment in non-typhoidal 
salmonellosis. 
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1.5. Bacterial virulence of non-typhoidal Salmonella 
1.5.1. Virulence factors and virulence-associated genes of Salmonella 
Bacterial virulence factors among Salmonella species include classic virulence factors 
such as virulence plasmids, toxins, fimbriae, and flagella (van Asten and van Dijk 2005). 
There may also be non-classical Salmonella virulence factors that await discovery. Most 
of the virulence factors are supposed to be encoded by virulence or virulence-associated 
genes on the bacterial genome or genetic components within the bacteria, which are 
referred to as 'molecular virulence factors'. The virulence gene clusters of Salmonella 
can be classified into three groups, including pathogenicity islands (SPI, SGI, and HPI), 
plasmids, and lysogenic phages; their encoded proteins confer a diverse range of 
functions which still remain unknown and require additional characterisation (Table 
1.3).  
 
The majority of virulence genes are clustered in regions distributed over the 
chromosome, called Salmonella pathogenicity island (SPI). So far at least 10 SPIs (SPI-
1 to SPI-10) have been identified on the Salmonella chromosome (Table 1.3). 
Topologies of SPI-1, SPI-2, SPI-3, SPI-5, SPI-7, and SGI with some important genes 
are shown in Figure 1.5. The other genes discovered on plasmids or lysogenic phages 
may possibly contribute to Salmonella virulence. 
 
Table 1.3 Characteristics of virulence gene clusters in Salmonella; summarised from 
(Rychlik et al. 2006;Salyers and Whitt 2002b;van Asten and van Dijk 2005) 
Virulence gene clusters Virulence factors encoded in the 
region 
Possible function of 
virulence factors 
Distribution 
Pathogenicity islands     
    SPI-1 Type III secretion system (T3SS) 
Protein secreted by T3SS 
Chaperones that control folding of 
proteins 
Regulatory proteins (PhoPQ, HilA, InvF, 
SirA) 
Involved in early stages of 
infection because no effect on 
LD50 due to intraperitoneal 
injection; iron uptake 
Salmonella spp. 
    SPI-2 T3SS (different from that encoded on 
SPI-1) 
Proteins secreted by T3SS 
Chaperones that control folding of 
proteins 
Inhibition of phagosome-
lysosome fusion; important 
during systemic phase of 
disease 
Salmonella 
enterica 
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    SPI-3 Mg2+ transporter (mgtC) 
Protein of unknown function 
Survival and growth in Mg2+–
limiting environment like in 
phagosomes; Mg2+  uptake 
Salmonella spp. 
    SPI-4 T1SS involved in toxin secretion Required for intra-
macrophage survival 
Salmonella spp. 
    SPI-5 Genes encoding T3SS effectors (sopB) Effector protein of SPI-1-
encoded T3SS 
Salmonella spp. 
    SPI-6 saf and tcf fimbrial operons Fimbriae subsp. I, parts in 
IIIb, IV, VII  
    SPI-7 Vi biosynthetic genes (viaB) 
Type IV fimbrial operon 
Phage habouring sopE 
Vi antigen 
Type IVB pilus assembly 
Effector protein of SPI-1-
encoded T3SS 
subsp. I serovars 
    SPI-8  Resistance to bacteriocins serovar Typhi 
    SPI-9 Genes encoding for T1SS and a single 
RTX (repeats in toxin)-like protein 
Putative toxin, unknown subsp. I serovars 
    SPI-10 sef fimbrial operon Sef fimbriae subsp. I serovars 
    SGI-1   5 antibiotic resistance genes subsp. I serovars 
(e.g. Typhimurium 
DT104, Paratyphi 
B, Agona) 
    HPI Genes encoding for biosynthesis of a 
siderophore and the cognate iron uptake 
system 
High-affinity iron uptake Subspecies IIIa, 
IIIb, IV 
Plasmids    
Virulence plasmids 
pSLT 
Salmonella plasmid virulence 
(spvRABCD) 
 
Plasmid-encoded fimbriae (pef) 
Resistance to complement killing (rck)  
 
SdiA-regulated genes (srg) 
 
Macrophage-inducible gene (mig-5) 
Survival in macrophage; 
important in all stages of 
virulence 
Adhesion 
Adhesion/resistance to 
completement killing 
Putative disulphide bond 
oxidoreductase 
Putative carbonic anhydrase 
Salmonella 
enterica (spv in all 
serovars; other 
genes depending 
on serovars) 
    Other high molecular 
weight plasmids 
IncI, IncH, IncF, IncN, IncP, and IncQ 
incompatibility group 
Resistance to multiple 
antibiotics (R-plasmids) 
 
    Low molecular 
weight plasmids 
 Unknown; relative instability; 
used in differentiation and 
molecular typing 
10% of 
Salmonella field 
strains 
Lysogenic phages    
    Gifsy-1, 2 Superoxide dismutase 
Protein (GrvA) that reduces virulence 
May contribute to survival 
during systemic phase of 
infection 
 
Abbreviations:  
SPI: Salmonella pathogenicity island 
SGI-1: Salmonella genomic island-1 
HPI: High pathogenicity island 
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Figure 1.5 Topologies of representative Salmonella pathogenicity islands; adapted from 
(Hensel 2006). 
 
Basically, both SPI-1 and SPI-2 encode type III secretion systems (T3SS) which can 
translocate effector proteins into host cells or secrete them into the extracellular 
environment to directly affect host biochemistry and cell physiology (Coburn et al. 
2007). SPI-1 is responsible for key events mainly involved in the early phase of disease 
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such as membrane ruffling, regulation of virulence genes, and activation of innate 
immunity, including recruitment of neutrophils across the epithelium and activation of 
NF-κB signalling. In contrast, SPI-2 accounts for intracellular transport and survival 
mainly in the systemic phase of disease, induction of cyclo-oxygenase, modulation of 
host cytokines, and cell death (Coburn et al. 2007;Santos et al. 2003;Zhang et al. 2003). 
Virulent Salmonella adhere, colonise, and then invade the intestinal epithelium. Upon 
contact with epithelium, Salmonella translocate effector proteins into the host cell 
cytosol via T3SS to induce morphological and immunological host cell responses, and 
subsequent systemic reactions. In salmonellosis, proinflammatory stimuli comprise two 
categories: pathogen-associated motifs inducing innate immunity and virulence-
associated behaviours inducing host-processing disease pathology, both of which 
constitute the host responses (Coburn et al. 2007). Whether specific early events in 
Salmonella infection play a causative role in subsequent virulence-related host 
responses warrants further elucidation. 
 
The virulence genes distributed on different pathogenic islands may be involved in the 
early interactions between non-typhoidal Salmonella and intestinal epithelium. Taking 
bacterial attachment into account, intimate association of Salmonella Typhimurium with 
host cells requires SPI-1-encoded T3SS-mediated translocases SipB, SipC, and SipD 
(Lara-Tejero and Galan 2009), whilst SPI-3-encoded MisL (Dorsey et al. 2005), SPI-4-
encoded T1SS and SiiE (Gerlach et al. 2007), as well as the pef and rck genes on the 
virulence plasmids (Friedrich et al. 1993;Heffernan et al. 1994) also contribute to 
bacterial adhesion. Moreover, SPI-1 and SPI-4 can reciprocally coordinate in the 
interaction of Salmonella Typhimurium with the host intestinal mucosa (Main-Hester et 
al. 2008). These findings indicate that a single event during early Salmonella infection 
may require interactive orchestration of the virulence genes on the different loci in the 
chromosome and/or plasmids, rather than of the genes merely within one pathogenicity 
island. 
 
Bacterial entry into the intestinal epithelial cells occurs as an early step for Salmonella 
virulence and host responses with involvement of host factors and bacterial effectors. 
SPI-1 encodes T3SS which injects bacterial effector proteins via a needle-like 
supramolecular structure (Kubori et al. 1998) into the cytosol of the target cell that 
results in an uptake of the bacterium by the cell (Figure 1.6). These effectors comprise 
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not only SipA, SipB, SipC, SptP, and AvrA encoded by genes within the SPI-1, but also 
SopA, SopB (encoded by SPI-5), SopD, SopE, and SopE2 which are encoded by 
independent loci outside of SPI-1 (Mirold et al. 2001). SipC activates cytoskeletal 
rearrangement of the target cells in cooperation with SipA which stabilises the 
polymerisation of actin structures to support bacterial entry (Figure 1.6), whilst SipB, 
SipC, and SipD are crucial to the efficient delivery of effectors into the cell. SopE/E2 
and SopB respectively mediate direct and indirect activation of RhoGTPases to promote 
formation of actin filaments for bacterial entry. Contrarily, SptP deactivates 
RhoGTPases of host cells to terminate actin polymerisation and membrane ruffling 
during the later stages of invasion process (Figure 1.6). SopB also plays a key role in 
assembling and trafficking SCV (Bakowski et al. 2010). More details in the mechanism 
of Salmonella invasion will be discussed in Chapter 3a.3. 
 
 
Figure 1.6 Multiple host and bacterial effectors function in concert to promote 
Salmonella entry; adapted from (Patel and Galan 2005). 
 
In addition to getting involved in Salmonella internalisation, the effector proteins 
directly contribute to host pathophysiology and innate immunity. SopB is an inositol 
phosphate phosphatase which activates chloride channels in the membrane of the 
intestinal target cells to enhance the secretion of chloride and loss of fluid into the 
intestinal lumen (Norris et al. 1998). Intriguingly, SopE, SopE2, and SopB can stimulate 
host innate immune responses through mechanisms that involve neither bacterial 
PAMPs nor the innate immune receptors such as TLRs or NLRs, leading to the 
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activation of MAPK and NF-κB signalling (Bruno et al. 2009). These observations 
unveil a broader spectrum in the implications of intensively studying Salmonella 
virulence genes. 
 
Bacterial virulence can be regulated by a sophisticated interplay of regulators, which 
involves two-component regulatory systems allowing pathogenic bacteria such as 
Salmonella enterica to adapt to different microenvironments during infection (Altier 
2005;Beier and Gross 2006). Two-component systems, which consist of a membrane-
located sensor with histidine kinase activity and a cytosolic transcriptional regulator, 
can sense physical and chemical signals in the microenvironments, including bile, 
different pH, temperatures, ions, oxygen pressure, osmolarity, short chain fatty acids, 
autoinducer compounds, the redox status of electron carriers, and the contact with host 
cells (Altier 2005;Beier and Gross 2006). At least 6 two-component systems contribute 
to regulation of Salmonella virulence, including PhoP-PhoQ, PmrA-PmrB, RcsC-YojN-
RcsB, OmpR-EnvZ, SsrB-SsrA, and SirA-BarA (Figure 1.7). With sensing of the 
kinase PhoQ in Mg2+-limiting environments, the PhoP-PhoQ system not only regulates 
the expression of the SsrB-SsrA to control the transcription of genes encoding the SPI-2 
T3SS and the relevant effector proteins, but is also implicated in the repression of SPI-
1-encoded invasion genes (Altier 2005;Groisman 2001). In addition, the transcription of 
the Fe3+-responsive PmrA-PmrB regulon can be activated in vivo directly through 
PhoP-PhoQ and PmrD, or directly involving autophosphorylation of PmrB to regulate 
genes that modify LPS and aid survival in host and non-host microenvironments (Gunn 
2008;Wosten et al. 2000). The RcsC-YojN-RcsB phosphorelay system can be triggered 
by bacterial growth at low temperature or on solid surfaces osmotic shock, or exposure 
to polymyxin B to modulate the expression of genes related to motility and chemotaxis, 
cell division, synthesis of outer membrane proteins, flagellum, and Vi antigen 
(Pescaretti et al. 2009;Pescaretti et al. 2010), as well as to play a role for the Salmonella 
ugd gene in capsule synthesis and resistance to polymyxin B (Mouslim and Groisman 
2003). Furthermore, OmpR-EnvZ and SirA-BarA are involved in expression control of 
HilA, which regulates SPI-1 genes (Figure 1.7), whilst SsrA-SsrB controls the 
expression of SPI-2 T3SS and its translocated effectors by direct binding of OmpR to 
the ssrA-ssrB promoters (Garmendia et al. 2003). In the OmpR-EnvZ two-component 
system, the cognate sensor kinase EnvZ can sense extracellular osmolarity and pH, then 
OmpR further regulates those genes which are related to porin, flagella, and stationary 
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phase acid tolerance responses (Bang et al. 2000;Beier and Gross 2006;Garmendia et al. 
2003). 
 
 
Figure 1.7 Schematic presentation of the regulatory network controlling virulence gene 
expression in Salmonella enterica; adapted from (Beier and Gross 2006). The grey line 
represents the cytoplasmic membrane containing the different histidine kinases depicted 
in various colours. Dashed arrows indicate presumptive regulatory interactions for 
which conflicting results have been reported in the literature. Abbreviations: OMP, outer 
membrane protein; LPS, lipopolysaccharide. 
 
The local or global regulatory genes can control the expression of invasion genes. For 
example, HilA directly regulates the transcription of the SPI-1 apparatus genes and 
transcription of hilA is regulated by a complex feed-forward loop (Ellermeier and 
Slauch 2007;Mirold et al. 2001). In this loop, HilD activates HilC and RtsA and these 
three regulators orchestrate to control hilA transcription. At the upstream of 
transcription from hilD to HilD, all of the known global regulators may control activity 
of HilD at some level to indirectly mediate SPI-1 expression (Figure 1.8). Thus, the 
whole system acts as a switch to ensure full expression of SPI-1 at the appropriate time 
(Ellermeier and Slauch 2007;Mirold et al. 2001). It is desirable to ascertain if any 
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regulatory genes could play a decisive role in the early interactions between Salmonella 
and the human intestinal epithelium. 
 
 
Figure 1.8 A working model for SPI-1 regulation; adapted from (Ellermeier and Slauch 
2007). Blue arrows indicate activation of gene expression. Repression is expressed as 
red lines with blunt ends. Solid lines represent direct transcriptional regulation. Short-
dashed lines represent regulation where the mechanism is unknown. Long-dashed lines 
represent posttranscriptional effects. X represents an unknown intermediate through 
which Fur controls HilD posttranscriptionally.  
 
1.5.2. Identification of non-typhoidal Salmonella virulence-associated 
genes responsible for early interactions with human epithelium 
In humans, the virulence genes related to early interaction of non-typhoidal Salmonella 
with intestinal epithelium have not been clearly identified and analysed. To date, over 
70 virulence genes have been discovered and most of them were recognised in vivo for 
survival of Salmonella in animals, mainly using insertional mutagenesis, in vivo 
expression technology (IVET), differential fluorescence induction (DFI), and signature-
tagged transposon mutagenesis (STM) (Andrews-Polymenis et al. 2006;Andrews-
Polymenis et al. 2009;Unsworth and Holden 2000). Many of these genes were further 
studied using in vitro virulence assays (Adaska et al. 2008;Chang et al. 2008). The in 
vivo approaches have provided insights into the complicated interactions between 
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pathogen and host. However, there are difficulties including the lack of suitable animal 
models for human and animal diseases, and the ability to screen large numbers of 
mutants without using large numbers of animals (Andrews-Polymenis et al. 2006). In 
contrast to that, in vitro identification can delineate specific events such as adherence to 
epithelial cells (Rubino et al. 1993), invasiveness (Lee et al. 1992;Lodge et al. 1995), 
and internalisation of bacteria into epithelial cells (Ginocchio et al. 1992) during 
Salmonella infection.  
 
IVET and DFI adopt a promoter trap strategy to detect promoters activated during 
infection and to identify virulence genes expressed in vivo (Andrews-Polymenis et al. 
2006). IVET utilises a library of random genomic fragments to investigate 
transcriptional activity of the bacterial reporter genes required for in vivo growth or 
survival. This approach has been used to identify Salmonella Typhimurium genes that 
are specifically expressed during infection of BALB/c mice and/or murine cultured 
macrophages. Briefly, random fragments of bacterial DNA in a purA mutant 
background strain are cloned into IVET vector consisting of a promoterless lacZ gene, 
which allows lactose fermentation of the postselected bacteria on lactose indicator 
plates, and a downstream promoterless purA gene, which creates a nutritional purine 
deficiency for a positive selection after survival of the bacterial clones due to 
transcription of the purA gene in vivo (Heithoff et al. 1997;Mahan et al. 1993). The 
recombinant Salmonella Typhimurium pur-lac fusion pools can be used to monitor the 
expression of the entire synthetic operon when bacteria are grown on laboratory 
medium or in animal tissues/macrophages. Induction of these in vivo induced (ivi) genes 
is poorly expressed on laboratory medium but is exhibited indicating bacterial survival 
in host tissues or in cultured macrophages. In addition, modified IVET such as a 
recombinase-based IVET coupled with a PCR-based method was developed to rapidly 
identify activated promoters. This screen identified 31 genes expressed during 
colonisation of the porcine intestine and/or tonsil, including several known adhesins and 
colonisation factors (Huang et al. 2007). In summary, advantages of IVET include the 
ability to screen positively a large number of promoters using few animals and the 
ability to identify virulence genes encoding proteins with redundant functions 
(Andrews-Polymenis et al. 2006). However, this approach can neither recognise 
transiently active promoters nor distinguish virulence genes simultaneously expressed in 
vitro and in vivo.  
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Similarly, DFI uses a library of bacteria expressing random gene fusions with genomic 
fragments ligated to a promoterless gfp reporter gene which encodes the green 
fluorescent protein (GFP) for direct monitoring transcriptional activity of the reporter in 
vivo (Bumann 2001;Valdivia and Falkow 1996). Fluorescent bacteria are recovered 
directly from host tissues using fluorescence-activated cell sorting (FACS). In contrast 
to IVET, DFI has additional advantages of allowing the single cell, spatial, and temporal 
surveillance of bacterial gene expression levels in vivo (Bumann and Valdivia 2007). 
However, genes induced in vivo in these two approaches may not necessarily be 
required for causing disease in an animal. 
 
Insertional mutagenesis is a popular approach to identify gene functions by construction 
of gene disruption mutants and subsequent analysis of the phenotypes of the resultant 
mutants. In the mid 1980s, traditional transposon mutagenesis created individual 
mutants which were tested in animals for loss of function in vivo. However, this method 
has the drawbacks that large numbers of animals are required, the screening is highly 
labourious, and virulence genes with redundant protein functions can not be indentified 
(Andrews-Polymenis et al. 2006).  
 
With the introduction of microarrays into insertional mutagenesis, STM was developed 
to efficiently identify microbial genes required for the survival and replication of a 
pathogen in an infected host. STM can simultaneously compare pools of signature-
tagged transposon mutants with changes of their hybridisation signals in the population 
before and after in vivo infection in a typhoidal-mouse model for simultaneous 
identification of Salmonella virulence genes by negative selection (Hensel et al. 1995). 
From a library of ~1200 mutant strains of Salmonella Typhimurium, 43 strains 
attenuated in virulence after intraperitoneal infection in mice were isolated, and 16 
strains of them were characterised to have insertion sites within SPI-2 (Shea et al. 1996). 
Although STM is currently one of the most extensively used in vivo approaches for 
screening virulence genes, this approach has five main drawbacks. First, it requires the 
pathogen to replicate in vivo as a mixed population, and it only identifies virulence 
genes that cannot be transcomplemented by other virulent strains in the same inoculum. 
Second, the animal model of a human disease is unlikely to reproduce all the 
characteristics of the bacterial-human interaction. Third, any gene whose loss can be 
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compensated for by another is unlikely to be identified. Fourth, mutant strains generated 
by insertional mutagenesis should be viable after inoculation into an animal host, so 
genes essential for life cannot be identified (Unsworth and Holden 2000). Fifth, only a 
limited number (<100) of signature tagged mutants can be used together at one time 
(Hensel et al. 1995). Therefore, a more proficient strategy is warranted to identify 
virulence genes in vivo and in vitro at various stages of infection.  
 
1.6. Aims 
The first aim of this PhD study is to establish in vitro and ex vivo human epithelium 
culture models for assessing bacterial virulence characters, host responses, and the 
effects of probiotic bacteria upon bacteria/host cells in the early disease process during 
Salmonella Typhimurium infection. The second aim is to retrospectively conduct a 
study of immunohistochemistry on the human intestinal biopsied tissues from paediatric 
patients with non-typhoidal salmonellosis for seeking evidence of Salmonella invasion 
in human intestinal epithelial cells and immune cells in vivo. The third aim is to identify 
virulence-associated genes responsible for bacterial adherence, invasiveness, and 
intracellular replication of Salmonella Typhimurium in the in vitro human epithelial cell 
model from the transposon-disrupted genes represented by the 1,440 mutants in a big 
library pool using a high throughput screening model based on Transposon mediated 
differential hybridisation (TMDH) and Transposon directed insertion-site sequencing 
(TraDIS). As a result, the attenuated mutants identified in this screen can be further 
characterised and host responses can be monitored using the in vitro and ex vivo human 
epithelium models or in vivo models for better understanding of the genetic mechanisms 
of Salmonella Typhimurium virulence. These selected mutant strains are potential 
candidates as oral vaccines or targeted vectors for prevention and treatment of non-
typhoidal salmonellosis.  
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Chapter 2. Materials and Methods 
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2.1. Bacterial strains, plasmids, cultures, and DNA preparation 
2.1.1. Bacterial strains 
The wild-type and mutant strains of Salmonella Typhimurim used in this study are listed 
in Table 2.1. Unless otherwise mentioned all mutant strains of Salmonella Typhimurim 
were generated by the providers indicated in the sources or references.  
  
The wild-type strain NCTC 12023, which is identical to ATCC 14028, was isolated 
from bovine septicaemic liver in 1987 and was used as a prototroph wild-type virulent 
strain in mice and calves. To generate its isogenic SPI-1 and SPI-2 mutant strains, the 
prgH gene and ssaV gene of NCTC 12023 were respectively disrupted by a mTn5lacZ 
insertion and a aphT cassette (Deiwick et al. 1998). 
 
Salmonella Typhimurim ST TML, a wild-type human isolate strain isolated from a 
patient with gastroenteritis, had been previously shown not only to induce diarrhoea in 
rhesus monkeys but also to invade and induce fluid secretion in the rabbit ileal-loop 
tests (Giannella et al. 1973), whilst other wild-type virulent strains, such as ST4/79, 
ST4/74 Nalr, and ST12/75, used in this study were derived from animal isolates. 
 
Salmonella Typhimurim SL1344 is a virulent wild-type strain in mice and calves, and 
was derived from a calf bowel isolate strain ST4/74 (Hoiseth and Stocker 1981). This 
strain is one of several Salmonella Typhimurium strains of which the bacterial genomes 
have been fully sequenced (http://www.xbase.ac.uk/genome/salmonella-enterica-subsp-
enterica-serovar-typhimurium-sl1344-nctc-13347). The complete SL1344 genome 
sequence and preliminary annotation can be obtained from the Wellcome Trust Sanger 
Institute (http://www.sanger.ac.uk/Projects/Salmonella).  
 
To generate the SPI-1 mutant ∆spaS, SPI-2 mutant ∆ssaU, and flagellin-deficient 
mutant ∆fliM of Salmonella Typhimurim SL1344, Dr Jinhong Wang in Cambridge 
completed marked deletions of a structural component of Type III secretion system 
(T3SS)-1 (spaS), a structural component of T3SS-2 (ssaU), and a flagella motor switch 
protein (fliM), respectively, in the restriction-deficient strain LB5010 by lambda Red 
recombinase-mediated integration of linear PCR amplicons using the same method as 
previously detailed (Buckley et al. 2010).  
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Table 2.1 Salmonella Typhimurium strains 
Name  Description and characteristics Source (Reference) 
For infection assays 
NCTC 12023 Prototroph wild-type virulent strain in 
mice and calves (ATCC 14028) 
Prof David W Holden, 
NCTC (Deiwick et al. 
1998) 
∆prgH 
 
prgH deletion (prgH020::Tn5lacZY) 
SPI-1 mutant from NCTC 12023 
Prof David W Holden 
(Bajaj et al. 
1995;Deiwick et al. 
1998) 
∆ssaV 
 
ssaV deletion (ssaV::aphT) SPI-2 
mutant from NCTC 12023, Nalr 
Prof David W Holden 
(Deiwick et al. 1998) 
ST4/79 Wild-type virulent strain Prof David W Holden 
(unpublished) 
ST4/74 Nalr Nalidixic acid resistant strain from 
ST4/74 (also known as SL1344), a 
wild-type bovine dysentery isolate  
Prof Mark P Stevens 
(Jones et al. 
1988;Morgan et al. 
2004) 
ST12/75 Wild-type virulent strain in calves Prof Mark P Stevens 
(Baird et al. 1985) 
ST TML Wild-type human isolate from a 
patient with salmonellosis 
Prof Mark P Stevens 
(Giannella et al. 1973) 
SL1344 Virulent wild-type strain in mice and 
calves (NCTC 13347); a derivative of 
strain ST 4/74 
Prof Duncan J Maskell 
(Hoiseth and Stocker 
1981) 
∆spaS spaS deletion SPI-1 mutant from 
SL1344, Kmr 
Dr Jinhong Wang, this 
study  
∆ssaU ssaU deletion SPI-2 mutant from 
SL1344, Kmr 
Dr Jinhong Wang, this 
study  
∆fliM fliM deletion flagellin-deficient mutant 
from SL1344, Kmr 
Dr Jinhong Wang, this 
study 
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For construction of mutants or wild-type isogenic tagged strains 
LB5010 Restriction-deficient derivative of LT2 Dr Jinhong Wang & Dr 
Andrew J Grant, (Bullas 
and Ryu 1983) 
JH3016 SL1344, Φ(rpsM’-gfp+)1, Cmr 
The gfp gene fusion was inserted at 
the putPA locus at positions 1,210,040 
to 1,211,657 in the LT2 genome. Φ 
indicates a transcriptional gene fusion. 
Dr Andrew J Grant 
(Hautefort et al. 2003) 
 
Moreover, eight wild-type isogenic tagged strains (WITS) listed in Table 2.2 were 
constructed by Dr Andrew Grant in Cambridge as previously described (Grant et al. 
2008). Their parental strain is a wild-type virulent Salmonella Typhimurim JH3016 
(Hautefort et al. 2003), derived from SL1344, which has an LD50 of fewer than 20 CFU 
for BALB/c mice (Hoiseth and Stocker 1981). The identification tags were produced by 
PCR amplification from DNA donated by Professor David Holden (Hensel et al. 1995). 
Theoretically, these pseudogene-tagged strains phenotypically behave as their parental 
wild-type Salmonella Typhimurim SL1344 but can be genomically detected by 
quantitative real-time PCR using tag-specific primers; therefore, WITS can be a 
powerful tool for quantitative evaluation of individual genome-tagged strains in a 
pooled library during different stages of infection (Grant et al. 2008). 
 
Table 2.2 Wild-type isogenic tagged strains (WITS) of Salmonella Typhimurium  
Name  Description and characteristics Source (Reference)
WITS 1 
WITS 2 
WITS 11 
WITS 13 
WITS 17 
WITS 19 
WITS 20 
WITS 21 
JH3016, with 40 bp signature tag and 
kanamycin resistance cassette cloned between 
malXY, Cmr, Kmr 
The individual tag::kan cassette was inserted at 
the malXY locus at base 1,678,843 in the 
SL1344 genome 
(http://www.sanger.ac.uk/Projects/Salmonella/) 
Dr Andrew J Grant 
(Grant et al. 2008) 
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For identifying virulence genes responsible for colonisation, invasion, and intracellular 
replication, 1,440 transposon mutants of Salmonella Typhimurim SL1344 were 
generated as previously described (Chaudhuri et al. 2009b) and detailed in 2.10.1 that 
will be utilised in Transposon Directed Insertion-site Sequencing (TraDIS) in Chapter 5. 
 
All bacterial strains of E. coli and Lactobacillus used in this study are listed in Table 2.3. 
The E. coli strain E2348/69 is a prototype Enteropathogenic E. coli (EPEC) strain which 
was isolated from outbreaks of infantile diarrhoea (Levine et al. 1978). The isogenic 
flagellin-deficient mutant strain AGT01 and its complemented strain AGT02 were 
generated as previously described (Giron et al. 2002). These strains had been used to 
study flagellin-mediated adherence to human epithelial cells in vitro (Giron et al. 2002) 
and flagellin/TLR5-mediated human intestinal mucosal responses ex vivo (Schuller et al. 
2009). In addition, the Escherichia coli strain DH5α (Invitrogen) was used for gene 
cloning during construction of mutants and WITS, unless otherwise indicated. 
 
Lactobacillus rhamnosus GG (ATCC 53103) and Lactobacillus plantarum 299v are two 
of the most commonly used probiotic strains in the treatment and prevention of enteric 
infections of diseases (Mack et al. 1999). Lactobacillus rhamnosus GG is a probiotic 
strain isolated in 1983 from the intestinal tract of a healthy human being; filed for patent 
on 17 April 1985, by Sherwood Gorbach and Barry Goldin (Gorbach and Goldin 1989) 
with the 'GG' deriving from the initials of their surnames (Silva et al. 1987). The patent 
refers to a strain of Lactobacillus acidophilus GG with ATCC No. 53103; later 
reclassified as a strain of Lactobacillus rhamnosus. Another probiotic strain 
Lactobacillus plantarum 299v isolated from sour dough exerts genotypic and 
phenotypic similarity to a strain isolated in vitro from the human intestinal tract 
(Johansson et al. 1993).  
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Table 2.3 E. coli and Lactobacillus strains 
Name  Description and characteristics Source (Reference) 
E. coli strains 
For comparison of flagellin expression 
E2348/69 Wild-type EPEC strain (serotype 
O127:H6) 
Prof James P Nataro 
(Levine et al. 1978) 
AGT01 ∆fliC Flagellin-deficient mutant from 
E2348/69, Kmr 
Prof James B Kaper (Giron 
et al. 2002) 
AGT02 ∆fliC (pFliC) Flagellin-complemented strain 
from AGT01 ∆fliC with plasmid 
harbouring fliC, Kmr 
Prof James B Kaper (Giron 
et al. 2002) 
For gene cloning during generation of mutants or WITS 
DH5α F-(φ80lacZΔM15)Δ(lacZYA-
argF) U169 recA1 endA1 
hsdR17 (rk
-, mk
+) phoA supE44 λ- 
thi-1 gyrA96 relA 
Dr Jinhong Wang & Dr 
Andrew J Grant; Invitrogen 
(Buckley et al. 2010;Grant 
et al. 2008) 
 
Lactobacillus strains 
Lactobacillus 
rhamnosus GG  
Probiotic strain isolated from 
stool specimens of healthy 
humans (ATCC 53103) 
Dr David R Mack  (Mack 
et al. 1999) 
Lactobacillus 
plantarum 299v 
Probiotic strain isolated from 
sour dough 
Dr David R Mack (Mack et 
al. 1999)  
 
 
2.1.2. Storage and culture conditions of bacterial strains 
For long term storage, bacterial strains were maintained in Microbank (Pro-Lab 
Diagnostic) tubes at –80°C. For generation of mutants, Salmonella Typhimurium and E. 
coli strains were aerobically grown in Luria-Bertani broth (LB broth, Sigma-Aldrich) at 
37°C for 16 hours with shaking at 225 rpm. For routine cell or tissue infections, 
Salmonella Typhimurium or E. coli strains were aerobically grown in 2 to 4 ml of LB 
broth, with appropriate antibiotics if necessary, at 37°C for 18 hours to reach a bacterial 
density of ~1×109 CFU/ml; these bacterial overnight cultures in LB broth or 
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resuspended solutions in phosphate buffer saline (PBS, Sigma-Aldrich) after adjustment 
of spectrophotometric absorbance at the wavelength 600 nm with an optical density 
(OD600) of ~0.8, which is equivalent to a bacterial density of ~8×108 CFU/ml, were 
subsequently used to infect cells or tissues. The infected cells or tissues in culture plates 
were then incubated in an atmosphere of 95% O2 (or air) and 5% CO2 at 37°C for varied 
duration according to treatment protocols. When necessary, bacterial strains were 
aerobically grown in 2 to 4 ml of LB broth, with kanamycin if necessary, at 37°C for 2 
to 4 hours with shaking at 225 rpm to reach an OD600 of ~0.7, which is equivalent to a 
bacterial density of ~7×108 CFU/ml. If required to maintain plasmids, antibiotics were 
used at the following concentrations: ampicillin (Am) 100 μg/ml, kanamycin (Km) 50 
μg/ml, and chloramphenicol (Cm) 10 μg/ml. 
 
Prior to each experiment, the Lactobacillus strains were recovered from Microbank® 
(Pro-Lab Diagnostics) stocks at –80°C onto MRS (Fluka) agar plates, which were 
subsequently incubated at 37°C for 2 days. Then, single colonies of each strain were 
selected to be grown in 2 ml of non-aerated MRS broth at 37°C for 18 hours as 
inoculums for coincubation with cells. 
 
2.1.3. Preparation of bacterial DNA 
In preparation of bacterial DNA, each 2 ml (~2 × 109 CFU) of individual 18-hour 
cultures of Salmonella Typhimurium strains was centrifuged, resuspended, and the 
pellet was dissolved in 180 l of Buffer ATL (Qiagen); then DNA extraction was carried 
out using DNeasy® Blood & Tissue Kit (Qiagen) according to the manufacturer’s 
instruction. For details, 20 l of Proteinase K (Qiagen) was added into the above lysate 
in 180 l of Buffer ATL, mixed by vortexing, and incubated for 2 hours at 55oC or until 
completely lysed. Then 4 l of RNaseA (100 g/ l) was added, vortexed, and incubated 
for 2 minutes at room temperature. The lysate was added with 200 l of of Buffer AL 
and 200 l of pure ethanol, mixed, and pipetted into a DNeasy Mini spin column placed 
in a 2 ml collection tube, centrifuged at 6,000 × g for 1 minute. After discarding flow-
through and collection tube, the spin column was placed in a new collection tube, added 
with 500 l of Buffer AW1, and centrifuged at 6,000 × g for 1 minute. The spin column 
was placed into another new collection tube, added with 500 l of Buffer AW2, and 
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centrifuged at 20,000 × g for 3 minutes to dry the DNeasy membrane. Finally the spin 
column was removed into a clean 1.5 ml nuclease-free tube and 100 l of Buffer AE was 
added, incubated at room temperate for 1 minute, and then centrifuged for 1 minute at 
6,000 × g to elute DNA. DNA concentrations at OD260 and purity were measured using 
a NanoDrop ND-1000 spectrophotometer (Thermo Scientific). 
 
2.2. Human epithelial cell lines 
2.2.1. HEp-2 cell culture 
Human epithelial HEp-2 cells, a cell line of HeLa (Gey et al. 1952) derivative purchased 
from European Collection of Cell Cultures (ECACC), are derived from tumours 
produced in irradiated-cortisonised weanling rats after injecting with epidermoid 
carcinoma tissue from the larynx of a 56-year-old Caucasian male. This cell line was 
found to be indistinguishable from HeLa cells by short tandem repeat DNA profiling 
(Masters et al. 2001). 
 
For maintenance, HEp-2 cells were grown in 'complete Dulbecco’s modified Eagle 
medium' (DMEM, Sigma-Aldrich) containing 4 mM L-glutamine (Sigma-Aldrich), 1% 
non-essential amino acids (Sigma-Aldrich), and 10% foetal bovine serum (Sigma-
Aldrich) using 75-cm2 flasks, which were maintained in humidified 5% CO2 at 37°C. 
HEp-2 cell cultures reaching 90–95% confluence were split 1:10 by 0.25% Trypsin-
EDTA (Sigma-Aldrich) twice per week.  
 
For infection arrays with subsequent immunostaining, HEp-2 cells were seeded at a 
density of 5×104 cells/well into coverslip-loaded 12-well plates and incubated for 2 days 
to reach about 80% confluence in the experiments. For all the other assays, HEp-2 cells 
were either seeded at a density of 1×105 cells/well into 24-well plates or 4×105 cells/well 
into 12-well plates and incubated for 1 to 2 days to achieve complete confluence with a 
density of between 3–5×105 cells/well and 8–9×105 cells/well respectively, or they were 
seeded at a density of 5×105 cells/well into 6-well plates and incubated for 1 day to 
achieve subconfluence with a density of between 6–8×105 cells/well. One hour before 
commencement of all the experiments, complete DMEM was replaced by 1 ml/well of 
'plain DMEM', defined in this study as DMEM supplemented with 4 mM L-glutamine 
and 1% non-essential amino acids. 
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2.2.2. Polarised Caco-2 cell culture 
Human epithelial Caco-2 cells, a cell line of human Caucasian colon adenocarcinoma 
purchased from European Collection of Cell Cultures (ECACC), was isolated from a 
primary colonic tumour in a 72-year-old Caucasian male using the explant culture 
technique in nude mice (Fogh et al. 1977). This cell line differentiates from post-
confluence into a polarised monolayer of cells expressing properties of foetal ileal 
epithelial cells and can be characterised as an incomplete conversion from proliferative 
crypt cells to differentiated villous cells (Engle et al. 1998). During differentiation, 
changes in protein expression represent a shift from a tumoural colon phenotype 
towards to a more normal small intestinal phenotype (Stierum et al. 2003).  
 
For maintenance, Caco-2 cells were grown in complete DMEM containing 4 mM L-
glutamine, 1% non-essential amino acids, 10% foetal bovine serum, 100 units/ml 
penicillin, and 100 µg/ml streptomycin (Sigma-Aldrich) using 75-cm2 flasks, which 
were maintained in humidified 5% CO2 at 37°C. Caco-2 cell cultures were split 1:10 by 
0.25% Trypsin-EDTA twice per week before reaching complete confluence.   
 
First, before seeding out of Caco-2 cells, the 12-well Transwell® plates (3462, Corning) 
with inserts of 3.0 µm pore polyester filter membrane were pre-coated with 10 µg/cm2 
of type I collagen from rat tail (C7661, Sigma-Aldrich) per well and dried in a sterilised 
hood. Second, for assays Caco-2 cells were seeded at a density of 5×105 cells/well into 
the collagen-precoated membrane inserts in 12-well Transwell® plates and incubated for 
5, 14, or 20 days, all to achieve complete confluence with various stages of 
differentiation. Third, one day before assays complete DMEM containing penicillin and 
streptomycin was apically (0.5 ml/well) and basolaterally (1.5 ml/well) replaced by 
complete DMEM without antibiotics. Fourth, one hour before commencement of all the 
experiments, complete DMEM was apically (0.5 ml/well) and basolaterally (1.5 ml/well) 
replaced by 'plain DMEM' without foetal bovine serum. Thus, the polarised Caco-2 cell 
monolayers on the membranes in Transwell® plates were prepared for treatment in 
various assays (Figure 2.1).  
 
Various assays will be detailed in the following subchapters including transepithelial 
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electrical resistance (TEER) in 2.3, gentamicin protection assays in 2.4, scanning 
electron microscopy (SEM) in 2.6, ELISA for IL-8 and hBD-2 protein secretion in 2.9, 
quantitative real-time PCR for IL-8, hBD-1, and hBD-2 mRNA expression in 2.10.1. 
 
Figure 2.1 Schematic illustration of the Transwell® polarised Caco-2 cell culture model 
 
In summary, there were the following six main experiments using this polarised Caco-2 
cell culture model: 
1. TEER values (Ω cm2) for the cell monolayers of 5-day, 14-day, and 20-day polarised 
Caco-2 cells were measured to evaluate integrity of the intestinal epithelial barrier. 
2.  Observation of cell surface morphology was performed in 5-day, 14-day, and 20-
day polarised Caco-2 cells using SEM to evaluate differentiation. 
3. A kinetic time-course study in 14-day polarised Caco-2 cells infected with 
Salmonella Typhimurium SL1344 (MOI = 20–25) was undertaken from 2 hours up 
to 24 hours to seek the best time point for IL-8, hBD-1, and hBD-2 mRNA 
expression. 
4. Gentamicin protection assays, including invasion assays and intracellular replication 
assays, were carried out in 14-day polarised Caco-2 cells infected with Salmonella 
Typhimurium wild-type strain SL1344, and isogenic mutants ∆spaS, ∆ssaU, and 
∆fliM (MOI = 20–25) to compare their differences in rates of invasion and 
intracellular replication. 
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5. Stimulation of IL-8, hBD-1, and hBD-2 by various bacterial PAMPs including 10 
µg/ml of Salmonella lipopolysaccharide (LPS, L6143, Sigma-Aldrich), 2 µg/ml of 
flagellin (Purified Flagellin from S. Thyphimurium, Invivogen), and 25 µg/ml of 
bacterial CpG DNA of Salmonella Typhimurium as well as 20 ng/ml pro-
inflammatory cytokine IL-1β in each well of polarised Caco-2 cells was performed 
to explore differences in triggering host innate immune responses. 
6. Stimulation of mRNA expression (IL-8, hBD-1, and hBD-2) in 5-day, 14-day, and 
20-day polarised Caco-2 cells and protein secretion (IL-8 and hBD-2) in 14-day 
polarised Caco-2 cells were performed after infection of Salmonella Typhimurium 
wild-type strain SL1344, and its isogenic mutants ∆spaS, ∆ssaU, and ∆fliM (MOI = 
20–25). 
 
2.2.3. Long-term storage and defrosting of cell lines 
For long-term cryostorage, cells maintained in 75-cm2 flasks were trypsinised, counted, 
and then aliquoted into 15-ml centrifuge tubes to yield a final concentration of between 
2–4×106 cells/ml. Cells were then pelleted by centrifugation at 300 × g for 8 minutes at 
20°C and resuspended in a 4°C pre-cooled solution of 90% complete DMEM and 10% 
dimethyl sulfoxide (DMS, Sigma-Aldrich), from which each one ml of 2–4×106 cells 
were removed to a cryovial (Triple Red) and frozen down to –80°C in isopropanol 
(Sigma-Aldrich) for 24 hours before being transferred to just above the fluid-gas 
interphase in a liquid nitrogen tank. 
 
For reviving cells from cryostorage, cells in a cryovial were defrosted in warm water 
bath at 37°C. Immediately upon their being completely thawed, cells were transferred to 
5 ml pre-warmed complete DMEM, mixed up thoroughly, and centrifuged at 300 × g for 
8 minutes at 20°C to obtain pellet cells and remove DMS which is harmful to cells at 
37°C. Again, pellet cells were resuspended in pre-warmed fresh complete DMEM and 
transferred to a 75-cm2 flask for cell culture maintenance. 
 
2.3. Measurement of Transepithelial electrical resistance (TEER) 
Transepithelial electrical resistance (TEER) of polarised epithelial cell monolayers can 
be quantified to provide an indication of tight junction function, intestinal epithelial 
permeability, and barrier properties (Hidalgo et al. 1989;Tang et al. 1993). The effect of 
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pathogenic organisms on the integrity of cell monolayers was determined by measuring 
TEER after bacterial challenges, e.g. Salmonella spp. disrupt TEER of Caco-2 
monolayers within 2 to 4 hours following bacterial infection (Tang et al. 1993). A 
voltage meter EVOM (World Precision Instruments) with chopstick-like electrodes of 
different length was used to measure TEER across the monolayers of polarised Caco-2 
cells in Transwell® plates. TEER values are expressed as resistance × the area (Ω cm2) 
and calculated by multiplying the measured resistance (in ohms, Ω) by the area of the 
filter (in cm2). First, a background resistance value of 112 Ω was obtained by measuring 
a non-cell collagen-precoated Transwell® insert membrane in complete DMEM. Then, 
the total resistance values in Ω of the polarised Caco-2 cell monolayers in different 
experimental conditions were measured. Finally, the genuine monolayer resistance 
values were calculated by subtracting the background resistance values from the total 
resistance values, after that multiplying by 1.12 cm2, which is the unit area of each 
insert membrane in 12-well Transwell® plates. 
 
2.4. Cell culture gentamicin protection assays 
2.4.1. Invasion assay 
The gentamicin protection assay was modified from previously described procedures 
(Coconnier 1997c;Small et al. 1987). Basically, a period of 1 to 2 hours was adopted for 
Salmonella Typhimurium infection in HEp-2 cells or polarised Caco-2 cells, followed 
by 1-hour gentamicin (100 μg/ml) protection, and then the cells were lysed in 1% Triton 
X-100 (Sigma-Aldrich) to allow quantification of the invading bacteria (Figure 2.2).  
 
For details, well prepared HEp-2 cells or polarised Caco-2 cells were infected with a 
logarithmic culture or overnight culture of Salmonella Typhimurium strains in an 
optimised multiplicity of infection (MOI) between 5 and 50 in each experiment as 
described in individual chapters, with or without centrifugation at 800 × g for 10 
minutes at 20°C. After 1 or 2 hours infection at 37°C in an atmosphere of 95% O2 and 
5% CO2, the cells were washed with PBS three times to remove non-adherent bacteria 
and treated with 100 μg/ml of gentamicin for 1 hour to kill only extracellular bacteria 
while intracellular bacteria remained alive. At the end of gentamicin protection, the cells 
were washed with PBS three times and lysed with 1% Triton X-100. Serial dilutions of 
lysates were plated out, and colony-forming units (CFU) were counted after overnight 
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incubation to calculate the total numbers of viable intracellular bacteria in CFU relative 
to initial inoculums, expressed as % relative to initial inoculums or as CFU per initial 
inoculum of 107 CFU.  
 
 
Figure 2.2 Gentamicin protection assay for quantification of invading bacteria (Tang et 
al. 1993). 
 
In addition, the HEp-2 cells on coverslips after 2-hour infection were washed with PBS 
three times and immediately fixed in ice cold water-free acetone (BDH Chemicals) for 
20 minutes for immunofluorescence staining (2.7.1.2.). 
 
To investigate if there was any evidence of intracellular lactobacilli, 2-day-old HEp-2 
cells in 12-well plates were co-incubated with overnight culture of Lactobacillus 
rhamnosus GG or Lactobacillus plantarum 299v in an MOI of ~50. After incubation at 
37°C in 5% CO2 for 7 hours, the cells were washed with PBS three times to remove 
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non-adherent bacteria and treated with 200 μg/ml of gentamicin for 2 hours. At the end 
of gentamicin protection, the cells were washed with sterile PBS three times and lysed 
with 1% Triton X-100. The last washing of PBS and the gentamicin-containing medium 
used during the 2-hour gentamicin protection were also collected for bacterial 
quantification to see how many viable lactobacilli existed in washing PBS and if the 
killing effect of gentamicin was satisfactory. Lactobacilli were assayed after appropriate 
dilutions and plating out, and colony-forming units (CFU) were counted after 2-day 
incubation at 37°C to calculate the total numbers of viable intracellular bacteria in CFU 
relative to initial inoculums, expressed as % relative to initial inoculums. 
 
2.4.2. Intracellular replication assay 
The intracellular replication assays in this study was based on prolongation of the 
invasion assays discussed in 2.4.1. At the end of 1-hour gentamicin protection, the 
infected cells were incubated for longer durations, during which intracellular infections 
of Salmonella Typhimurium continued and a low concentration (10 μg/ml) of 
gentamicin in plain DMEM was used to inhibit any possible extracellular bacterial 
growth without any accumulated gentamicin effect in the intracellular environment 
(Martinez-Moya et al. 1998). At the end of the total incubation duration up to 10 hours 
in HEp-2 cells or as long as 24-hours in polarised Caco-2 cells, the cells were lysed in 
1% Triton X-100 to quantitatively evaluate intracellular replication of Salmonella 
Typhimurium at different time points after appropriate serial dilutions of lysates, plating 
out, and CFU counting after overnight incubation.  
 
To study the probiotic effects upon pathogens and cells in accompany with intracellular 
replication assays of Salmonella Typhimurium (MOI = 20), low (MOI = 4) or high 
(MOI = 40) dose overnight cultures of Lactobacillus strains were coincubated in plain 
DMEM with the infected cells containing intracellular Salmonella Typhimurium after 
gentamicin killing of extracellular Salmonella using a single one-dose regimen (Figure 
2.3A) or a repeated 4-dose regimen (Figure 2.3B), or were simultaneously incubated 
with Salmonella Typhimurium strains onto cells during the first 1-hour infection period 
before gentamicin protection using a single one-dose co-treatment regimen (Figure 
2.3C). At the end of the total incubation duration, quantification of viable intracellular 
Salmonella Typhimurium replication was performed as above after appropriate serial 
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dilutions of lysates, plating out, and CFU counting after overnight incubation. Co-
existing lactobacilli in the lysates did not interfere with the counting of viable 
Salmonella Typhimurium because the tiny colonies of both lactobacilli on LB agar 
plates can only be recognised after incubation for more than 2 days. 
 
 
Figure 2.3 Four protocols for treatment of HEp-2 cells to study probiotic effects of 
Lactobacillus rhamnosus GG and Lactobacillus plantarum 299v. Filled arrowheads 
above the bars indicate the timing for addition of Salmonella Typhimurium SL1344 or 
IL-1β, and replacement of gentamicin-supplemented DMEM or plain DMEM into wells. 
Open arrowheads above the bars show the different time points for administration of 
lactobacilli. Black arrows below the bars illustrate the time points for harvest of media 
or cells in various assays. 
 
At the end of each experiment in cell culture gentamicin protection assays, monolayer 
integrity was assessed by Trypan blue (Fluka) exclusion with 90–99% viability of the 
infected cells (Figure 2.4) in different conditions. Each condition was performed within 
wells in duplicate and each experiment repeated three times. 
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Figure 2.4 A representative microscopic image in trypan blue exclusion showing 90–
99% viability of the HEp-2 cells infected with Salmonella Typhimurium SL1344 for 
totally 10 hours. 
 
2.4.3. Modified invasion and intracellular replication assays using a library 
of pooled WITS or transposon mutants 
In each independent in vitro infection using a library of pooled tagged strains of 
Salmonella Typhimurium (e.g. WITS and transposon mutants), a total of 6 wells of 1-
day-old HEp-2 cells in 6-well plates for 3 experimental conditions in duplicate and 2–4 
ml of single 18-hour cultures of WITS (WITS 1, 2, 11, 13, 17, 19, 20, and 21) or 
transposon mutants were prepared. On the infection day, equal amounts of individual 
18-hour cultures or their OD600-adjusted PBS resuspensions were then pooled into one 
library of mixed WITS or transposon mutants. After vortexing, 20–30 μl of the mixed 
pool with a MOI of 30–50 was inoculated onto subconfluent HEp-2 cell monolayers 
which remained incubated in an atmosphere of 95% air and 5% CO2 at 37°C for 2 hours, 
by which invasion rates were supposed to be increased. After washing with sterile PBS 
three times, two wells of the infected cells were incubated in plain DMEM at 37°C for 1 
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hour prior to discarding media, washing off non-adherent non-invading bacteria, and 
lysis of cells with only adherent and invading bacteria using 1% Triton X-100 or Buffer 
ATL (DNeasy® Blood & Tissue Kit, Qiagen) as Output pool A in Figure 2.5. At the 
same time, another 4 wells of infected cells were incubated in gentamicin (100 μg/ml)-
supplemented plain DMEM for 1 hour before removal of media, washing off killed 
extracellular bacteria by sterile PBS three times, and lysis of cells with only invading 
bacteria in two wells using 1% Triton X-100 or Buffer ATL as Output pool B in Figure 
2.5. The last 2 wells of cells after gentamicin protection were incubated in gentamicin 
(10 μg/ml)-supplemented plain DMEM allowing intracellular infections to continue for 
7 hours, then washed with sterile PBS three times, and cells were finally lysed by 1% 
Triton X-100 or Buffer ATL with only those bacteria that had already invaded and had 
been multiplying intracellularly as Output pool C in Figure 2.5. The harvested cell 
lysates were serially diluted and plated out for bacterial quantification, or processed for 
DNA extraction and subsequent quantitative real-time PCR or TraDIS. 
 
 
Figure 2.5 Treatment protocol using a library of pooled tagged strains to infect HEp-2 
cell monolayers and illustration of its input pool and 3 output pools, representative of 3 
different stages (colonisation, invasion, and intracellular replication) during Salmonella 
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Typhimurium infection in vitro. 
 
2.5. Ex Vivo Human Intestinal Organ Culture 
2.5.1. Tissue samples 
An ex vivo human intestinal organ culture, alternatively termed as in vivo organ culture 
(IVOC), was performed as previously prescribed (Hicks et al. 1998). With fully 
informed parental consent and ethical approval of Royal Free Hospital and UCL 
Medical School ethics committee, human intestinal biopsies were obtained from 
paediatric patients receiving upper endoscopy and/or ileo-colonoscopy for 
investigations in diagnosing or monitoring paediatric bowel diseases. All biopsies were 
obtained from the gastrointestinal sites which were endoscopically normal without 
disease pathology involvement. Immediately after removal, biopsies were maintained in 
37°C pre-warmed IVOC medium consisting of 0.47% (w/v) NCTC-135 medium, 0.11% 
(w/v) sodium bicarbonate, 0.5% (w/v) D-mannose, 45% (v/v) sterile DMEM, and 10% 
(v/v) neonatal calf serum (all from Sigma-Aldrich) for further use in the experiments of 
ex vivo human intestinal organ cultures. 
 
2.5.2. Non-polarised ex vivo human intestinal organ culture 
Upon availability after initial storage in IVOC medium, biopsies taken from the distal 
part of duodenum, terminal ileum and ascending colon were placed onto the central part 
of a 2-mm thick foam support (Simport Plastics Limited) cut to 2 × 2 cm2, which had 
been pre-soaked in IVOC medium. Under a dissecting microscope, the biopsies were 
carefully spread out with the apical side facing upwards and basal side facing 
downwards in direct contact with the underlying sponge. The foam supports with 
properly loaded biopsies were transferred to 12-well culture plates with approximately 
600–700 µl of IVOC medium per well to create a thin film of medium on the apical 
sides of biopsies, which presents a good air-fluid interface for gas exchange (Figure 
2.6). Then, 50 µl of overnight cultures or their PBS resuspension solutions of 
Salmonella Typhimurium strains were inoculated onto the mucosal side of the prepared 
biopsies and incubated at 37°C on a rocker in an atmosphere of 95% O2 and 5% CO2 for 
2 hours, followed by replacement of fresh IVOC medium every 2 hours during the 8-
hour maintenance of the ex vivo infections. At the end of the experiments, biopsies were 
removed and shaken vigorously in IVOC medium for 40 seconds to remove mucus and 
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non-adherent bacteria. Thus, the treated biopsies can be further manipulated for 
isolation of intestinal epithelia, or directly harvested for fixation and subsequent 
evaluation. 
 
biopsy sample sponge immersed 
in IVOC medium
 
Figure 2.6 A standard human intestinal IVOC model showing a biopsy sample mounted 
on a sponge immersed in the medium. 
 
2.5.2.1. Isolation of intestinal epithelium 
Isolation of intestinal epithelium from ex vivo human intestinal organ cultures was 
modified from the previously described procedures (Cano-Gauci et al. 1993;Knutton et 
al. 1985;Seidelin et al. 2003). At the end of the experiments, the washed biopsies were 
transferred into 1.5 ml transparent microcentrifuge tubes each containing 1 ml of 
filtered sterile 30 mM EDTA (Sigma-Aldrich) in Ca2+- and Mg2+-free Dulbecco’s 
Phosphate Buffered Saline (DPBS, Gibco®, Invitrogen) and were incubated at 37°C for 
15 minutes for duodenal or ileal biopsies or 20 minutes for colonic biopsies to chelate 
epithelial cells. After incubation, the tubes with biopsies were steadily and manually 
shaken ~160 times for duodenal or ileal biopsies, or ~200 times for colonic biopsies; in 
betweens the biopsies were observed under a dissecting microscope to determine when 
to stop shaking. The separated lamina propria tissues were carefully taken out whilst 
enterocytes remained suspended in EDTA/DPBS. The tubes were centrifuged at 700 × g 
for 10 minutes that was shortly repeated at 4,000 × g for 20 seconds. After removal of 
supernatants, cell pellets were carefully resuspended in 30 µl of 4% formaldehyde per 
tube. Finally, 15 µl of the above cell suspension was placed onto a poly-lysine coated 
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slide within a frame created by a Liquid Block pen. The slides were kept at room 
temperature overnight to evaporate formalin and dry cells, and subsequent double 
immunofluorescence staining in 2.7.2. was performed within 1 day. 
 
2.5.3. Polarised ex vivo human intestinal organ culture 
A polarised ex vivo human intestinal organ culture system, also termed as polarised in 
vivo organ culture (pIVOC), was established as previously described (Schuller et al. 
2009), which was modified from a micro-snapwell system (El et al. 2002;Raffatellu et 
al. 2005a) for specific use of 2–3 mm diameter paediatric intestinal biopsies. Different 
from traditional IVOC, this modified pIVOC was developed to secure apical infections 
of pathogenic bacteria with negligible leakage via biopsy edges and to provide a 
directional epithelial exposure without serosal or cut surface stimulation, which can 
genuinely simulate an in vivo infection route during pathogen-host interactions in the 
gut. Each biopsy sample was snapped as a sandwich between two 12 mm diameter 
Perspex (acrylic glass) discs with a 2 mm central aperture (manufactured by the 
Anatomy and Developmental Biology Department workshop, UCL, London) that fits 
into SnapwellTM inserts (Figure 2.7).  
 
 
Figure 2.7 Illustration in mounting of intestinal biopsies for polarised ex vivo human 
intestinal organ culture (Schuller et al. 2009) with the picture taken by Fang SB. 
 
Before mounting of the biopsy, a circular cellulose nitrate filter (3 µm pore, Whatman) 
was soaked in IVOC medium and placed on top of the lower disc. Under a dissecting 
microscope, the biopsy was placed centrally on the filter, excess medium was removed, 
and the tissue was spread out with its orientated mucosal side upwards. To minimise 
bacterial leakage from the apical to the basolateral compartment, the upper disc was 
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sealed to the mucosal side of the biopsy in its peripheral area using Histoacryl tissue 
glue (Braun Medical) with only the central portion of the biopsy exposed through the 
central aperture. The sandwich holding the biopsy was then mounted in a 0.4 µm pore 
polycarbonate membrane SnapwellTM insert (3407, Corning) with a 2 × 2 mm cross cut 
on the bottom membrane by a scalpel and placed into a 6-well culture plate. Apical and 
basolateral compartments were respectively filled with 175 µl and 3 ml of IVOC 
medium and 25 µl of overnight cultures of Salmonella Typhimurium strains or their 
PBS re-suspension solutions were added apically. To optimise epithelial survival, most 
of the apical medium was removed, washed with 200 µl of IVOC medium once, and 
replaced by ~50 µl of fresh IVOC medium at 2 hours post infection leaving a thin film 
of medium covering the mucosal surface. The tissue was incubated a further 3–6 hours 
during which IVOC medium was replaced by ~50 µl of fresh medium every 2 hours. 
Aliquots of the basolateral media were serially diluted and plated out for confirmation 
of negligible bacterial leakage into the basolateral compartment. The biopsies were 
incubated at 37°C on a rocker in an atmosphere of 95% air and 5% CO2. After 
incubation, biopsies were removed from the SnapwellTM inserts, washed in cold PBS to 
remove mucus and non-adherent bacteria, and processed for ex vivo gentamicin 
protection invasion assay (2.5.3.1.) or fixed in glutaraldehyde solution for scanning 
electron microscopy (2.6.). Some biopsies were directly fixed in situ by 4% 
formaldehyde for further sectioning and staining for Salmonella Typhimurium (2.7.2.). 
The human intestinal biopsy samples after ex vivo Salmonella infections were lysed and 
homogenised in Buffer RLT (RNeasy® Mini Kit, Qiagen) for further total RNA 
extraction (2.10.1.1.). 
 
2.5.3.1. Ex vivo gentamicin protection invasion assay 
This ex vivo gentamicin protection assay was modified from the cell culture gentamicin 
protection invasion assay (2.4.1.). 25 µl of overnight cultures of Salmonella 
Typhimurium was inoculated onto the apical side of a polarised ex vivo human intestinal 
organ culture as earlier described (2.5.3) for 2 hours, then most of the apical medium 
was removed, the tissue was washed with 200 µl of IVOC medium once, then this was 
replaced by ~50 µl of fresh IVOC medium at 2 hours post infection. The tissue was 
incubated for a further 6 hours, during which IVOC medium was replaced by ~50 µl of 
fresh medium every 2 hours until 6 hours post infection. At this time point, the apical 
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and basolateral media were removed for quantification of bacteria after appropriate 
serial dilution, and refilled with fresh IVOC medium containing 100 μg/ml gentamicin 
in both compartments to kill extracellular bacteria. The infected tissue with any 
remaining intracellular bacteria was incubated for another 2 hours. Subsequently, the 
sample was removed from the SnapwellTM insert, washed by vigorous shaking in cold 
PBS for 40 seconds three times to remove mucus and non-adherent bacteria, then lysed 
in 1 ml of 1% Triton X-100 with homogenisation of the tissue sample. Intracellular 
bacteria were assayed after serial dilutions of lysates were plated out, and CFU were 
counted after overnight incubation to calculate the total numbers of viable intracellular 
bacteria in CFU relative to initial inoculums, expressed as %. 
 
2.6. Scanning electron microscopy (SEM) 
At the end of infection, cell monolayers on coverslips and biopsied tissues were washed 
with PBS three times, then fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer, 
and stored at 4°C for further processing. The glutaraldehyde-fixed cell monolayers and 
biopsy tissues were washed three times with cold 0.1 M phosphate buffer supplemented 
with 3% (w/v) sucrose (Sigma-Aldrich) for 60 minutes and 90 minutes respectively, 
followed by post-fixation in 1% aqueous osmium tetroxide (Agar Scientific) for 15 
minutes and 60 minutes respectively. After being washed with distilled water three times 
over 10 minutes, the cell monolayers and biopsied tissues were dehydrated in acidified 
2,2 dimethoxy-propoane (Sigma-Aldrich) for 5 minutes and repeated for another 2 
minutes before transfer to 100% ethanol (BDH Chemicals) for 2 minutes. Then the 
samples were critically point dried in liquid carbon dioxide using an Emitech K850 
apparatus, mounted on aluminium stubs using silver paint (Agar Scientific) as a 
conductive mountant under a dissecting microscope, and sputter-coated with a mixture of 
gold and palladium using a Polaron E5100 sputter coater to generate a conductive 
surface over the specimen and stub. The above prepared samples were viewed in a JEOL 
JSM-5300 SEM and images were captured using a JEOL Semafore digital capture 
system. 
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2.7. Immunohistochemistry and fluorescence microscopy 
2.7.1. Immunofluorescence staining for identification of intracellular 
Salmonella Typhimurium  
2.7.1.1.Double immunofluorescence staining for differentiation between 
intracellular and extracellular bacteria in vitro and ex vivo 
A double immunofluorescence staining technique was adopted as previously described 
for differentiation between HEp-2 cell adherent (extracellular) and ingested 
(intracellular) bacteria (Heesemann and Laufs 1985). This method is based on the 
phenomenon that membranes of viable mammalian cells are impermeable for antibodies 
but are rendered permeable by treatment with fixatives. Hence, extracellular bacteria 
will be stained by specific tetramethyl rhodamine isothiocyanate (TRITC)-labelled 
antibodies before fixation, whereas both extracellular and intracellular bacteria will be 
stained by treatment with specific fluorescein isothiocyanate (FITC)-labelled antibodies 
after fixation. 
 
The in vitro cell monolayers on coverslips or the ex vivo intestinal epithelial cells 
isolated from human biopsies were blocked in 0.5% BSA in PBS at room temperature 
for 20 minutes, followed by incubation with the primary rabbit Salmonella O Factor 4 
(Group B) antibody (R30956901, Oxoid Limited) diluted 1:800 in 0.5% BSA in PBS for 
60 minutes, and then were washed with PBS for 5 minutes. After air-drying at room 
temperature, the cells were fixed and permeabilised using ice-cold pure methanol at –
20°C for 2 minutes. The coverslips were again air dried and subsequently overlaid with 
secondary Alexa Fluor 568 goat anti-rabbit IgG (Invitrogen) diluted 1: 400 in 0.5% BSA 
in PBS for 60 minutes at room temperature to stain extracellularly located bacteria. 
After being washed with PBS for 5 minutes, the monolayers were treated a second time 
with the primary rabbit Salmonella O Factor 4 (Group B) antibody diluted 1:800 in 
0.5% BSA in PBS for 60 minutes. At this step, antibodies were also able to bind with 
intracellular bacteria. After being washed with PBS for 5 minutes to remove excessive 
antiserum, the cells were incubated with secondary Alexa Fluor 488 goat anti-rabbit IgG 
(Invitrogen) diluted 1: 400 in 0.5% BSA in PBS for 30 minutes. The cells on coverslips 
were again washed with PBS for 60 minutes, air dried for 5 minutes, and then mounted 
in Citifluor (Agar Scientific) on slides. Images were recorded using a fluorescence 
microscope (ZEISS AxioImager M1, Carl Zeiss). 
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2.7.1.2.Combined immunofluorescence staining using anti-Salmonella 
O4 and LAMP-1 antibodies for intracellular bacteria in vitro 
The HEp-2 cells on coverslips fixed in ice cold water-free acetone were permeabilised 
and blocked in 0.1% Triton X-100 in PBS with 0.5% BSA and 2% normal goat serum 
(Sigma-Aldrich) at room temperature for 20 minutes, followed by incubation with the 
primary rat anti-mouse Lysosome-Associated Membrane Protein (LAMP)-1 monoclonal 
antibody (Santa Cruz) diluted 1:10 in 0.1% Triton X-100 in PBS with 0.5% BSA and 
2% normal goat serum for 60 minutes, and then were washed with PBS for 10 minutes. 
Subsequently, the sections were incubated with secondary Alexa Fluor 488 goat anti-rat 
IgG (Invitrogen) diluted 1: 400 in 0.1% Triton X-100 in PBS with 0.5% BSA and 2% 
normal goat serum for 30 minutes protected from light onwards, and then were washed 
with PBS for 10 minutes. Next, the cell monolayers were incubated with another 
primary rabbit Salmonella O Factor 4 (Group B) antibody (R30956901, Oxoid Limited) 
diluted 1:800 in 0.1% Triton X-100 in PBS with 0.5% BSA and 2% normal goat serum 
for 60 minutes, and then were washed with PBS for 10 minutes, rocking. The sections 
were then incubated with secondary Alexa Fluor 568 goat anti-rabbit IgG (Invitrogen) 
diluted 1: 400 in 0.1% Triton X-100 in PBS with 0.5% BSA and 2% normal goat serum 
for 30 minutes, and then were washed with PBS for 60 minutes, rocking. Finally the cell 
monolayers on coverslips were air dried for 5 minutes and mounted in Citifluor on 
slides. Images were recorded using a fluorescence microscope (ZEISS AxioImager M1) 
with AxioVision Version 4.3. 
 
2.7.2. Immunohistochmistry for formaldehyde-fixed paraffin wax-
embedded tissues in vivo and ex vivo 
The formalin-fixed, paraffin wax embedded in vivo infected human tissues were kindly 
provided by Dr Ivor Hill and Dr Kim Geisiner from Department of Paediatrics, Wake 
Forest University School of Medicine, Winston-Salem in North Carolina, USA. They 
had reported three children who presented with symptoms and endoscopic findings 
indicative of idiopathic inflammatory bowel disease, but who subsequently were 
diagnosed with Salmonella colitis (Friesen et al. 2008). These individual mucosal 
biopsies were taken from the large intestines in all three cases, and even from the 
terminal ileum in one case, extending the area of study into the distal small intestine. 
Each formalin-fixed biopsy specimen had been embedded into 2 to 6 paraffin blocks 
(Table 2.4). The mucosal biopsies were restudied to look for the presence of bacteria 
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using routine histology with haematoxylin and eosin (H&E) staining and also 
immunohistochemistry to determine if the bacteria were Salmonella using Salmonella-
specific antibodies. Intestinal cells beside the epithelium, including neutrophils and 
lamina propria macrophages, were also examined to see if they had interactions with the 
Salmonella.  
 
Table 2.4 Formalin-fixed biopsy specimens in prepared paraffin-embedded blocks and 
their original locations in the intestinal tracts from the three clinical case reports 
(Friesen et al. 2008).  
Patient  Biopsy specimen Block No Location 
1 1 1-6 Ileum 
1 2 7-9 Colon 
2 1 10-14 Colon 
2 2 15, 16 Colon 
3 1 17, 18 Colon 
3 2 19-21 Colon 
 
Similarly, using a polarised ex vivo human intestinal organ culture, Salmonella 
Typhimurium-infected human biopsies that had already been fixed in formaldehyde in 
situ (2.5.3.) were paraffin wax embedded, sectioned, and stained using H&E staining 
and immunofluorescence staining. 
 
To obtain appropriate positive controls for immunofluorescence staining of Salmonella, 
HEp-2 cells were seeded at a density of 5×105 cells/well into a 6-well plate and 
incubated for 2 days. After replacement of all media with 1 ml/well of plain DMEM, the 
HEp-2 cells were infected with 30 μl/well of overnight culture of Salmonella 
Typhimurium SL1344 and incubated in 5% CO2 at 37°C for 2 hours. Then the infected 
HEp-2 cells in 6 wells were scratched off, pooled together into totally 6 ml within one 
tube, and then centrifuged at 300 × g for 8 minutes at 40°C 1100 rpm at 40°C for 8 
minutes. After removal of the supernatant, the cell pellet was added with 1 ml of pre-
warmed liquid LB agar and mixed up. Afterwards the liquid LB agar containing 
Salmonella-infected cells was poured into several wells of a 96-well microplate and 
kept standstill for cooling down. Upon complete solidification, these LB agar blocks 
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were removed from the wells, cut into cubic blocks (about 5×5×5 mm3 in size), fixed 
with 4% formaldehyde for 1 day, and then embedded in paraffin with sectioning. 
 
The section cutting and H&E staining was performed by Dr Stephan Davison in the 
hospital’s routine histopathology department. H&E staining was performed in some the 
sections and the remaining unstained sections were processed for de-paraffinisation of 
embedded tissue sections (2.7.2.1.), antigen retrieval (2.7.2.2.), and 
immunofluorescence staining for Salmonella (2.7.2.3.) in this study. 
 
2.7.2.1. De-paraffinisation and rehydration of embedded tissues 
The slides with embedded tissue sections were incubated in clean Histo-Clear (Agar 
Scientific) for 5 minutes, which was repeated once by substituting with fresh Histo-
Clear for another 5 minutes. Next, the sections were incubated in 100% ethanol for 5 
minutes, which was repeated once by replacing with fresh 100% ethanol. Subsequently, 
the sections were incubated in a solution of 90% aqueous ethanol for 5 minutes, 
followed by incubation with a solution of 70% aqueous ethanol for another 5 minutes. 
After the serial hydration finished, de-paraffinisation was completed and the slides were 
stored in a PBS buffer until ready to use. 
 
2.7.2.2. Heat-induced antigen retrieval 
Formaldehyde fixation results in formation of protein-protein crosslinks, mainly 
methylene bridges, which can be cleaved by heating to unfold epitopes, and such 
breakdown in crosslinks with calcium ions and proteins can be facilitated by citrate 
buffer at pH 6.0 to maintain the conformation of the unfolded protein, and to partially 
extract the macromolecules. Hence, antibodies can easily penetrate into tissue sections 
and the immunoreaction is reinforced by heat-induced antigen retrieval (Yamashita 
2007). 
 
The de-paraffinised slides of tissue sections were immersed into sodium citrate buffer 
consisting of 10 mM tri-sodium citrate dihydrate (AnalaR Normapur) and 0.05% Tween 
20 (Sigma-Aldrich) at pH 6.0, which had been prepared in a staining dish within a water 
bath at 95–100°C, for 40 minutes. Afterwards, the slides were cooled down at room 
temperature for 20 minutes. After being rinsed in PBS for 2 minutes twice, the sections 
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proceeded to standard immunohistochemistry protocol. 
 
2.7.2.3. Combined immunofluorescence staining using anti-Salmonella 
O4 and LAMP-1 antibodies for intracellular bacteria in vivo and 
ex vivo 
The sections within the area framed by a Liquid Blocker pen (Daido Sangyo Co Ltd, 
Japan) were permeabilised and blocked in 0.1% Triton X-100 in PBS with 0.5% BSA 
and 2% normal goat serum (Sigma-Aldrich) at room temperature for 20 minutes, 
followed by incubation with the primary mouse anti-human Lysosome-Associated 
Membrane Protein (LAMP)-1 IgG1 (BioLegend) diluted 1:150 in 0.1% Triton X-100 in 
PBS with 0.5% BSA and 2% normal goat serum for 60 minutes, and then were washed 
with PBS for 10 minutes, rocking. Subsequently, the sections were incubated with 
secondary Alexa Fluor 488 goat anti-mouse IgM (Invitrogen) diluted 1: 400 in 0.1% 
Triton X-100 in PBS with 0.5% BSA and 2% normal goat serum for 30 minutes 
protected from light onwards, and then were washed with PBS for 10 minutes. Next, the 
sections were incubated with another primary rabbit Salmonella O Factor 4 (Group B) 
antibody (R30956901, Oxoid Limited) diluted 1:800 in 0.1% Triton X-100 in PBS with 
0.5% BSA and 2% normal goat serum for 60 minutes, and then were washed with PBS 
for 10 minutes. The sections were then incubated with secondary Alexa Fluor 568 goat 
anti-rabbit IgG (Invitrogen) diluted 1: 400 in 0.1% Triton X-100 in PBS with 0.5% BSA 
and 2% normal goat serum for 30 minutes, and then were washed with PBS for 60 
minutes. Finally the sections were air dried for 5 minutes and mounted in Citifluor on 
slides. Images were recorded using a fluorescence microscope (Leica DM LB) with 
Image-Pro Plus Version 6.2. 
 
2.7.3. Immunofluorescence staining for NF-κB nuclear translocation in 
vitro 
Four protocols (Figure 2.3) were adopted for probiotic treatment of HEp-2 cell cultures 
in Chapter 3b. First, the 2-day-old HEp-2 cells in each well were infected with 10 μl of 
overnight cultures of Salmonella Typhimurium SL1344 with MOI of 5, or 10 μl of LB 
broth as negative controls for 1 hour. This initial treatment was followed by plain 
DMEM containing 100 μg/ml of gentamicin for 1 hour to kill extracellular bacteria, and 
the intracellular infections were allowed to continue in plain DMEM for another 7 hours. 
To determine the effect of postinfectious administration of probiotics on these 
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parameters in an existing intracellular Salmonella infection, low-dose (10 μl of 
overnight cultures diluted in MRS broth to 100 μl; MOI of 2) or high-dose (100 μl of 
overnight cultures in MRS broth; MOI of 20) of Lactobacillus rhamnosus GG or 
Lactobacillus plantarum 299v, or 100 μl of MRS broth as negative controls were 
incubated with the Salmonella Typhimurium SL1344-invaded cells (Figure 2.3A). To 
study the effects of probiotics upon NF-κB activation, 1 ng of IL-1β (PHC0815, 
Invitrogen) diluted in 1 ml of plain DMEM was added to the cells in each well during 
the first hour (Figure 2.3A) that was followed by replacement of medium with 
gentamicin-containing plain DMEM for 1 hour. Afterwards at 1 hour, 5 hours and 7 
hours post treatment of lactobacilli, cells on coverslips were harvested for 
immunostaining.  
 
Second, to investigate the time-dependent and direct-contact interactive effects between 
pathogens and lactobacilli at an earlier stage, low- or high-dose Lactobacillus 
rhamnosus GG or Lactobacillus plantarum 299v were administered simultaneously 
together with Salmonella Typhimurium SL1344 or IL-1β during the first hour, followed 
by gentamicin protection for another hour and subsequent incubation of plain DMEM 
for the last 7 hours before harvest of the cells (Figure 2.3C).  
 
Third, to clarify if probiotics could inhibit phosphorylation of NF-κB p65 and IκBα 
degradation in IL-1β-treated HEp-2 cells and to localise any impact upon NF-κB 
signalling, the priority of IL-1β and lactobacilli treatment was reversed from the single 
one-dose regimen (Figure 2.3 A) in gentamicin assays to the reverse regimen as the 
protocol D (Figure 2.3 D) because translocation of NF-κB into nuclei can be completed 
within 10–20 minutes with a half-time of several minutes following that of IκBα 
degradation in HeLa cells (Ding et al. 1998). Such a modification maintained the cells 
in plain DMEM containing Lactobacillus rhamnosus GG or Lactobacillus plantarum 
299v for the initial 5 hours and 7 hours, followed by incubation in gentamicin-
supplemented plain DMEM for another hour, and then the cells were stimulated with 
IL-1β (1 ng/ml) for 20 minutes before harvest of the cells (Figure 2.3D). 
 
When harvested, cell monolayers on coverslips were fixed with 4% formaldehyde for 
15 minutes and stored in PBS for immunostaining. The fixed cells were permeabilised 
and blocked in 0.1% Triton X-100 in PBS with 0.5% BSA at room temperature for 20 
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minutes, followed by incubation with the primary rabbit anti-NFκB p65 polyclonal 
antibody (Santa Cruz Biotechnology) diluted 1:50 in 0.5% BSA in PBS for 60 minutes, 
and then were washed with PBS for 5 minutes, rocking. Subsequently, cells were 
incubated with secondary Alexa Fluor 488 goat anti-rabbit IgG (Invitrogen) diluted 1: 
400 in 0.5% BSA in PBS for 60 minutes. The samples were washed with PBS for 60 
minutes, coverslips with cells were air dried for 5 minutes, and then mounted in 
Citifluor on slides. Images were recorded using a ZEISS AxioImager M1 fluorescence 
microscope with AxioVision Version 4.3. 
 
2.8. Western blotting 
2.8.1. NF-κB p65 nuclear translocation and IκBα degradation 
For the same reason that had been described in 2.7.3., the reverse regimen (Figure 2.3 
D) was utilised to treat cells for Western blotting. At 20 minutes after IL-1β treatment 
following pre-incubation with Lactobacillus rhamnosus GG or Lactobacillus plantarum 
299v for 5 hours and 7 hours, the treated cells were washed with ice-cold PBS three 
times, and then lysed using a SDS lysis buffer containing 10% Glycerol, 2% sodium 
dodecyl sulfate (SDS), 62.5 mM Tris-HCl pH 6.8, and 50 mM dithiothreitol (DTT) 
(Sigma-Aldrich). The protein lysates were boiled at 100°C for 5 minutes before loading 
15 μl of each lysate into each well of SDS-polyacrylamide gel electrophoresis (PAGE) 
gel.  
 
SDS-PAGE was performed on a 12% acrylamide (Sigma-Aldrich) gel. Proteins were 
transferred to two nitrocellulose membranes using Tris-buffered saline with 0.1% Tween 
20 (TBST) and independently blocked with 5% BSA-TBST and 5% skimmed milk 
TBST for 1 hour. After washing with TBST for 10 minutes, both membranes were 
individually incubated with primary rabbit anti-phospho-NF-κB p65 monoclonal 
antibody (Cell Signaling Technology) diluted 1:1,000 in 5% BSA-TBST and mouse 
IκBα monoclonal antibody (Cell Signaling Technology) diluted 1:5000 in 5% skimmed 
milk TBST at 4°C overnight. After washing with TBST for 10 minutes, these two 
membranes were individually incubated with goat anti-rabbit IgG conjugated with 
horseradish peroxidase (Sigma-Aldrich) and rabbit anti-mouse IgG conjugated with 
horseradish peroxidase (Sigma-Aldrich) diluted 1:10,000 in TBST at room temperature 
for 1 hour, followed by washing with TBST for 90 minutes.  
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To ensure equal loading of proteins, Western blots using anti-phospho-NF-κB p65 
antibody were stripped using a buffer containing 100 mM 2-mercaptoethanol, 2% SDS, 
and 62.5mM Tris-HCl pH 6.8 at 50°C for 30 minutes, and re-probed with primary rabbit 
anti-NFкB p65 polyclonal antibody (Santa Cruz Biotechnology) diluted 1:300 in TBST 
at 4°C overnight. ECL Western Blotting Detection Reagents (GE Healthcare) were 
applied to the blots; multiple exposures were performed to develop films for 
comparison of bands. 
 
2.8.2. Structural and secreted flagellin in bacterial strains 
Structural and secreted flagellin proteins in Salmonella Typhimurium strains (SL1344, 
ΔspaS, ΔfliM, ΔssaU) and EPEC strains (E2348/69, AGT01 ∆fliC , AGT02 ∆fliC pFliC) 
were prepared using a trichloroacetic acid (TCA) precipitation protocol modified from 
the previously described procedures (Komoriya et al. 1999;Uchiya and Nikai 2008). 
After 18-hour culture of each bacterial strain in 4 ml of LB broth was obtained, 150 μl 
of each overnight culture was inoculated into 15 ml of fresh LB at 1:100 dilution, and 
then grown with shaking at 225 rpm at 37°C for 2–4 hours. When its OD600 was 
approaching ~0.7, 10 ml of each mid-logarithmic culture from individual bacterial 
strains was removed from the shaking incubator and centrifuged at 18,500 × g for 15 
minutes to generate two separate parts: supernatants containing secreted proteins and 
pellets containing bacterial cells or supramolecules such as flagella or pilli. After 
filtrating of the above supernatants through a 0.2 μm pore-size filter to retain only 
secreted proteins, the filtrates were mixed with 6% trichloroacetic acid (Sigma-Aldrich), 
chilled on ice for 30 minutes, and centrifuged at 14,000 × g for 20 minutes. After drying, 
the pellets were dissolved in 40 μl of SDS sample buffer (50 mM Tris-HCl, pH 6.8, 
2.5% SDS, 10% glycerol, 25 mM DTT) per sample. For preparation of whole-cell 
proteins, the bacterial pellets from the centrifugation step were dissolved in 200 μl of 
SDS sample buffer per sample. Total protein concentrations were measured in all 
prepared protein samples in SDS sample buffer using DC protein assay (Bio-Rad) for 
normalisation to 2 μg/μl using SDS sample buffer supplemented with 0.01% 
bromophenol blue. Using the same buffer, 5 μg of purified flagellin from Salmonella 
Typhimurium (InvivoGen) was prepared as a positive control. The protein lysates were 
boiled at 100°C for 5 minutes before loading 15 μl of each lysate into each well of SDS-
PAGE gel. 
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SDS-PAGE was performed on a 10% acrylamide (Sigma-Aldrich) gel. Proteins were 
transferred to nitrocellulose membranes using Tris-buffered saline with 0.1% Tween 20 
(TBST) and independently blocked with 3% BSA-TBST for 1 hour. After washing with 
TBST for 10 minutes, membranes were incubated with primary purified mouse anti-
FliC IgG1 (BioLegend) diluted 1:500 in 3% BSA-TBST at 4°C overnight. After 
washing with TBST for 10 minutes, membranes were incubated with secondary rabbit 
anti-mouse IgG conjugated with horseradish peroxidase (Sigma-Aldrich) diluted 
1:10,000 in 3% BSA-TBST at room temperature for 1 hour, followed by washing with 
TBST for 90 minutes. ECL Western Blotting Detection Reagents (GE Healthcare) were 
applied to the blots; multiple exposures were performed to develop films. 
 
2.9. Enzyme-Linked ImmunoSorbent Assay (ELISA) 
At the end of treatment in cell or tissue cultures, the media were removed into 1.5 ml 
microcentrifuge tubes and frozen at –20°C until their use in ELISA assays. All samples 
were only thawed once before disposal. ELISA for quantifying protein levels of human 
IL-8 and β-defensin-2 was respectively carried out using human IL-8 and BD-2 ELISA 
development kits (PreproTec EC) according to the manufacturer’s instructions. 
 
2.9.1. Human IL-8 ELISA 
One day prior to ELISA assays, 100 μl of rabbit anti-human IL-8 capture antibody (0.5 
μg/ml) in Ca2+- and Mg2+-free DPBS (DPBS, Gibco®, Invitrogen) was added into each 
well of 96-well MaxiSorpTM plates (Nunc). The plates were sealed and incubated at 
room temperature overnight allowing capture antibody to be absorbed and coated onto 
the wells. On the ELISA day, the plates were washed 4 times using washing buffer 
comprised of DPBS with 0.05% (v/v) Tween-20 (Sigma-Aldrich) before being blocked 
in 300 μl of DPBS with 1% (w/v) ELISA grade BSA per well for 2 hours. After being 
aspirated and washed 4 times, each well was loaded with 100 μl of standards or samples 
in triplicate and incubated at room temperature for 2 hours. The IL-8 standards were 
generated by 2-fold serial dilutions of recombinant human IL-8 from 2 ng/ml to zero in 
assay diluent consisting of 0.05% (v/v) Tween-20 and 0.1% (w/v) ELISA grade BSA in 
DPBS. The sample media were thawed and centrifuged at 13,300 × g for 5 minutes 
before their supernatants were added into wells. After being aspirated and washed 4 
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times, each well was added with 100 μl of biotinylated rabbit anti-human IL-8 detection 
antibody (0.25 μg/ml) in assay diluent and incubated at room temperature for 2 hours. 
Then after being aspirated and washed 4 times, each well was loaded with 100 μl of 
avidin horseradish peroxidise conjugate (PreproTec EC) diluted 1:2,000 in assay diluent 
and incubated at room temperature for 30 minutes. Finally, after last aspiration and 
washing 4 times, 100μl of 3,3′,5,5′-tetramethylbenzidine liquid substrate (Sigma-
Aldrich) was added into each well. The plates were incubated at room temperature for 
colour development, and absorbance OD405-650 values were monitored at 5-minute 
intervals for approximately 40 minutes using a 3550 Bio-Rad microplate reader at 405 
nm with wavelength correction set at 650 nm. The data of IL-8 levels expressed as pg 
per ml were calculated in Microplate Manager PC 4.0 software according to the 
standard curves created by Cubic Spline Curve Fit from serially diluted standards. The 
same experimental conditions were analysed in duplicate. 
 
2.9.2. Human β-defensin-2 ELISA 
Human β-defensin (hBD)-2 ELISA assay was executed using specific antibodies and 
hBD-2 standard in human BD-2 ELISA development kit (PreproTec EC) with the same 
procedures as in IL-8 ELISA assay (2.9.1.), except for different concentrations in goat 
anti-human BD-2 capture antibody (0.25 μg/ml), recombinant hBD-2 standards (serially 
diluted from 1 ng/ml to zero), and biotinylated goat anti-human detection antibody (0.5 
μg/ml). All samples within wells in duplicate or triplicate were measured for reading of 
absorbance OD405-650 values.  
 
2.10. Quantitative real-time polymerase chain reaction (PCR) 
2.10.1. Quantitative real-time PCR for target gene expression 
2.10.1.1. RNA extraction 
Following infection of cell lines in vitro, the cell monolayers in each well were directly 
lysed with 1 ml of TRIzol® Reagent (Invitrogen), a mono-phasic solution of phenol and 
guanidine isothiocyanate, to extract total cellular RNA. The cell lysates were passed 
several times through a pipette, removed into a 1.5 ml sterile nuclease-free tube, and 
incubated for 5 minutes at room temperature to permit the complete dissociation of 
nucleoprotein complexes. Then 0.2 ml of chloroform was added into 1 ml of each lysate 
per tube which was further shaken vigorously by hand for 15 seconds and incubated at 
room temperature for 3 minutes. Each sample was centrifuged at 12,000 × g for 15 
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minutes at 4°C to separate the mixture into a lower phenol-chloroform phase, an 
interphase, and an upper aqueous phase. This organic extraction enabled total RNA to 
remain in the aqueous phase and leave cellular debris at the interface and in the organic 
phase. Following centrifugation, 400 μl of the aqueous phase was transferred to a fresh 
tube and mixed with 400 μl of isopropanol (Sigma-Aldrich) to precipitate RNA. The 
samples were incubated at room temperature for 10 minutes and centrifuged at 12,000 × 
g for 10 minutes at 4°C to form visible RNA pellets on the side and bottom of the tube. 
After removal of supernatant, the RNA pellets were washed once with 1 ml of 75% 
ethanol by vortexing and then centrifuged at 7,500 × g for 5 minutes at 4°C. Finally, 
RNA pellets were briefly air dried, re-dissolved in 30 μl of nuclease-free water per tube, 
and incubated for 10 minutes at 55°C to ensure complete dissolution.  
 
Following Salmonella Typhimurium infection ex vivo, each human intestinal biopsy 
sample was disrupted and homogenised by passage through a 21 gauze needle directly 
in 1 ml of Buffer RLT (RNeasy® Mini Kit, Qiagen) with addition of 20 µl of 2 M 
dithiothreitol (Sigma-Aldrich) and stored in at –80°C until further total RNA isolation 
was performed according to the manufacturer’s instruction. Eventually each RNA 
sample was eluted in 30 µl of nuclease-free water. RNA concentrations were determined 
by measuring the absorbance at 260 nm by spectrophotometry. The extracted RNA 
continued procedures for DNase clean-up or were stored as aliquots at –80°C.  
 
To minimise genomic DNA contamination, RNA samples were treated with DNase 
using a TURBO DNA-free kit (Ambion) based on the manufacturer’s instruction. Each 
30 μl of extracted RNA was diluted to 50 μl by adding 20 μl of nuclease-free water, 
added with 5 μl of DNase Buffer (10×) and 1.5 μl of DNase 1 enzyme, and then 
incubated at 37°C for 30 minutes. Another 1.5 μl of DNase 1 enzyme was added with 
ongoing incubation at 37°C for further 30 minutes. Then 10 μl of DNase Inactivation 
Reagent was added and incubated at room temperature for 5 minutes to chelate DNase 
and cease its activity. Finally the RNA solutions were spun for 3 minutes at 10,000 × g 
to precipitate DNase Inactivation Reagent with chelated DNases. The supernatants 
containing cleaned RNA were immediately processed for cDNA synthesis or stored as 
aliquots at –20°C for long-term storage.  
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The isolated and cleaned RNA samples were spectrophotometrically assessed with 
A260/A280 ratios of between 1.7–1.9 being indicative of acceptable protein contamination. 
Integrity of RNA was confirmed by gel electrophoresis on an ethidium bromide (Sigma-
Aldrich)-stained 1% agarose gel to shows two discrete ribosomal RNA bands at ~5 kb 
(28S) and at ~2 kb (18S), and one low molecular weight RNA band at between 0.1–0.3 
kb (5S) (Figure 2.8). Such images proved no degradation in extracted RNA samples. 
 
 
Figure 2.8  A representative gel of total RNA samples, which were extracted from 
Salmonella Typhimurium SL1344-infected HEp-2 cells with postinfectious treatment of 
lactobacilli using single one-dose regimen (Figure 2.3 A) after incubation of totally 9 
hours, showed two prominent ribosomal RNA bands of 28S and 18S and one faint RNA 
band of 5S. 
 
2.10.1.2. Reverse transcription 
After DNase clean-up, 1 μg of total RNA was reverse transcribed in a 20-μl reaction to 
generate cDNA using the BioScript® cDNA Synthesis Kit (Bioline). Briefly, 1 μl (50 ng) 
of Random Hexamer and 1 μl (270 ng) of Oligo (dT)18 were added into 5 μl of RNA 
template and then filled with 3 μl of nuclease-free water to compose a 10-μl reaction. 
The reaction mixtures were heated at 65°C for 5 minutes and then chilled on ice for 2 
minutes to allow annealing between the Oligo dT and the poly-A tail at the 3' end of 
mRNA templates. Then 4 μl of reaction buffer (5×), 4 μl of dNTPs, 0.3 μl (60 U) of 
BioScript® Reverse Transcriptase, and 1.7 μl of nuclease-free water were added to 
generate a 20-μl reaction. Amplification reactions proceeded at 25°C for 10 minutes, 
42°C for 60 minutes, and 75°C for 10 minutes. The generated cDNA samples were 
diluted 1: 3 in TE buffer (10 mM Tris, 0.1 mM EDTA, pH 7.94) were stored at 4°C 
within 2 months and some were aliquoted for long-term storage at –20°C. 
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2.10.1.3. Real-time PCR 
The primers for IL-8, hBD-1, hBD-2, hBD-3, human α-defensin 5 (HD5), human α-
defensin 6 (HD6) and housekeeping genes (GAPDH, RPLP0, POLR2A, B2M, and VILI) 
were either previously published or designed by Dr Mark Lucas (Centre for Paediatric 
Gastroenterology, Royal Free Campus, UCL Medical School) using online Primer3 
software (http://frodo.wi.mit.edu/primer3/) (Rozen and Skaletsky 2000) in Table 2.5, 
which lists their sequences and PCR product sizes. Criteria for selection of primers 
included high PCR amplification efficiency with early take-off points, low primer-dimer 
formation using no template control (NTC) PCR reactions, and good primer specificity 
by melting curve analysis and gel electrophoresis showing correct PCR product sizes. 
All the primers were purchased from Eurofins MWG Operon (Germany). 
 
Real-time PCR was performed using a Rotor-Gene 6000 analyser (Corbett Research).   
After reverse transcription, 2 μl of the diluted cDNA was amplified in a 20 μl reaction 
containing 0.5 μM of each forward/reverse primer and 10 μl of 2× SYBR Green 
JumpStart Taq ReadyMix (Sigma-Aldrich) with an initial hot start step of 5 minutes at 
95°C, followed by 40 or 45 cycles of denaturisation, annealing, and extension with 
slightly modified conditions in the annealing step for different target and housekeeping 
genes (Table 2.6), and finally a melting step at 72–95°C. 
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Table 2.5 Primer sequences, PCR product sizes, and sources of different target and 
housekeeping genes 
Primer Forward (5'-3') Reverse (5'-3') Product size (bp) Source/usage 
IL-8 ATG ACT TCC AAG CTG GCC GTG GC 
TCT CAG CCC TCT 
TCA AAA ACT TC 
292 (Kiss et al. 
1999) 
hBD-1 ACC TTC TGC TGT TTA CTC TCT GCT 
GAC ATT GCC CTC 
CAC TGC T 
120 Dr M Lucas, 
Primer3 
hBD-2 CCA GCC ATC AGC CAT GAG GGT 
GGA GCC CTT TCT 
GAA TCC GCA 
255 (O'Neil et al. 
1999); for in 
vitro cells 
hBD-2 TGC CTC TTC CAG GTG TTT TTG 
CTT TTT GCA GCA 
TTT TGT TCC 
143 (Wehkamp et 
al. 2002); for 
ex vivo tissues 
hBD-3 GTG TGT TCT GCA TGG TGA GAG 
TAT AAA GGT TCC 
AGC CAC AGC 
106 (Sperandio et 
al. 2008);  for 
in vitro cells 
hBD-3 CTT CTG TTT GCT TTG CTC TTC CT 
CTG TTC CTC CTT 
TGG AAG GCA 
138 (Buhimschi et 
al. 2004); for 
ex vivo tissues 
HD5 CGC CAT CCT TGC TGC CAT TCT 
AAC GGC CGG TTC 
GGC AAT AGC 
203 (Wehkamp et 
al. 2002); for 
ex vivo tissues 
HD6 GTG GGG CAA ATG ACC AGG ACT 
TCC CTC AGA GGC 
AGC AGA ATC 
186 (Wehkamp et 
al. 2002); for 
ex vivo tissues 
GAPDH AGG TCG GAG TCA ACG GAT TT 
TGG AAG ATG GTG 
ATG GGA TTT 
220 Dr M Lucas, 
Primer3 
RPLP0 GCA ATG TTG CCA GTG TCT G 
GCC TTG ACC TTT 
TCA GCA A 
140 (Dydensborg 
et al. 2006) 
POLR2A GGA TGA CCT GAC TCA CAA ACT G 
CGC CCA GAC TTC 
TGC ATG G 
183 Dr M Lucas, 
Primer3 
B2M GGG TTT CAT CCA 
TCC GAC A 
ACA CGG CAG GCA 
TAC TCA TC 
161 Dr M Lucas, 
Primer3 
VILI CAT GCG CTG AAC TTC ATC AAA GCC 
CCA CTT CTG GAA 
GAG CTG CTG AAA 
108 (Simms et al. 
2008) 
IL-8, interleukin-8; hBD, human β-defensin; HD, human α-defensin; GAPDH, 
Glyceraldehyde 3-phosphate dehydrogenase; RPLP0, ribosomal phosphoprotein, large, 
P0; POLR2A, Polymerase (RNA) II polypeptide A; B2M, β-2-microglobin; VILI, villin 
1. 
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Table 2.6 Settings of real-time PCR thermocycles for different target and 
housekeeping genes 
Gene Cycles Denaturisation Annealing Extension 
IL-8 40 95oC for 15 sec 60˚C for 20 sec 72oC for 25 sec 
hBD-1, 2, 3, 4, 
HD5, HD6 
45 95oC for 15 sec 60˚C for 15 sec 72oC for 25 sec 
Housekeeping 40 95oC for 15 sec 58˚C for 20 sec 72oC for 25 sec 
 
Specificity of PCR products was confirmed by melting curve analysis and by 
electrophoresis on ethidium bromide- or GelRedTM (Biotium)-stained 2% agarose gels. 
Using standard curves created from known copy numbers of the IL-8 and hBD-2 genes 
cloned into plasmid vectors, their absolute quantitative data were analysed using Rotor-
Gene 1.7 software and expressed as copies of IL-8/hBD-2 mRNA transcripts per 106 
cells. Without a plasmid vector with cloned hBD-1 gene, the comparative fold 
expression levels of hBD-1 mRNA in infected samples were calculated as relative to 
matched non-infected controls. The geometric mean of comparative data from three 
housekeepers was used to normalise differences in total cDNA between samples 
(Vandesompele et al. 2002): GAPDH, RPLP0, and POLR2A were selected as good 
housekeepers for HEp-2 cells; whilst GAPDH, RPLP0, and B2M were more stably 
expressed than other genes in polarised Caco-2 cells (Dydensborg et al. 2006). VILI was 
chosen as the housekeeper for Salmonella-infected ex vivo organ culture tissues because 
villin is a major marker protein located in the cores of the microvilli present on the 
intestinal epithelial cells (Bretscher and Weber 1980;Simms et al. 2008). Reactions for 
each target or housekeeping gene were performed in triplicate and the same 
experimental conditions were analysed in duplicate. 
 
2.10.2. Quantitative real-time PCR for WITS 
A sophisticated experimental model using 8 wild-type isogenic tagged strains (WITS) 
has been developed by Dr Andrew Grant in Cambridge to analyse heterogeneous traits 
of simultaneous infections with tagged Salmonella enterica populations, and to map 
spatiotemporal population dynamics of bacteria during an infection in vivo (Grant et al. 
2008). Application of this novel method facilitated a comprehensive view of the spatial 
and stochastic nature of within-host dynamics, particularly time-course variations in 
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quantities of individual WITS in different organ tissues during a systemic infection. 
Although WITS and transposon mutants may or may not phenotypically behave the 
same as their parental wild-type strain, both share a common characteristic which is 
disruption in the bacterial genome. Therefore, quantification of individual WITS using 
real-time PCR enables utilisation of WITS to investigate the pooling effects within a 
library of mixed tagged strains upon individual tagged strains at different stages during 
in vitro infections. 
 
In the modified invasion and intracellular replication assays using a library of pooled 6 
or 8 WITS (2.4.3.), 2 ml (~2 × 109 CFU) of pooled 18-hour cultures or their OD600-
adjusted PBS re-suspensions from 6 or 8 WITS was centrifuged, resuspended, and the 
pellet was dissolved in 180 l of Buffer ATL (DNeasy® Blood & Tissue Kit, Qiagen) as 
Input pool. The infected cells in a condition within wells in duplicate after 3 different 
treatment protocols in Figure 2.4 were individually lysed in totally 180 l of Buffer ATL 
per output pool to generate 'Output pools' A, B, and C. 
 
DNA extraction was carried out using DNeasy® Blood & Tissue Kit (Qiagen) according 
to the manufacturer’s instruction as described in 2.1.3.. Finally bacterial DNA was 
eluted into 100 l of Buffer AE. DNA concentrations at OD260 and purity were measured 
using a NanoDrop ND-1000 spectrophotometer (Thermo Scientific). 
 
All primers were purchased from Eurofins MWG Operon (Germany) with their 
sequences shown in Table 2.7. These primers were designed for real-time PCR to 
specifically and quantitatively detect the 40 base-pair signature tag and kanamycin 
resistance cassette inserted in the malXY locus at base 1,678,843 in the SL1344 genome 
of 8 individual WITS (Table 2.2). Using the Rotor-Gene 6000 (Corbett Research), 2.5 
μl of DNA was amplified in a 25 μl reaction containing 0.5 μM of each paired primers 
and 12.5 μl of 2× SYBR Green JumpStart Taq ReadyMix (Sigma-Aldrich) with an 
initial hot start step of 15 minutes at 95°C, followed by 40 cycles of 94°C for 15 
seconds, 61°C for 30 seconds and 72°C for 20 seconds and finally a melting step at 65–
95°C. Specificity of PCR products was confirmed by melting curve analysis and by 
electrophoresis on GelRed-stained 2% agarose gels.  
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Table 2.7 Primer sequences for Salmonella Typhimurium WITS 
Primer ID  Sequence (5'-3') Target strain 
ajg497 ACGACACCACTCCACACCTA WITS 1 
ajg498 ACCCGCAATACCAACAACTC WITS 2 
ajg503 ATCCCACACACTCGATCTCA WITS 11 
ajg504 GCTAAAGACACCCCTCACTCA WITS 13 
ajg507 TCACCAGCCCACCCCCTCA WITS 17 
ajg509 GCACTATCCAGCCCCATAAC WITS 19 
ajg510 ACCTAACTATACCGCCATCC WITS 20 
ajg511 ACAACCACCGATCACTCTCC WITS 21 
ajg520 CACGGAAAACATCGTGAGTC Common 
 
To analyse absolute quantification data, DNA copies per reaction in real-time PCR 
should be calculated from known DNA template concentration prior to establishment of 
standard curves. First, the number of copies of DNA per reaction was calculated using 
the equation (Mass of DNA x Avogadro’s constant)/(Average molecular weight of a 
deoxynucleotide base pair × number of base pairs in the genome) (Adams 2006). The 
Avogadro’s constant is 6.02214179 × 1023 molecules/mole. The average molecular 
weight of a deoxynucleotide base pair was taken to be 660 daltons, with genome length 
taken to be 4.9 × 106 base pairs. After the concentrations of DNA in the samples (X ng/
l) were measured, the corresponding numbers of DNA copies in each 2.5 l were 
calculated as the following: 
 
(X × 10-9 g/ l × 2.5 l × 6.02214179 × 1023 molecules/mole)/(660 g/mole/base pairs × 
4.9 × 106 base pairs) 
= X × 2.5 × 10-9 × 6.02214179×1023/3,234,000,000 molecules (copies of DNA) 
 
Second, each standard curve per primer pair was calculated over seven 10-fold dilutions 
using nuclease-free water from the original extracted DNA from WITS, starting with 4–
7 × 107 DNA copies and ending with 4–7 × 101 DNA copies per reaction that is 
approximately parallel to DNA concentrations of from 100 ng/ l down to 0.0001 ng/ l 
per reaction. This is based on a phenomenon that the standard curve equation, 
Concentration = 10(A(Ct) + B), links the concentration of DNA to the number of 
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thermocycles (Ct) that was required to reach the fluorescence threshold at which point 
individual amplification reactions contain identical amounts of DNA. The values of the 
unknown parameters A and B can be estimated by fitting a simple linear regression 
model to log10(concentration) against Ct value. For each standard curve the Rotor-Gene 
1.7 software calculated the threshold that corresponds to the values of A and B that 
provided the best-fit line through the data points. This automatically software-adjusted 
equation can be used to predict the unknown DNA amounts of each WITS in an 
experimental sample for each primer pair. The final data were expressed as DNA copies 
per 5×105 cells (per well). 
 
2.11. Transposon directed insertion-site sequencing (TraDIS) 
2.11.1. Construction of transposon libraries in Salmonella Typhimurium 
SL1344 
A library of totally 10,368 transposon mutants from Salmonella Typhimurium SL1344 
were generated by Dr Sarah Peters and her colleagues in Cambridge Veterinary School 
using refined Tn5 and Mu transposons, which were based on Tn5 and Mu 
transpososome constructs from EZ-Tn5TM R6Kãori/KAN-2 and HyperMuTM 
R6Kãori/KAN-1 Tnp TransposomeTM Kits (Epicentre) (Chaudhuri et al. 2009b). This 
Tn5 or Mu transposon, also named 'Gene-Kelly' Transposon, was initially designed for 
Transposon Mediated Differential Hybridisation (TMDH) (Charles and Maskell 2001) 
but later applied to Transposon Directed Insertion-site Sequencing (TraDIS) in this 
study (Langridge et al. 2009).  
 
The 'Gene-Kelly' Transposon comprises outward-facing T7 and SP6 promoters RNA 
polymerase recognition sites, homing endonuclease recognition sites for I-SceI and PI-
PspI, and an R6K origin of replication (R6Kγori) adjacent to the kanamycin resistance 
cassette (Kanr) flanked by hyperactive 19 base pair Mosaic End (ME) EZ-Tn5 
Transposase recognition sequences (Figure 2.9) (Maskell et al. 2003). First, T7 and SP6 
promoters RNA polymerase recognition sites allow the generation of both left and right-
arm RNA products corresponding to the regions flanking the site of transposon 
integration in genomic DNA. These RNA products can be labelled for hybridisation in 
microarrays. Second, incorporation of recognition sites for rare-cutting enzymes I-SceI 
and PI-PspI introduces these sites into a bacterial genome following transposition. 
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Subsequent digestion of transposed DNA with the rare-cutting enzymes can rescue the 
transposon ends using a ligation-capture method: biotinylated linkers with 
complementary ends corresponding to either the I-SceI or the PI-PspI overhangs are 
ligated to the I-SceI or PI-PspI digested chromosomal DNA followed by streptavidin-
conjugated magnetic beads to recover the transposon-flanking sequence fragments. This 
technique can rapidly and selectively purify the regions of genomic DNA at the site of 
transposon insertion. A linear amplification of target from chromosomal DNA can be 
achieved using ligation-capture and either T7 or SP6 RNA polymerase without any PCR 
step. Third, incorporation of R6Kγori adjacent to Kanr allows rescue for plasmids 
containing the complete Gene-Kelly transposon plus the flanking regions of 
chromosomal DNA near the insertion site. Chromosomal DNA was digested using a 
restriction endonuclease not present in the transposon sequence, re-ligated, transformed 
into a strain of pir+ E. coli allowing R6Kγori to function, and finally selected on 
kanamycin plates. Hence, only plasmid DNA with R6Kγori and Kanr were rescued and 
purified.  
 
Figure 2.9 Diagrammatic representation of the 'Gene-Kelly' Transposon (Maskell et al. 
2003). 
 
The complete sequence of the 'Gene-Kelly' transposon is listed in Figure 2.10, with 
highlights of specific regions in the mosaic ends, the RNA polymerase binding sites, the 
homing endonuclease sites, and the sequence complementary to the linker PCR primer 
(LPCR-INT) that will be described in 2.11.5.. 
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CTGTCTCTTATACACATCTCTTCTATAGTGTCACCTAAATAGGGATAACAGGGT
AATGAATTCGTTAATACAGATGTAGGTGTTCCACAGGGTAGCCAGCAGCATCC
TGCGATGCAGATCCGGATGCCATTTCATTACCTCTTTCTCCGCACCCGACATA
GATCCGAAGATCAGCAGTTCAACCTGTTGATAGTACGTACTAAGCTCTCATGT
TTCACGTACTAAGCTCTCATGTTTAACGTACTAAGCTCTCATGTTTAACGAACT
AAACCCTCATGGCTAACGTACTAAGCTCTCATGGCTAACGTACTAAGCTCTCA
TGTTTCACGTACTAAGCTCTCATGTTTGAACAATAAAATTAATATAAATCAGCA
ACTTAAATAGCCTCTAAGGTTTTAAGTTTTATAAGAAAAAAAAGAATATATAA
GGCTTTTAAAGCTTTTAAGGTTTAACGGTTGTGGACAACAAGCCAGGGATCT
GCCATTTCATTACCTCTTTCTCCGCACCCGACATAGATCCGGAACATAATGGT
GCAGGGCGCTGACTTCCGCGTTTCCAGACTTTACGAAACACGGAAACCGAA
GACCATTCATGTTGTTGCTCAGGTCGCAGACGTTTTGCAGCAGCAGTCGCTT
CACGTTCGCTCGCGTATCGGTGATTCATTCTGCTAACCAGTAAGGCAACCCCG
CCAGCCTAGCCGGGTCCTCAACGACAGGAGCACGATCATGCGCACCCGTGG
CCAGGACCCAACGCTGCCCGAGATGCGCCGCGTGCGGCTGCTGGAGATGGC
GGACGCGATGGATATGTTCTGCCAAGGGTTGGTTTGCGCATTCACAGGGTGT
CTCAAAATCTCTGATGTTACATTGCACAAGATAAAAATATATCATCATGAACAA
TAAAACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTATGAGCCATATT
CAACGGGAAACGTCTTGCTCGAGGCCGCGATTAAATTCCAACATGGATGCTG
ATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACA
ATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGG
CAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGG
CTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGAT
GATGCATGGTTACTCACCACTGCGATCCCCGGAAAAACAGCATTCCAGGTATT
AGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCC
TGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGC
GTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGC
GAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAA
GAAATGCATAAACTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGA
TTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGA
TGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGG
AACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATA
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TGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGA
GTTTTTCTAATCAGAATTGGTTAATTGGTTGTAACACTGGCAGAGCATTACGC
TGACTTGACGGGACGGCGGCTTTGTTGAATAAATCGAACTTTTGCTGAGTTG
AAGGATCAGATCACGCATCTTCCCGACAACGCAGACCGTTCCGTGGCAAAGC
AAAAGTTCAAAATCACCAACTGGTCCACCTACAACAAAGCTCTCATCAACCG
TGGCGGGGATCCTCTAGAGTCGACTGGCAAACAGCTATTATGGGTATTATGGG
TAATACGACTCACTATAGGGAGATGTGTATAAGAGACAG 
 
Figure 2.10 Sequence of the 'Gene Kelly' transposon (kindly provided by Dr Sarah 
Peters from Cambridge Veterinary School). Mosaic ends (ME) are italicised, the RNA 
polymerase binding sites are in bold, the homing endonuclease sites are underlined, and 
the sequence complementary to the linker PCR (LPCR-INT) is in blue colour. 
 
2.11.2. Preparation of Input pool and collection of Output pools in a HEp-2 
cell culture model 
To prepare inoculums for TraDIS in vitro infection in HEp-2 cells, 1,440 Tn5 
transposon mutants from Set 6 of the total library (Chaudhuri et al. 2009b) were 
individually grown in 1 ml of LB broth with kanamycin (30 g/ml) in 2 ml 96-well 
blocks at 37°C overnight. Then 1,440 overnight cultures with 500 μl from each were 
pooled into a sterile bottle and evenly mixed. Next, 3 ml of the pooled culture was 
removed, centrifuged at 4300 × g at for 8 minutes, and pellets were resuspended in PBS 
with an adjusted OD600 of ~0.8 and its equivalent density of ~0.8 × 109 CFU/ml. The 
PBS bacterial resuspension was used for inoculation into HEp-2 cells. The remainder 
was used for preparation of 'Input pool' genomic DNA. A dose of 2.4 × 107 CFU was 
chosen empirically as sufficient to prevent random dropout of mutants and to maintain 
90–99% viability of the infected cells after 10 hours, and was prepared in 30 l of PBS 
to inoculate 1-day-old HEp-2 cells per well in 6-well plates with a MOI of 40-50. At the 
time points for harvest using the treatment procotol detailed in 2.4.3., the infected HEp-
2 cells were lysed in 1 ml of 1% Triton X-100 per well and totally 2 ml of cell lysates 
from each output pool (A, B, and C) were plated out on two large 50 ml LB agar plates 
and incubated at 37°C overnight. In this way, DNA of bacterial cells became more 
predominant than DNA of eukaryotic cells as Salmonella bacteria grew on agar plates 
whereas lysed HEp-2 cells did not. On the next day, colonies were scraped off and 
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bacteria from each 2 plates in the same output pool were re-suspended by adding 20ml 
of LB broth then poured into 10 ml Falcon tubes for preparation of genomic DNA in 
three 'output pools'.  
 
2.11.3. Extraction and preparation of genomic DNA from Input/Output 
pools 
For the library of 1,440 mutants, genomic DNA from the Input pool and three Output 
pools was prepared by combined use of phenol extraction and the DNeasy® Blood & 
Tissue Kit (Qiagen). For the Input pool, bacteria were recovered from 200 ml of pooled 
overnight culture by centrifugation at 4,300 × g at 15°C for 10 minutes. For each Output 
pool, bacteria in 20 ml of LB broth resuspensions from confluent plates were collected 
by centrifugation at 4,300 × g at 15°C for 10 minutes. In each Input/Output pool, the 
pellet was re-suspended in 20 ml of TE buffer (10 mM Tris pH 8, 10 mM EDTA), 400 l 
of 10 mg/ml lysozyme (Sigma-Aldrich) in water was added, and incubated at 42°C for 
30 minutes. Then 200 l of Proteinase K (Qiagen), 40 l of RNase A (Qiagen), and 2 ml of 
10% (w/v) N-laurylsarcosine sodium (Sigma-Aldrich) were added and incubated at 50–
55°C for 1 hour or until completely lysed (clear). DNA of the lysates was extracted by 
adding 1 volume of buffered phenol (Sigma-Aldrich), shaking, and centrifuging at 7,000 
× g for 10 minutes. In this step, less-polar side chains of cellular proteins were unfolded 
inside-out to react with phenol in the lower organic layers, whilst polar DNA was 
dissolved and isolated in the upper aqueous layers. Afterwards, a 250 l aliquot of each 
phenol-extracted lysate was removed into a 1.5 ml nuclease-free tube, cleaned, and 
processed using a DNeasy® Blood & Tissue Kit (Qiagen), starting at step 3 of the 
Animal Tissues (Spin-Column protocol). Briefly, 250 l of phenol-extracted lysate was 
added with 250 l of Buffer AL and 250 l of pure ethanol, mixed well, and pipetted into a 
DNeasy® Mini spin column placed in a 2 ml collection tube, centrifuged at 6,000 × g for 
1 minute. After discarding flow-through and collection tube, the spin column was 
placed in a new collection tube, added with 500 l of Buffer AW1, and centrifuged at 
6,000 × g for 1 minute. The spin column was placed into another new collection tube, 
added with 500 l of Buffer AW2, and centrifuged at 20,000 × g for 3 minutes to dry the 
DNeasy® membrane. Finally the spin column was removed into a clean 1.5 ml nuclease-
free tube and 50 l of Buffer AE was added, incubated at room temperate for 1 minute, 
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and then centrifuged for 1 minute at 6,000 × g to elute DNA. DNA elution was repeated 
once using the flow-through 50 l of Buffer AE to maximise yield. Similarly, genomic 
DNA was prepared from 50 ml of wild-type Salmonella Typhimurium SL1344 
overnight culture at 37°C in LB broth for use as an untransposed control. 
 
DNA concentrations at OD600 and purity were measured using a NanoDrop ND-1000 
spectrophotometer. The DNA concentrations ranged 140–400 ng/l and the A260/A280 
ratios of all DNA were within 1.7–1.9. To check if any degradation, 1 l of extracted 
DNA was run on a GelRed-stained 0.8% agarose gel. DNA samples without degradation 
should be predominantly visible above the top of 1,000 bp ladder. Both unused phenol-
extracted lysates and cleaned DNA were stored at 4°C. 
 
2.11.4. Digest of genomic DNA from Input/Output pools 
To evaluate if there was any dropout of transposon mutants in the pooled library during 
infection and processing, their genomic DNA was digested by a restriction enzyme into 
smaller pieces prior to Linker PCR for assessing the pool complexity. From each 
Input/Output pools and the untransposed control DNA, 5 g of genomic DNA was 
digested using 3 l of RsaI (Promega), 5 l of 10× Buffer C (Promega), 0.5 l of 100× 
BSA (Promega), and nuclease-free water in a 50 l of total reaction volume for 
incubation at 37°C overnight. Digested DNA was cleaned using a QIAquick PCR 
Purification Kit (Qiagen) according to the manufacturer’s instruction, and eluted in 30 l 
of nuclease-free water to keep the concentration sufficiently high.  
 
The DNA concentrations were 120–170 ng/ l and A260/A280 ratios were all within 1.7–
1.9 after measurement using a NanoDrop ND-1000 spectrophotometer. To check if 
digest was complete, 1 l of cleaned DNA digest was run on a GelRed-stained 0.8% 
agarose gel. Ideally, DNA RsaI digests should be discernible as fragments ranging from 
very small up into the 2–2.5 kb range with an average of ~1,000 bp in size. Cleaned 
DNA digests were stored at –20°C. 
 
2.11.5. Linker PCR 
As applied to identification of essential Staphylococcus aureus genes using TMDH 
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(Chaudhuri et al. 2009a), this linker PCR technique was designed to generate a gel 
profile for a pool of mutants by PCR-amplifying the region of each mutant’s genome 
between the transposon and its end containing the restriction fragment. Linker PCR on 
digested DNA of both the input and output pools from the established Salmonella 
infection in vitro (2.4.3.) allows us to compare the numbers and relative frequencies of 
mutants between the output pools and the input pool, and to assess if significant dropout 
of mutants has occurred. If there is significant dropout, many bands in the input pool’s 
gel profile will disappear in the output pool(s) and often a few output pool bands will 
increase in their intensity to form dominant bands. 
 
Linker PCR is based on the blunt-end ligation of a significantly overhanging 
oligonucleotide linker (oligos 256 and 254) to both ends of each restriction fragment cut 
by RsaI (GT↓AC), followed by PCR with one primer (LPCR-INT) complementary to 
the transposon DNA (sequence in blue colour in Figure 2.9) and another primer (oligo 
258) identical to the overhanging DNA of the linker (Table 2.8) as shown in Figure 
2.10 and as below:  
 
Oligo LPCR INT                                      TTAGAGACTACAATGTAACGTGTTC-5' 
Corresponding region in transposon     5'-AATCTCTGATGTTACATTGCACAAG 
 
The binding site for this linker primer (oligo 258), which is corresponding to the 
overhanging DNA of the linker as shown in the following underlined sequence, only 
exists after DNA extension from the transposon primer (LPCR-INT). This prevents the 
amplification of restriction fragments lacking a transposon, which could otherwise 
result from binding of the linker primer to the linker at each end of every fragment. 
 
                          5'-GATAAGCAGGGATCGGAACCTCCAGGTCCAGTCG 
                               CTATTCGTCCCTAGCCTTGGAAGGTCCAGGTCAGC-5' 
Oligo 258          5'-GATAAGCAGGGATCGGAACC 
 
The sequence of oligo 258 is identical to overhang of the linker, which is underlined in 
the partial sequence of oligo 256. 
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Table 2.8 Primer sequences for use in linker PCR 
Primer 
ID  
Sequence (5'-3') Source 
(Reference) 
Oligo 
256 
GATAAGCAGGGATCGGAACCTCCAGGTCCAGTCG  (Chaudhuri 
et al. 2009a) 
Oligo 
254 
CGACTGGACCTGGA  (Chaudhuri 
et al. 2009a) 
Oligo 
258 
GATAAGCAGGGATCGGAACC  (Chaudhuri 
et al. 2009a) 
LPCR-
INT 
CTTGTGCAATGTAACATCAGAGATT  Dr Sarah 
Peters 
 
First, the linker was generated by annealing 10 M of each oligo 256 and oligo 254 in an 
annealing buffer (10 mM Tris pH 8, 50 mM NaCl, 1mM EDTA; Sigma-Aldrich) after 
incubation at 95°C for 3 minutes followed by cooling on bench for 1 hour and chilling 
on ice. When two oligonucleotides annealed, the linker formed as follow: 
 
Oligo 256          5'-GATAAGCAGGGATCGGAACCTCCAGGTCCAGTCG 
Oligo 254                                                      AGGTCCAGGTCAGC-5' 
 
Second, ligation between the linker and both ends of restriction fragments 
was done using a Quick Ligation Kit (New England BioLabs) by incubating 50 ng of 
cleaned digested DNA, 4 l of the annealed oligos, 5 l of 2× Quick ligation reaction 
buffer, and 0.5 l of Quick T4 DNA ligase, and nuclease-free water in a 10.5 l of total 
reaction volume at room temperature for 5 minutes followed by chilling on ice. Thus, 
blunt-end ligation was completed as shown in Figure 2.10. After being added up to a 25 
l total volume by adding 14.5 l of nuclease-free water, ligated DNA templates were 
cleaned with QiaQuick PCR Purification Kit (Qiagen) and eluted with 50 l of Buffer 
EB. This linker PCR template was kept on ice for PCR or stored at –20°C for later use. 
 
Third, linker PCR was carried out as illustrated in Figure 2.11. Using a GeneAmp PCR 
System 9700 thermocycler (BioRad), 2 μl of DNA template was amplified in a 25 μl 
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reaction containing 1 μM of each oligos 258 and LPCR-INT, 0.2 mM of each dNTP 
(Fermentas), 2.5 μl of 10× Buffer (Qiagen), 5 μl of  5× Buffer Q (Qiagen), and 0.25 μl 
of HotStarTaq polymerase (Qiagen) with an initial hot start step of 95°C for15 minutes, 
followed by 30 cycles of 94°C for 45 seconds, 55°C for 1 minute and 72°C for 2 
minutes, with a final extension step of 72°C for 5 minutes. 
 
To check pool complexity, 5 l of each PCR sample was run on a GelRed-stained 1.2% 
agarose gel as most bands will be below 1.5 kb. Ideally, gel profiles of linker PCR 
products should show similarity in their banding patterns between Input pool and 
Output pools without significant dropout of mutants. 
 
 
Figure 2.11 Schematic illustration of linker PCR. 
 
2.11.6. Determination of transposon integration sites in the genomes of  
individual mutants from Input/Output pools 
Integration sites of the transposon Tn5 into the genomes of individual mutants from 
Input and Output pools were determined with comparisons in their relative abundance 
using Transposon Directed Insertion-site Sequencing (TraDIS) in the Wellcome Trust 
Sanger Institute (Cambridge, UK) as previously described (Langridge et al. 2009). This 
very high-throughput sequencing technology can simultaneously assay every gene in 
the genome to map 370,000 unique transposon insertion sites to the Salmonella enterica 
serovar Typhi chromosome using genomic DNA from a huge bacterial mutant pool 
consisting of estimated 1.1 million transposon mutants (Langridge et al. 2009). 
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Briefly, 5 µg of genomic DNA was fragmented to an average size of 300 bp by Adaptive 
Focused Acoustic (AFA™, Covaris) (Quail et al. 2008) and Illumina DNA fragment 
library preparation was performed following the manufacturer’s instructions, but using 
1.5× the recommended reagent volumes in each step. Ligated fragments without the 
preceding column clean-up step were run on a 12-cm 2% agarose gel in 1× TBE buffer 
at 6 Volts/cm. After 45 minutes, fragments corresponding to an insert size of 250–350 
bp were excised, and DNA was extracted from the gel slice without heating (Quail et al. 
2008). The DNA was quantified on an Agilent DNA1000 chip according to the 
manufacturer’s instructions. To amplify the transposon insertion sites, 22 cycles of PCR 
were performed using a transposon-specific forward primer and a custom Illumina 
reverse primer (Langridge et al. 2009), and 100 ng of DNA fragment library per reaction. 
Amplified libraries were cleaned up using a QiaQuick PCR Purification Kit (Qiagen) 
according to the manufacturer’s instruction, eluted into 30 µl of Buffer EB, and 
followed by quantitative PCR (Quail et al. 2008). The amplified DNA fragment libraries 
were sequenced on paired or single end Illumina flow cells using an Illumina GAII 
sequencer, for 36 or 54 cycles of sequencing, using a custom sequencing primer and 23 
hybridization buffer (Langridge et al. 2009). This primer was designed such that the first 
10 bp of each read was transposon sequence. 
 
2.11.7. Analysis of TraDIS data 
Sequence reads from the Illumina FASTQ files were parsed for 100% identity to the last 
10 bp of the transposon (TAAGAGACAG). Matching sequence reads were stripped of 
this transposon tag, and mapped to the Salmonella Typhimurium SL1344 chromosome 
using MAQ version MAQ-0.6.8 as previously described (Li et al. 2008). The output 
from the MAQ mapview command was used to determine the first nucleotide position 
to which each read mapped, giving a precise insertion site. The number and frequency 
of insertions mapping to each nucleotide in the Salmonella Typhimurium SL1344 
genome from the duplicate Input/Output pool samples were then determined for each 
condition. Comparison of these data with gene boundaries was defined from the 
GenBank annotation (http://www.ncbi.nlm.nih.gov/nuccore/301156631) enabled the 
number of sequence reads and the number of different insertion sites to be determined 
for every gene. For comparison of the genes identified in vitro and in vivo, the dataset 
obtained from incubating the library of Salmonella Typhimurium with HEp2 cells was 
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compared to the results from the mouse infection model (Chaudhuri et al. 2009b) (see 
last two columns of Tables 5.1, 5.3, and 5.4). 
 
2.12. Statistical analysis 
Quantitative data are expressed as means ± standard errors of the means (SEM) for 
parametric data, and median or geometric means (scatter plot) for non-parametric data. 
When the mRNA transcripts were undetectable in Quantitative real-time PCR for 
analysis of their absolute quantitative data, the highest concentrations of the used 
standard curves in IL-8 or hBD-2 were utilised for statistical comparison. Statistical 
analyses were performed using SPSS 14.0. Two-tailed Student’s t-test was used to 
evaluate significant differences between two groups or one-way analysis of variance 
(ANOVA) was used for multiple groups in parametric data. Wilcoxon signed rank test 
was used to determine significant differences between two groups or Friedman test was 
used for multiple groups in non-parametric data. A P-value of < 0.05 was considered 
statistically significant. 
  
In analysis of the data from TraDIS (2.11.7.), the raw sequence counts for each mutant 
in each sample (two replicates each for Input, Output A, B and C) were converted into 
the log2 fold changes for a comparison between any two sets of pools among the Input 
and the Output A, B, and C. The log2 fold changes and P values were calculated using 
the software DESeq (http://www-huber.embl.de/users/anders/DESeq/). This yields the P 
values for each pairwise comparison, which was corrected for multiple testing using 
Benjamini and Hochberg's False Discovery Rate. A P-value of < 0.1 was considered 
statistically significant. 
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3a.1. Background 
The validity of in vitro cultured cells as a model to evaluate physiological function in 
vivo has been questioned because they are not always able to fully express a 
characteristic in vivo phenotype due to the lack of heterogeneity, three-dimensional 
architecture and an appropriate microenvironment. Complex interplays between 
different cells/tissues in vivo can not be entirely re-established in cell cultures in vitro to 
reflect cell-cell or cell-matrix interactions. With less or no stimuli from cytokines, 
growth factors, hormones, and other regulating factors, the microenvironment in vitro 
favours proliferation of undifferentiated cells rather than expression of their 
differentiated functions. Therefore, the nature of substrate on or in which cells grow, the 
degree of contact with other cells, the constitution of the media, the gas composition, 
and the incubation temperature can influence not only cell growth and differentiation 
but also expression of specialised functions in cultured cells (Freshney 2005). 
 
Researchers use both in vitro and in vivo models to better understand the underlying 
mechanisms of infectious diseases despite a gap in complexity between those two 
systems. In order to explore how Salmonella initiates disease at the intestinal epithelium, 
in vitro models have served as a useful tool for identifying molecular mechanisms 
involved in cellular internalisation of Salmonella and stimulation of host inflammatory 
responses, which can be further tested using in vivo models (Hurley and McCormick 
2003). 
 
In vitro cell culture models have been optimised in this study to explore early 
interactions between non-typhoidal Salmonella and human epithelium. First, an in vitro 
cell culture model is feasible to investigate early events during Salmonella infection 
which can be focused on the superficial layer of epithelium with less involvement of 
underlying tissue and inflammatory cells. However, an in vivo animal model is mostly 
preferred to investigate adaptive immunity, induction of diseases, and systemic 
pathogenesis. Second, an in vitro cell culture model is more reproducible and stable than 
an ex vivo organ culture model. Biopsy specimens from individuals with inconsistent 
immunological and pathophysiological conditions may show considerable variations in 
tissue expression. Such reproducibility and stability of an in vitro cell culture model in 
certain phenotypes have a great advantage for screening Salmonella virulence genes 
responsible for cellular adherence, invasion, and intracellular replication. Last but not 
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least, to maintain an in vitro cell culture model is practically more convenient and 
efficient than an in vivo animal model particularly when repeated tests are needed. 
 
Different cell culture lines including COS-1, MDCK, HeLa (Henle-407, HEp-2), Caco-
2, T84, and HT-29 cells have been utilised for the identification of Salmonella 
determinants and host factors responsible for its invasion  process (Hurley and 
McCormick 2003;Raffatellu et al. 2005b). COS-1 and MDCK are suitable for 
transfection of plasmids with encoding genes but they are derived from kidney tissues in 
monkey and canine respectively (Chen et al. 1996;Shi et al. 2005). Henle-407 cells and 
HEp-2 cells were originally from human embryonic intestinal epithelium and laryngeal 
epithelium respectively (Galan and Curtiss, III 1989;Leung and Finlay 1991), but later 
were found to be contaminated by HeLa cells which are human cervical epithelial 
cancer cells (Gey et al. 1952). However, neither HEp-2 cells nor HeLa cells were 
derived from intestinal epithelium where Salmonella infection is usually initiated. Caco-
2 and T84 cells derived from human colonic cancer cells can somehow simulate human 
small and large intestinal cells respectively (Benya et al. 1999;Stierum et al. 2003). 
MDCK, Caco-2, T84, and HT-29 cells can be developed into polarised cell monolayers 
when grown on filter inserts (Schuller and Phillips 2010;Shi et al. 2005;Wells et al. 
1998). Such polarised cell cultures, despite costly and lengthy processing, can be 
approached from apical and basolateral sides of the monolayers, evaluated for 
differentiated enterocytes functions such as formation of tight junctions and microvilli 
(Schuller and Phillips 2010), and co-cultured with other cells for simulating intercellular 
relations within the intestinal mucosa (Fang et al. 2010). 
 
HEp-2 or HeLa cells have been extensively used to study these initial events during 
early stages of bacterial infections, including attachment/adherence (Boddicker et al. 
2002;Hancox et al. 1997), invasion/internalisation (Douce et al. 1991;Lee et al. 
1992;Small et al. 1987), and intracellular replication/proliferation (Leung and Finlay 
1991;Small et al. 1987) for not only Salmonella spp. but also other enteropathogens 
such as enteroinvasive E. coli, Yersinia spp. (Small et al. 1987), Shigella spp. (Niesel et 
al. 1985), and Helicobacter pylori (Wilkinson et al. 1998). This human epithelial cell 
line was also used as a model to assess NF-κB activation in immunohistochemical 
staining because of an optimal nucleus-to-cytoplasm ratio (Ma et al. 2004) that 
facilitates our image approach to intracellular Salmonella. Moreover, this cell line 
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allows electron microscopical recording of characteristic membrane ruffling (La 
Ragione et al. 2003) and microscopic observation of cytoskeletal rearrangement in non-
phagocytic cells during Salmonella invasion (Finlay et al. 1991;Garcia-del and Finlay 
1994). Taking these advantages, a HEp-2 cell culture model was considered to study 
early interactions of non-typhoidal Salmonella with human epithelium. 
 
Furthermore, application of HEp-2 cell cultures has been extended into molecular 
analysis, including investigation into allelic variation in a specific gene related to 
binding to and biofilm formation on cells (Boddicker et al. 2002), identification of the 
induced specific Salmonella genes using luciferase reporter gene cassette insertion 
mutants upon bacterial invasion into cells (Pfeifer et al. 1999), detection of novel 
chromosomal loci affecting entry of Salmonella using transposon mutants (Lee et al. 
1992;Stone et al. 1992), and microarray analysis of time-dependent changes in 
Salmonella gene expression within epithelial cells (Hautefort et al. 2008). Therefore, 
integrating the time course of bacterial infection into genetic selection can validate 
HEp-2 cell cultures as an appropriate model for identifying Salmonella virulence genes 
in screening of transposon mutants using microarrays (e.g. TMDH) or bacterial 
transposon-targeted sequencing (e.g. TraDIS). 
 
During infection of microbial pathogens, host intestinal barrier function and 
inflammatory responses of innate immunity can directly or indirectly reflect pathogen 
virulence via diverse mechanisms. Host inflammation mainly begins with the 
recognition of microbial products, known as pathogen associated molecular patterns 
(PAMPs), by specific cell receptors, known as pattern recognition receptors (PRRs), 
triggering various generic responses to eliminate invading pathogens. For bacterial 
pathogens, PAMPs are recognised by two main PRRs–transmembrane Toll-like 
receptors (TLRs), or intracellular nucleotide oligomerisaton domain-like receptors 
(NLRs), leading to downstream signalling cascades that result in the activation of NF-
κB, mitogen-activated protein kinases (MAPK), and the production of pro-inflammatory 
cytokines (Akira et al. 2006). PAMPs of Salmonella include triacyl lipopeptides or  
(Tukel et al. 2010), bacterial lipoproteins, lipopolysaccharide (LPS), flagella, and CpG 
DNA which can be individually recognised by TLR1/TLR2, TLR2, TLR4, TLR5, and 
TLR9 from 12 TLR members in mammals (Akira et al. 2006;Balaram et al. 2009). The 
sensing PRRs are widely expressed in different cells of the immune system. In contrast 
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to macrophages, neutrophils, and dendritic cells which are allowed to fully respond to 
any invading pathogen, intestinal epithelial cells exposed to massive amounts of 
bacterial products from both pathogens and commensal flora are responsible for 
maintenance of intestinal bacteria-cell homeostasis. Uncontrolled and controlled 
inflammation can be dynamically balanced for host cells to tackle pathogens and 
minimise pathology. Nevertheless, NF-κB and MAPK signalling pathways leading to 
innate immune responses in epithelial cells can also be PRR-independently mediated by 
effector proteins of Salmonella Typhimurium (Bruno et al. 2009). 
 
Defensins are important small cationic antimicrobial peptides of innate immunity in 
mammals and play a key role in the host defence properties of granulocytic leucocytes, 
mucosal surface, skin, and other epithelia (Selsted and Ouellette 2005). Antimicrobial 
peptide expression in the gastrointestinal tract is either constitutive or inducible: the 
major constitutive human β-defensin (hBD)-1 synthesised in the surface of colonic 
epithelium; and the major inducible hBD-2 and hBD-3 and smaller amounts of hBD-4 
are expressed only during infection or inflammation (Wehkamp et al. 2007). The 
induction of hBD expression is mediated by proinflammatory cytokines such as IL-1β, 
through TLR-dependent (e.g. NF-κB, MAPK) and TLR-independent (e.g. NOD2, IL-
17R, PAR-2) signalling pathways (Froy 2005;Wehkamp et al. 2007). Using non-
polarised Caco-2 cells in plastic wells, hBD-2 mRNA expression can be upregulated in 
response to IL-1α and Salmonella dublin (O'Neil et al. 1999), and induced by 
Salmonella enteritidis FliC (Ogushi et al. 2001). Interestingly, non-polarised HT-29 
cells responded with IL-8 secretion to bacterial DNA extracted from a wide range of 
bacterial strains in a differential manner (Jijon et al. 2004). Using polarised Caco-2 cells 
in transwells, both TLR4 and MD-2 are proven to be required for LPS-mediated 
expression of hBD-2 in TLR4/MD-2-transfected cells (Vora et al. 2004). Nevertheless, a 
comprehensive study using polarised Caco-2 cells to overview host innate immune 
responses after stimulation with different Salmonella PAMPs is still lacking. 
 
Polarised Caco-2 cells have been proven superior to polarised T84 cells in Salmonella 
Typhimurium-induced hBD-1 and hBD-2 mRNA expression and IL-1β-stimulated IL-8 
mRNA expression (Ou et al. 2009). However, a thorough investigation has never been 
undertaken in both protein secretion and mRNA expression of IL-8 and hBD using 
bidirectional stimulation of polarised intestinal epithelial cell monolayers from apical 
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and/or basolateral sides. Therefore, a polarised Caco-2 cell culture model was 
established. A variety of characteristics of cell differentiation at three different ages 
were compared, including integrity of monolayers, vulnerability to bacterial invasion, 
and morphological changes of cell surfaces. Consequently, 14-day-old polarised Caco-2 
cells were selected for further experiments to evaluate if this in vitro model could 
reliably examine host innate responses after stimulation of various Salmonella PAMPs 
that would be useful in characterisation of selected Salmonella transposon mutant 
strains. 
 
Overall, adhesion is a prerequisite for Salmonella invasion (Baumler et al. 1996) with 
accompanying recruitment of host neutrophils and transcellular signalling (McCormick 
et al. 1993). Bacterial invasion into host cells (Pace et al. 1993) and intracellular 
replication (Leung and Finlay 1991) are essential for the pathogenicity and virulence of 
Salmonella Typhimurium. Therefore, reductionist models are required for unravelling 
the relationships between Salmonella Typhimurium and epithelial cells by exploring all 
these events. For seeking an appropriate in vitro cell culture model for Salmonella 
infection to assess bacterial attachment, invasion, and intracellular replication in non-
phagocytic epithelial cells, various approaches have been developed. First, scanning 
electron microscopy was performed to observe bacterial adhesion and morphological 
changes on host cell surfaces during early stages of infection. Second, two different 
methods of immunofluorescence staining were conducted to seek qualitative evidence 
of intracellular bacteria. Third, gentamicin protection assays were carried out for 
quantitative evidence of invasion and intracellular replication of Salmonella 
Typhimurium. Different bacterial strains were compared in their invasive capacity and 
the advantages/disadvantages of three cell culture models including HEp-2 cells, non-
polarised Caco-2 cells, and polarised Caco-2 cells were analysed. Selected HEp-2 and 
polarised Caco-2 cell culture models were tested in host barrier or innate responses 
(Chapter 3a), probiotic modulation of lactobacillus strains, or cellular NF-κB signalling 
(Chapter 3b). An optimised HEp-2 cell culture model was employed to indentify 
virulence gene by screening large pools of random transposon mutants (Chapter 5).  
 
3a.2. Results 
3a.2.1. Establishment of a reproducible in vitro HEp-2 cell culture model 
Many factors may affect invasiveness of Salmonella species within in vitro cell culture 
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models, including bacterial virulence, host defence, and bacteria-cell contact created by 
artificial manipulation in laboratories. Expression of bacterial virulence factors are 
influenced by bacterial growth phase and anaerobic conditions (Ernst et al. 1990;Lee 
and Falkow 1990), activation of bacteria by cultivations in cell-culture media under 
increased CO2 atmosphere (Rhen et al. 1993), carbohydrate concentration in media 
during infection (Schiemann 1995), and bacterial storage conditions for preparing 
overnight cultures. In this study, approximately 18-hour overnight cultures without 
activation in media were prepared for most in vitro infections except for mid-log-phase 
cultures that were used in preliminary experiments and studies concerning bacterial 
secreted FliC. All infections were carried out under conditions free of foetal bovine 
serum in plain DMEM with a constant glucose concentration of 4500 mg/L. A mixed 
gas of 5% CO2 and 95% O2 was utilised before July 2009 and after that time an 
atmosphere of 5% CO2 and 95% air followed for laboratory consistency. All overnight 
cultures were prepared from colonies on LB agar plates that had been restored from 
bacterial stocks in Microbank® at –80°C every month. This manipulation was found to 
significantly increase invasiveness of bacteria rather than using overnight cultures 
directly prepared from thawed bacterial stocks in 20% Glycerol in LB broth at –80°C 
for in vivo infections (Chaudhuri et al. 2009b;Douce et al. 1991). 
 
Theoretically, longer periods of infection, higher bacteria-to-cell ratios (i.e. multiplicity 
of infection, MOI), and reduced confluence of cell monolayers may render host cells 
more vulnerable to invasive bacteria because of more and/or closer contact between 
bacteria and cells. It can be difficult to discriminate between invasion and intracellular 
replication because intracellular bacterial infection is actually a dynamic process with 
time. It has been shown that the distribution of bacteria was uneven in many cells 
without associated bacteria but aggregated microcolonies were identified in some cells 
when interaction times were longer than 2 hours particularly with low inoculums 
(Douce et al. 1991). Therefore invasion rates in this study were defined as the 
intracellular viable bacterial amounts relative to the initial inoculum at certain time 
points, which are set at 1 hour or 2 hours after initiation of infections. Intracellular 
replication was regarded as the increment of intracellular bacteria which started after 
killing of extracellular bacteria by appropriate gentamicin treatment and continued 
within cells in plain DMEM with no or low concentration of gentamicin for an 
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incubation period as long as cellular viability could be secured. 
 
Centrifugation has been used to enhance of bacterial invasion in cells. However, such 
assistance is controversial because it may increase invasion of attenuated mutants 
compared with their parent wild-type strains, but may also tend to cause detachment of 
cell monolayers as well as create different biological fates of bacteria (Bolton et al. 
2000;Douce et al. 1991;Vesikari et al. 1982). Hence, other than in some early tests using 
HEp-2 cells for image studies and comparison of invasion in different Salmonella 
Typhimurium wild-type strains, non-centrifuge-assisted attachment was adopted as 
routine in subsequent assays and screening of transposon mutants in this study. 
 
3a.2.1.1. Assessment of bacterial colonisation and invasion 
First, SEM was performed to observe early events on HEp-2 cell surfaces after 
Salmonella infection. After inoculation of mid-log-phase cultures of Salmonella 
Typhimurium SL 1344 at a MOI of 20 for 10 minutes, 30 minutes, 1 hour, 2 hours , 4 
hours, and 6 hours, infected HEp-2 cells were fixed for SEM after washing off non-
adherent bacteria and the time-course images are shown in Figure 3.1. After 10 minutes 
of exposure to Salmonella, a small number of scattered single bacterial rods were found 
to be entangled by the protruding cellular microfilaments but still not entirely attached 
to the cell surface; representing the first identified step of interaction between bacteria 
and cells (white arrowheads). After 30 minutes, bacterial rods become more closely 
adhered to the cell surface in a cluster (white arrowheads) next to a site of membrane 
ruffling (white arrow), in the central part of which a rod appeared to be invading into 
the cell whilst a big lamellipodia (black arrows) developed nearby. After 1 hour, 
bacterial rods (white arrowheads) were more aggregated into bigger clusters by closely 
overlapping with each other on the cells. After 2 hours, bacterial aggregation become 
looser, possibly reflecting that bacteria had already invaded cells, or/and were detached 
after bacteria-cell interactions. Some paired bacteria were connected on their ends 
(white arrowhead) that could be bacteria after dividing and filopodia developed in their 
proximity (black arrowheads). After 4 hours, the cell surfaces remained similar to those 
at 2 hours with scattered single or linked bacteria (white arrowheads) rather than 
bacterial clusters. As late as 6 hours after infection, only very few single bacilli were 
visible (white arrowhead) but lamellipodia was still noticeable (black arrows). These 
interactive SEM images of Salmonella Typhimurium and human epithelial cells indicate 
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evidence of early bacterial colonisation and possible internalisation despite the inability 
of SEM to detect intracellular bacteria. 
 
10 min 30 min
1 hr
6 hr4 hr
2 hr
 
Figure 3.1 Kinetic morphological changes of Salmonella Typhimurium SL1344-
infected HEp-2 cells by ×5,000 SEM (white arrow: membrane ruffling; white 
arrowheads: colonisation of rods; black arrows: lamellipodia; black arrowheads: 
filopodia). 
 
Second, two methods of double immunostaining were employed to seek direct evidence 
of bacterial invasion within HEp-2 cells. After inoculation of mid-log-phase cultures of 
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five wild-type Salmonella Typhimurium strains at a MOI of 10 for 2 hours including an 
initial 10-minute period of centrifugation, infected HEp-2 cells after washing off non-
adherent bacteria were fixed for double immunofluorescence staining. The Alexa Fluor 
568 (alternative to TRITC) and Alexa Fluor 488 (alternative to FITC) images are shown 
in Figure 3.2. The extracellular bacteria were visualised as red rods by the TRITC filter 
system (left column marked as Alexa 568). After FITC filtering, additional bacteria 
appeared and were obviously intracellular (right column marked as Alexa 488). In other 
words, red and green stained bacteria were extracellular (arrows), whereas only green 
but not red stained bacteria were intracellular (arrowheads). By this simple 
immunostaining, intracellular Salmonella were easily identified. Despite possible 
differences in the intracellular bacterial amounts between six Salmonella Typhimurium 
wild-type strains, quantitative assays are still required to objectively compare their 
invasiveness. Furthermore, elongated filamentous rod-shaped bacteria were found in 
only some extracellular Salmonella Typhimurium NCTC 12023 and ST12/75, indicative 
of their growing either under steady-state conditions (Grover et al. 1977) or when 
exposed to marginal growth conditions (Mattick et al. 2003). 
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Figure 3.2 Double fluorescence immunostaining in 2-day-old HEp-2 cells after 2-hour 
infection of five wild-type Salmonella Typhimurium strains (400×). Bacteria shown in 
both red and green were extracellular (arrows). Bacteria shown in green, but not in red, 
were intracellular (arrowheads). 
 
In epithelial cells, the intracellular pathogen Salmonella Typhimurium resides and 
replicates within a cytoplasmic organelle, the Salmonella-containing vacuole (SCV) 
(Steele-Mortimer et al. 1999). Using this character, combined anti-Salmonella O4 and 
LAMP-1 immunostaining provides an alternative method for assessing intracellular 
Salmonella in vitro (Freeman et al. 2003). After inoculation of overnight cultures of 
Salmonella Typhimurium SL1344 at a MOI of 10 for 2 hours, infected HEp-2 cells after 
washing off non-adherent bacteria and uninfected controls were fixed for combined 
immunofluorescence staining using anti-Salmonella O4 and LAMP-1 antibodies. In the 
merged image from the Alexa Fluor 568 and 488 systems, red rods surrounded by 
cytoplasmic green SCV were identified as intracellularly localised Salmonella (Figure 
3.3). 
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Figure 3.3 Combined immunofluorescence staining using anti-Salmonella O4 and 
LAMP-1 antibodies for intracellular bacteria in vitro. Arrows indicate intracellular 
Salmonella Typhimurium SL1344 (red rods) surround by Salmonella containing 
vacuoles (SCV; bright green) in the cytoplasm adjacent to the nuclei (400×). 
 
Third, bacterial invasion was quantitatively analysed using gentamicin protection assays, 
including invasion assays for six wild-type Salmonella Typhimurium strains and 
intracellular replication arrays for two wild-type Salmonella Typhimurium strains and 
their SPI-1/SPI-2 isogenic strains. 
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Six wild-type strains of Salmonella Typhimurium were examined for their invasion rates. 
After inoculation of overnight cultures of Salmonella Typhimurium strains NCTC 
12023, ST4/79, ST4/74 Nalr, ST12/75, ST TML, and SL1344 at a MOI of 10 for 2 
hours including an initial 10-minute centrifugation, the infected 2-day-old HEp-2 cells 
and 10-day-old non-polarised Caco-2 cells in plastic wells were lysed for quantification 
of viable invading bacteria using gentamicin protection invasion assays. A similar trend 
was detected in the invasion rates of >2% for ST4/79 and SL1344 in HEp-2 cells which 
were higher than those of the other four strains (Figure 3.4), indicating that both might 
be good candidates for establishing novel Salmonella infection models in HEp-2 cell 
cultures. However, unlike the reproducible results in HEp-2 cells, when grown on 
plastic wells, Caco-2 cells might form dome-shaped blebs (Grasset et al. 1984) that 
easily led to detachment despite careful washing, resulting in the failure to maintin 
intact infected cell monolayers for accurate bacterial quantification. Therefore, a 
different polarised Caco-2 cell culture model was applied to gentamicin protection 
assays in 3a.2.2.3 and 3a.2.2.4.  
 
 
Figure 3.4  Invasion rates of 6 wild-type Salmonella Typhimurium strains after 
infection for 2 hours with an initial 10-minute centrifugation in HEp-2 cells (results 
represent the mean + SEM, n = 3) as judged by gentamicin protection assay. 
 
Intracellular replication assays were performed on the basis of the above infection 
protocol in gentamicin protection invasion assays, followed by prolonged incubation of 
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the HEp-2 cells infected with parental wild-type Salmonella Typhimurium NCTC 12023 
and its two isogenic mutant strains (SPI-1 mutant ∆prgH and SPI-2 mutant ∆ssaV) for 5 
more hours with three different time points at 3, 5, and 7 hours post inoculation for 
harvesting cells (Table 3.5). Similarly, following 1-hour infection and another 1-hour 
gentamicin protection, another set of HEp-2 cells infected with parental wild-type 
Salmonella Typhimurium SL1344 and its two isogenic mutant strains (SPI-1 mutant 
∆spaS and SPI-2 mutant ∆ssaU) remained incubated for another 7 hours and were 
finally lysed at 9 hours post inoculation for quantification of intracellular bacteria 
(Table 3.6).  
 
Salmonella Typhimurium NCTC 12023 continuously proliferated within the infected 
cells over the 5-hour duration, with increasing ~3.5-fold intracellular bacterial amounts 
from at 2 hours (0.82 ± 0.29%) to reach the highest peak at 7 hours (2.82 ± 0.40%) after 
inoculation. Simultaneously, the intracellular bacterial rate of the SPI-2 mutant ΔssaV 
remained almost unchanged (0.26 ± 0.17% at 2 hours, 0.30 ± 0.17% at 3 hours, 0.32 ± 
0.19% at 5 hours, 0.40 ± 0.22% at 7 hours) (Table 3.5). This result confirmed that 
disruption of the SPI-2 gene ssaV remarkably suppressed the capability of intracellular 
replication in its parental wild-type strain NCTC 12023. At 3 hours after inoculation 
when extracellular bacterial infection had been stopped for 1 hour, the intracellular 
viable bacterial rate for the SPI-1 mutant ΔprgH (0.06 ± 0.03%) was much lower than 
those of the other two strains (NCTC 12023: 1.40 ± 0.39%, ΔssaV: 0.30 ± 0.17%) that 
validated the close correlation of the SPI-1 gene prgH to bacterial virulence of 
invasiveness. 
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Figure 3.5 Kinetics of bacterial intracellular rates in the wild-type strain NCTC 12023, 
the SPI-2 mutant strain ΔssaV, and the SPI-1 mutant strain ΔprgH of Salmonella 
Typhimurium in 2-day-old HEp-2 cells in 24-well plates (results represent the mean ± 
SEM, n = 3). 
 
Similarly, in another set of the Salmonella Typhimurium wild-type strain SL1344 and its 
two isogenic strains, the SPI-1 mutant ΔspaS had much lower invasion rates at 2 hours 
and 9 hours (0.005 ± 0.004%, 0.151 ± 0.066% respectively) after inoculation compared 
with those of the other two strains (SL1344: 5.63 ± 1.23%, 42.38 ± 13.51%; ΔssaU: 
3.00 ± 0.45%, 25.56 ± 2.41%) that proved its incompetence in invasion after knocking 
out the SPI-1 gene spaS (Table 3.6). Although the wild-type SL1344 significantly 
multiplied within cells for ~8-fold over the 7-hour period from 2 hours to 9 hours post 
infection, the SPI-2 mutant ΔssaU seemed not entirely deprived of its competence in 
intracellular replication after disruption of the SPI-2 gene ssaU, indicative of this single 
gene within SPI-2 not fully responsible for intracellular replication in non-phagocytic 
epithelial cells. 
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Figure 3.6 Intracellular bacterial rates in 2-day-old HEp-2 cells after the wild-type 
strain SL1344, the SPI-2 mutant ΔssaU, and the SPI-1 mutant ΔspaS of Salmonella 
Typhimurium in 12-well plates (results represent the mean ± SEM, n = 3). 
 
3a.2.1.2. Assessment of host responses 
3a.2.1.2.1. Morphological responses 
Host responses were firstly observed on the surface of the infected HEp-2 cells. 
Rather than the ×5,000 SEM images in Figure 3.1, ×10,000 SEM pictures in higher 
magnification power reveal more informative details in Figure 3.7. As early as 10 
minutes after the initiation of infection, some elongated bacteria rods were trapped by 
the distal part of the filaments but still not “ground” on the cell surface (Figure 3.7A). 
At 30 minutes after inoculation, bacterial rods were closer to the cell surface, with cells 
displaying a typical splash-like membrane ruffling, triggered by a rod entering the cell 
(Figure 3.7B). This membrane rumbling could originally derive from filopodia which 
was initially a thin cell surface extension, reported to be filled with tight parallel 
bundles of actin filaments to explore the surfaces of other cells for identifying adhesion 
targets (Wood and Martin 2002). At 1 hour after infection, lamellipodia were visible 
larger than filopodia and possibly developed from migrating epithelial sheets to zipper 
and fuse to one another (Figure 3.7C). Moreover, the temporal SEM images provided 
dynamic evidence of cell viability during Salmonella Typhimurium SL1344 infection.  
 
 138
10 min
30 min
1 hour
A
B
C
 
Figure 3.7 Morphological changes on the surface of Salmonella Typhimurium SL1344-
infected HEp-2 cells by ×10,000 SEM. 
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3a.2.1.2.2. Innate immune responses 
To evaluate different host responses such as proinflammatory cytokine IL-8, enzyme-
linked immunosorbent assay (ELISA) and quantitative real time PCR (qRT-PCR) were 
used to measure protein and gene expression levels. In addition, Western blots can 
provide qualitative and semiquantitative analysis of specific proteins, such as 
phosphorylated and total NF-κB p65 involved in the pro-inflammatory signalling 
pathways, and immunostaining can illustrate kinetic distribution of the target protein 
inside cells during Salmonella infection, e.g. the translocation of total NF-κB p65. 
These approaches for innate immune responses of host cells were used to assess 
probiotic modulation of existing Salmonella Typhimurium infection by lactobacilli in 
3b.2. 
 
3a.2.2. Establishment of a reproducible in vitro polarised Caco-2 cell culture 
model 
In this study, the second in vitro cell culture model using Caco-2 cells rather than HEp-2 
cells was adopted to examine if virulence factors of Salmonella Typhimurium and host 
immune responses could be reproducibly evaluated. The use of Caco-2 cells has been 
employed as a model of the absorptive and the defensive properties of the intestinal 
mucosa to show a spontaneous differentiation pathway in long-term culture, and to 
express several morphological and biochemical characteristics of small intestinal 
enterocytes (Sambuy et al. 2005). Polarised Caco-2 cells can be cultured for up to 5 
days to achieve undifferentiated cells as the in vitro counterpart of crypt cells after 5-day 
culture, and for 19 days to grow into differentiated cells as the in vitro counterpart of 
villous cells (Malago et al. 2003). TEER of filter-grown Caco-2 cell monolayers can 
increase and reach a plateau after 21 days (Bravo et al. 2004). Therefore, a series of 
experiments were undertaken in 5-day-old, 14-day-old, and 20-day-old polarised Caco-
2 cells to decide an appropriate duration for evaluation of bacterial virulence and host 
reactions during early stages of Salmonella Typhimurium infections. 
 
3a.2.2.1. Morphology and integrity of polarised Caco-2 cell 
monolayers with different differentiation 
The SEM morphological features illustrated age-dependent differentiation of filter-
grown polarised Caco-2 cells. After 5 days of incubation, cellular microvilli were evenly 
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distributed without distinct cell margins on the surfaces of Caco-2 cells (Figure 3.8A). 
With more differentiation, after 14 days of incubation, polarised Caco-2 cells revealed 
identifiable cell margins with different microvillous patterns on individual single cells 
(Figure 3.8B). On the surfaces of the cells incubated for 20 days, some showed 
prominent individual microvilli and the others displayed flattened or confluent 
microvilli. These different microvillous patterns between adjacent cells made the cell 
borders more visible under SEM (Figure 3.8C). 
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Figure 3.8 Morphological changes on the cell surfaces of 5-day-old (A), 14-day-old (B), 
and 20-day-old (C) polarised Caco-2 cells in various degrees of differentiation (arrows: 
border margin of a single cell) by ×3,500 SEM. 
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The integrity of filter-grown Caco-2 cells increased parallel with their time of 
incubation as measured by TEER values. Thus the TEER of Caco-2 cells increased from 
461.9 ± 21.6 Ω cm2 at 5 days, to 921.9 ± 107.6 Ω cm2 at 14 days, and reached a high 
level of 1598.7 ± 150.2 Ω cm2 at 20 days after incubation (Figure 3.9). All these TEER 
values of >400 Ω cm2 were higher than the previously described TEER values of ~200–
300 Ω cm2 in uninfected polarised Caco-2 cells (Bravo et al. 2004;Malago et al. 2003). 
 
 
Figure 3.9 TEER changes in 5-day-old, 14-day-old, and 20-day-old filter-grown Caco-2 
cells at various stages of differentiation (results represent the mean + SEM, n = 3). 
 
3a.2.2.2. Assessment of bacterial colonisation, invasion, and 
intracellular replication 
For assessing bacterial colonisation, SEM was conducted to observe early events on 
polarised Caco-2 cell surfaces after Salmonella Typhimurium and EPEC infection. After 
inoculation of mid-log-phase cultures of Salmonella Typhimurium SL 1344 and EPEC 
E2348/69 with MOI of 50 for one hour, infected filter-grown Caco-2 cells after washing 
off non-adherent bacteria were incubated for another 3 hours and then fixed for SEM 
(Figure 3.10). Compared to uninfected cells with prominent microvilli (Figure 3.10C), 
both Salmonella Typhimurium SL1344- and EPEC E2348/69-infected cells showed a 
paucity of the microvilli with colonised bacteria on the cell surface. Scattered bacterial 
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rods of Salmonella Typhimurium SL 1344 (white arrowheads) were found on or near 
the protruding surfaces (white arrow) that may represent some variation of lamellipodia 
(Figure 3.10A), whilst bacterial rods of EPEC E2348/69 (black arrowheads) were more 
compactly associated on the cell surface without membrane ruffling or 
fipopodia/lamillepodia (Figure 3.10B).  
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Figure 3.10 Morphological changes on the cell surfaces of 20-day-old polarised Caco-2 
cells after infection with Salmonella Typhimurium SL1344 (white arrowheads) (A) and 
EPEC E2348/69 (black arrowheads) (B) for 4 hours (long arrow: probable extruding 
cell with lamellipodia formation). An uninfected cell is shown in the bottom picture (C). 
×3,500 SEM.  
 
A preliminary experiment was performed to seek evidence of bacterial invasion in 
Caco-2 cells: 7-day-old Caco-2 cells grown in plastic wells were infected with mid-log-
phase cultures of 5 wild-type Salmonella Typhimurium strains at a  MOI of 30 for 4 
hours and then fixed for double fluorescence immunostaining, as in the images in HEp-
2 cells shown in Figure 3.2. In the Alexa Fluor 568 and 488 images of infected Caco-2 
cells only the strains ST4/79, ST4/74 Nalr, and ST12/75 showed a few green but not red 
stained bacteria which were intracellular bacteria (arrowheads, Figure 3.11). Evidence 
in invasiveness of Salmonella Typhimurium NCTC 12023 and ST TML was not 
convincingly strong and compatible with their low invasion rates in HEp-2 cells as 
measured by the gentamicin protection assay (see Figure 3.4) that necessitated further 
assays for confirmation.  
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Figure 3.11 Double fluorescence immunostaining in 7-day-old Caco-2 cells grown on 
coverslips in plastic wells after 4-hour infection of five wild-type Salmonella 
Typhimurium strains (400×). Bacteria shown in both red and green were extracellular 
(arrows). Bacteria shown in green, but not in red, were intracellular (arrowheads). 
 
To quantitatively confirm bacterial invasion and compare vulnerability of the variously 
differentiated cells, 5-, 14-, and 20-day-old polarised Caco-2 cells were infected with 
Salmonella Typhimurium wild-type SL1344 with MOI of 20–25 for 1 hour, followed by 
another 1-hour period of gentamicin protection. Cells were then lysed and the viable 
intracellular bacterial load was determined. The result showed that the average invasion 
rates of Salmonella Typhimurium SL1344 relative to inoculums were respectively 1.2%, 
7.7%, and 4.6% in 5-, 14-, and 20-day-old filter-grown Caco-2 cells (Figure 3.12). 
Obviously, 14-day-old polarised Caco-2 cells was the most vulnerable model to 
invasion of Salmonella Typhimurium SL1344. 
 
 
Figure 3.12 Invasion rates of Salmonella Typhimurium SL1344 in 5-day-old, 14-day-
old, and 20-day-old polarised Caco-2 cells (results represent the mean + SEM, n = 3). 
 
To further quantify and compare the capabilities of bacterial intracellular replication in 
Salmonella Typhimurium SL1344 wild-type and SPI-1/SPI-2 mutant strains, 14-day-old 
polarised Caco-2 cells were infected with Salmonella Typhimurium SL1344, ΔspaS, and 
ΔssaU for 2 hours, followed by gentamicin protection for 1 hour, and the intracellular 
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infections continued for another 7 and 21 hours. During the prolonged period of 
intracellular bacterial infection, the viable intracellular bacterial replication rates of 
Salmonella Typhimurium SL1344 increased from 4.7 ± 1.7% to 6.7 ± 1.4% for the first 
7 hours, but declined to 3.0 ± 0.5% for the last 21 hours; the rates of Salmonella 
Typhimurium ΔssaU replication rose from 2.9 ± 1.2% to 5.2 ± 0.4% after the first 7 
hours, but fell to 3.0 ± 0.8% after the last 21 hours. In contrast, the intracellular bacterial 
rates of Salmonella Typhimurium ΔspaS remained extremely low during the entire 
period, from 0.09 ± 0.01% at 3 hours to 0.05 ± 0.01% at 10 hours and finally 0.20 ± 
0.04% at 24 hours after initial inoculation (Figure 3.13A) that was compatible with the 
strong correlation of the SPI-1 gene spaS with bacterial invasiveness. When these 
intracellular rates were expressed as CFU per inoculum of 107 CFU in groups of 
individual strains at different time points, Salmonella Typhimurium SL1344 and ΔssaU 
had significantly higher rates than Salmonella Typhimurium ΔspaS at any time, and 
both their intracellular rates tended to reach a peak at 10 hours (6.7 × 105 ± 1.4 × 105 
and 5.2 × 105 ± 0.4 × 105 CFU per inoculum of 107 CFU, respectively) but could not 
proliferate intracellularly post this 10 hour time point (Figure 3.13B). However, despite 
a much lower intracellular bacterial amount after invasion than the other two strains, 
Salmonella Typhimurium ΔspaS could still grow from 5,316 ± 1,155 CFU to 20,545 ± 
3,493 CFU per inoculum of 107 CFU during the last 21 hours (Figure 3.13B), hinting 
that there could be a saturation capacity of the infected cells to accommodate limited 
amounts of intracellular viable Salmonella bacteria after infection. 
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Figure 3.13 Kinetic changes of intracellular bacterial rates of Salmonella Typhimurium 
SL1344, ΔspaS, and ΔssaU in 14-day-old polarised Caco-2 cells at 3 hours, 10 hours, 
and 24 hours after commencement of infection, shown in percentage (% of inoculum) 
(A), and in viable intracellular bacterial amounts (CFU per inoculum of 107 CFU) 
arranged in groups of individual strains (B) (results represent the mean ± or + SEM, n 
=3). 
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3a.2.2.3. Growth rates of the utilised Salmonella Typhimurium and 
EPEC strains and presence of FliC in their structural and 
secreted proteins 
Prior to utilisation of Salmonella Typhimurium wild-type SL1344 and its three isogenic 
strains ∆spaS , ∆ssaU, and ∆fliM in stimulating host cells or tissue for evaluating host 
immune responses, their growth rates in logarithmic cultures using time-course OD600 
values were compared. After that Western blots were used to examine their protein 
expression of FliC. Since FliC has been shown to exert an important role in stimulating 
host responses such as hBD-2 mRNA expression in non-polarised Caco-2 cells (Ogushi 
et al. 2001), it is necessary to confirm if FliC is deficient in the structural and secreted 
proteins of individual strains and the control strains of EPEC wild-type  E2348/69, 
AGT01 ∆fliC, and AGT02 ∆fliC (pFliC). 
 
The relationships between OD600 and durations of bacterial logarithmic cultures 
revealed a very similar pattern in the growth rates of Salmonella Typhimurium wild-
type and mutant strains but different trends in the growth rates of EPEC wild-type and 
mutant strains. After overnight cultures of bacterial strains were re-inoculated 1:100 into 
LB broth, small aliquots of the continuing logarithmic cultures were removed every 30 
minutes for OD600 reading from 1 hour to 4.5 hours after re-inoculation. Interestingly, 
the growing curves of Salmonella Typhimurium wild-type SL1344 and its three 
isogenic mutant strains ∆spaS , ∆ssaU, and ∆fliM were similarly reaching the mid-log-
phase point after ~3 hours with OD600 of ~0.7 (red, green, blue, and orange dots/curves 
respectively, Figure 3.14). However, compared with wild-type EPEC E2348/69 (purple 
dots/lines, Figure 3.14), its isogenic FliC-deficient strain AGT01 ∆fliC was growing 
slightly more slowly (brown dots/lines, Figure 3.14), both faster with earlier time points 
at ~2–2.5 hours to reach OD600 of ~0.7  than the four aforementioned Salmonella 
Typhimurium strains; and its FliC-complemented strain AGT02 ∆fliC pFliC was 
growing much more slowly with a later time point at 4 hours to reach OD600 of ~0.7 and 
a totally different growing curve (black circular triangles/lines, Figure 3.14). This 
indicated that growth velocity could not be completely restored after plasmid 
complementation of the knock-out gene in the bacterial genome. Because 
supramolecular bacterial structures such as flagella or pili are unintentionally emitted 
into media during bacterial growth when flagellar construction is carried on, mid-log-
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phase cultures are better than overnight cultures for harvest of secreted FliC (Komoriya 
et al. 1999). 
 
 
Figure 3.14 Time-course OD600 values of logarithmic cultures of Salmonella 
Typhimurium and EPEC wild-type and mutants (results represent the mean ± SEM, n = 
3). The dashed line indicates the OD600 value of 0.7, which is a selected point during the 
mid-log phase of Salmonella Typhimurium cultures in this study. 
 
Western blots using recombinant FliC as the positive control demonstrated that FliC was 
completely deficient in whole cells and supernatants of the flagellar switch protein 
knockout mutant (Toker et al. 1996) Salmonella Typhimurium ∆fliM compared to the 
presence of FliC in structural and secreted proteins of both wild-type SL1344 and its 
SPI-1 mutant strain ∆spaS (Figure 3.15). Interestingly, the SPI-2 mutant ∆ssaU with 
FliC found in its whole-cell structure did not appear to secrete FliC into the medium 
(Figure 3.15). Complete absence of FliC in structural and secreted proteins of all EPEC 
E2348/69 wild-type and mutant strains validated the specificity of anti-FliC antibody to 
Salmonella. Collectively, Salmonella Typhimurium ∆fliM can be used as a FliC-
deficient strain irrespective of its structural or secreted proteins, whilst Salmonella 
Typhimurium ∆ssaU can be regarded as a FliC-secretion incompetent strain with 
normal FliC expression in its whole-cell structure. 
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Figure 3.15 Representative Western blots of FliC (44-51 kD) in (A) structural protein 
(whole-cell) and (B) secreted protein (supernatant) from wild-type and mutant strains of 
Salmonella Typhimurium and EPEC using an anti-FliC antibody.  
 
3a.2.2.4. Comparison of polarised Caco-2 cells with three different 
stages of differentiation in their vulnerability to bacterial 
invasiveness and host innate immune responses 
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For better understanding of bacterial invasiveness and host innate immunity the 
invasion rates of Salmonella Typhimurium SL1344, ∆spaS, and ∆fliM as well as mRNA 
expression of IL-8, hBD-1, hBD-2, and hBD-3 in the infected cells were investigated in 
polarised Caco-2 cells with varied differentiation characteristics.  
 
In addition to comparing invasion rates of Salmonella Typhimurium SL1344 in 
polarised Caco-2 with three different stages of differentiation (Figure 3.12), the 
differences in the invasiveness of Salmonella Typhimurium SL1344, ∆spaS, and the 
FliC-deficient mutant ∆fliM were also compared in 5-, 14-, and 20-day-old polarised 
Caco-2 cells after a 2-hour period of infection (MOI = 20) and subsequent 1-hour period 
of gentamicin protection. In brief, Salmonella Typhimurium ∆spaS and ∆fliM had 
considerably lower invasiveness than Salmonella Typhimurium SL1344 in polarised 
Caco-2 cells at any age in differentiation (Figure 3.16). Although all remained very low, 
the invasiveness of Salmonella Typhimurium ∆spaS was 4,354 ± 1,068 CFU per 
inoculum of 107 CFU in 5-day-old Caco-2 cells, 10,915 ± 1,883 CFU per inoculum of 
107 CFU in 14-day-old Caco-2 cells, and 12,750 ± 4,233 CFU per inoculum of 107 CFU 
in 20-day-old Caco-2 cells, that increased ~2.5 fold and ~2.9 fold from the incubation 
periods of 5 days to 14 days and 20 days, respectively. With slightly higher average 
invasion rates than that of Salmonella Typhimurium ∆spaS in any case, Salmonella 
Typhimurium ∆fliM had the highest rate (82,496 ± 21,859 CFU per inoculum of 107 
CFU) in 20-day-old Caco-2 cells, followed by the intermediate rate (57,925 ± 3,479 
CFU per inoculum of 107 CFU) in 14-day-old Caco-2 cells, and the lowest rate (6,063 ± 
2,411 CFU per inoculum of 107 CFU) in 5-day-old Caco-2 cells. These generated a 
~9.6-fold increase and a ~13.6-fold increase from the incubation periods of 5 days to 14 
days and 20 days, respectively. In summary, among these Caco-2 cells of three different 
ages, 14-day-old cells are the most vulnerable to invasiveness of Salmonella 
Typhimurium SL1344, whilst 20-day-old cells are the most susceptible to invasion of 
Salmonella Typhimurium ∆spaS and ∆fliM. 
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Figure 3.16 Invasion rates of Salmonella Typhimurium SL1344, ∆spaS, and ∆fliM in (A) 
5-day-old, (B) 14-day-old, and (C) 20-day-old polarised Caco-2 cells (results represent 
the mean + SEM, n =3). 
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Using a protocol in which filter-grown Caco-2 cells were treated with Salmonella 
Typhimurium SL1344, ∆spaS, ∆fliM (MOI = 20), IL-1β, and PBS (uninfected control) 
for 2 hours, subsequent gentamicin protection for 1 hour, and further prolonged 
incubation in low-dose gentamicin for 7 hours, host immune responses were evaluated 
for host cell mRNA expression of IL-8, hBD-1, and hBD-2. The pro-inflammatory 
cytokine IL-1β has been used as a good stimulator for both protein and mRNA 
expression of IL-8 (Lugering et al. 1998) and hBD-2 (Schlee et al. 2007). Despite 
diverse ages in the polarised Caco-2 cells, hBD-1 mRNA was quite stably expressed 
without significant fluctuation after a variety of immunological stimulation (middle 
group, Figure 3.17A-C). The trends of induction in IL-8 mRNA expression were very 
similar in Caco-2 cells of three different ages after infection of three Salmonella 
Typhimurium strains, from the highest response induced by Salmonella Typhimurium 
SL1344, stepping down to the intermediate response by Salmonella Typhimurium 
∆spaS, and to the lowest response by Salmonella Typhimurium ∆fliM; whilst the 
general mRNA expression levels by any bacterial stimulation were slightly lower in 14-
day-old Caco-2 cells than the other two Caco-2 cells (left group, Figure 3.17A-C).  IL-
1β induced IL-8 mRNA expression with the highest response in 5-day-old cells (left 
group, Figure 3.17A), an intermediate response in 14-day-old Caco-2 cells (left group, 
Figure 3.17B), and the lowest in 20-day-old cells (left group, Figure 3.17C). In 
contrast, there were no detectable responses in hBD-2 mRNA expression in Salmonella 
Typhimurium ∆fliM-infected Caco-2 cells of three different ages (right group, Figure 
3.17A-C). The hBD-2 mRNA expression levels between Salmonella Typhimurium 
SL1344 and invasion-deficient ∆spaS in Caco-2 cells of three different ages showed no 
considerable differences, indicating that SPI-1 or bacterial invasion might not play a key 
role in hBD-2 expression. IL-1β triggered a significantly higher hBD-2 mRNA 
expression in 5-day-old Caco-2 cells than Salmonella Typhimurium SL1344 (right 
group, Figure 3.17A); such a stimulatory effect by IL-1β waned in 14-day-old Caco-2 
cells and declined to a very low level in 20-day-old Caco-2 cells (right group, Figure 
3.17B, C) that described a gradual resistance of differentiated Caco-2 cells to IL-1β 
stimulation in hBD-2 gene expression with a similar trend to IL-1β-induced IL-8 gene 
expression. Lastly, polarised Caco-2 cells were poorly responsive to different 
Salmonella Typhimurium strains and IL-1β in hBD-3 mRNA expression. 
 
 156
After taking all into consideration including adequate cellular differentiation, 
vulnerability to bacterial invasiveness, and acceptable host immune responses, 14-day-
old polarised Caco-2 cells were selected for further experiments to investigate the 
relationships between Salmonella PAMPs and host innate immunity. 
 
 
 157
Figure 3.17 IL-8, hBD-1, and hBD-2 mRNA expression after challenge of Salmonella 
Typhimurium SL1344, ∆spaS, ∆fliM, and IL-1β in (A) 5-day-old, (B) 14-day-old, and 
(C) 20-day-old polarised Caco-2 cells (results represent the mean + SEM, n =3) (NS: 
non-significant; ND: non-detectable). 
 
3a.2.2.5. Kinetic time-course study of IL-8, β-defensin-1 and β-
defensin-2 mRNA expression after Salmonella Typhimurium 
infections 
To seek an appropriate harvest time for studying IL-8, hBD-1 and hBD-2 mRNA 
expression, 14-day-old polarised Caco-2 cells were infected with Salmonella 
Typhimurium SL1344 at a MOI of 20 for 2 hours, protected from gentamicin for 1 hour, 
and intracellular bacterial infection continued in low-dose gentamicin media for another 
21 hours. During the entire period of 24 hours, infected cells with different incubation 
times were harvested at 2, 4, 6, 8, 10, and 24 hours post infection for quantitative RT-
PCR. After extracellular challenge of Salmonella Typhimurium SL1344 for the first 2 
hours but ongoing intracellular infection afterwards, IL-8 mRNA expression reached a 
highest level very early at 2 hours, declined with time until a stationary period between 
8–10 hours, and finally fell to the lowest level at 24 hours (Figure 3.18A). However, 
hBD-2 expression was initially low at 2 hours, increasing with time to reach a peak at 
10 hours, eventually falling to the lowest level at 24 hours. In contrast, hBD-1 gene was 
constitutionally expressed at different times during the entire infection period. 
Individual groups of IL-8, hBD-1, and hBD-2 mRNA expression clearly demonstrated 
an early peak in IL-8, a consistent pattern in hBD-1, and a steadily increasing trend with 
a later peak in hBD-2 (Figure 3.18B). Collectively, 10 hours post infection was selected 
as the harvest time point for subsequent experiments regarding host innate immunity in 
this in vitro model. 
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Figure 3.18 Kinetic time-course study of IL-8, hBD-1, and hBD-2 mRNA expression in 
14-day-old polarised Caco-2 cells over a total 24-hour duration after an initial 2-hour 
period of Salmonella Typhimurium SL1344 infection (results represent the mean + 
SEM, n =3). 
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3a.2.2.6. Host innate immune responses after Salmonella infection or 
challenge with various PAMPs 
To investigate which pathogen-associated molecular patterns (PAMPs) of Salmonella 
Typhimurium stimulate epithelial IL-8 and hBD-2 mRNA expression and protein 
secretion in human intestinal epithelial cells, the following experiments were processed 
and analysed. 
 
3a.2.2.6.1. IL-8, β-defensin-2 mRNA expression using real-time PCR 
Taking advantage of the characteristic Transwell® system that allows bidirectional 
approaches to cell monolayers, filter-grown polarised 14-day-old Caco-2 cells were 
stimulated with apical, basolateral, or bidirectional application of three Salmonella 
PAMPs including LPS, FliC, and Salmonella Typhimurium SL1344 DNA or IL-1β for 
10 hours to measure IL-8 and hBD-2 mRNA expression using quantitative real-time 
PCR.  
 
As shown in Figures 3.19, IL-8 transcriptional activity was undetectable in LPS-
stimulated and PBS-treated cells despite different direction of stimulation. Apical, 
basolateral, and bidirectional stimulation of Caco-2 cells with FliC (62.5×104, 24.9×104, 
and 118.6×104 copies of mRNA transcripts/μg total RNA, respectively), or Salmonella 
Typhimurium DNA (10.5×104, 7.3×104, and 18.5×104 copies of mRNA transcripts/μg 
total RNA, respectively) induced IL-8 mRNA expression. Upon challenge of FliC and 
bacterial DNA from whichever direction(s), the induced IL-8 mRNA expression levels 
after bidirectional stimulation were higher than those after either apical or basolateral 
stimulation, which disclosed some effects on IL-8 mRNA expression including 
synergism after FliC stimulation and an additive effect after DNA challenge. In any host 
IL-8 mRNA expression after whichever direction(s), IL-1β induced the highest response, 
whilst FliC induced the highest levels of IL-8 gene expression among three PAMPs.  
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Figure 3.19 (A) IL-8 mRNA expression in 14-day-old polarised Caco-2 cells after 
apical, basolateral, and bidirectional stimulation of Salmonella PAMPs and IL-1β 
(results represent the mean + SEM, n = 3) (ND: non-detectable). (B) Representative 
real-time PCR product bands of IL-8 mRNA transcripts (292 bp) on 2% agarose gel 
from triplicate. 
 
The transcriptional activity of hBD-2 gene showed a similar trend to that of IL-8 gene. 
Apical, basolateral, and bidirectional stimulation of Caco-2 cells with FliC (115.2×104, 
19.2×104, and 128.8×104 copies of mRNA transcripts/μg total RNA, respectively), or 
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Salmonella Typhimurium DNA (1.6×104, 0.2×104, and 2.6×104 copies of mRNA 
transcripts/μg total RNA, respectively) induced hBD-2 mRNA expression (Figure 3.20). 
After challenged with bacterial DNA from whichever direction(s), the average level of 
induced hBD-2 mRNA expression after bidirectional stimulation was approximately the 
sum of both hBD mRNA expression levels after apical and basolateral stimulation that 
indicated an additive effect. There was no such a phenomenon in FliC- or IL-1β-induced 
hBD-2 mRNA expression. In any host hBD-2 mRNA expression after whichever 
direction(s), IL-1β induced the highest response whilst FliC induced the highest levels 
among three PAMPs.  
 
 
Figure 3.20 (A) hBD-2 mRNA expression in 14-day-old polarised Caco-2 cells after 
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apical, basolateral, and bidirectional stimulation of Salmonella PAMPs and IL-1β 
(results represent the mean + SEM, n = 3) (ND: non-detectable). (B) Representative 
real-time PCR product bands of unnormalised hBD-2 mRNA transcripts (255 bp) on 2% 
agarose gel from triplicate. 
 
To confirm the roles of bacterial invasion and FliC in host innate immunity, cell 
monolayers were apically infected with Salmonella Typhimurium SL1344, ∆spaS, and 
∆fliM at a MOI of 20:1, or basolaterally stimulated with IL-1β for 2 hours before 
infections were stopped with 1-hour gentamicin treatment. At 7 hours post infection IL-
8 and hBD-2 mRNA expression were measured using quantitative real-time PCR.  
 
Salmonella Typhimurium SL1344, ∆spaS, and ∆fliM induced IL-8 mRNA levels 
(93.2×104, 45.5×104, and 20.3×104 copies of mRNA transcripts/μg total RNA, 
respectively), whilst only Salmonella Typhimurium SL1344 and ∆spaS, but not 
Salmonella Typhimurium ∆fliM, induced hBD-2 mRNA levels (62.2×104, 38.0×104 
copies of mRNA transcripts/μg total RNA, respectively) (Figure 3.21). In other words, 
FliC is essential for hBD-2, but not absolutely decisive to IL-8, at the mRNA expression 
level. 
 
 
Figure 3.21 IL-8 and hBD-2 mRNA expression in 14-day-old polarised Caco-2 cells 
after apical stimulation of Salmonella Typhimurium SL1344, ∆spaS, and ∆fliM, and 
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basolateral stimulation of IL-1β (results represent the mean + SEM, n =3) (ND: non-
detectable). 
 
3a.2.2.6.2. IL-8, β-defensin-2 protein production using ELISA 
To further inspect protein expression of IL-8 and hBD-2, cell monolayers were apically 
infected with Salmonella Typhimurium SL1344, ∆spaS, and ∆fliM at a MOI of 20:1, or 
basolaterally stimulated with IL-1β for 2 hours before infections were stopped with 1-
hour gentamicin treatment. At 21 hours post infection basolateral supernatants, apical 
supernatants, and cellular lysates were respectively collected to measure protein levels 
of IL-8 and hBD-2 using ELISA. 
 
Salmonella Typhimurium SL1344 and ∆spaS, but not Salmonella Typhimurium ∆fliM, 
induced basolateral secretion of IL-8 (SL1344: 98.0±10.4 pg/ml, ∆spaS: 75.5±19.7 
pg/ml, P <0.05; ∆fliM: 43.5±9.4 pg/ml, P >0.05; vs non-infected controls: 51.4±17.9 
pg/ml) (Figure 3.22) and apical secretion of hBD-2 (SL1344: 12.1±2.7 pg/ml, ∆spaS: 
10.1±3.6 pg/ml, P <0.05; ∆fliM: 4.4±0.2 pg/ml, P >0.05; vs non-infected controls: 
4.6±0.8 pg/ml) (Figure 3.23A). However, there were no significant differences in cell-
associated hBD-2 protein concentrations after stimulation of IL-1β, Salmonella 
Typhimurium SL1344, ∆spaS, ∆fliM, and PBS (IL-1β: 3.2±0.7 pg/ml, SL1344: 2.8±0.2 
pg/ml, ∆spaS: 3.4±0.9 pg/ml, ∆fliM: 2.3±0.3 pg/ml, P >0.05; vs non-infected controls: 
2.5±0.3 pg/ml) (Figure 3.23B). 
 
 
Figure 3.22 Basolateral IL-8 secretion from 14-day-old polarised Caco-2 cells after 
apical stimulation of Salmonella Typhimurium SL1344, ∆spaS, and ∆fliM, and 
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basolateral stimulation of IL-1β (results represent the mean + SEM, n = 3). 
 
 
Figure 3.23 (A) Apical and (B) cellular hBD-2 production from 14-day-old polarised 
Caco-2 cells after apical stimulation of Salmonella Typhimurium SL1344, ∆spaS, and 
∆fliM, and basolateral stimulation of IL-1β (results represent the mean + SEM, n = 3). 
 
3a.3. Discussion 
In this study, two in vitro cell culture models were established to investigate early 
interactions of non-typhoidal Salmonella with human epithelium. First, HEp-2 cells 
showed advantages of convenience, reliability, and reproducibility because they had 
faster growth, more intact cell monolayers, better cell viability, and allowed higher 
invasiveness of Salmonella Typhimurium than Caco-2 cells when grown in plastic wells. 
This is based on a series of tests considering different conditions, including seeding cell 
densities, overnight or logarithmic cultures, bacterial inoculums, centrifugation, 
duration of infection, intracellular invasion rates, integrity of monolayers, and cellular 
viability. Second, 14-day-old filter-grown polarised Caco-2 cells were chosen to study 
host innate immunity and will be utilised to characterise selected transposon mutants 
from TraDIS because of their polarity and differentiation states. 
 
Salmonella colonisation and invasion in vitro occur earlier than in vivo, and may 
correlate with membrane ruffling. SEM showed image evidence of characteristic ruffles 
accompanying possible bacterial entry into HEp-2 cells as early as 30 minutes, 
considerable aggregating colonisation at 1 hour post infection, lasting lamellipodia 
without adherent bacteria as late as 6 hours post infection (Figure 3.1), and paucity of 
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microvilli in both HEp-2 and polarised Caco-2 cells (Figure 3.12). These characteristic 
features of degenerated microvilli, penetrated brush border, and cytoplasmic projection 
into the lumen developed no sooner than 12 hours post oral challenge of Salmonella to 
guinea pig intestinal epithelium using electron microscopy as first described (Takeuchi 
1967). Apical entry of Salmonella Typhimurium directly into epithelial cells and 
subsequent residence within membrane-bound vacuoles occurred more frequently than 
passing through intercellular junctional complex (Takeuchi 1967). Salmonella attach to 
cell surface and trigger signals in epithelial cells that causes cytoskeletal rearrangements, 
involving recruitment of actin, α-actinin, and tropomyosin, which generates force with a 
phagocytic-like mechanism for bacterial uptake (Finlay et al. 1991). Another study 
indicated that membrane ruffling triggered by bacterial entry into epithelial cells is 
required to induce subsequent macropinosomes, which is due to the massive 
extracellular fluid intake into infected epithelial cells after specific signalling to the 
Salmonella invasion process but not to the bacterial attachment stage (Garcia-del and 
Finlay 1994). This validates our observation in membrane ruffling associated with the 
invading bacteria (Figure 3.7B).  
 
Molecular biological evidence unveiled more, but not all, mysteries regarding how 
Salmonella species utilise a Trojan horse strategy to infect cells. Upon attachment to the 
host cell surface, Salmonella translocate at least five T3SS effector proteins into 
cytoplasm for activation of the host cell Rho GTPases Cdc42 and Rac1, and RhoA, 
which in turn orchestrate actin assembly to respectively form filopodia, 
lamellipodia/ruffles, and stress fibres that can further augment cell motility and 
membrane trafficking events to facilitate bacterial entry into the cell (Bulgin et al. 
2010;Hall 1998;Le and Drubin 2004). The bacterial guanine nucleotide exchange factor 
(GEF) SopE and the inositol phosphatase SopB can activate Rho GTPases Rac-1 and 
Cdc42 to stimulate actin assembly, whilst another Salmonella protein SptP may inhibit 
Rho GTPases to downregulate actin assembly (Le and Drubin 2004). SipC can nucleate 
actin polymerisation and cooperate with SipA for bundling of actin filaments to cause 
ruffles and internalisation of Salmonella because SipA-coated actin filaments are not 
dynamic after SipA directly bind with actin, thus increases polymerisation in its vicinity 
to dynamically extend protrusions that underlies ruffling phenomenon (Jepson et al. 
2001;McGhie et al. 2001). Subversion of Rho family small GTPases to manipulate actin 
dynamics is a common infection strategy adopted by Salmonella Typhimurium, Shigella 
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flexneri, EPEC, and EHEC. Some of their T3SS effector proteins based on a conserved 
Trp-xxx-Glu (WxxxE) motif were grouped together into a WxxxE family, including 
SifA and SifB of Salmonella; representatives of these WxxxE effectors were recently 
found to share with SopE a 3-dimension fold and GEF activity (Bulgin et al. 2010). 
However, these ruffling-associated effector proteins are not necessarily indispensible 
with Salmonella colonisation and invasion. SipC is essential for Salmonella 
internalisation into cells (Kaniga et al. 1995), but SipA is not crucial for uptake but 
promotes the efficiency of the entry process (Zhou et al. 1999). Thus, systemic 
screening of all the genomic genes of Salmonella Typhimurium responsible for 
colonisation and invasion may hopefully discover more novel genes or to characterise, 
if any, their encoding virulence proteins involved in cellular cytoskeleton 
rearrangements for better understanding of correlations between these early actions of 
Salmonella and their comparable reactions of host cells. 
 
Adhesion is an important early step in bacterial colonisation to inaugurate the ensuing 
invasion in the intestinal mucosa. Lacking interference from gastric acid, bile salts, 
commensal flora, and mucus during in vivo infection via the oral route, Salmonella in 
vitro can quickly induce elongated microvilli by contact with epithelial cells, but not 
wholly and closely attach to the cell surface, as early as 10 minutes prior to occurrence 
of membrane ruffling with likely bacterial entry (Figures 3.1 and 3.7). In addition, 
SEM images showed different distribution patterns between Salmonella Typhimurium 
and EPEC on the surfaces of the infected HEp-2 cells (Figure 3.10). This could be 
explained by the phenomenon that Salmonella Typhimurium SL1344 were adherent to 
cell surfaces for a short time prior to invading cells, whereas EPEC E2348/69 are 
generally considered to be non-invasive and possess fimbriae, such as bundle forming 
pili, that promote compact colony formation, termed localised adhesion (Saldana et al. 
2009).  Alternatively it may just reflect a higher adherent capability of EPEC E2348/69 
in colonisation than Salmonella Typhimurium SL1344. 
 
Bacterial attachment to cell surface could be the first step of crosstalk and wrestling 
between pathogens and host cells during the adherence process. Before bacterial 
invasion into cells, Salmonella Typhimurium should encounter and attach to one or 
more cell types found in the intestinal tissue that may involve at least four types of 
fimbriae or pili including type 1 fimbriae (Fim), plasmid-encoded fimbriae (Pef), long 
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polar fimbriae (Lpf), and thin aggregative fimbriae (curli, Tafi). These fimbriae might 
also account for tropism in cell types and animal species (Darwin and Miller 1999). So 
far at least 13 putative fimbrial operons termed agf (csg), fim, pef, lpf, bcf, saf, stb, stc, 
std, stf, sth, sti, and stj have been identified from the Salmonella Typhimurium genome 
sequence and expression of 11 of these operons have been demonstrated (Humphries et 
al. 2003). An in vitro study using Salmonella Typhimurium single mutant strains in lpf, 
fim, or pef in various epithelial cell lines demonstrated that adhesion is a prerequisite for 
invasion and that fimbriae allow pathogenic bacteria to distinguish different epithelial 
cell types for invasion (Baumler et al. 1996). However, another in vivo study using 
Salmonella Typhimurium quadruple mutant in all four fim, lpf, pef, and agf in 
comparison with single mutant strains suggested a synergistic action of fimbrial operons 
during colonisation of the intestine and requirement of multiple fimbrial adhesins for 
full virulence of Salmonella Typhimurium in mice (van der Velden et al. 1998). 
Salmonella Typhimurium requires the Fim, Lpf, Pef, and Tafi fimbriae for biofilm 
formation in adhering to and adapting to the cell surface on HEp-2 cells and chicken 
intestinal epithelium (Boddicker et al. 2002;Ledeboer et al. 2006). In addition, other 
non-fimbrial adhesins were also discovered, including the SPI-4-encoded T1SS-secreted 
substrate protein SiiE resembling the type I fimbrial adhesins in binding to eukaryotic 
cells (Gerlach et al. 2007), the SPI-3-encoded autotransporter protein MisL as an 
extracellular matrix adhesin involved in intestinal colonisation (Dorsey et al. 2005), and 
the non-SPI-encoded T1SS-secreted protein BapA with its expression coordinated with 
genes encoding curli fimbriae and cellulose via csgD to biofilm formation and 
colonisation (Latasa et al. 2005). Moreover, the SPI-1-encoded T3SS translocases SipB, 
SipC, and SipD are coordinately organised to mediate intimate attachment of 
Salmonella Typhimurium to target host (Lara-Tejero and Galan 2009). Upon successful 
Salmonella adhesion to host cells, these pathogen-host interactions may unite individual 
single adherent bacteria into clusters or groups of bacteria (e.g. 1 hour, Figure 3.1), or 
create wider “colonies” like biofilm formation as a constant source of infection, to 
secure breakdown of the host defence and to facilitate subsequent bacterial invasion.  
 
Bacterial specificity is not necessarily correlated with their invasiveness and host 
specificity; different wild-type strains of Salmonella Typhimurium may behave 
differently in their invasiveness into human epithelial cells. It has been observed that 
Salmonella species can infect and cause diseases in a broad range of host species, and 
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can enter most animal cells except yeast and red blood cells (Finlay et al. 1991;Tsolis et 
al. 1999b). However, a human isolate strain does not presumably invade human 
epithelial cells more proficiently than other animal isolate strains. Among all the 6 
Salmonella Typhimurium wild-type strains in the present study, the two animal isolate 
strains ST 4/79 and SL1344 invaded into HEp-2 cells more proficiently than the only 
wild-type human isolate strain ST TML; another bovine septicaemia liver isolate strain 
NCTC 12023 invaded cells with a lowest efficiency (Figure 3.4). In contrast, in vitro 
virulence assays of adhesion and invasion for 12 human and 10 bovine isolates of 
Salmonella Typhimurium demonstrated that human isolates had higher adhesion to 
HEp-2 cells than animal isolates, but no differences in the invasion rates of human and 
bovine source isolates (Adaska et al. 2008), suggestive of genetically defined in vitro 
virulence factors in Salmonella Typhimurium associated with host range or specificity. 
A putative Salmonella Typhmurium host range factor gene slrP with homology to ipaH 
and yopM was identified in host adaptation by comparative screening of signature-
tagged mutants in mice and calves (Tsolis et al. 1999b). As the severity of in vivo 
infections cause by Salmonella Typhimurium varies depending on the host species 
(Morgan et al. 2004), the human HEp-2 cell line was selected as the in vitro host cell 
model to be infected with the fully genome-sequenced animal isolate wild-type strain 
SL1344 for convenience in screening virulence genes, then followed by characterisation 
of gene-deficient mutants using human in vitro and ex vivo intestinal epithelium models 
to minimise any bias in cell responses concerning host specificity. 
 
Different single genes within pathogenicity islands may exert different impacts on 
cellular invasion and intracellular replication with various degrees of predominance. 
Deletion of two different single SPI-1 genes (prgH and spaS) in two sets of Salmonella 
Typhimurium wild-type strains (NCTC 12023 and SL1344) both failed in their effective 
invasiveness into HEp-2 cells, however knockouts of two different single SPI-2 genes 
(ssaV and ssaU) dissimilarly affected intracellular replication (Figures 3.5 and 3.6). 
Several bacterial genes and their encoded proteins required for invasion have been 
identified. Salmonella invasion into cells requires the production and transport of SPI-1-
encoded T3SS transcriptional regulators (HilA, HilD, HilC, and InvF) with overlapping 
sets of target genes, which can be controlled by regulators outside SPI-1 such as the 
two-component regulators BarA/SirA and PhoP/Q and the csr post-transcriptional 
control system, and can also be regulated by environmental factors including pH, 
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osmolarity, oxygen tension, bile, Mg2+ concentration, and short chain fatty acids (Altier 
2005). In addition to the genetic locus inv which accounts for invasion but remains 
unaffected in bacterial ability of attachment to cells (Galan and Curtiss, III 1989), SPI-1 
genes prgH and spaS also play a key role in Salmonella invasion. PrgH is a structural 
component of the SPI-1 T3SS necessary for secretion. Several SPI-1-encoded T3SS 
proteins organise a supermolecular needle complex comprising a base across cell 
membranes and a needle for translocation of effector proteins: InvJ determines the 
length of the needle segment, PrgH, PrgK, and InvG constitute the base and PrgI is the 
main component of the needle complex (Kubori et al. 2000). SpaS is crucial for 
invasion because of potential interactions with another protein SpaL, which contains 
ATP binding sites (Groisman and Ochman 1993). Not only associated with invasion, the 
SPI-1-encoded T3SS of Salmonella Typhimurium is also necessary for vacuole 
biogenesis and intracellular survival in non-phagocytic cells (Steele-Mortimer et al. 
2002). Moreover, Salmonella can inject at least 6 effector proteins SopE, SopB, SptP, 
SopE2, SipC, and SipA to manipulate the host cytoskeleton resulting in 
macropinocytosis and succeeding engulfment of attached bacteria to facilitate bacterial 
invasion (Ly and Casanova 2007). On the other hand, regulated Rho GTPases 
expression with reorganised host cytoskeleton is essential for Salmonella invasion: 
Cdc42 is required for Salmonella invasion in non-polarised cells (Chen et al. 1996), 
whilst Rac1 is requisite for apical internalisation of Salmonella in polarised cells (Criss 
et al. 2001). However, disruption in the SPI-2 gene ssaU did not attenuate bacterial 
intracellular replication for the first 7 hours post infection (Figures 3.6 and 3.13) as 
significantly as impairment of another SPI-2 gene ssaV (Figures 3.5). This encourages 
further investigation in varying phenotypes of individual SPI-2 genes for their 
significance in Salmonella intracellular growth within non-phagocytic cells, which will 
be introduced in Chapter 5. 
 
The timing and degree of phenotypic switch have implications for the interpretation of 
experiments using Caco-2 cells in long-term cultures. At various culture stages, the 
characteristics of filter-grown Caco-2 cells can be considered in two ways: crypt-villus 
axis and colonocyte-enterocyte differentiation. In between, transient mosaic patterns in 
Caco-2 phenotype can be morphologically and functionally influenced by the degree of 
colonic conversion from colonic-type to enterocyte-type cells (Vachon and Beaulieu 
1992). First, the Caco-2 cells were cultured for 5 days to achieve undifferentiated cells 
 170
as the in vitro counterpart of crypt cells or 19 days to achieve differentiated cells as the 
in vitro counterpart of villus cells (Malago et al. 2003). Second, Caco-2 cells showed a 
spontaneous differentiation with time from a human colonic adenocarcinoma into small 
intestine-like cells after confluence (Engle et al. 1998). Interestingly, filter-grown 14-
day-old intermediately differentiated Caco-2 cells were most vulnerable to Salmonella 
Typhimurium SL1344 with the highest invasion rate, followed by 20-day-old fully 
differentiated Caco-2 cells with the second highest invasion rate, and 5-day-old nearly 
undifferentiated Caco-2 cells were most resistant to Salmonella invasion with the lowest 
invasion rate (Figure 3.14). These observations hinted that human IE in the junctional 
zones between crypts and villus, or cells with mixed phenotypes of colonocytes and 
enterocytes could be more susceptible to Salmonella invasion; villus-like cells or 
colonocyte-like cells could be more resistant to Salmonella invasion. In addition, the 
20-day-old polarised villus-like Caco-2 cells were more able to internalise the FliC-
deficient mutant ∆fliM than those 5-day-old crypt-like cells and 14-day-old borderzone 
cells (Figure 3.16), implying that FliC could be more involved in crypt cells than villus 
cells for invasion of Salmonella Typhimurium. Further in vivo or ex vivo studies are 
warranted for elucidation of correlations between Salmonella internalisation and cellular 
tropism in the gut. 
 
Filter-grown polarised Caco-2 cells are not as robust as HEp-2 cells for evaluation of 
long-term intracellular replication in non-phagocytic epithelial cells (Figure 3.13), 
although they can be an in vitro model for assessment of Salmonella invasion (Figures 
3.12 and 3.16). An earlier study demonstrated increased amounts of intracellular 
Salmonella Typhimurium in non-polarised Caco-2 cells up to 20 hours after initial 1-
hour infection, but 60% cell viability reduced its validity (Wells et al. 1996). Other 
studies showed that viable Salmonella Typhimurium within HEp-2 cells quantitatively 
increased ~2 to 5 fold at the time point of 6 hours post the initial 2-hour infection period 
(Martinez-Moya et al. 1998;Small et al. 1987). In this study, a better cell viability and 
much fewer losses from detachment of cell monolayers were observed in HEp-2 cells 
compared with Caco-2 cells. Despite similar growing patterns to those in HEp-2 cells 
(Figure 3.6) with lower intracellular bacterial rates during the early stage of <9–10 
hours, Salmonella Typhimurium wild-type SL1344 and its SPI-2 mutant ∆ssaU both 
declined in their viable bacterial amounts within filter-grown Caco-2 cells during the 
late longer incubation period of between 10–24 hours post infection (Figure 3.13), 
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suggestive of stronger inhibition on intracellular Salmonella proliferation in polarised 
Caco-2 cells than in HEp-2 cells. This observation could be explained by their different 
capabilities of intracellular defence system, or permission to bacterial translocation 
across the cell monolayers by the bottoms of plastic wells and the bacteria-permeable 
filters of transwells. Epithelial cells can exert a similar bactericidal effect to certain 
fibroblast cells on intracellular Salmonella (Martinez-Moya et al. 1998) probably due to 
production of nitric oxide (Saarinen et al. 1996). Such a bactericidal effect of non-
phagocytic cells on intracellular Salmonella should be considered as another type of 
host response in the Salmonella-host interaction that differs depending on the host cell 
type. Another possibility is that some of the intracellular Salmonella might translocate 
through epithelial cells in endocytic vacuoles and escape from the basolateral surface of 
the epithelium (Finlay et al. 1988). After a minimum of 2 hours in Caco-2 cells, apically 
added bacteria could be found in the basolateral medium (Finlay and Falkow 1990). 
Collectively, HEp-2 cells are better than polarised Caco-2 cells for studying intracellular 
Salmonella, particularly in their advanced susceptibility for allowing more bacterial 
invasion and in their superior capability of maintaining longer intracellular replication. 
Also, the HeLa cell line has been used to characterise the biogenesis and evolution of 
the SCV, and analyse time-dependent transcriptome changes in Salmonella gene 
expression related to the T3SS inside epithelial cells (Hautefort et al. 2008). Thus, 1 to 
2-day-old HEp-2 cells were selected as the first-line Salmonella infection model in the 
TraDIS study.  
 
Caco-2 cells of different ages behave differently in host innate immunity. hBD-1 was 
constitutionally expressed in polarised Caco-2 cells irrespective of different cellular 
stages or bacterial strains in the present study (Figure 3.17), which similarly echoed the 
previous observations (Dommett et al. 2005;O'Neil et al. 1999). IL-1β-induced 
expression of both IL-8 and hBD-2 were highest in 5-day-old Caco-2 cells and lowest in 
20-day-old Caco-2 cells (Figure 3.17), suggestive of higher inducible innate immune 
responses in crypt-like cells than villus-like cells. hBD-3 expression was non-inducible 
in polarised Caco-2 cells as previously observed (Ou et al. 2009). During the time-
course study after 2-hour Salmonella Typhimurium infection, IL-8 and hBD-2 mRNA 
expression showed opposite trends whilst hBD-1 expression was stable with time in the 
first 2–10 hours, indicative of a more important role of intracellular Salmonella in 
eliciting expression of hBD-1 and hBD-2 than IL-8. Later than 10 hours of infection, 
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the expression in all three genes dropped to lower levels (Figure 3.18). Taken together 
10 hours after inoculation was selected as the timing for harvest of 14-day-old polarised 
cells to study their IL-8, hBD-1, and hBD-2 mRNA expression after stimulation of 
various PAMPs of Salmonella Typhimurium. 
 
Polarised monolayers of Caco-2 cells respond to apical Salmonella Typhimurium 
challenge and basolateral IL-1β stimulation better than T84 cells in hBD-1 and hBD-2 
expression (Ou et al. 2009). However, bidirectional approach of various Salmonella 
PAMPs has rarely been employed in this model to thoroughly investigate host innate 
immune responses at both protein and gene levels; the results could presumably exhibit 
the host responses on both sides across the cell monolayers and the significance of 
individual PAMPs to trigger host innate immunity for estimation of functional 
expression of PRRs. Host sensing of TLRs and NLRs by PAMPs of Salmonella 
Typhimurium can account for induction of hBD-2 in epithelial cells (Uehara et al. 
2007;Voss et al. 2006). However, innate immune responses in intestinal epithelial cells 
can also be induced by Salmonella effector protein not mediated via TLRs (Bruno et al. 
2009), implying possible involvement of non-TLR, non-NLR pathways in expression 
and function of inducible β-defensins in the human alimentary tract. 
 
Apical, basolateral, or bidirectional stimulation of Salmonella LPS induced undetectable 
IL-8 and hBD-2 mRNA expression as non-treated controls in polarised Caco-2 cells 
(Figures 3.19 and 3.20). Similar IL-8 unresponsiveness of Caco-2 cells to LPS has 
been found at either protein production (Abreu et al. 2001) or mRNA expression (Hall 
1998). However, expression of the LPS-sensor TLR4 in Caco-2 cells was variable. 
Human TLR4 protein was expressed in polarised Caco-2 cells, but TLR4 mRNA 
expression was only detectable at low levels (Abreu et al. 2001) or no TLR4 mRNA 
expression (Bocker et al. 2003;Naik et al. 2001) in non-polarised Caco-2 cells. In 
addition, the degree of inflammation in the human intestinal primary epithelium may 
determine different expression levels of TLR4. No TLR4 mRNA expression was 
detectable in non-inflamed human small and large intestinal cells (Naik et al. 2001). 
Low TLR4 expression by human intestinal epithelial cells was demonstrated by 
immunohistochemistry in normal human intestinal biopsies (Cario and Podolsky 2000) 
and by mRNA transcripts in normal colonic crypt epithelial cells (Abreu et al. 
2002;Bocker et al. 2003). However, TLR4 expression could be abundantly detected in 
 173
the inflamed whole colonic mucosa (Naik et al. 2001) and in the intestinal epithelial 
cells from the patients with active inflammatory bowel disease (Cario and Podolsky 
2000). IFN-γ and TNF-α regulate TLR4 mRNA expression in intestinal epithelial cell 
lines and pre-incubation of IFN-γ and/or TNF-α could sensitise intestinal epithelial cells 
to LPS-dependent IL-8 secretion (Abreu et al. 2002). Hence, the expression levels of 
TLR4 may be variable to functionally regulate LPS-mediated chemokine secretion and 
the mere presence of TLR4 does not necessarily represent LPS susceptibility. One 
possibility is that co-expression of TLR4 and MD-2, in fact the TLR4-MD2 receptor 
complex, is required for LPS recognition and responsiveness (Abreu et al. 2001;Bryant 
et al. 2010); another possibility is that LPS tolerance, a regulatory mechanism involving 
LPS internalisation, causes unresponsiveness to repeated LPS stimulation in intestinal 
epithelial cells (Hornef et al. 2002).  
 
Irrespective of stimulatory directions to the polarised Caco-2 cell monolayers, FliC is 
the principle Salmonella Typhimurium PAMP that elicits IL-8 and hBD-2 gene 
transcription and protein translation among three PAMPs selected for stimulation 
(Figures 3.19 and 3.20). Although TLR5 is expressed on the basolateral, but not apical, 
surface of in vitro polarised epithelial cell monolayers (Gewirtz et al. 2001), or on both 
surface sides of noninvasive EPEC-infected ex vivo small intestinal epithelium (Schuller 
et al. 2009), direct basolateral stimulation of FliC in this study did not provoke higher 
levels of IL-8 or hBD-2 mRNA expression than apical challenge of FliC with the same 
dosage; whilst simultaneous challenge of FliC upon both surfaces of the polarised Caco-
2 cells created a synergistic effect on IL-8 expression and an additive effect on hBD-2 
expression from the individual host responses triggered by unidirectional FliC 
stimulation (Figures 3.19 and 3.20). Hence, a SPI-2 dependent process by which 
microbes that invade, proliferate, or translocate flagellin (Gewirtz et al. 2001;Lyons et al. 
2004) is more important than sensing sufficient amounts of TLR5 on either side of 
intestinal epithelial cell monolayers to induce chemokine or innate immune responses. 
 
FliC plays a crucial role in host hBD-2 protein and gene responses because of total 
unresponsiveness of hBD-2 mRNA expression to stimulation of FliC-deficient ∆fliM in 
polarised Caco-2 cells (Figure 3.21). Partial responsiveness of IL-8 mRNA expression 
to Salmonella Typhimurium ∆fliM was posttrascriptionally suppressed at its protein 
level as the uninfected control. Basolateral IL-8 secretion (Figure 3.22) and apical 
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hBD-2 secretion (Figure 3.23A) both showed similar patterns to their parallel mRNA 
expression levels in Caco-2 cells infected with Salmonella Typhimurium SL1344, 
∆spaS, and ∆fliM, except for lower basolateral IL-8 protein levels than their mRNA 
expression levels relative to those in IL-1β-treated Caco-2 cells, probably also due to 
posttranscriptional suppression in Salmonella-infected cells. Both of the IL-8 and hBD-
2 protein levels induced by Salmonella Typhimurium ∆fliM were as low as those in 
uninfected controls. As antimicrobial peptides and proteins might be retained in close 
proximity to the epithelial layer by its association with the mucus layer (Meyer-Hoffert 
et al. 2008), the quantities of cell-associated hBD-2, including intracellular proteins and 
cell surface attached proteins, were quantified in the present study but showed no 
significant differences in various conditions (Figure 3.23B). Conclusively, FliC is not 
only the main molecule mediating induction of hBD-2 by Salmonella, in the form of 
either secreted or structural protein via NF-κB activation (Ogushi et al. 2001;Takahashi 
et al. 2001), but also the major factor eliciting epithelial secretion of IL-8 in Salmonella 
Typhimurium infection (Gewirtz et al. 2001). IL-8 protein production might be a result 
of posttranscriptional modification, or a balance between FliC induction and FliC 
tolerance, which is a rapid process that requires no protein synthesis and facilitates the 
internalisation of a fraction of the basolateral TLR5 without affecting the polarity or 
total expression of TLR5 (Sun et al. 2007a). Additionally, this study discovered that 
SPI-2 gene ssaU could dominantly control secretion of FliC because FliC was 
completely absent in the log-culture supernatant of Salmonella Typhimurium ∆ssaU 
(Figure 3.15). 
 
Interestingly, exposure of polarised Caco-2 cells to Salmonella Typhimurium DNA 
triggers IL-8/hBD-2 mRNA expression and infection with a FliC-deficient mutant strain 
Salmonella Typhimurium ∆fliM stimulates IL-8 mRNA expression, indicating that 
additional PAMP bacterial CpG DNA, rather than FliC, may play a role in eliciting 
epithelial pro-inflammatory responses. In contrast to hBD-2 mRNA expression (Figure 
3.20), IL-8 mRNA expression after basolateral DNA stimulation relative to after apical 
and bilateral DNA challenges was relatively more responsive (Figure 3.19), suggesting 
that Salmonella DNA might be a more important basolateral stimulator to IL-8 than 
hBD-2. These observations raised further questions including how Salmonella CpG 
DNA could be extracellularly exposed to host epithelial cells in vivo, and how 
Salmonella CpG DNA could interact with various DNA PRRs and influence their 
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expression/distribution in host cells. Several possibilities might explain the presence of 
bacterial DNA in the intestinal lumen in vivo. Most bacteria release vesicle-mediated 
DNA during growth in vitro, particularly gram-negative pathogens such as Salmonella 
Typhimurium to export its linear chromosomal DNA; but the effects of the DNA on 
infected hosts remained little known (Dorward and Garon 1990). The bacterial DNA 
derived from such vesicles or lysed cells could be an important component of bacterial 
biofilms (Whitchurch et al. 2002) and an immunostimulant to intestinal epithelial cells 
as shown in this study. TLR9 is mainly located within endosomes inside the cells 
(Ewaschuk et al. 2007) and internalisation of CpG DNA with subcellular localisation of 
TLR9 in the early endosomes lying just below the plasma membrane can occur within 
10 minutes after infection (Takeshita et al. 2004). Surface expression of TLR9 can be 
upregulated in response to pathogenic, but not non-pathogenic, bacterial DNA on 
intestinal epithelial cells (Ewaschuk et al. 2007). In addition, bacterial DNA can also be 
recognised by TLR9-independent sensing pathways including ZBP1, DNA-dependent 
activator of interferon-regulatory factors (DAI), and DNA sensing inflammasome 
consisting of HIN200 protein, absent in melanoma 2 (AIM2) (Vilaysane and Muruve 
2009). All of these DNA sensors may provide a diverse sentinel system to alert the cell 
to microbial DNA and possibly aberrant host DNA for activation of the innate immunity. 
 
In conclusion, two proposed in vitro reproducible models were successfully established 
for evaluation of bacterial invasion and intracellular replication as well as host epithelial 
cell cytokine and innate immune responses. These works can be further applied to high 
throughput screening of the transposon mutants and subsequent characterisation of the 
selected mutant strains. The novel observations, including varying responsiveness of 
Caco-2 cells with time, phenotypes of the mutants with different genetic disruptions 
within SPI-1 and SPI-2, and host cell reactions at both mRNA and protein expression 
levels to directional stimulation of PAMPs particularly bacterial DNA, in this study 
provide a blueprint for future studies in characterisation of the identified Salmonella 
virulence genes by TraDIS in Chapter 5.   
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Chapter 3b. In Vitro Epithelial Cell Culture Model and 
Probiotic Modulation of IL-1β- and Salmonella 
Typhimurium-Induced Host Responses 
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3b.1. Background 
Probiotics have been widely used in prevention and treatment of human diseases 
(Montrose and Floch 2005). Despite efficacy of probiotics in a reduction in the 
incidence, severity and duration of diarrhoea as well as prevention of antibiotic-
associated diarrheoa in children, only a few clinical trials of probiotics examined 
bacterial aetiologies of diarrhoea, which have disclosed limited information in their 
effects on bacterial infection (Guandalini 2008). Probiotic lactobacilli can be as 
effective as antibiotics to treat, rather than prevent, bacterial vaginosis (Anukam et al. 
2006). Lactobacillus rhamnosus can dose-dependently reduce faecal shedding of 
rotavirus in children as a therapeutic agent (Fang et al. 2009a). Hence, it is worth 
clarifying if postinfectious administration of different probiotic strains with appropriate 
dosages could ameliorate existing infection or reverse an established disease. 
 
Salmonella Typhimurium, which is a facultative intracellular bacterium, can invade, 
survive, and multiply within diverse eukaryotic cell types including epithelial cells 
(Leung and Finlay 1991;Small et al. 1987). The major roles of two functionally distinct 
type III secretion systems encoded on Salmonella pathogenicity islands (SPI)-1 and 
SPI-2 are to enable bacterial invasion and to facilitate intracellular replication, 
respectively (Waterman and Holden 2003). Recruitment of neutrophils to the infected 
epithelium is the histopathological hallmark of salmonellosis (McCormick et al. 1993), 
which is driven by secretion of interleukin-8 (IL-8), a major pathogen-elicited epithelial 
chemoattractant. Given that bacterial invasion and intracellular replication are essential 
for the pathogenicity of Salmonella Typhimurium (Leung and Finlay 1991;Pace et al. 
1993), it would be highly desirable to see if SPI-1 and SPI-2 might play a key role in 
host IL-8 responses. 
 
Antimicrobial activities of probiotic Lactobacillus strains have been demonstrated in 
vivo and in vitro during interactions with pathogenic bacteria and their infected cells. 
Lactobacillus strains can not only express adhesiveness properties to preventively 
inhibit subsequent adhesion of pathogens to host cells (Chan et al. 1985), and to 
competitively exclude Salmonella species or inhibit their invasion when simultaneously 
administered to host cells, but can also duration-dependently and strain-specifically 
displace adhered bacteria when postinfectiously applied to pathogen-infected cells 
(Candela et al. 2008;Hudault et al. 1997;Lee et al. 2003). Moreover, pre-treatment with 
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Lactobacillus strains can protect against translocation of Salmonella Typhimurium and 
accelerate their elimination in conventional mice, and increase the survival of germ-free 
mice (Gill et al. 2001;Hudault et al. 1997). Without direct contact with pathogenic 
bacteria, spent culture supernatants of probiotic lactobacilli can exert antibacterial 
activities by lowering of pH (Coconnier 1997b;De Keersmaecker et al. 2006;Fayol-
Messaoudi et al. 2005), synthesising lactic acid and other non-lactic acid molecules (De 
Keersmaecker et al. 2006;Fayol-Messaoudi et al. 2005), or producing heat-stable 
bacteriocins like defensins (Coconnier 1997a;Lin et al. 2008). Furthermore, some 
probiotics can prevent activation of the proinflammatory NF-κB and subsequently 
attenuate IL-8 secretion. Regardless of live or dead bacteria, their spent culture 
supernatants, or bacterial DNA, certain probiotic strains can also prevent pathogen-
associated molecular pattern (PAMP)- or proinflammatory cytokine-elicited NF-κB 
translocation from the cytosol to the nucleus by blocking phosphorylation and following 
ubiquinitation of IκB (Coconnier et al. 2000;Jijon et al. 2004;Lopez et al. 2008;Neish et 
al. 2000;O'Hara et al. 2006). However, this phenomenon may be transient and other 
probiotic strains can conversely activate NF-κB to increase levels of the 
proinflammatory cytokine IL-6 (Boirivant and Strober 2007). Considering these 
discrepancies, further studies are required to validate the strain-specific, time- and dose-
dependent effects of probiotics upon invading Salmonella Typhimurium after antibiotic 
treatment and host responses with cell signalling. 
 
Thus, this study was conducted using two of the most extensively studied probiotic 
strains, Lactobacillus rhamnosus GG and Lactobacillus plantarum 299v (Szajewska et 
al. 2007;Wullt et al. 2003), to examine whether postinfectious administration of 
probiotics following Salmonella Typhimurium infection could modulate IL-8 
transcription/production and intracellular Salmonella Typhimurium replication in HEp-2 
cells. Subsequent experiments were undertaken to determine if repeated doses of 
lactobacilli or early co-administration of lactobacilli with Salmonella Typhimurium 
could be more efficacious than single one-dose regimen. Also, we treated HEp-2 cells 
with IL-1β to compare its differences from Salmonella Typhimurium in host responses, 
and in modified experiments to explore if both lactobacilli could affect degradation of 
IκBα, phosphorylation of NF-κB p65 and its nuclear translocation in NF-κB signalling. 
Finally, quantities of viable intracellular bacteria and IL-8 secretion in HEp-2 cells 
infected by wild-type, SPI-1 and SPI-2 mutants of Salmonella Typhimurium were 
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investigated to determine the importance of bacterial invasion and both SPIs in host IL-
8 responses.  
 
3b.2. Results 
3b.2.1. Single-dose Lactobacillus rhamnosus GG or Lactobacillus plantarum 
299v time- and dose-dependently inhibits IL-8 production after IL-
1β induction. 
Supernatants and RNA samples from the IL-1β-treated cells at 5 hours and 7 hours after 
one-dose treatment of lactobacilli (Figure 3.24A) were used for IL-8 ELISA and real-
time PCR, respectively. Compared to non-lactobacilli-treated MRS-controls, single 
high-dose Lactobacillus rhamnosus GG, and low- and high-dose Lactobacillus 
plantarum 299v significantly suppressed IL-1β-induced IL-8 secretion after 5-h 
treatment of lactobacilli (P<0.01, P<0.05, P<0.001, respectively; Figure 3.24A). 
However, single low-dose Lactobacillus plantarum 299v significantly enhanced IL-8 
secretion after 7-hour probiotic treatment (P<0.05; Figure 3.24A) whilst most IL-8 
levels at 7 hours were lower than those at 5 hours indicating a peak effect of IL-8 
secretion before 7 hours. Despite different lactobacilli in various doses, all of the levels 
of IL-1β-induced IL-8 mRNA expression at 5 hours were higher than at 7 hours. Unlike 
IL-8 protein expression, there was no significant difference in IL-8 mRNA levels 
between lactobacilli-treated cells and non-lactobacilli-treated controls; the impacts of 
either single low- or high-dose Lactobacillus rhamnosus GG and Lactobacillus 
plantarum 299v on IL-8 gene expression were not parallel to their effects on IL-8 
protein expression after IL-1β induction (Figure 3.24C). ELISA was also performed to 
measure IL-8 secretion in supernatants from the cells at 7 hours after 4-dose treatment 
of lactobacilli (Figure 3.24B). There was no significant alteration in IL-8 secretion from 
IL-1β-stimulated cells at 7 hours after a 4-dose regimen of low- or high-dose 
Lactobacillus rhamnosus GG and Lactobacillus plantarum 299v compared to non-
lactobacilli-treated controls (Figure 3.24B). Comparing the modulatory effects of 
probiotics on IL-8 production between one-dose and 4-dose regimens of lactobacilli, a 
4-dose treatment of Lactobacillus plantarum 299v showed a decreased trend relative to 
non-lactobacilli-treated controls at 7 hours rather than an increased trend by a one-dose 
treatment of Lactobacillus plantarum 299v. A 4-dose treatment of low-dose 
Lactobacillus plantarum 299v significantly inverted the upward increase in IL-8 
secretion by a single low-dose regimen of Lactobacillus plantarum 299v (–5.1% vs 
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34.8%, P <0.05; Figure 3.24D). 
 
 
Figure 3.24 (A) IL-8 protein levels from the supernatant of the HEp-2 cells treated with 
single dose of lactobacilli or MRS during the last 5 hours and 7 hours using protocol A 
in Figure 2.3A, and (B) four doses of lactobacilli or MRS during the last 7 hours using 
protocol B in Figure 2.3B; (C) IL-8 mRNA levels in the HEp-2 cells treated with single 
dose of lactobacilli or MRS using protocol A in Figure 2.3A; all pretreated with IL-1β 
for 1 hour followed by gentamicin for anther 1 hour. IL-8 levels significantly different 
from non-lactobacilli-treated controls are indicated by an asterisk or asterisks (*P<0.05, 
**P<0.01, ***P<0.001; results represent the mean + SEM, n = 3). Dashed horizontal 
lines in (A) and (B) indicate the IL-8 levels of non-lactobacilli IL-1β-treated controls as 
baselines. (D) Alterations in IL-8 levels relative to non-lactobacilli-treated controls at 7 
hours were converted to changes in percentage of IL-8 levels from non-lactobacilli-
treated controls. Values of significantly altered percentage are indicated by a dagger 
(†P<0.05; results represent the mean ± SEM, n = 3). 
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3b.2.2. Repeated high-dose Lactobacillus plantarum 299v reverses the 
increased trend in IL-8 secretion caused by single high-dose 
Lactobacillus plantarum 299v after Salmonella serovar Typhimurium 
infection. 
Supernatants and RNA samples from Salmonella Typhimurium-infected cells at 5 hours 
and 7 hours after one-dose treatment of lactobacilli (Figure 2.3A) were used for IL-8 
ELISA and real-time PCR, respectively. ELISA was also performed to measure IL-8 
secretion in supernatants from the cells at 7 hours after 4-dose treatment of lactobacilli 
(Figure 2.3B). Using a one-dose or 4-dose regimen of Lactobacillus rhamnosus GG or 
Lactobacillus plantarum 299v, no significant difference was found in the IL-8 levels 
between lactobacilli-treated cells and non-lactobacilli-treated cells after Salmonella 
Typhimurium SL1344 infection (Figure 3.25A, B). In contrast to IL-1β induction, 
Salmonella Typhimurium infection seemed to continuously stimulate IL-8 secretion 
with time that was compatible with the higher IL-8 levels at 7 hours than at 5 hours 
(Figure 3.25A). Compared to the HEp-2 cells treated with one-dose MRS broth or 
lactobacilli for 7 hours (Figure 3.25A), IL-8 secretion was ~2- to 3-fold higher in the 
cells treated with 4 repeated doses of MRS broth or lactobacilli within the same period 
(Figure 3.25B). This might be due to MRS-enhanced intracellular bacterial amounts 
(data not shown) with their antigenic stimulation. Compared to the protein levels of IL-
8, the mRNA expression levels of IL-8 from the cells in the same experimental 
conditions showed a higher transcriptional level of Salmonella Typhimurium SL1344-
infected controls at 5 hours than at 7 hours, but no significant changes by low- or high-
dose Lactobacillus rhamnosus GG or Lactobacillus plantarum 299v at two time points 
(Figure 3.25C). High-dose Lactobacillus rhamnosus GG or Lactobacillus plantarum 
299v sustained a similar mRNA expression level, but low-dose Lactobacillus 
rhamnosus GG or Lactobacillus plantarum 299v was likely to enhance mRNA 
expression compared to non-lactobacilli controls at 5 hours after gentamicin protection 
despite no statistical significance (Figure 3.25C). Comparing the modulatory effects of 
probiotics on IL-8 production between one-dose and 4-dose regimens of lactobacilli, all 
4-dose regimens of Lactobacillus rhamnosus GG or Lactobacillus plantarum 299v 
showed a tendency to suppress IL-8 secretion from Salmonella Typhimurium-infected 
cells relative to non-lactobacilli-treated controls at 7 hours, whilst one-dose protocols of 
high-dose Lactobacillus rhamnosus GG, and low- and high-dose Lactobacillus 
plantarum 299v tended to increase IL-8 production (Figure 3.25D). Elevated IL-8 
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secretion from the cells treated with single high-dose Lactobacillus plantarum 299v 
significantly differed from reduced IL-8 secretion caused by a 4-dose treatment of high-
dose Lactobacillus plantarum 299v (21.8% vs. –20.2%, P <0.01; Figure 3.25D). 
 
 
Figure 3.25 (A) IL-8 protein levels from the supernatants of the HEp-2 cells treated 
with single dose of lactobacilli or MRS during the last 5 hours and 7 hours using 
protocol A in Figure 2.3A, and (B) four doses of lactobacilli or MRS broth during the 
last 7 hours using protocol B in Figure 2.3B. (C) IL-8 mRNA levels in the HEp-2 cells 
treated with single dose of lactobacilli or MRS broth using protocol A in Figure 2.3A; 
all pretreated with Salmonella Typhimurium SL1344 for 1 hour followed by gentamicin 
for anther 1 hour. Dashed horizontal lines in (A) and (B) indicate the IL-8 levels of non-
lactobacilli-treated controls as baselines. (D) Alterations in IL-8 levels relative to non-
lactobacilli-treated controls at 7 hours were converted to changes in percentage of IL-8 
levels from non-lactobacilli-treated controls. Values of significantly altered percentage 
are indicated by daggers (††P<0.01; results represent the mean ± SEM, n = 3).  
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3b.2.3. Inhibition of Lactobacillus rhamnosus GG and Lactobacillus 
plantarum 299v on IL-8 secretion is independent on degradation of 
IκBα and phosphorylation of NF-κB p65. 
To study the modulation of either low- or high-dose Lactobacillus rhamnosus GG or 
Lactobacillus plantarum 299v on NF-κB, a Western blot analysis of IκBα and 
phosphorylated NF-κB p65 was conducted on whole HEp-2 cells lysates. Incubation of 
IL-1β with lactobacilli-pretreated HEp-2 cells for 20 min using protocol D (Figure 2.3D) 
caused a mild reduction of the amount of IκBα and a considerable increase in the 
amount of phosphorylated NF-κB p65 compared with the IL-1β-untreated controls 
(Figure 3.26). There were no significant differences in the amounts of IκBα and 
phosphorylated NF-κB p65 between the IL-1β-treated cells without pretreatment of 
lactobacilli and the IL-1β-treated cells with 5-hour or 7-hour pretreatment of lactobacilli 
(Figure 3.26). Degraded IκBα and phosphorylated NF-κB p65 after stimulation of IL-
1β for 20 minutes was not significantly inhibited by pretreatment with either low- or 
high-dose Lactobacillus rhamnosus GG or Lactobacillus plantarum 299v for 5 hours 
and 7 hours compared to two MRS-pretreated controls (Figure 3.26). 
 
 
Figure 3.26 Representative Western blots for IL-1β-induced phosphorylated NF-κB and 
IκBα degradation by Lactobacillus rhamnosus GG or Lactobacillus plantarum 299v 
showed no significant difference in bands indicating phosphorylated NF-κB p65 and 
IκBα between low- or high-dose lactobacilli groups and non-lactobacilli controls in 
HEp-2 cells treated with low- or high-dose Lactobacillus rhamnosus GG or 
Lactobacillus plantarum 299v for 5 hours (A) and 7 hours (B) followed by 1-hour 
treatment of gentamicin and final 20-minute treatment of IL-1β. 
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3b.2.4. Lactobacillus rhamnosus GG or Lactobacillus plantarum 299v does 
not block NF-κB p65 nuclear translocation. 
Immunostaining showed kinetic distribution of NF-κB p65 in Salmonella- or IL-1β-
treated HEp-2 cells after 1-hour gentamicin protection followed by high-dose 
Lactobacillus rhamnosus GG or Lactobacillus plantarum 299v for 1 hour, 5 hours, and 
7 hours using the treatment protocol A (Figure 2.3A). Without nuclear translocation, 
NF-κB p65 was constitutively expressed in the cytoplasm of non-Salmonella-infected 
(Figure 3.27A, E, I) and non-IL-1β-treated HEp-2 cells (Figure 3.27M, Q, U) at three 
time points. After 1-hour treatment of Lactobacillus rhamnosus GG or Lactobacillus 
plantarum 299v, only a few Salmonella-treated cells showed translocated NF-κB p65 
into the nuclei (Figure 3.27B) that was similar to those in Lactobacillus rhamnosus 
GG- or Lactobacillus plantarum 299v-treated cells (Figure 3.27C, D). Such a 
phenomenon sustained until administration of both lactobacilli for 5 hours (Figure 
3.27F, G, H) and 7 hours (Figure 3.27J, K, L) that could be due to ongoing 
immunological stimulation by intracellular replicating Salmonella Typhimurium 
SL1344. In contrast, almost all the IL-1β-treated cells showed a higher degree of 
translocated NF-κB p65 into the nuclei (Figure 3.27N) at 1 hour after gentamicin 
treatment that was also reflected by their higher levels of IL-8 protein and mRNA 
expression (Figure 3.24) than Salmonella Typhimurium SL1344-infected cells (Figure 
3.25). Nuclear translocation of NF-κB p65 diminished in the IL-1β-treated cells without 
and with lactobacilli at 5 hours (Figure 3.27R, S, T) and almost all the translocated NF-
κB p65 shifted from nuclei back to cytoplasm at 7 hours post the ending of gentamicin 
treatment (Figure 3.27V, W, X). Here, it is clear to differentiate IL-1β, which triggered 
one-shot short-duration stimulation, from Salmonella Typhimurium SL1344, which 
tended to continue intracellular stimulation after eradication of extracellular bacteria by 
gentamicin with lesser involvement of NF-κB p65 nuclear translocation than IL-1β. 
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Figure 3.27 Immunostaining for NF-κB p65 translocation after treating HEp-2 cells 
with Salmonella Typhimurium SL1344 and IL-1β for 1 hour and high-dose 
Lactobacillus rhamnosus GG or Lactobacillus plantarum 299v for 1 hour (A-D, M-P), 5 
hours (E-H, Q-T), and 7 hours (I-L, U-X) (400×) using the treatment protocol A in 
Figure 2.3A (A, E, I: uninfected controls; B, F, J: Salmonella Typhimurium SL1344 
followed by MRS broth; C, G, K: Salmonella Typhimurium SL1344 followed by 
Lactobacillus rhamnosus GG; D, H, L: Salmonella Typhimurium SL1344 followed by 
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Lactobacillus plantarum 299v; M, Q, U: untreated controls; N, R, V: IL-1β followed by 
MRS broth; O, S, W: IL-1β followed by Lactobacillus rhamnosus GG; P, T, X: IL-1β 
followed by Lactobacillus plantarum 299v). 
 
To achieve a considerable NF-κB p65 translocation as possible, we fixed the treated 
cells with 4% formaldehyde for immunostaining after 1-hour co-treatment of 
Salmonella Typhimurium SL1344 or IL-1β and high-dose Lactobacillus rhamnosus GG 
or Lactobacillus plantarum 299v (Figure 2.3C). NF-κB p65 translocation into the 
nuclei was shown in only some non-lactobacilli Salmonella-treated cells (Figure 3.28B) 
and also in a uncertain quantity of cells co-treated with Salmonella Typhimurium 
SL1344 and Lactobacillus rhamnosus GG or Lactobacillus plantarum 299v (Figure 
3.28C, D). Dissimilarly, all the IL-1β-treated cells universally showed a significant NF-
κB p65 nuclear translocation (Figure 3.28F) compared to untreated controls (Figure 
3.28E). Co-treatment with Lactobacillus rhamnosus GG or Lactobacillus plantarum 
299v did not inhibit such NF-κB p65 nuclear translocation at all (Figure 3.28G, H). 
 
 
Figure 3.28 Immunostaining for NF-κB p65 translocation after treating HEp-2 cells 
with Salmonella Typhimurium SL1344 (A-D) or IL-1β (E-H) simultaneously with high-
dose Lactobacillus rhamnosus GG or Lactobacillus plantarum 299v for 1 hour (400×) 
using the treatment protocol C in Figure 2.3C (A: uninfected control; B: Salmonella 
Typhimurium SL1344 and MRS broth; C: Salmonella Typhimurium SL1344 and 
Lactobacillus rhamnosus GG; D: Salmonella Typhimurium SL1344 and Lactobacillus 
plantarum 299v; E: untreated control; F: IL-1β and MRS broth; G: IL-1β and 
Lactobacillus rhamnosus GG; H: IL-1β and Lactobacillus plantarum 299v). 
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To investigate the probiotic effect of lactobacilli and to coordinate with the peak effect 
of IL-1β on NF-κB p65 translocation, high-dose Lactobacillus rhamnosus GG- or 
Lactobacillus plantarum-pretreated cells for 5 hours and 7 hours were challenged with 
IL-1β for 20 minutes using protocol D in Figure 2.3D for NF-κB p65 immunostaining. 
Without nuclear translocation, NF-κB p65 was constitutively expressed in the cytoplasm 
of IL-1β-untreated HEp-2 cells (Figure 3.29A, E). Incubation of IL-1β with HEp-2 
cells for 20 minutes triggered a prominent nuclear translocation of NF-κB p65 
compared with the IL-1β-untreated controls (Figure 3.29B, F). Considerable nuclear 
translocation of NF-κB p65 were still visualised in the IL-1β-treated cells with 5-hour 
(Figure 3.29C, D) and 7-hour (Figure 3.29G, H) pretreatment of lactobacilli. 
Compared to non-lactobacilli-treated controls, neither high-dose pretreatment of 
Lactobacillus rhamnosus GG nor Lactobacillus plantarum 299v for 5 hours or 7 hours 
could block NF-κB p65 nuclear translocation induced by IL-1β for 20 minutes.  
 
 
Figure 3.29 Immunostaining for NF-κB total p65 nuclear translocation after treating 
HEp-2 cells with IL-1β for 20 minutes following high-dose Lactobacillus rhamnosus 
GG or Lactobacillus plantarum 299v for 5 hours (A-D) and 7 hours (E-H) (400×) (A, E: 
untreated controls; B, F: MRS broth followed by IL-1β; C, G: Lactobacillus rhamnosus 
GG followed by IL-1β; D, H: Lactobacillus plantarum 299v followed by IL-1β). 
 
3b.2.5. Early co-treatment of Lactobacillus rhamnosus GG or Lactobacillus 
plantarum 299v with Salmonella serovar Typhimurium dose-
dependently inhibits IL-8 production. 
To gain a better understanding of the probiotic effect on IL-8 protein and gene 
expression induced by IL-1β and Salmonella Typhimurium at different time periods, co-
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treatment of either low- or high-dose Lactobacillus rhamnosus GG or Lactobacillus 
plantarum 299v with IL-1β or Salmonella Typhimurium SL1344 was applied to HEp-2 
cells during the first hour using protocol C in Figure 2.3C. Supernatants and RNA 
samples from the treated cells at 7 hours after the end of gentamicin treatment were 
used for IL-8 ELISA and real-time PCR, respectively. IL-1β triggered a ~4- to 5-fold 
higher IL-8 secretion (Figure 3.30A, B) and a ~2- to 3-fold higher IL-8 mRNA 
expression (Figure 3.30C, D) than Salmonella Typhimurium SL1344 no matter whether 
there were lactobacilli. In the IL-1β-stimulated cells co-treated with lactobacilli or MRS 
broth, there were no significant differences in either IL-8 protein (Figure 3.30A) or IL-8 
mRNA (Figure 3.30C) expression between lactobacilli-treated cells and non-
lactobacilli-treated controls. Except for the cells co-treated with low-dose or high-dose 
Lactobacillus plantarum 299v, the trends between IL-8 protein levels and IL-8 mRNA 
levels were not parallel in the non-lactobacilli-treated controls and the cells co-treated 
with low-dose or high-dose Lactobacillus rhamnosus GG (Figure 3.30A, C). However, 
early co-treatment of high-dose, but not low-dose, Lactobacillus rhamnosus GG or 
Lactobacillus plantarum 299v with Salmonella Typhimurium SL1344 during the first 
hour inhibited IL-8 levels during the last 7 hours more significantly than non-
lactobacilli-treated controls (both P<0.05; Figure 3.30B). IL-8 protein secretion was 
dose-dependently inhibited by Lactobacillus rhamnosus GG and Lactobacillus 
plantarum 299v when administered simultaneously with Salmonella Typhimurium 
SL1344 (Figure 3.30B), but not inhibited when added after killing extracellular 
Salmonella Typhimurium SL1344 (Figure 3.25A). When co-treated with Salmonella 
Typhimurium SL1344, Lactobacillus rhamnosus GG and Lactobacillus plantarum 299v 
exerted no significant impacts upon IL-8 mRNA expression that did not completely 
reflect IL-8 protein expression (Figure 3.30D). Taken together, concomitant high-dose 
treatment of Lactobacillus rhamnosus GG or Lactobacillus plantarum 299v with 
Salmonella Typhimurium SL1344 during the first hour significantly inhibited IL-8 
protein expression at 7 hours after gentamicin protection (Figure 3.30B), but did not 
correspondingly affect IL-8 mRNA expression (Figure 3.30D) that not only raises the 
importance of antibacterial activity of lactobacilli directly against Salmonella 
Typhimurium but also implies a post-transcriptional or post-translational modulation 
exerted by lactobacilli. 
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Figure 3.30 Quantitation of IL-8 protein (A, B) and mRNA (C, D) expression from the 
supernatants and HEp-2 cells after 1-hour co-treatment of IL-1β (A, C) or Salmonella 
Typhimurium SL1344 (B, D) with single dose of Lactobacillus rhamnosus GG, 
Lactobacillus plantarum 299v, or MRS broth, followed by gentamicin treatment for 1 
hour, and subsequently incubated in plain DMEM for 7 hours. IL-8 levels significantly 
different from non-lactobacilli-treated controls in Salmonella Typhimurium-infected 
cells are indicated by an asterisk (*P<0.05; results represent the mean + SEM, n = 3).  
 
3b.2.6. Postinfectious or concurrent treatment of Lactobacillus rhamnosus 
GG or Lactobacillus plantarum 299v does not affect intracellular 
replication of Salmonella serovar Typhimurium. 
To study the effects of lactobacilli on intracellular replicating Salmonella Typhimurium, 
a gentamicin protection assay was extended from 1-hour infection of Salmonella 
Typhimurium SL1344 and 1-hour of gentamicin protection to further coincubation with 
low- or high-dose Lactobacillus rhamnosus GG or Lactobacillus plantarum 299v in 
plain DMEM for another 5 hours or 7 hours using the single one-dose regimen (5 h and 
7 h in Figure 2.3A) or the repeated 4-dose regimen (7 h in Figure 2.3B) for quantifying 
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intracellular Salmonella Typhimurium. To explicate the timing effect of lactobacilli, we 
also co-treated the HEp-2 cells with Salmonella Typhimurium SL1344 and single low- 
or high-dose Lactobacillus rhamnosus GG or Lactobacillus plantarum 299v during the 
first hour using the single one-dose co-treatment regimen (7 h in Figure 2.3C) for 
quantifying intracellular Salmonella Typhimurium. Identical volumes of MRS broth to 
inoculums of lactobacilli were used as non-lactobacilli-treated controls because our 
preliminary study showed enhanced intracellular growth of Salmonella Typhimurium 
SL1344 by MRS broth when compared to non-MRS broth containing controls (data not 
shown), probably due to the effect of MRS broth. The average viable intracellular 
numbers of Salmonella Typhimurium SL1344 at 7 hours were lowest in the cells co-
treated with Salmonella Typhimurium and lactobacilli during the first hour, followed by 
the cells treated with single-dose lactobacilli during the last 7 hours, and were highest in 
the cells incubated with 4-dose lactobacilli during the last 7 hours. None of the three 
probiotic regimens significantly differed in viable intracellular bacterial numbers of 
Salmonella Typhimurium SL1344 between lactobacilli-treated cells and non-lactobacilli 
controls (Figure 3.31A-C).  
 
 
Figure 3.31 Quantitation of viable intracellular bacteria in intracellular replication 
assays. The HEp-2 cells infected with Salmonella Typhimurium SL1344 for 1 hour, 
followed by gentamicin treatment for 1 hour, and subsequently coincubated with single 
dose of lactobacilli or MRS broth in plain DMEM for 5 hours or 7 hours (A), or 
coincubated with four repeated doses of lactobacilli or MRS broth during the last 7 
hours (B). Moreover, single dose of lactobacilli or MRS broth together with Salmonella 
Typhimurium SL1344 were simultaneously incubated with HEp-2 cells during the first 
hour, followed by 1-hour gentamicin treatment, and the intracellular infection continued 
in plain DMEM during the last 7 hours (C). At the above time points, the infected cells 
were lysed for quantifying the numbers of viable intracellular Salmonella Typhimurium 
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SL1344 that was not significantly different from non-lactobacilli-treated controls and 
Lactobacillus rhamnosus GG- or Lactobacillus plantarum 299v-treated cells in either of 
the three regimens (results represent the mean + SEM, n = 3). 
 
3b.2.7. Integrity of SPI-1 rather than SPI-2 is essential for IL-8 production 
after Salmonella serovar Typhimurium infection. 
Pilot experiments in this study confirmed that 5-hour and 7-hour incubation of low- or 
high-dose Lactobacillus rhamnosus GG, Lactobacillus plantarum 299v or non-
lactobacilli-treated controls induced low IL-8 secretion from HEp-2 cells, and MRS 
broth declined IL-8 levels in the media with and without presence of HEp-2 cells when 
compared to non-MRS broth controls (data not shown). Thus, identical volumes of 
MRS broth to inoculums of lactobacilli were used as non-lactobacilli-treated controls 
throughout this study. Next, we compared secreted IL-8 levels in the media during the 
last 7 hours after HEp-2 cells were infected with Salmonella Typhimurium SL1344 and 
its two SPI mutants for the first hour followed by gentamicin protection for the second 
hour. The viable intracellular number of Salmonella Typhimurium SL1344 within HEp-
2 cells at 7 hours after gentamicin protection was ~280-fold higher than that of ΔspaS 
(***P<0.001; Figure 3.32A), which was unable to efficiently invade HEp-2 cells. 
Although the amounts of viable ΔssaU were only about half of those of viable 
Salmonella Typhimurium SL1344 within the cells (P<0.05; Figure 3.32A), both strains 
were able to induce similar IL-8 levels which were significantly higher than those 
induced by ΔspaS and LB broth in the uninfected control (P<0.01; Figure 3.32B). 
Collectively, these data suggest that IL-8 secretion from HEp-2 cells is predominantly 
dependent on SPI-1 and Salmonella Typhimurium invasion rather than SPI-2 and 
intracellular Salmonella Typhimurium replication. 
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Figure 3.32 Gentamicin protection assays for invasion at 0 h and intracellular 
replication at 7 hours (A), and IL-8 production from the HEp-2 cells at 7 hours during 
the last 7-hour incubation (B) after 1-hour treatment with LB, Salmonella Typhimurium 
SL1344, ΔspaS, or ΔssaU, followed by another 1-hour gentamicin protection using 
protocol A in Figure 2.3A. Values significantly different between groups are indicated 
by an asterisk or asterisks (*P<0.05, **P<0.01, ***P<0.001; results represent the mean 
+ SEM, n = 3). 
 
3b.3. Discussion 
The ability of probiotics to modulate IL-8 secretion has been investigated mostly in 
polarised intestinal cells, which were either pretreated with probiotics prior to challenge 
with Salmonella (Fajdiga et al. 2006;O'Hara et al. 2006;Vizoso Pinto et al. 2009) or 
simultaneously exposed to probiotics and Salmonella (Fajdiga et al. 2006;Otte and 
Podolsky 2004). However, postinfectious modulation of probiotics upon IL-8 
production has rarely been discussed. First, our preliminary study substantiated the non-
proinflammatory properties of Lactobacillus rhamnosus GG and Lactobacillus 
plantarum 299v that both strains do not provoke IL-8 secretion, as previously reported 
(McCracken et al. 2002;Vizoso Pinto et al. 2009). Second, to investigate whether 
probiotic lactobacilli could affect IL-8 responses after immunological stimulation and 
inflammatory cascades, we administered IL-1β at a low dose of 1 ng/ml in HEp-2 cells 
for 1 hour to induce IL-8 secretion, which was significantly diminished by high-dose 
Lactobacillus rhamnosus GG or low-/high-dose Lactobacillus plantarum 299v for 5 
hours but increased by low-dose Lactobacillus plantarum 299v after 7 hours (Figure 
3.24A), despite no significant changes in IL-8 secretion from Salmonella Typhimurium-
infected cells at the same time points (Figure 3.25A). Despite different timings of 
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administration and cell lines, pre-treatment of alive or dead Lactobacillus rhamnosus 
GG or its conditioned medium with Caco-2 cells inhibited IL-8 production induced by 
IL-1β, tumour necrosis factor-α (TNF-α), or flagellin for 12-48 hours (Choi et al. 
2008;Lopez et al. 2008;Zhang et al. 2005). Similar to our protocol A in Figure 2.3A, 
administration of Lactobacillus plantarum 299v for 3 hours following TNF-α (10 ng/ml) 
stimulation for 3 h decreased IL-8 secretion from HT-29 cells (McCracken et al. 2002). 
Contrary to the reduced IL-8 secretion by co-administration of Lactobacillus plantarum 
and TNF-α (10 ng/ml) for 5 hours to Caco-2 cells (Ko et al. 2007), the present study 
showed no suppression in IL-8 secretion after 1-hour co-treatment of high-dose 
Lactobacillus rhamnosus GG or Lactobacillus plantarum 299v with IL-1β in HEp-2 
cells (Figure 3.30A). Therefore, adequate duration for interactions of lactobacilli with 
cells might be necessary for such inhibition. Paradoxically, after pretreatment of TNF-α 
with a higher dose (100 ng/ml) for 2 hours, subsequent treatment of Lactobacillus 
rhamnosus GG or Lactobacillus plantarum BFE1685 surprisingly enhanced IL-8 
secretion after incubation for 24 hours, but not as short as for 2 hours (Vizoso Pinto et al. 
2009). Additional studies are required to elucidate whether IL-1β and TNF-α differ in 
their lactobacilli-affected signalling pathways, or whether different cell lines respond 
differently to IL-1β or TNF-α and probiotics. Altogether with our findings, these two 
probiotic strains could inhibit IL-8 secretion from proinflammatory cytokine-pretreated 
epithelial cells at early hours but inversely enhance IL-8 secretion at late hours. 
Pretreatment of probiotic lactobacilli tends to be more effective than catch-up probiotic 
treatment to inhibit IL-8 production.  
 
It arouses growing concern how and where probiotic lactobacilli modulate IL-8 
expression and its cell-signalling pathways. Although some probiotic strains can 
downregulate IL-8 protein or gene expression induced by IL-1β (Sougioultzis et al. 
2006), TNF-α (Ma et al. 2004), or Salmonella Typhimurium (O'Hara et al. 
2006;Skjolaas et al. 2007), modulation of Lactobacillus rhamnosus GG and 
Lactobacillus plantarum on IL-8 gene expression in human epithelial cells remain 
largely uncharacterised. IL-8 mRNA expression was upregulated in TNF-α-stimulated 
HT-29 cells exposed to Lactobacillus plantarum 299v, but its protein expression was 
discordantly inhibited with unknown mechanisms (McCracken et al. 2002). This study 
discovered no parallel effects of Lactobacillus rhamnosus GG and Lactobacillus 
plantarum 299v on IL-8 gene expression to protein expression in IL-1β- and Salmonella 
 194
Typhimurium-stimulated HEp-2 cells. Given that mRNA expression occurred earlier to 
protein expression of IL-8, no comparable trends were found between mRNA levels at 5 
hours and protein levels at 7 hours (Figure 3.24A vs C, Figure 3.25A vs C). Moreover, 
other probiotic strains could inhibit IL-8 production in intestinal epithelial cells via 
blocking NF-κB signalling irrespective of stimulation with IL-1β, TNF-α, or Salmonella 
Typhimurium (Ma et al. 2004;O'Hara et al. 2006;Sougioultzis et al. 2006). NF-κB is a 
central regulator of IL-8 gene activation to infection with enteroinvasive bacteria such 
as Salmonella and Shigella (Gewirtz et al. 2000;Philpott et al. 2000). Also, 
Lactobacillus reuteri can inhibit degradation of IκB and translocation of NF-κB to the 
nuclei (Ma et al. 2004). Thus, we employed IL-1β-stimulated HEp-2 cells to inspect if 
Lactobacillus rhamnosus GG or Lactobacillus plantarum 299v could block degradation 
of IκBα, phosphorylation of NF-κB p65 at Ser536, or its subsequent nuclear 
translocation in NF-κB signalling to inhibit IL-8 expression. The data in this study 
showed that neither of the above three steps was impacted by Lactobacillus rhamnosus 
GG nor Lactobacillus plantarum 299v, which supports that their inhibition on IL-8 
secretion might occur after NF-κB p65 nuclear localisation at promoter targeting, 
transcription activation/repression, posttranscription, or posttranslation. Nevertheless, 
Extracellular signal Regulated Kineases 1 (ERK1) and ERK2, p38 Mitogen Activated 
Protein Kinase (p38 MAPK), and c-Jun-N-terminal Kinases (JNKs) pathways can 
integrate or crosstalk with the NF-κB pathway to directly or indirectly affect IL-8 
expression (Figueiredo et al. 2009;Hobbie et al. 1997;Yang et al. 2008). Additionally, 
the commensal strain Bacteroides thetaiotaomicron can trigger peroxisome proliferator 
activated receptor-γ (PPAR-γ) in the nucleus to bind with nuclear RelA (p65) to 
attenuate expression of NF-κB-regulated inflammatory genes (Kelly et al. 2004). 
Whether Lactobacillus rhamnosus GG or Lactobacillus plantarum 299v could inhibit 
IL-8 production via these pathways requires further studies for elucidation. As TLRs 
have a highly homologous cytoplasmic Toll/IL-1 receptor (TIR) domain which is 
similar to that of the IL-1 receptors (IL-1Rs) (Akira and Takeda 2004), binding of either 
PAMPs with TLRs or IL-1β with IL-1Rs triggers downstream signalling for activation 
of NF-κB and IL-8 expression. PAMPs of intracellular bacteria can be recognised by 
cell sensors such as bacterial CpG DNA by endosomal TLR-9 and cytosolic DNA 
sensors, and bacterial flagellin by cytosolic Nod-like receptors Ipaf and NAIP5 
(Delbridge and O'Riordan 2007;Takaoka and Taniguchi 2008). Hence, not only can 
Salmonella Typhimurium initially bind with TIRs analogously to IL-1β on the cell 
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membrane but survive and proliferate within cells to continuously trigger or sustain IL-
8 production. This fact, at least partly, explains why IL-8 secretion in IL-1β-treated cells 
at early hours was inhibited by single high-dose Lactobacillus rhamnosus GG or 
Lactobacillus plantarum 299v (Figure 3.24A), but not in Salmonella Typhimurium-
infected HEp-2 cells (Figure 3.25A).  
 
The timing of intervention of probiotics and their direct contact with pathogens play a 
key role in modulating host IL-8 responses during Salmonella Typhimurium infection. 
In this study, HEp-2 cells were concurrently treated with Lactobacillus rhamnosus GG 
or Lactobacillus plantarum 299v and IL-1β or Salmonella Typhimurium during the first 
hour (Figure 2.3C), which dose-dependently suppressed Salmonella Typhimurium-
stimulated, but not IL-1β-induced, IL-8 production during the last 7 hours (Figure 
3.30B). Using a similar protocol to ours, simultaneous exposure of Caco-2 cells to 
Salmonella Enteritidis and Lactobacillus gasseri or Lactobacillus rhamnosus for 1 hour 
inhibited IL-8 synthesis shortly after 3 hours but not persistently after 6 hours (Fajdiga 
et al. 2006). Such transient protection by lactobacilli on Salmonella-infected cells might 
be overwhelmed by increased IL-8 production with time and by continuous stimulation 
of intracellular proliferating Salmonella. Two studies using different probiotic strains 
prior to Salmonella Typhimurium infection in HT29 cells showed contradictory results: 
pretreatment of Bifidobacterium infantis or Lactobacillus salivarius for 2 hours without 
washing inhibited Salmonella Typhimurium-induced IL-8 levels after 24 hours (O'Hara 
et al. 2006), but pretreatment of Lactobacillus rhamnosus GG or Lactobacillus 
plantarum BFE 1685 for 2 hours with subsequent washing enhanced Salmonella 
Typhimurium-induced IL-8 production after 4 hours (Vizoso Pinto et al. 2009). Washing 
off lactobacilli might compromise the probiotic effect and duration upon IL-8 secretion 
during subsequent Salmonella Typhimurium infection. However, a shorter period of 1-
hour preincubation with Lactobacillus gasseri or Lactobacillus rhamnosus followed by 
washing and a shorter period of 1-hour Salmonella Enteritidis infection in Caco-2 cells 
did not induce higher IL-8 levels after 3 hours and 6 hours (Fajdiga et al. 2006). 
Collectively, either kinetic characteristics and strain specificity of probiotic lactobacilli 
or their direct interactions with Salmonella are important in regulating IL-8 secretion 
from host cells. After initiation of Salmonella Typhimurium infection, early treatment of 
probiotics in direct contact with pathogens is preferable to their inhibition on IL-8 
secretion. When postinfectiously administered in no direct contact with intracellular 
 196
Salmonella, probiotic lactobacilli may exert a dose-dependent inhibition upon IL-8 
production, as shown in this study for the capability of repeated high-dose Lactobacillus 
plantarum 299v to suppress the IL-8 secretion enhanced by single high-dose 
Lactobacillus plantarum 299v (Figure 3.25D). If commenced after use of antibiotics 
which eradicates extracellular but survives intracellular pathogens, treatment of 
probiotics with repeated doses for a longer duration may potentially suppress the rise of 
IL-8 secretion with time. This warrants further studies to confirm its efficacy and 
mechanisms.  
 
Probiotic lactobacilli exert antagonistic activities against microbial pathogens via 
various mechanisms during their interactions with bacteria and host cells. In this study, 
pH-unadjusted overnight cultures of Lactobacillus rhamnosus GG were utilised and 
Lactobacillus plantarum 299v because co-cultivation of both probiotic strains with 
pathogens showed considerable inhibition on Salmonella enterica growth under 
microaerobic conditions and stronger suppression from their pH-unadjusted supernatant 
than the whole cells (Hutt et al. 2006). Without presence of host cells, such pH-
dependent antimicrobial activities of Lactobacillus rhamnosus GG against Salmonella 
Typhimurium were consistent and mediated by lactic acid and non-lactic acid molecules 
(De Keersmaecker et al. 2006;Fayol-Messaoudi et al. 2005). A microarray analysis 
showed that the spent culture supernatant of Lactobacillus rhamnosus GG can 
antagonise Salmonella Typhimurium by influencing bacterial invasion gene expression 
(De Keersmaecker et al. 2005).With presence of host cells, however, in vitro studies 
showed controversies: 1-hour pretreatment with cell-free culture supernatants of 
Lactobacillus rhamnosus GG containing lactic acid and other compounds inhibited 
Salmonella Typhimurium invasion into Caco-2/TC7 cells (Makras et al. 2006); 1-hour 
co-treatment with either the culture or the supernatant of Lactobacillus rhamnosus GG 
impeded Salmonella Typhimurium invasion into Caco-2 cells (Hudault et al. 1997), but 
3-hour co-treatment with Lactobacillus rhamnosus, a similar strain to Lactobacillus 
rhamnosus GG, did not affect Salmonella Enteritidis invasion into a polarised Caco-2 
subline cells (Hirano et al. 2003). In animal studies, 7-day pretreatment of Lactobacillus 
rhamnosus GG eliminated faecal viable Salmonella Typhimurium in mice (Hudault et al. 
1997), 7-day postinfectious administration of Lactobacillus acidophilus also decreased 
faecal amounts of Salmonella Typhimurium in mice (Bernet-Camard et al. 1997), but 
14-day pretreatment of another probiotic strain, Enterococcus faecium, enhanced faecal 
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excretion and colonisation of Salmonella Typhimurium in organs of piglets (Szabo et al. 
2009). Such discrepancies might derive from different timings and durations of 
treatment using various probiotic strains in diverse cell types or animals. In contrast to 
the result that postinfectious 1-hour treatment of the spent culture supernatant of 
Lactobacillus acidophilus LB after 2-hour Salmonella Typhimurium infection of Caco-
2/TC-7 cells decreased the level of intracellular bacteria (Coconnier et al. 2000), this 
study demonstrated that the three regimens using either Lactobacillus rhamnosus GG or 
Lactobacillus plantarum 299v were unable to inhibit intracellular Salmonella 
Typhimurium replication in HEp-2 cells up to 7 hours (Figure 3.31). Overall, host cell 
responses after treatment of probiotic lactobacilli play a decisive role in whether 
probiotics could affect intracellular Salmonella Typhimurium replication.     
 
Bacterial invasion is essential for virulence of Salmonella Typhimurium (Pace et al. 
1993) that is compatible with my finding of no IL-8 secretion induced by the non-
invasive SPI-1-deficient mutant ΔspaS (Figure 3.32). In addition, previous studies 
showed quantitative correlations between intracellular replicating Salmonella 
Typhimurium and IL-8 expression at both protein and gene levels. In in vitro cultured 
T84 and HeLa cells, comparable relationships between numbers of intracellular bacteria 
and level of IL-8 secretion up to 4 hours were found in not only Salmonella 
Typhimurium but other bacterial strains (Eckmann et al. 1993). Another in vivo study 
using a porcine ligated ileal loop model revealed that faster replication of Salmonella 
Typhimurium than Salmonella Choleraesuis in the infected intestinal mucosa was 
associated with greater induction of IL-8 gene expression (Paulin et al. 2007). However, 
the SPI-2-deficient mutant ΔssaU, which inefficiently replicate within cells, produced a 
similar IL-8 level to the wild-type Salmonella Typhimurium up to 7 hours (Figure 3.32). 
Hence rather than SPI-2, intact SPI-1and its corresponding phenotype – invasion are 
indispensible for IL-8 induction, with no correlation between amounts of viable 
intracellular bacteria and levels of IL-8 secretion as long as 7 hours.  
 
To date, it remains unclear whether probiotic lactobacilli could affect intracellular 
Salmonella Typhimurium replication to further modulate IL-8 responses. Using a HEp-2 
cell culture model, we observed that postinfectious administration of either 1-dose or 4-
dose Lactobacillus rhamnosus GG or Lactobacillus plantarum 299v for 7 hours showed 
comparable trends in intracellular viable Salmonella Typhimurium levels (Figure 3.31A, 
 198
B) and host IL-8 secretion (Figure 3.25A, B) despite no significant inhibition on both, 
but the 4 repeated high-dose Lactobacillus plantarum 299v suppressed a uprising trend 
in IL-8 production caused by the single high-dose Lactobacillus plantarum 299v 
(Figure 3.25D). Such an effect of lactobacilli upon intracellular environments was most 
likely achieved via probiotic mediators across the cell/vacuole membranes or via cell-
mediated reactions to indirectly modulate invading pathogens, because a previous report 
showed that viable probiotic lactobacilli were not internalised in the host cells (Hirano 
et al. 2003). Nevertheless, when co-administered with Salmonella Typhimurium for 1 
hour prior to antibiotic eradication of extracellular bacteria, high-dose Lactobacillus 
rhamnosus GG or Lactobacillus plantarum 299v significantly suppressed IL-8 secretion 
(Figure 3.30B) but did not overtly influence intracellular replication of existing 
Salmonella Typhimurium (Figure 3.31C). Inconsistent with the correlation between 
quantities of intracellular bacteria and IL-8 levels for 4 hours as previously reported 
(Eckmann et al. 1993), probiotic lactobacilli intervention for 7 hours did not show 
correlation between intracellular Salmonella Typhimurium replication and IL-8 
production in the present study. Taken together, intracellular Salmonella Typhimurium 
replication increased or decreased in parallel with the altered IL-8 levels as long as 
probiotic lactobacilli had no direct contact with intracellular pathogens. The early direct 
interactions between lactobacilli and Salmonella Typhimurium before invasion may 
contribute to suppression of IL-8 secretion more than the late effects of probiotic 
mediators or lactobacilli-mediated host cell modulation upon intracellular Salmonella 
Typhimurium.  
 
In conclusion, Lactobacillus rhamnosus GG or Lactobacillus plantarum 299v could 
dose-, time-, and duration-dependently inhibit IL-8 responses induced by IL-1β or 
Salmonella Typhimurium in vitro under appropriate conditions. The earlier we started 
probiotic treatment allowing better direct contact of lactobacilli with pathogens, the 
better therapeutic efficacy would be in ameliorating host inflammatory IL-8 responses. 
Nevertheless, how to overcome amplification of inflammatory cascades triggered by 
continuous replication of intracellular pathogens is a key to success in developing any 
probiotic strain as an effective postinfectious therapeutic agent for invasive Salmonella. 
Appropriate sites in signalling pathways of Salmonella-infected cells for blockage by 
probiotic strains should be further localised. Specific targeting of these influential 
factors provides effective strategies in the probiotic treatment of Salmonella infection. 
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4a.1. Background: Clinical case reports of human Salmonella 
Typhimurium infections 
Human non-typhoidal Salmonella infection is usually diagnosed on basis of suspected 
clinical symptoms or signs and the following laboratory confirmation, which is mainly 
dependent on faecal culture or PCR of Salmonella species from patients. Direct 
evidence from the lesion is hardly available because non-typhoidal Salmonella enteritis 
is usually self-limiting and rarely necessitates biopsies for investigation. Because it is 
not routine practice to perform endoscopy in patients with acute gastroenteritis, there 
are limited data on the in vivo interaction between non-typhoidal Salmonella and 
humans. Most endoscopy procedures for taking biopsies are performed due to other 
reasons such as inflammatory bowel disease (IBD) and they sometimes incidentally 
disclose histopathological findings of patients with non-typhoidal salmonellosis. One of 
the reasons is that Salmonella infection sometimes simulates ulcerative colitis both 
clinically and radiologically. As early as in 1967, the coincidental occurrence of 
Salmonella infection in the patients with ulcerative colitis raised the question of 
possible increased susceptibility of chronic ulcerative colitis to Salmonella enteritis 
(Lindeman et al. 1967). Not only is the small intestine the principal site involved in 
human Salmonella infection of food poisoning type, but also colonic involvement is 
regarded as common in human salmonellosis because of sigmoidoscopic evidence of 
active colitis in 21 of 23 patients of salmonellosis (Mandal and Mani 1976). However, 
only one in 67 patients with salmonellosis had coincident IBD and the frequency of 
Salmonella complicating in 105 diarrhoeal patients with confirmed IBD was only 0.9%, 
indicating that patients with IBD are not predisposed to Salmonella infections and both 
disorders may occur together coincidentally (Szilagyi et al. 1985). 
 
Pathological findings are usually obtained from patients where there is a suspicion of 
diagnoses other than salmonellosis, usually via endoscopic biopsies, dissected 
specimens during surgeries, or necropsies after mortality. Recruitment of neutrophils to 
intestinal epithelium is the histopathological hallmark of acute inflammation or 
infection, raising a suspicion of salmonellosis or other bacterial infections; other 
inflammatory responses proceed with crypt abscesses, epithelial necrosis, oedema, and 
fluid retention which are clinically compatible with secretory exudates and diarrhoea 
(Coburn et al. 2007). In mild cases, the histological appearances of biopsies are usually 
nonspecific, consisting of mucosal oedema with focal inflammatory cell infiltration 
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(Day et al. 1978;McGovern and Slavutin 1979). Severe cases can be characterised by 
crypt abscess with infiltrating neutrophils in non-ulcerated areas, mucus depletion, 
extensive necrosis of the mucosa even mucosal ulceration, haemorrhage in the mucosa 
and submucosa, or microthrombi either in the mucosa or extending into venules in the 
submucosa mimicking acute ischaemic colitis (Day et al. 1978;Geyer et al. 
2007;McGovern and Slavutin 1979). The histological features of food-poisoning type 
Salmonella infection are similar to those seen in other types of infective colitis caused 
by Shigella, gonococcus, and amoeba; in the majority of their appearances are 
adequately discriminated from those seen in IBD (Day et al. 1978;Szilagyi et al. 1985). 
The changes in the biopsies from the patients with IBD and coincidental Salmonella 
infection generally showed histology of underlying idiopathic IBD (Day et al. 1978). In 
necropsies from mortality cases, the inflammation, haemorrhage, and ischaemia can be 
extended into wider ranges by necrosis into the muscularis mucosae, or by leucocyte 
invasion into the serosa with pictures of hemorrhagic necrotic enteritis/typhloenteritis or 
pyoperitonitis. Meanwhile, systemic manifestations can be more commonly seen such 
as enlargement of mesenteric lymph nodes, enlargement of the spleen, abscesses in the 
enlarged medulla and sinus spaces, or oedema of the brain and meninges (Ogata et al. 
2009;Shibusawa et al. 1997;Uzunovic-Kamberovic et al. 2003). However, histological 
presence of Salmonella bacteria in the biopsies or necropsies has rarely been described. 
 
Some observations based on sites of inflammation revealed the preference of non-
typhoidal Salmonella to invasion in the lower intestinal tract in human diseases. 
Commonly a disease of the ileum, inflammation in non-typhoidal disease also occurs in 
the large bowel, with rare infections in the jejunum, duodenum, and stomach (Boyd 
1985;McGovern and Slavutin 1979). Although some reports indicated that human 
serovar Typhimurium infection tended to be localised in the caudal ileum, caecum, and 
proximal colon (Coburn et al. 2007), active protocolitis in the distal colon was also 
histologically found via sigmoidoscopy in 21 of 23 inpatients with acute Salmonella 
infection (Mandal and Mani 1976). Nevertheless, the underlying mechanisms of such 
tissue tropism remain obscure. 
 
Hence, a retrospective tissue based investigation was undertaken using the formalin-
fixed paraffin wax-embedded biopsy tissue sections from three cases of Salmonella 
gastroenteritis mimicking the onset of IBD as previously reported, but where no 
 203
description of detecting bacteria in the tissues was reported (Friesen et al. 2008). These 
cases with a working diagnosis of IBD were found to have Salmonella infections 
subsequent to the endoscopic examination. After arrival in our laboratory, their mucosal 
biopsies were restudied for the presence of bacteria using routine H&E stain histology 
and also immunohistochemistry to determine if they are Salmonella using Salmonella-
specific antibodies. They offer the opportunity to provide information on the 
distribution of Salmonella in the large bowel, both within individual mucosal biopsies 
and regionally, along the large intestine. In one case the terminal ileum was also 
accessed, extending the area of study into the distal small intestine. It is thought that 
Salmonella preferentially invade via the epithelium overlying lymphoid follicles, and 
these areas were sought in histological sections. The interactions between the 
Salmonella and intestinal cells beside the epithelium, including neutrophils and lamina 
propria macrophages, were also examined. 
 
4a.2. In vivo histological evidences of Salmonella Typhimurium 
colonisation and invasion in the human intestinal tract 
H&E staining and combined immunofluorescence staining using anti-Salmonella O4 
and LAMP-1 antibodies (2.7.2.3.) were performed in the in vivo human intestinal tissue 
sections from three clinical case reports (Friesen et al. 2008). The purpose of H&E 
staining in these tissue samples is to search for clues as to any evidence of bacteria 
which might be invading Salmonella. In addition, application of anti-Salmonella O4 
antibody can specifically detect Salmonella in the biopsy tissues and provides evidence 
in the presence of Salmonella in human intestinal tissues/cells. Utilisation of LAMP-1 
antibody was supposed to more clearly delineate intracellular Salmonella contained in 
lysosomes or phagosomes. 
     
The first patient was a 5-year-old girl presenting with a 13-day history of abdominal 
cramping pain, fever, and diarrhoea. Her colonoscopy showed multiple deep ulcers in 
the rectum and descending colon with surrounding mucosal hyperaemia and oedema, 
but normal intervening mucosa and the transverse and ascending colon. The second 
patient was an 11-year-old girl presenting with a 25-day history of abdominal pain, 
fever, and diarrhoea. Her colonoscopy revealed a pancolitis with marked mucosal 
oedema, erythema, loss of haustra, and superficial ulcerations. The third patient was an 
8-year-old boy presenting with a 4-month history of recurrent monthly 5-day episode of 
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crampy abdominal pain and a high fever prior to admission. His colonoscopy showed 
diffuse, moderately severe colitis with mucosal hyperaemia, loss of haustra, and oedema 
with the cacem affected to a greater degree than the rectosigmoid colon in the severity 
of the inflammation. A few scattered aphthous ulcers were in the rectum. The terminal 
ileum was nodular and mildly hyperaemic, but without ulceration. Stool cultures grew 
Salmonella Enteritidis in Case 1 and Salmonella Typhimurium in Case 2 and Case 3. 
 
Histological pictures at low magnification (Figure 4.1) showed abscess formation in 
various sizes both in ileum (Figure 4.1A & B) and colon (Figure 4.1C–H). The 
abscesses could be as small as inflammatory cell aggregates within the submucosa 
(cross sections, Figure 4.1C & F), they could disrupt the muscularis mucosae layers 
across mucosa and submucosa (longitudinal sections, Figure 4.1G & H), and they 
could be as large as big huge lakes with mixtures of haemorrhage, cell debris, and 
inflammatory cell infiltrates (cross sections, Figure 4.1B, D, & E). H&E staining of the 
ileal samples showed mild oedematous villi and a underlying nodule without significant 
liquefaction in one area (cross or oblique section, Figure 4.1A) but severe oedema of 
the villi with loss of their leaflike shape, inflammatory cell infiltration among the 
intestinal glands in the lamina propria of the mucosa, and big abscess formation with 
central necrosis and haemorrhage in another area, which could also possibly be abscess 
formation extending into a lymph nodule (cross section, Figure 4.1B) because the 
nodules are partly within the mucosa of the ileum and extend into the submucosa with 
only scattered muscle cell bundles as presumptive muscularis mucosae rather than a 
muscle layer within nodules (Ross and Reith 1985a).  However, the epithelium of the 
ileum remained intact despite underlying severe inflammation or abscess formation in 
the deep areas. In colonic samples, the inflammation tended to be severe because of part 
loss or complete detachment of the intestinal epithelium with ensuing ulcers 
(arrowheads, Figure 4.1C & D), mucosal haemorrhage (H, Figure 4.1D, E, & H), 
congested blood vessels with possible internal microthrombus formation (BV, Figure 
4.1G & H). Basal lymphoid aggregates, which were regarded as features of IBD 
(Szilagyi et al. 1985), were also found in some of the colonic samples (white arrows, 
Figure 4.1E, G, & H) that might be confusing in making a diagnosis. Only little mucus 
could be found and it was difficult to discriminate if bacteria were tinged with mucus at 
such low magnification (white arrowheads, Figure 4.1C & H) that is compatible with 
the characteristic mucus depletion of severe infectious colitis. In all the tissue sections, 
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visible clusters of bacteria could not be seen in low-power fields. 
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Figure 4.1 H&E staining in low-power fields (40×) of the in vivo human intestinal 
tissue sections from different locations (A & B: ileum, C-H: colon) in  the intestinal 
tracts of the three paediatric patients (CASE 1 patient: A–D; CASE 2 patient: E & F; 
CASE 3 patient: G & H) with salmonellosis (MM: muscularis mucosae; SM: 
submucosa; H: haemorrhage; black arrows: abscess; black arrowheads: detached 
epithelium with ulcers; white arrows: basal lymphoid aggregates; white arrowheads: 
mucus). 
 
Histological images at higher magnification of the Case 1 patient revealed more 
information on bacteria rather than alterations in tissue architectures. Inflammatory cell 
infiltration of lymphocytes, neutrophils, plasma cells, and macrophages was 
characteristic particularly in the lamina propria (Figure 4.2A–C, E, G, & H). In the 
ileum sections, mucus was secreted by goblet cells and mixed with inflammatory cells 
above the intact epithelium (Figure 4.2A & B); bacterial rods were not discovered in 
the epithelial cells or cells within the lamina propria but only found in a macrophage 
away from a segment of the disrupted epithelium (Figure 4.2C & D). In the colon 
sections, some bacterial rods were recognised in the mucus secreted from the goblet 
cells just above the intact epithelium (Figure 4.2E & F). In another area where the 
epithelium was disrupted and a shallow ulcer formed, some bacterial rods could be 
found on the base of the ulcer or beneath the redundant epithelium, but still outside the 
cells (Figure 4.2G & H). 
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Figure 4.2 H&E staining in high-power fields (400×: left column; 1,000× oil: right 
column) of the in vivo human intestinal tissue sections from different locations (A–D: 
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ileum, E–H: colon) in the intestinal tracts of the Case 1 patient with salmonellosis (LP: 
lamina propria; G: goblet cell; Neu: neutrophil; Mac: macrophage; Epi: epithelium; 
arrows: bacterial rods; arrowheads: mucus). 
 
Similarly, histological images of the Case 2 patient illustrated a diffuse infiltration of 
inflammatory cells mainly in the lamina propria (Figure 4.3A–H). At higher 
magnification, one bacterial rod was identified between the lamina propria and just 
beneath the unbroken colonic epithelium (Figure 4.3B). Bacterial rods were visible in 
clusters inside a macrophage beneath the columnar colonic epithelial cells just beside 
the broken crypt in a loosen area of the lamina propria (Figure 4.3C & D), and close to, 
perhaps adhered to or phagocytosed by, another macrophage within the inflamed lamina 
propria (Figure 4.3G). Another bacterial rod was found in the mucus lake outside cells 
but could be either a solid brown rod or a yellowish crystal-like rod with slightly 
different focuses of microscopy (Figure 4.3E & F). Another bacterial rod was found 
just beneath, but outside, the basal membrane of the columnar epithelial cells in the 
lamina propria (Figure 4.3H). 
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Figure 4.3 H&E staining in high-power fields (400×: A & C; 1,000× oil: others) of the 
in vivo human colonic tissue sections from the Case 2 paediatric patients with 
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salmonellosis (Epi: epithelium; LP: lamina propria; C: crypt of colonic epithelium; G: 
goblet cell; Mac: macrophage; arrows: bacterial rods; arrowheads: mucus). 
 
Evidence of more bacteria was found in the histological pictures of the Case 3 patient. 
Bacterial rods adhered to not only epithelial and inflammatory cells but also fibroblast 
cells and again they could be either in solid brown rod colour or in crystal yellowish 
colour in different focuses of microscopy (Figure 4.4A & B). Numerous bacterial rods 
were trapped in a clump of mucus together with inflammatory cells (Figure 4.4C & D). 
There were only 2 to 4 rods associated with each neutrophil (Figure 4.4C & D) but 
many found inside barely one macrophage (Figure 4.4D). In the long sheet of mucus 
covering above an area of the lamina propria, numerous bacterial rods were tinged with 
the mucus and other cell debris (Figure 4.4E). In addition, bacterial rods could be 
sporadically found in between the collagen fibres and cells within the lamina propria 
(Figure 4.4F). Bacterial rods could be attached to mucus-secreting or containing goblet 
cells (Figure 4.4G) or in the mucus lake within the lumen of colonic intestinal glands 
(Figure 4.4H). 
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Figure 4.4 H&E staining in high-power fields (1,000× oil) of the in vivo human colonic 
tissue sections from the Case 3 paediatric patient with salmonellosis (G: goblet cell; Epi: 
epithelium; Neu: neutrophil; Mac: macrophage; asterisk: lumen of intestinal glands; 
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arrows: bacterial rods; arrowheads: mucus). 
 
It is necessary to confirm whether the aforementioned bacterial rods discovered under 
H&E staining were either Salmonella or other bacteria such as commensal flora. First of 
all, a positive control using Salmonella Typhimurium SL1344-containing HEp-2 cells in 
the LB agar block section (2.7.2.) showed a reddish bacterial rod in the cytoplasm 
adjacent to the nucleus of a HEp-2 cell (Figure 4.5A). Next, any bacterial rod with the 
same shape and size as that in the positive control was sought in all the section samples 
from three clinical cases after combined immunofluorescence staining using anti-
Salmonella O4 and LAMP-1 antibodies.  
 
Bacterial rods were found to be attached to the surface of the intact colonic epithelium 
(Figure 4.5B) from the Case 1 patient with Salmonella Enteritis infection despite of its 
weak staining by anti-O4 serum. 
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Figure 4.5 Combined immunofluorescence staining (1,000× oil) using anti-Salmonella 
O4 and LAMP-1 antibodies of the Salmonella-infected HEp-2 cells in paraffin-
embedded LB agar block section as a positive control (A), the in vivo human colonic 
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tissue section from the Case 1 patient with salmonellosis (B), and the endoscopically 
normal non-infected ileal tissue section from a patient with Crohn’s disease as a 
negative control (C). Staining by anti-Salmonella O4 antibody in red, LAMP-1 antibody 
in green, and DAPI in blue (G: goblet cell; Epi: epithelium; LP: lamina propria; arrow: 
bacterial rods). 
 
In the colonic sections of the Case 2 patient with Salmonella Typhimurium infection, 
combined immunofluorescence staining using anti-Salmonella O4 and LAMP-1 
antibodies demonstrated that Salmonella Typhimurium mostly were located in the 
detached tissues of the lamina propria (Figure 4.6A, B, E, & G), inflammatory cells 
possibly in the mucus outside the lamina propria (Figure 4.6C & D), and cells within 
the lamina propria (Figure 4.6F & H). Several Salmonella rods were obviously 
internalised into two cells probably macrophages (Figure 4.6D). 
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Figure 4.6 Combined immunofluorescence staining (400×: left column; 1,000× oil: 
 216
right column) using anti-Salmonella O4 and LAMP-1 antibodies of the in vivo human 
colonic tissue sections from the Case 2 patient with salmonellosis. Staining by anti-
Salmonella O4 antibody in red, LAMP-1 antibody in green, and DAPI in blue (LP: 
lamina propria; arrowheads: probably macrophages; asterisks: lumen of intestinal 
glands; arrows: bacterial rods). 
 
In the colonic sections of the Case 3 patient with Salmonella Typhimurium infection, 
combined immunofluorescence staining using anti-Salmonella O4 and LAMP-1 
antibodies showed that Salmonella Typhimurium resided not only above the epithelium 
or within the lamina propria beneath the epithelium but also inside the epithelial cell 
(Figure 4.7). Salmonella Typhimurium rods were found to be associated with the 
detached cells above the epithelium (Figure 4.7D), adhere to the surface of absorptive 
cells in the epithelium (Figure 4.7A), and attached to the outlet of a goblet cell in the 
epithelium (Figure 4.7F). In addition, some Salmonella rods were sporadically 
distributed in the lamina propria in different association with various cells (Figure 4.7B, 
C, E, & H). Intracellullar Salmonella Typhimurium was also found just next to the 
nucleus of the columnar epithelial cell (Figure 4.7G). 
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Figure 4.7 Combined immunofluorescence staining (400×: A & B; 1,000× oil: C–H) 
using anti-Salmonella O4 and LAMP-1 antibodies of the in vivo human intestinal tissue 
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sections from the Case 3 patient with salmonellosis. Staining by anti-Salmonella O4 
antibody in red, LAMP-1 antibody in green, and DAPI in blue (G: goblet cell; LP: 
lamina propria; Epi: epithelium; IG: intestinal glands; C: crypts of colonic epithelium; 
arrows: bacterial rods). 
 
4a.3. Discussion 
The H&E staining in this study demonstrates that mucosal or submucosal focal abscess 
or multiple crypt abscess formation is the most common histological characteristic in 
human non-typhoidal Salmonella infection in vivo. In addition, mucosal erosion or 
detachment is another remarkable feature that can make Salmonella bacteria more easily 
access deeper areas of the infected intestinal tissues than bacterial translocation across 
intact epithelial barriers. Although visible bacterial rods suspected as Salmonella were 
found in the different locations in the biopsied intestinal tissues, they were difficult to be 
confidently discriminated with other bacteria in rod shapes such as commensal flora in 
the intestine that vindicated the combined immunofluorescence staining for 
identification of Salmonella in the in vivo tissues. 
 
Discovered in paediatric patients with salmonellosis using the combined 
immunofluorescence staining, non-typhoidal Salmonella interacted with different cells 
in diversity. They were mostly trapped in the mucus layer with inflammatory cells (e.g. 
neutrophils and macrophages) above the epithelium, but also colonised or invaded the 
epithelial cells (enterocytes and goblet cells), interacted with inflammatory cells (e.g. 
neutrophils, lymphocytes, monocytes, or macrophages), mesenchymal cells (e.g. 
fibroblasts), or crypt cells of intestinal glands in the lamina propria of the lower 
intestinal tract. Unfortunately, no upper endoscopy was performed to acquire available 
duodenal biopsies for investigation of human Salmonella infection in the upper 
gastrointestinal tract. Meanwhile, the bacterial identified by anti-Salmonella O4 
antibody were not too many except for those in the mucus layers outside the epithelium 
of the intestinal biopsy tissues from the three paediatric patients with the endoscopic 
features of chronic colitis or ulcers. Such observation could be explained by several 
possibilities. The endoscopic biopsies were all obtained at the subacute/chronic, but not 
acute, stage of 7 days to 27 days after onset of their clinical symptoms that could 
possibly miss a perfect timing for catching most of the Salmonella bacteria. Such long 
duration of interactions between the Salmonella and the host immune systems allowed 
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the patients to expel, diminish, or eliminate the infective Salmonella bacteria by 
shedding of pathogens (e.g. diarrhoea) and/or the defence immune system in vivo. Also, 
the low quantities of Salmonella bacteria were indirectly revealed by the lengthy 
durations of stool cultures from two of these three patients, particularly for 8 days in the 
Case 1 and for 4 days in the Case 3 (Friesen et al. 2008) because bacterial culture on the 
agar plates usually takes 1–2 days (Fang et al. 2009b) followed by biochemical 
confirmation for another one day. Additionally, it is unavoidable that random locations 
of biopsies in inflamed areas via endoscopy can not guarantee to catch the right sites 
which Salmonella bacteria mostly niche in.  
 
Two different serotypes of non-typhoidal Salmonella, Salmonella Typhimurium and 
Salmonella Enteritidis respectively, were identified by stool cultures in these three case 
reports. Analysis of the serologic responses against serotypes Typhimurium and 
Enteritidis indicate that the O4 antigen and the O9 antigen are respectively 
immunodominant determinants of their LPS (Nicholson and Baumler 2001). 
Nevertheless, Salmonella Typhimurium consists of  the antigens O1, 4, 5, and 12, and 
Salmonella Enteritidis comprises the antigens O1, 9, and 12 (Popoff 2001;Yoshida et al. 
2007). The O antigen repeat units of serotypes Enteritidis and Typhimurium share the 
trisaccharide backbone (mannose-rhamnose-galactose) which is termed the O12 antigen. 
However, the two serotypes differ in the sugar residues branching from the mannose 
residues in the trisaccharide backbone of their O antigen repeat units, with the branching 
sugar tyvelose (O9 antigen) in the serotype Enteritidis and the sugar abequose attached 
as the side unit to mannose (O4 antigen) in the serotype Typhimurium (Nicholson and 
Baumler 2001). While the anti-O4 serum has been absorbed to minimise cross-reactions 
according to the user’s manual (Oxoid Limited), the possibility of cross-reactions with 
other Salmonella antigens (e.g. O1 or O12 antigens) or related organisms of other 
species cannot be completely excluded that may explain for the weak 
immunofluorescence staining of the Salmonella Enteritidis in the Case 1 patient in this 
study. 
 
In this study, the utilised anti-LAMP-1 antibodies stained a number of inflammatory or 
immunomodulatory cells outside the epithelium and in the lamina propria better than 
the epithelial cells. However, it is not sure whether such weak staining of LAMP-1 in 
the intestinal epithelium from the paraffin wax-embedded tissue sections in this study 
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was due to formaldehyde fixation or due to longer survival in phagocytic cells than in 
epithelial cells. My preliminary study showed that the anti-LAMP-1 antibodies stained 
HEp-2 cells better when fixed in ice-cold acetone than those fixed in formaldehyde 
(data not shown). From the human duodenum of healthy adults, the cryosections of 
endoscopic biopsy specimens fixed in ice-cold acetone could be clearly stained by the 
mouse monoclonal anti-LAMP-1 antibody showing that the LAMP-1 were located both 
apically and basolaterally, with the most prominent staining in the apical part of the IEC 
(Lin et al. 2005). In bone marrow-derived mice macropahges, phagosomes containing 
Salmonella Typhimurium merged rapidly and completely with the lysosomal 
compartment within 20 minutes of phagocytosis. These wild-type bacteria were viable 
20 minutes after infection and survived longer incubations for at least 16 hours inside 
macrophages, indicating that Salmoenlla Typhimurium can survive within the 
phagolysosome of macrophages (Oh et al. 1996). Approximately 1–5% of the total 
number of intracellular bacteria lacking LAMP-1 in the wild-type infected cells, 
indicative of rupture of SCV (Brumell et al. 2002;Garcia-del et al. 1997). Meanwhile, 
loss of maintenance of the SCV by the host endosomal system allows increased 
replication of Salmonella Typhimurium in the cytosol of epithelial cells (Brumell et al. 
2002). A recent study indicated that these intracellular replicating Salmonella out of 
SCV but in the cytoplasm can induce epithelial extrusion from the monolayer, releasing 
invasion-primed and -competent Salmonella into the lumen which is accompanied by 
inflammatory epithelial cell death (Knodler et al. 2010). Collectively, it would be 
desirable to know if such an intracellular survival of non-typhoidal Salmonella in 
macrophages could last longer than that in intestinal epithelial cells in vivo that might 
result in persistently viable bacteria within macrophages but disappearance of bacteria 
in the epithelium after a long time post infection. This assumption might possibly and 
partly explain why intracellular Salmonella bacteria with surrounding LAMP-1 staining 
were mostly found in macrophages in this study because of the late acquirement of 
biopsied tissues. 
 
It remains questionable which route(s) Salmonella bacteria preferably get through the 
intestinal epithelial barriers into the deeper part of the infected gut tissue after human 
Salmonella infection in vivo. A number of alternative explanations may account for this 
phenomenon. The first route for crossing the intact epithelium is termed bacterial 
translocation that Salmonella bacteria invade the intestinal epithelial cells (e.g. 
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enterocytes and goblet cells), survive in the cells, and finally leave the cells into lamina 
propria, remaining the penetrated epithelium still viable. The second route could be that 
Salmonella bacteria break down the integrity of the intestinal epithelium by damaging 
or killing the host epithelial cells which releases the invading bacteria into the 
extracellular environment to infect other cells. Such severe inflammation or death of the 
invaded epithelial cells can cause detachment of the epithelium and subsequent erosion 
or ulcer to expose the underlying lamina propria, allowing massive amounts of bacteria 
to reach the deeper part of the infected gut tissues. The third route is termed paracellular 
translocation that Salmonella bacteria bypass the epithelial cells but penetrate the 
epithelium via loosening of the intercellular tight junctions to get into the lamina propria 
with or without assistance of transepithelial migrating neutrophils or dendritic cells 
projecting their dendrites into the intestinal lumen (Bueno et al. 2010). Another 
alternative route could be via M cells mostly found in the follicle-associated epithelium 
(FAE) overlying the intestinal Peyer’s patches (Jepson and Clark 2001), but also found 
as intestinal villous M cells in the non-FAE (Jang et al. 2004), or solitary intestinal 
lymphoid tissue (SILT) comprising small lymphoid cell clusters surrounding numerous 
inflammatory foci in the entire intestinal mucosa in parallel to a strong inflammatory 
response in Peyer’s patches (Halle et al. 2007). M cells are specialised intestinal 
epithelial cells characterised by sparse, irregular microvilli on their apical surface and 
basolateral cytoplasmic invagination harbouring lymphocytes and macrophages, and by 
function in antigen sampling and their vulnerability to infection by pathogens (Jepson 
and Clark 2001). Interestingly, Salmonella Typhimurium preferably invade M cells 
located in the FAE of Peyer’s patches in mouse (Jones et al. 1994) and swine 
(Meyerholz et al. 2002), but they can invade both M cells and enterocytes without 
predilection in cattle (Santos et al. 2002). So far there have been no available reports 
regarding M cell tropism of Salmonella in humans. Pitifully, the number of the available 
infected human biopsy gut tissues containing FAE was limited and the stage of the 
obtained biopsies might be too late to observe an initial event. It requires more human 
biopsies from different intestinal sites, favourably at an earlier stage, to conclude 
whether Salmonella infection in humans adopts a preferable invasion route to M cells 
than enterocytes. 
 
During the in vivo human intestinal infections in this subchapter, more evidence of 
invading Salmonella bacteria was found in the inflammatory cells (mainly macrophages 
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and neutrophils) than in the intestinal epithelial cells that could be attributed to the cell 
tropism of non-typhoidal Salmonella. This observation in humans is similar to the 
findings in the other animal models in vivo (Santos and Baumler 2004). Bacteria were 
not found in fibroblasts or other mesenchymal cells in bovine intestinal tissue infected 
with Salmonella Typhimurium in vivo but were located exclusively in epithelial cells, 
mononuclear cells (dendritic cells and/or macrophages), and neutrophils (Santos et al. 
2002). Likewise, Salmonella Typhimurium bacteria were located exclusively within 
macrophages and neutrophils of the murine liver in vivo (Richter-Dahlfors et al. 1997). 
In contrast to macrophages which tend to be a safe reservoir for bacterial proliferation 
and persistence in systemic diseases, neutrophils play as a scavenger of extracellular 
bacteria during non-typhoidal Salmonella infection in vivo (Santos and Baumler 2004). 
How these two cells behave towards Salmonella bacteria in human infections warrants 
further studies for elucidation. 
 
This subchapter explored the in vivo human Salmonella intestinal infection which is a 
rarely investigated field due to limitations by ethical consideration and difficult 
availability of human tissue samples. However, not only did it show focal abscess 
formation as the typical histological feature of human non-typhoidal Salmonella 
infection, but it also disclosed evidence of Salmonella invasion into the intestinal 
epithelial cells, neutrophils, and macrophages. These findings are similar to what have 
been reported in the previous animal studies although they did not genuinely reflect the 
‘early’ interactions between the bacteria and human cells. Moreover, the 
immunostaining using anti-Salmonella antibodies confirmed the diagnosis of 
salmonellosis previously just based on faecal cultures and inflammation on histology, 
revealing more information in bacterial invasion and distribution. Therefore, this study 
is only a beginning in a series of studies for human non-typhoidal Salmonella intestinal 
infections. More prospective studies can be dedicated using surgical specimens from 
patients with acute non-typhoidal salmonellosis and surgical complications such as 
bowel perforation to catch the facts occurring at the acute stage during infections. 
Adjuvant evidence of intracellular bacteria in fluorescence staining should be reinforced 
by improving the fixation methods for LAMP-1 antibodies or by applying other more 
specific intracellular markers. Transmission electron microscopy or confocal 
microscopy could be considered to obtain details in the subcellular level. Simulated ex 
vivo human Salmonella intestinal infections will be introduced in the next subchapter. 
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4b.1. Background 
Following the in vivo human intestinal infection of non-typhoidal Salmonella, an ex vivo 
human intestinal organ culture model was established. The known bacterial strains were 
inoculated to the artificially established human intestinal tissues outside the human 
bodies for detection of disease findings in the tissue or cell levels such as 
histopathological changes, presence of invading bacteria, and host innate responses. 
This model creates a feasible platform to more precisely understand the control of 
human gene expression, developmental biology, and tissue interaction than in vitro cell 
lines and in vivo animal models.  
 
Human tissue samples are definitely irreplaceable for studying the genuine human host 
responses, especially during the early stages. For the past several decades, researchers 
have been keen to employ various experimental models both in vitro and in vivo for 
better understanding of human enteric infections. These models consist of cell culture 
lines deriving from human or animal cancer cells, selected animals which can be orally 
or peritoneally inoculated with bacteria, or intraluminally inoculated with bacteria into 
their ligated bowel loops. Theoretically, the signs of disease observed in primate models 
closely resemble the symptoms in human patients, but the high cost and paucity of 
primate animals (e.g. rhesus monkeys) have prevented their widespread use. Another 
two animal models, the mouse and the calf, are most commonly used for elucidating 
Salmonella virulence mechanisms. Mice infected with serotype Typhimurium that 
present with a systemic disease without diarrhoea can be a good model of typhoid fever, 
however, is not suitable as a model of enteritis. In contrast, natural or experimental 
infection of calves with serotype Typhimurium results in an enteric disease with clinical 
and pathological features resembling the disease in man. Therefore, it can be a good 
model of Salmonella-induced human enteritis (Santos et al. 2001). However, it remains 
questionable to directly assess the contribution made by Salmonella virulence-
associated genes to human gastroenteritis because in vitro cultured human epithelial 
cells and animals in different species cannot entirely mimic aspects of the pathogenesis 
of this human disease syndrome (Everest et al. 1999).  Hence, it would be informative 
to investigate the interactions between non-typhoidal Salmonella and fully differentiated 
human intestinal epithelium. 
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For the past decade, human intestinal ex vivo organ culture has been extensively applied 
to studies of various enteric infections from upper to lower gastrointestinal tracts, 
including pathogen virulence factors and host responses from the infected human gut. 
The spectrum of such application ranged from chronic Helicobacter pylori infection 
(Bodger et al. 2001) to acute bacterial infections such as E. coli (Fitzhenry et al. 
2002;Hicks et al. 1998;Phillips et al. 2000;Schuller et al. 2007), Salmonella (Haque et al. 
2004), and Campylobacter jejuni (Grant et al. 2006;Maccallum et al. 2005;MacCallum 
et al. 2006), for understanding the pathogenesis of the infectious bacteria in the human 
gut which is mainly orchestrated by bacterial colonisation (adhesion, invasion, and 
tissue tropism), interactions between pathogens and intestinal mucosa, and host immune 
responses.  
 
In non-polarised ex vivo organ cultures (Grant et al. 2006;Haque et al. 2004) stimulation 
of the serosal or cut surface might undermine a directional epithelial exposure. 
Therefore, a polarised ex vivo organ culture system was developed to overcome such 
limitations for the ideal inspection of the bacteria–host cell interaction. Exclusive apical 
bacterial infection produced negligible bacterial leakage via biopsy edges, resulted in 
enhanced colonisation and detachment of EPEC (Schuller et al. 2009). In the only 
previous attempt to develop an ex vivo model of Salmonella Typhimurium infection 
evidence of Salmonella Typhimurium colonisation in the human enterocytes with 
associated membrane ruffling was detected from 4–8 hours of non-polarised ex vivo 
organ culture incubation, despite a predominance of bacteria in the covering mucus 
layer and no large scale invasion of explant tissues (Haque et al. 2004). As far as known, 
polarised ex vivo human intestinal organ culture has not been utilised to study 
Salmonella infection and this modified model will be inspiring to provide more 
information than the non-polarised model in human intestinal Salmonella infection and 
allow the host response to be investigated. 
 
It is promising to employ this polarised ex vivo organ culture model to answer more 
questions regarding human Salmonella infections. In this subchapter, the process of a 
partially successful non-polarised human ex vivo organ culture model of Salmonella 
infection (Haque et al. 2004) was improved using the polarised ex vivo human intestinal 
organ culture, and the in vivo regional localisation of Salmonella in Chapter 4a helps 
with this work as it is helpful to focus on the area of the gut that might be best suited for 
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ex vivo infection. First, a pioneer study of gentamicin protection assay using this non-
polarised ex vivo organ culture model was conducted to see if reproducible invasion 
rates of Salmonella Typhimurium could be obtained. Second, SEM was performed to 
assess the tissue viability after ex vivo Salmonella infections. Third, double 
immunostaining for differentiation between intracellular and extracellular bacteria 
(2.7.1.1.) was applied to the isolated Salmonella-infected tissue explants using non-
polarised ex vivo organ culture for seeking evidence of bacterial invasion. Fourth, 
histology and immunohistochemistry (2.7.2.) in the Salmonella-infected tissues after 
polarised ex vivo organ cultures was also utilised to explore evidence of bacterial 
invasion and early stage interactions with host cells. Fifth, quantitative real-time PCR of 
mRNA expression in IL-8 and five human defensins (β-defensin-1, -2, and -3; α-
defensin-5 and -6) was undertaken to evaluate host innate immune responses in the 
Salmonella-infected intestinal explants after polarised ex vivo organ cultures. Both the 
preliminary and the conclusive data showed great potentials and unique values of this 
model for further studies of human Salmonella infection. 
 
4b.2. Results 
4b.2.1. Gentamicin protection assay using an ex vivo polarised human 
intestinal organ culture model 
To seek quantitative evidence of Salmonella invasion using the ex vivo gentamicin 
protection assay (2.5.3.1.), viable Salmonella Typhimurium bacteria were quantified in 
the basolateral media for calculating the leakage rates at 6 hours post infection and in 
the homogenised lysates of the infected tissues for calculating the invasion rates at 8 
hours post infection. Paired biopsy samples in the same locations either from duodenum, 
terminal ileum, or sigmoid colon of the paediatric patients were consecutively taken via 
endoscopy with ethical approval and after informed consent was obtained. The biopsy 
sites were ensured to be endoscopically non-inflamed. Totally 3–4 paired biopsy 
samples via upper or lower intestinal endoscopy from the first 5 patients were infected 
with Salmonella Typhimurium SL1344 and the SPI-1 mutant of Salmonella 
Typhimurium NCTC 12023 ∆prgH whilst awaiting for the SL1344 isogenic SPI-1 
mutant ∆spaS. Another 3 paired biopsy tissues via both upper and lower intestinal 
endoscopy from the subsequent 3 patients were inoculated with Salmonella 
Typhimurium SL1344 and its isogenic SPI-1 mutant ∆spaS. The invasion rates of 
individual strains in the different sites of the biopsied tissues and their corresponding 
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translocation rates into the basolateral compartments in these two preliminary tests were 
individually shown in Figure 4.8 and Figure 4.9. 
 
In the first preliminary test, no obvious differences were found between the invasion 
rates of the wild-type SL1344 and the SPI-1 mutant ∆prgH regardless of the tissue 
location (Figure 4.8A), with big deviation in the higher invasion rates from the No 3 
patient in the ∆prgH-infected duodenum tissue as well as in the SL1344- and ∆prgH-
infected terminal ileum tissues. Meanwhile, their leakage rates showed large variations 
in different conditions (Figure 4.8B). In the terminal ileal tissues from the No 3 patient, 
the leakage rate of Salmonella Typhimurium SL1344 was high but that of Salmonella 
Typhimurium NCTC 12023 ∆prgH was low (the third group and fourth group, 
respectively, Figure 4.8B). However, their matching invasion rates showed an opposite 
results that the invasion rate of the former was lower than that of the latter which was 
supposedly non-invasive (the third group and fourth group, respectively, Figure 4.8A). 
Another example in the terminal ileum tissue and in the sigmoid colon tissue from the 
No 2 patient showed that their leakage rates of Salmonella Typhimurium SL1344 were 
relatively high (the third group and fifth group, respectively, Figure 4.8B) but their 
invasion rates were unexpectedly low (the third group and fifth group, respectively, 
Figure 4.8A).  
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Figure 4.8 Invasion rates (A) and leakage rates (B) of Salmonella Typhimurium 
SL1344 and Salmonella Typhimurium NCTC 12023 ∆prgH in a preliminary test of ex 
vivo polarised human intestinal organ cultures (D4: the fourth portion of duodenum; TI: 
terminal ileum; Sig: sigmoid colon; horizontal lines indicate medians; digital numbers 
indicate serial identification numbers of the enrolled patients). 
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In the second preliminary test using Salmonella Typhimurium wild-type SL1344 and its 
isogenic SPI-1 mutant ∆spaS, both the invasion rates and the leakage rates in different 
conditions showed big variations (Figure 4.9). For example, the leakage rate of 
Salmonella Typhimurium SL1344 ∆spaS in the infected duodenum sample from the No 
2 patient was lowest (the second group, Figure 4.9B), but its matching invasion rate 
was highest (the second group, Figure 4.9A) among the three cases that was not logic 
supposing this SPI-1 mutant ∆spaS could not efficiently invade the epithelium as shown 
in the HEp-2 cells in vitro (Figure 3.32). Additionally, the leakage rates of Salmonella 
Typhimurium SL1344 ∆spaS in the infected sigmoid colon samples from the three 
patients were relatively high (the sixth group, Figure 4.9B), but their corresponding 
invasion rates were comparatively low (the sixth group, Figure 4.9A).  
 
No definite conclusion could be drawn because these quantitative data were neither 
reproducible nor reliable. Therefore, the direction of the study design was converted 
towards seeking visual evidence of bacterial invasion and investigating the host innate 
immune responses.  
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Figure 4.9 Invasion rates (A) and leakage rates (B) of Salmonella Typhimurium 
SL1344 and ∆spaS in a preliminary test of ex vivo polarised human intestinal organ 
cultures (D4: the fourth portion of duodenum; TI: terminal ileum; Sig: sigmoid colon; 
horizontal lines indicate medians; digital numbers indicate serial identification numbers 
of the enrolled patients). 
 231
4b.2.2. SEM morphological assessment of Salmonella-infected tissues in 
polarised ex vivo human intestinal organ culture 
To assess the tissue survival and integrity of the infected intestinal biopsy explants in 
the polarised ex vivo organ culture model after 8 hours incubation with the initial 2-hour 
infection (2.5.3.), SEM was performed (2.6.) to observe the cell surfaces of the non-
infected and Salmonella-infected intestinal mucosa which was exposed within the 
central apertures of the snapwell discs (white circles, Figure 4.10A–F) whilst the 
peripheral area of each tissue appeared to be compressed by the snapping upper disc. At 
higher magnification, most of the epithelial cells were still intact (Figure 4.10H & I) 
but some area was found to be detached and only part of the epithelium remained in situ 
(Figure 4.10G). In the subsequent SEM assessments, the tissue samples from different 
patients showed variable epithelial integrity that might either reflect the underlying 
condition of the patients or trauma arising from handling of the tissue.  
 
 
Figure 4.10 Morphological assessment on the surface of non-infected (A–C) and 
Salmonella Typhimurium SL1344-infected (D–I) tissues in polarised ex vivo human 
intestinal organ cultures (A, D, G: duodenum; B, E, H: terminal ileum; C, F, I: sigmoid 
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colon) by ×35 (A–F) and ×1,500 (G–I) SEM. The white circle shows the area of the 
biopsy within the central aperture. 
 
4b.2.3. Ex vivo histological evidence of Salmonella Typhimurium 
colonisation and invasion  
4b.2.3.1. Isolated intestinal epithelium from Salmonella-infected tissues 
in non-polarised ex vivo human intestinal organ culture 
Prior to using polarised ex vivo organ cultures for seeking histological evidence of 
Salmonella Typhimuium colonisation and invasion, non-polarised ex vivo organ cultures 
were infected with Salmonella Typhimurium SL1344 (2.5.2.) and followed by isolation 
of the intestinal epithelium (2.5.2.1.), which were then stained using double 
immunofluorescence staining for differentiation between intracellular and extracellular 
bacteria (2.7.1.1.). The isolated Salmonella-infected colonic epithelium was wholly 
detached from the lamina propria in a clump (Figure 4.11A) and several Salmonella 
bacteria were clearly shown inside the cells (arrows, Figure 4.11B) whilst other bacteria 
were only adherent to the cell surface without invading the cells (orange-yellowish rods, 
Figure 4.11B). At least, it is clear evidence of intracellular bacteria and Salmonella 
Typhimurium invasion into the ex vivo human colonic epithelium although it was 
difficult to determine which route(s) (apically, laterally, or basally) these Salmonella 
bacteria invaded the epithelial cells. 
 
 
Figure 4.11 Double immunofluorescence staining for differentiation between 
intracellular and extracellular bacteria (2.7.1.1.) in isolated Salmonella Typhimurium 
SL1344-infected colonic epithelial cells from non-polarised ex vivo human intestinal 
organ culture (A: 400×, B: 1,000× oil; arrows: intracellular Salmonella in green colour; 
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extracellular Salmonella in orange-yellowish colour) The square mark area which is 
examined at higher magnification in Figure 4.11 B. 
 
4b.2.3.2. Salmonella-infected tissues in polarised ex vivo human 
intestinal organ culture 
The polarised ex vivo human intestinal organ culture model (2.5.3.) was adopted to seek 
evidence of Salmonella invasion via a natural apical route into the human epithelium 
and/or lamina propria. Paired intestinal biopsy explants from duodenum, terminal ileum, 
and sigmoid colon were apically treated with OD600-adjusted PBS-resuspended 
overnight cultures of Salmonella Typhimurium SL1344 and PBS for 2 hours, followed 
by another 3 hours of incubation, in situ fixation, sectioning, and staining (2.7.2.). 
 
Histological pictures with H&E staining at low magnification showed diffuse 
infiltration of inflammatory cells mainly in the mucosa but also extending into the 
submucosa of either Salmonella-infected explants (Figure 4.12A, C, & E) or non-
infected tissues (Figure 4.12B, D, & F), suggesting that inflammation could be induced 
by either the traumatic biopsy or the process of ex vivo organ culture. Microabscess-like 
formation with few neutrophils was visible in the mucosa of the Salmonella-infected 
terminal ileum sample (Figure 4.12B), whilst diffuse aggregation of the inflammatory 
cells was seen in the submucosa of non-infected terminal ileal sample (Figure 4.12D). 
Such inflammatory cell infiltration could also be seen as glandular lymphoid aggregates 
in the non-infected sigmoid colon sample (Figure 4.12F). The epithelium was totally 
detached in both of the Salmonella-infected and non-infected duodenal explants (Figure 
4.12A & B). Most of the epithelium remained intact in both of the Salmonella-infected 
and non-infected explants from the terminal ileum and sigmoid colon except for some 
of the short epithelial segments that were detached and developed into erosions (black 
arrowheads, Figure 4.12C–F). Scattered mucus layers were found in the Salmonella-
infected samples from terminal ileum and sigmoid colon (Figure 4.12C & E).  
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Figure 4.12 H&E staining in low-power fields (40×) of the Salmonella Typhimurium 
SL1344-infected (A, C, E) and non-infected (B, D, F) human snap-well intestinal tissue 
sections (A & B: duodenum; C & D: terminal ileum; E & F: sigmoid colon) in polarised 
ex vivo intestinal organ cultures (M: mucosa; MM: muscularis mucosae; SM: 
submucosa; BG: Brunner’s glands; BV: blood vessel; black arrows: abscess-like 
formation; black arrowheads: detached epithelium with erosions; white arrows: 
glandular lymphoid aggregates; white arrowheads: mucus). 
 
Histological images with H&E staining at high magnification of the ex vivo small 
intestinal explants provided more evidence of bacteria in the epithelium and lamina 
 235
propria (Figure 4.13). In the duodenum sections, bacterial rods were found in the 
lamina propria with or without intact overlaying epithelium (Figure 4.13A & B). In the 
ileum sections, some bacterial rods were closely associated with the epithelial cells 
where adhesion and invasion could not be easily discriminated (Figure 4.13C & F). 
Additionally, numerous bacterial rods were discovered within the lamina propria 
(Figure 4.13D & E), including some rods closely attached to the neutrophil and 
macrophage or possibly phagocytosed by the macrophage (Figure 4.13D). 
 
Figure 4.13 H&E staining in high-power fields (1,000× oil) of the Salmonella 
Typhimurium SL1344-infected snap-well human small intestinal tissues (A & B: 
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duodenum; C–F: terminal ileum) in polarised ex vivo intestinal organ cultures (Epi: 
epithelium; G: goblet cell; LP: lamina propria; Neu: neutrophil; Mac: macrophage; 
arrows: bacterial rods; arrowheads: mucus). 
 
Histological images with H&E staining at high magnification of the ex vivo sigmoid 
colonic explants also showed evidence of bacteria in the epithelium and lamina propria 
(Figure 4.14). Bacterial rods were trapped in the mucus layer above the epithelium 
(Figure 4.14B) or in the mucus which was just secreted near the outlet of the goblet cell 
(Figure 4.14A). Bacterial rods were not only localised within the enterocytes (Figure 
4.14C & D) but also translocated across the epithelium into the lamina propria (Figure 
4.14D–F) whilst the epithelium still remained intact. In some areas where the 
epithelium had been detached, plenty of bacterial rods aggregated within the lamina 
propria (Figure 4.14G & H). 
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Figure 4.14 H&E staining in high-power fields (1,000× oil) of the Salmonella 
Typhimurium SL1344-infected snap-well human sigmoid colonic tissues in polarised ex 
vivo intestinal organ cultures (Epi: epithelium; G: goblet cell; LP: lamina propria; 
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arrows: bacterial rods; arrowheads: mucus). 
 
Similar to the methodology described in subchapter 4a.2., a positive control using 
Salmonella Typhimurium SL1344-containing HEp-2 cells in the LB agar block section 
(2.7.2.) showed reddish bacterial rods in the cytoplasm, some of which stayed very 
close to the nucleus of HEp-2 cells at low magnification (Figure 4.15A) and at high 
magnification (Figure 4.16A). Then, any bacterial rod with the same shape and size as 
that in the positive control were identified in the Salmonella Typhimurium SL1344-
infected snap-well human intestinal tissue sections after combined immunofluorescence 
staining using anti-Salmonella O4 and LAMP-1 antibodies.  
 
In low-power fields, several Salmonella rods were attached to the mucosal surface of 
the intact epithelium of terminal ileum sections (Figure 4.15B & C) or in the secreting 
mucus lake of the goblet cell (Figure 4.15C), whilst another Salmonella rod was found 
adjacent to the nucleus within the cytosol of the epithelial cell (Figure 4.15D), 
supposing this rod as an intracellular bacteria despite its weak staining of lysosome by 
LAMP-1 antibody in the surrounding area. 
 
 239
 
Figure 4.15 Combined immunofluorescence staining using anti-Salmonella O4 and 
LAMP-1 antibodies in high-power fields (A–E: 400×, F: 1,000× oil) of the Salmonella-
infected HEp-2 cells in paraffin-embedded LB agar block section (A), the Salmonella 
Typhimurium SL1344-infected snap-well human intestinal tissue sections (B & C: 
terminal ileum; D: sigmoid colon), and the non-infected sigmoid colonic tissue section 
(E & F) in polarised ex vivo intestinal organ cultures (G: goblet cell; LP: lamina propria; 
Epi: epithelium; arrows: bacterial rods identified by anti-Salmonella O4 antibody). 
 
In high-power fields, several Salmonella rods were adherent to the disconnected cells in 
the terminal ileum section (Figure 4.16B), trapped within the mucus layer, or engulfed 
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by the macrophage in the sigmoid colon section (Figure 4.16F). In some areas where 
the epithelium remained intact, one Salmonella rod colonised on the cell surface of the 
goblet cell in the terminal ileum section (Figure 4.16C), or Salmonella rods already 
entered the colonocyte and aggregated within the cytoplasm in the sigmoid colon 
section (Figure 4.16G). Salmonella rods could also be discovered beneath the intestinal 
glandular cells in the lamina propria of the terminal ileum section (Figure 4.16D), close 
to the exposed lamina propria above which the overlaying colonic epithelium had been 
disrupted (Figure 4.16H), or closely associated with various kinds of cells in the lamina 
propria of the sigmoid colon section (Figure 4.16E). 
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Figure 4.16 Combined immunofluorescence staining using anti-Salmonella O4 and 
LAMP-1 antibodies in high-power fields (1,000× oil) of the Salmonella-infected HEp-2 
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cells in paraffin-embedded LB agar block section (A) and the Salmonella Typhimurium 
SL1344-infected snapwell human intestinal tissue sections (B–E: terminal ileum; F–H: 
sigmoid colon) in polarised ex vivo intestinal organ cultures (G: goblet cell; LP: lamina 
propria; Epi: epithelium; arrowhead: probably macrophage; asterisk: lumen of intestinal 
glands; arrows: bacterial rods identified by anti-Salmonella O4 antibody). 
 
4b.2.4. Host innate immune responses after Salmonella infection  
To investigate the host innate immune responses in mRNA expression of six target 
genes, the triple intestinal biopsy explants in the same region of duodenum, terminal 
ileum, or sigmoid colon consecutively obtained from 5 paediatric patients were 
respectively infected with OD600-adjusted PBS-resuspended overnight cultures of 
Salmonella Typhimurium SL1344, ∆fliM, and sterile PBS (non-infected control) for 2 
hours with subsequent incubation for another 6 hours in the polarised ex vivo human 
intestinal organ culture (2.5.3.), and finally harvested for total RNA extraction 
(2.10.1.1.), cDNA synthesis (2.10.1.2.), and quantitative real-time PCR (2.10.1.3.) using 
specific primers for 6 target genes (IL-8, hBD-1, 2, 3, HD5, and HD6) and the 
housekeeper villin (VILI).  
 
The mRNA expression levels of IL-8, hBD-1, hBD-2, hBD-3, HD5, and HD6 were 
compared between Salmonella Typhimurium SL1344-infected, ∆fliM-infected intestinal 
explants, and non-infected controls in the tissue samples from duodenum, terminal 
ileum, and sigmoid colon. The only statistical difference showed that Salmonella 
Typhimurium SL1344 significantly downregulated hBD-3 mRNA expression in the 
duodenum when compared to the non-infected control (0.08 fold change vs 1.0 fold 
change, P = 0.043, Figure 4.17D). Otherwise, no other statistical differences of mRNA 
expression in IL-8, hBD-1, hBD-2, HD5, and HD6 were detected between any of two 
conditions including the Salmonella Typhimurium SL1344-infected group, ∆fliM-
infected group, and non-infected control group in any topographically different biopsy 
tissues (Figures 4.17 and 4.18). 
 
In order to confirm this preliminary result, the case number was increased from 5 to 8 
after obtaining three unpaired duodenal biopsies from 3 more patients, which were 
treated the same as the tissue explants of the earlier 5 patients in polarised ex vivo organ 
cultures. The re-analysed data of hBD-3 mRNA expression in the duodenum showed 
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again that Salmonella Typhimurium SL1344 significantly downregulated hBD-3 mRNA 
expression in the duodenum when compared to the non-infected control and the P value 
was even smaller (0.08 fold change vs 1.0 fold change, P = 0.011, Figure 4.19). 
 
 
Figure 4.17 IL-8 (A), hBD-1 (B), hBD-2 (C), and hBD-3 (D) mRNA expression in the 
ex vivo human intestinal organ culture samples from three different locations (D4: the 
4th portion of the duodenum, TI: terminal ileum, S: sigmoid colon) after treatment with 
Salmonella Typhimurium SL1344, ∆fliM, or PBS (NI: non-infected control). Horizontal 
lines indicate geometric means (*P<0.05, NS: non-significant; n = 5).  
 
In addition, tissue tropism in responsiveness of human α-defensins is validated to be 
localised in small intestines. Irrespective of different stimulation (Salmonella 
Typhimurium SL1344, ∆fliM, or PBS), the mRNA expression levels of HD5 and HD6 
in the duodenum and terminal ileum (Figure 4.18) were significantly higher than those 
extremely low levels in the sigmoid colon (data not shown). There were no significant 
alterations in the HD5 and HD6 mRNA expression in the duodenum and terminal ileum 
after treatment with Salmonella Typhimurium wild-type SL1344 and ∆fliM strains when 
compared with non-infected controls (Figure 4.18). 
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Figure 4.18 HD5 (A) and HD6 (B) mRNA expression in the ex vivo human intestinal 
organ culture samples from duodenum and terminal ileum after treatment with 
Salmonella Typhimurium SL1344, ∆fliM, or PBS (NI: non-infected control). Horizontal 
lines indicate geometric means (NS: non-significant; n = 5).  
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Figure 4.19 hBD-3 mRNA expression in ex vivo human intestinal organ culture samples 
from the 4th portion of the duodenum (D4) after treatment with Salmonella 
Typhimurium SL1344, ∆fliM, or PBS (NI: non-infected control). Horizontal lines 
indicate geometric means (*P<0.05; n = 8).  
 
4b.3. Discussion 
A series of experiments using ex vivo organ cultures were conducted in this subchapter 
to seek evidence of Salmonella Typhimurium invasion and to examine their effect upon 
mRNA expression of defensins in the infected human intestinal epithelium. To date, it 
was the first time to apply gentamicin protection invasion assay to the polarised ex vivo 
organ cultures for quantification of intracellular Salmonella in which the apical 
infection route of bacteria was confined (2.5.3.1.). However, the results showed 
variability that could not be logically explained by bacterial leakage into the basolateral 
compartment of the snapwell Transwell system. Several possibilities might account for 
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the failure of this ex vivo gentamicin protection assay. First, unlike in vitro cell lines, ex 
vivo intestinal tissue explants retain thick mucus layers covering over the epithelium. 
Some bacteria could be trapped and not completely killed in the mucus layers which 
might interfere with the gentamicin killing effect on the bacteria adhering to the 
epithelium. Second, different compositions of gut commensal flora that remain on the 
epithelial surface from individual patients might exert diverse effects on viability of 
inoculated Salmonella despite its similarity to the intraluminal situation in vivo. Third, 
the washing manoeuvre by vigorous shaking in cold PBS for 40 seconds three times 
might not sufficiently and consistently remove mucus and non-adherent bacteria. Fourth, 
it is questionable if the lysis of tissue sample in Triton X-100 with needle 
homogenisation could completely release the intracellular bacteria. Fifth, ex vivo 
intestinal tissue explants from individual patients with various underlying innate 
immunity might exert antibacterial activity against inoculated Salmonella to different 
degrees. Taken together, this assay appeared not feasible as an optimal quantitative 
method for evaluating intracellular bacteria in ex vivo intestinal tissues. 
 
Alternatively, efforts were redirected to seek image evidence of intracellular Salmonella 
in the ex vivo organ culture model. Double immunofluorescence staining for 
differentiation between intracellular and extracellular bacteria (2.7.1.1.) demonstrated 
initial evidence of Salmonella invasion into the epithelial cells which were isolated from 
the Salmonella-infected human colonic tissue (2.5.2.1.) using non-polarised ex vivo 
organ culture (2.5.2.). However, it might be criticised that these Salmonella might not 
invade the cells via a natural apical infection route towards the intestinal mucosa but via 
a lateral or serosal route via the cut surfaces of the tissue explant in this model. 
Therefore, the polarised ex vivo organ culture model (2.5.3.) which limits access to the 
apical surface was adopted and tested using SEM for evaluating tissue survival after 2-
hour Salmonella infection with a total incubation of 8 hours. Although most of the 
infected tissue explants maintained the integrity of the overlaying epithelium, the 
repeated tests using different biopsies from individual patients showed variable 
detachment of the infected epithelium, especially in the peripheries of the exposed areas 
within the central apertures of the snapwell discs. This unpredictable interference was 
minimised by shortening the infection duration from 8 hours to 5 hours for histology 
and immunohistochemistry (4b.2.3.2). In addition, villin was used as the housekeeping 
gene to analyse quantitative real-time PCR data using total RNA extracted from the 
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Salmonella-infected ex vivo organ culture tissues because villin is a protein that is only 
expressed in intestinal epithelial cells (Bretscher and Weber 1980;Simms et al. 2008). 
 
The histological and immunofluorescence images were captured at 8 hours post 
Salmonella infection in the polarised ex vivo human intestinal organ culture, with a 
much earlier timing than that in the three in vivo case reports which were studied at 7 
days to 27 days after onset of their clinical symptoms in the three case reports (Friesen 
et al. 2008). Similarly to the findings in H&E staining of the Salmonella-infected human 
tissues in vivo, inflammatory cell infiltration in varied sizes (e.g. crypt microabscess-
like formation and glandular lymphoid aggregates) is the hallmark of the human non-
typhoidal Salmonella infection ex vivo. Because no systemic circulation is present post 
biopsy sampling, neutrophils are not enriched in ‘microabscess-like’ formation but still 
can be seen probably due to re-distribution of the existing neutrophils in the tissue 
explants. Moreover, mucosal erosion or detachment is also visible in the certain areas 
with severe inflammation. In these three sets of ex vivo organ culture tissues from three 
sites (i.e. duodenum, terminal ileum, and sigmoid colon), the epithelium in the 
duodenum was gone and more of the epithelium in the terminal ileum and the sigmoid 
colon remained intact. However, the bacterial density within the epithelium in the 
terminal ileum (Figure 4.13C & F) tended to be lower than that in the colonic 
epithelium (Figure 4.14C–E), with a picture of bacterial aggregation in the latter. The 
population of invading bacterial rods in the lamina propria appeared to be denser in the 
explants of the sigmoid colon (Figure 4.14F–H) than in those of the duodenum (Figure 
4.13A & B) and the terminal ileum (Figure 4.13D & E). Although not conclusive, this 
hinted that Salmonella infection should be more commonly found in the lower intestinal 
tract rather than in the upper intestinal tract. Meanwhile, bacterial interactions with 
neutrophils, macrophages, and goblet cells were also delineated in H&E staining.  
 
With the aid of specific antibodies utilised in the combined immunofluorescence 
staining (2.7.1.2.), intracellular Salmonella were more specifically identified ex vivo.   
Compared to the findings of the human Salmonella infection in vivo, more evidence of 
intracellular Salmonella was discovered in the polarised ex vivo Salmonella infection 
that could be due to its earlier timing for harvest of the samples. Salmonella bacteria 
were not only found to adhere with epithelial cells (Figure 4.15B & C) but also inside 
the epithelial cells (Figure 4.15D & Figure 4.16G). Furthermore, they could interact 
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with mesenchymal cells near the intestinal glands in the lamina propria (Figure 4.16D 
& E), with the goblet cell within the epithelium (Figure 4.16C), or with the detached 
epithelial cell (Figure 4.16B), macrophage, and mucus outside the main piece of the 
dissected tissue (Figure 4.16F). In contrast to the findings in histology with H&E 
staining, no numerous Salmonella bacteria were detected by combined 
immunofluorescence staining using specific antibodies. This raised the suspicion that 
some of those bacterial rods found in the lamina propria by H&E staining could be 
merely commensal microbiota rather than Salmonella. As discussed earlier in the 
section 4a.3., LAMP-1 staining in the epithelial cells was not as strong as that in the 
inflammatory cells within the lamina propria (Figure 4.16E & F) that might be 
attributed to the poor effect of the utilised LAMP-1 antibody in the formalin-fixed cells 
or tissues. This is one of the drawbacks in this study that require further improvement of 
immunohistochemistry in the future. In addition, all mammalian cells can internalise 
solutes and small molecules by pinocytosis. However, only highly specialised 
phagocytic cells such as macrophages and neutrophils normally internalise large 
particles (>0.5 µm); epithelial cells usually do not uptake large particles (Meyer et al. 
1997). This could be one of the reasons why intracellular Salmonella bacteria were not 
very commonly discovered in the tissue sections because the intact epithelial barrier 
which had been breached allowed more contact of Salmonella with macrophages or 
neutrophils and easier ensuing bacterial internalisation. It raises great interest to take 
further time-course studies for investigation of initial interactions of Salmonella with 
human intestinal epithelium at time points earlier than 5 hours post infection whilst any 
part of the entire epithelium still remains unbroken. 
 
Lacking underlying blood supply, interactions with deep tissues, and linkage to other 
organs, the established human intestinal polarised ex vivo organ culture appears to be 
more suitable for investigation of innate immunity rather than adaptive immunity. As for 
as known, this model has not been employed to directly study host responses of human 
defensins to non-typhoidal Salmonella infection, although a successful in vivo study 
using HD5 transgenic mice has provided substantial evidence for epithelial-derived 
defensins in mammalian host defence (Salzman et al. 2003b). Except for topographical 
distribution of Paneth cell antimicrobial peptides (Wehkamp et al. 2006), epithelial 
responsiveness of diverse defensins to Salmonella infection in different locations of the 
human intestinal tract has never been systemically evaluated. 
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To date, it remains little known whether Salmonella could regulate gene expression of 
defensins in human intestinal epithelium. In mice, Salmonella Typhimurium, but not 
Listeria monocytogenes, inhibits α-defensin expression in Paneth cells to gain a specific 
survival advantage in the intestinal lumen. This modulatory effect is not due to the 
general presence of gram-negative bacteria or their cell wall components within the 
small intestinal lumen because of no alterations in the antimicrobial mRNA levels of the 
mice infected with heat-killed Salmonella Typhimurium (Salzman et al. 2003a). 
Similarly, screening of intestinal mucosal gene expression after Salmonella Enteritidis 
infection in rats using whole genome microarrays indicated that Salmonella time-
dependently downregulates the gene encoding defensin 5 in both ileum and colon 
(Rodenburg et al. 2007a;Rodenburg et al. 2007b). In contrast, another different bacterial 
species Helicobacter pylori causing prolonged infection induces the presence of Paneth 
cells and human defensin 5 expression in gastric intestinal metaplasia, which are 
normally absent from the upper gastrointestinal tract (Shen et al. 2005). So far, hBD-3 
expression in human intestinal epithelium after Salmonella infection has rarely been 
investigated. This preliminary experiment could possibly be the first study using a 
human intestinal ex vivo organ culture model to simultaneously inspect expression of 
five human defensins and IL-8 after treatment of Salmonella Typhimurium wild-type 
SL1344, the flagellin-deficient strain ∆fliM, or sterile PBS (non-infected control) in 
three different locations along the intestinal tract. In contrast to the findings in mice or 
rats (Rodenburg et al. 2007a;Rodenburg et al. 2007b;Salzman et al. 2003a), neither the 
wild-type nor the flagellin-deficient strain significantly inhibited HD5 or HD6 mRNA 
expression in human at 8 hours post infection when compared to non-infected controls. 
The only positive finding is that Salmonella Typhimurium significantly downregulated 
hBD-3 expression when compared to the non-infected control (Figure 4.19 & Figure 
4.20). This observation appears to be consistent with another recent in vivo study, which 
depicted that neutralisation of IL-17A in the intestinal lumen by Salmonella 
Typhimurium infection not only induces exacerbation of epithelial damage but also 
suppresses the constitutive localisation of β-defensin-3 (Mayuzumi et al. 2010). The IL-
17 family is the most recently described subclass of cytokines which plays a role in the 
mammalian immune system; IL-17-expressing cells are particularly abundant in the gut 
(Onishi and Gaffen 2010). The expression of β-defensin-1, -3, and -4, but not β-
defensin-2, was significantly impaired in the colons of Il17f-/-, Il17a-/-, and Il17a-/-Il17f-/- 
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knockout mice after Citrobacter rodentium infection, indicating that both IL-17F and 
IL-17A are important to induce the expression of β-defensins in the host innate 
immunity (Ishigame et al. 2009). It is assumed that IL-17A constitutively induces the 
expression of the antimicrobial peptide to kill invading pathogens at the epithelial 
surface the immediate early stage of protection against Salmonella Typhimurium 
intestinal infection (Mayuzumi et al. 2010). Therefore, neutralisation of IL-17A and 
consequent suppression of β-defensin-3 might be one of the strategies for Salmonella 
Typhimurium to evade host innate immunity during early interactions between bacteria 
and intestinal epithelium. This warrants further studies using human intestinal 
epithelium for clarification in potential correlations between IL-17 and hBD-3 during 
Salmonella infection. In addition, another Gram-negative bacterium Klebsiella 
pneumoniae impedes the expression of β-defensins via its capsule polysaccharide, but 
not the lipopolysaccharide O antigen, to mediate resistance against the bactericidal 
actions of antimicrobial peptides in the airway (Moranta et al. 2010) whilst 
Campylobacter jejuni capsule polysaccharide is not protective against the antimicrobial 
action of hBD-2 and hBD-3 (Zilbauer et al. 2005). Thus, it is highly desirable to answer 
another important question about which cell component(s) of Salmonella Typhimurium 
should be responsible for bacterial modulation on the bactericidal effects of human 
defensins. 
 
Time-course observation can genuinely reflect how pathogenic bacteria interact with 
hosts in different concerns during the kinetic process of entire disease. In an in vivo 
study using microarrays to investigate gene expression responses of the rat small 
intestine following oral Salmonella infection, early minor effects occur at day 1 mainly 
in the ileal mucosa as the primary site of invasion; later major responses develop at day 
3 especially in the Peyer’s patches, showing a more prominent immune and 
inflammatory response than the ileal mucosa (Rodenburg et al. 2007a). In this study, 
Salmonella inhibited the gene expression of defensins in the ileal mucosa at day 1 and 
this suppression mostly disappeared at day 3 and day 6 post infection, when expression 
of those genes related to immune responses and inflammation was induced with the 
strongest response at day 3 (Rodenburg et al. 2007a). Similarly, the findings in another 
in vivo study lead to the hypothesis that IL-17A-mediated suppression in localisation of 
hBD-3 occur at the immediate early stage prior to 3 days after Salmonella Typhimurium 
intestinal infection whereas interferon-γ is important at a later stage of the infection 
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(Mayuzumi et al. 2010). Salmonella-induced gene expression responses in vivo are 
fewer and smaller than those in vitro, and usually develop over a longer time 
(Rodenburg et al. 2007a). Although these observations in vivo are consistent, they were 
still too late to depict important events occurring in the very early stages of Salmonella 
infection. In contrast to acute Salmonella infection, hBD2 expression is NOD1- and NF-
κB pathway-dependent whilst hBD3 expression is NOD1-independent but EGFR and 
ERK pathway-dependent during in vitro Helicobacter pylori infection, which usually 
causes subacute or chronic human infection. The divergent signalling pathways 
governing hBD2 and hBD3 expression imply temporal functional variation, with 
contribution of hBD2 to antimicrobial barrier function during the inflammatory phase 
and involvement of hBD3 in healing tissues during the convalescent phase of infection 
(Boughan et al. 2006). Host defensin resistance is not only species- but also strain-
specific and may be clinically related to the host-bacteria interactions affecting mucosal 
translocation and systemic infection (Nuding et al. 2009). In the present ex vivo study, 
the host chemokine and innate immune responses were examined at only one time 
point–8 hours post infection that might possibly be too late to catch the peaks of 
induced expression of IL-8 and other defensins than hBD-3 in Salmonella-infected 
tissues compared to non-infected controls. More significant findings might be disclosed 
if the ex vivo Salmonella infection could be stopped at earlier time points. Further time-
course studies are required for better understanding of the whole spectrum in 
Salmonella-induced gene expression responses ex vivo. 
 
Commensal gut flora is another important factor which is difficult to control in the ex 
vivo organ culture model, and is also one of the common factors counting for individual 
variation in the human biopsied tissues. Despite no use of broad-spectrum antibiotics to 
kill commensal bacteria residing in the tissue explants before their infection ex vivo in 
our team (Haque et al. 2004;Schuller et al. 2009), other scientists in the group have used 
penicillin/streptomycin for 1 hour with subsequent washing to kill and remove the 
commensal gut flora on the tissue explants before their use in ex vivo organ cultures 
(Maccallum et al. 2005;MacCallum et al. 2006). The impact of commensal flora in the 
gut was also shown by the cases of periodontal disease, bacterial vaginosis, or possibly 
inflammatory bowel disease. Rather than single-organism diseases, these microbiota 
shift diseases should be cured if the original composition of the bacterial population can 
be restored (Salyers and Whitt 2002a). An analysis indicated that the extractable 
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secreted antibacterial activities for Salmonella Typhimurium originating from crypt, 
mucus, and lumen compartments were respectively 38%, 43%, and 19%. Enteric 
microbiota is allowed to be present in the lumen that is facilitated by the distribution of 
high local antimicrobial peptides on vulnerable mucosal surfaces (Meyer-Hoffert et al. 
2008). Thus, either killing the gut flora or removing the mucus layer should be regarded 
as an influential factor in the ex vivo organ culture model. 
 
In summary, this preliminary study vindicates that human Salmonella Typhimurium 
infection can be reproduced in the polarised human intestinal ex vivo organ culture 
model to display evidence of bacterial virulence and host innate immunity. The 
histological and immunofluorescence images showed supportive evidence of close 
Salmonella interactions with human intestinal mucosa including bacterial colonisation 
and invasion in epithelial cells and association with inflammatory cells. In addition, this 
polarised ex vivo organ culture model has been successfully established to evaluate 
Salmonella Typhimurium-induced host innate immune responses in mRNA expression 
of defensins. However, the small number of cumulative human biopsy explants might 
limit the power of statistical analysis and only tentative conclusions could be drawn. 
Therefore, sufficient numbers of the human intestinal tissue explants are required in 
further optimisation of this model, not only for commitment of statistical significance 
but also for selection of robust and healthy tissues with low leakage into the basolateral 
site of the snapswell. In addition, other approaches can be considered to understand a 
wider range of host responses, including application of specific staining for localisation 
of defensins in the tissues, ELISA for quantification of secreted defensins and cytokines 
in the apical and basolateral compartments of the snapwells, and isolation of epithelial 
cells following polarised ex vivo organ cultures to specifically focus on the intestinal 
epithelium and to minimise intervention from other cells in the lamina propria. 
Complete time-course studies should be performed for the best optimal timings of 
protein and gene expression in diverse cytokines and defensins. Influences of 
commensal gut flora and mucus layers on readouts of experiments in this model should 
be carefully considered. Appropriate positive controls can be sought and applied to 
further ex vivo studies, such as colonic mucosa of patients with ulcerative colitis for 
hBD-3/hBD-4 expression (Fahlgren et al. 2004). Several potential candidates of pro-
inflammatory cytokines in vitro to successfully induce expression of defensins can be 
tested in the human intestinal ex vivo organ culture, including interferon-γ inducing 
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increased hBD-3 mRNA expression in LS174T cells (Fahlgren et al. 2004), IL-1β 
triggering considerable hBD-1/hBD-2 expression in Caco-2 cells (Ou et al. 2009), and 
epidermal growth factor (EGF) and phorbol 1,2-myristate 1,3-acetate (PMA) enhancing 
significant hBD-3 mRNA expression in both human oral epithelial cells and in TR146 
oral cancer cells (Kawsar et al. 2009). After all, such a polarised ex vivo organ culture 
can be an important platform in prospective to study human non-typoidal Salmonella 
infection.    
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Chapter 5. Transposon Directed Insertion-site 
Sequencing (TraDIS) for Identifying Virulence Genes 
of Salmonella Typhimurium 
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5.1. Background 
The majority of virulence genes that have been characterised in Salmonella are known 
to be located within Salmonella Pathogenicity Islands (SPIs). These genes, particularly 
SPI-1 genes, are associated with bacterial adhesion or invasion of the target cells. Full 
expression of Salmonella virulence may require collaborative phenotypes of genes from 
different SPIs. Acquisition of a mosaic of separate genetic elements including SPI-1, 
SPI-5, and sopE2 can co-ordinately orchestrate host cell invasion by Salmonella 
(Mirold et al. 2001). In addition, the genes involved in the early interactions of 
Salmonella with human intestinal epithelium could possibly be located within or outside 
virulence islands on the chromosomes or plasmids. Although most of the characterised 
genes have been identified by in vivo IVET, DFI, or STM (Andrews-Polymenis et al. 
2006;Andrews-Polymenis et al. 2009;Unsworth and Holden 2000), it is possible that 
more unknown or uncharacterised Salmonella genes could be discovered if a more 
advanced technology were available. 
 
The patented technology Transposon Mediated Differential Hybridisation (TMDH) 
innovated at the Cambridge Veterinary School could be used to identify novel 
Salmonella virulence genes important in early Salmonella infection. TMDH is an 
efficient method that combines the advantages of both sequencing- and array-based 
approaches for identifying essential genes required for the survival and growth of the 
targeted microorganism (Charles and Maskell 2001;Chaudhuri et al. 2009a). TMDH 
comprises five main components: (i) a sequenced bacterial genome, (ii) a saturated 
genome-wide transposon library with a randomly integrating transposon or a number of 
transposons with different integration preferences, (iii) the ability to generate labelled 
DNA/RNA flanking the site of transposition (known as target), (iv) a good quality high-
density tiling whole genome nucleotide microarray (probes), and (v) novel 
bioinformatics (e.g. powerful analytic software and genome database). TMDH has been 
used to discover essential genes in vitro and to identify non-essential genes required for 
in vivo mice infection by Salmonella Typhimurium (Chaudhuri et al. 2009b). Briefly, 
TMDH was used to identify the attenuated strains in a large library of ~10,000 
transposon mutants which was generated using custom Tn5 and Mu transposons, 
containing outward-facing T7 and SP6 promoters. This library was screened through a 
mouse typhoid model to identify attenuated strains. Genomic DNA was isolated from 
the input pool of mutants used to infect the mice and from output pools obtained from 
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livers two days post-infection. In vitro transcription was induced from the two 
promoters in the presence of fluorescently-labelled dNTPs. Fluorescently-labelled 
transcripts from the promoters were hybridised to whole-genome tiling microarrays to 
determine the position of the transposon insertions. Comparison of microarray data 
from the mutant library grown in vitro (input) with correspondent data obtained after 
passage of the library through mice (output) enables identification of attenuated 
transposon mutants in vivo (Chaudhuri et al. 2009b). In summary, in vivo TMDH is 
faster, more accurate, semi-quantitative, less labour intensive, more informative, and 
can screen more mutants per animal than STM (Charles and Maskell 2001), although 
both share a common concept of negative selection (Figure 5.1). Mutant strains with 
deletions of genes identified in in vivo TMDH can be good candidates as live attenuated 
vaccines in mice (Paterson et al. 2009;Peters et al. 2010).   
 
 
 
Figure 5.1 Schematic illustration of in vivo TMDH for identification of important 
virulence genes during in vivo infection. The transposon mutant strains B and F which 
are present in Input pool but absent in Output pool in microarray represent the genes 
disrupted by transposon indispensible for in vivo infection. (Kindly provided by 
Professor Duncan Maskell) 
 
Complete genome sequencing is a revolutionary milestone for fast growth of knowledge 
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in Salmonella genetics. It allows the development of DNA microarrays and targeted 
deletion libraries for comparative genomics of Salmonella. These approaches 
considerably increase both the accuracy and the coverage in gene expression studies and 
in genetic analysis of mutants (Andrews-Polymenis et al. 2009). To date, the genome 
sequences of 14 Salmonella serovars have been completed and genome sequencing in 
additional serovars are in progress. Nowadays, extensive sequence comparison of 
nontyphoidal Salmonella has become faster and cheaper since 454 (Roche) and Solexa 
(Illumina) sequencing technologies were introduced (Holt et al. 2008). The complete 
genome sequences in Salmonella serovars not only allow the development of DNA-
based classification of Salmonella strains into 'genovars', but also provide a blueprint 
for functional genomic studies of Salmonella in particular environments in vivo and in 
vitro (Andrews-Polymenis et al. 2009).  
 
Complete or nearly complete single gene inactivation or deletion libraries are already 
available for Bacillus subtilis (Kobayashi et al. 2003), E. coli (Baba et al. 2006), 
Staphylococcus aureus (Chaudhuri et al. 2009a), and Salmonella Typhimurium SL1344 
(Chaudhuri et al. 2009b). A random distribution of transposon insertions throughout the 
bacterial genome can be validated by comparison between cumulative numbers of 
transposon and their chromosomal positions (Chaudhuri et al. 2009a), by use of several 
transposons with different integration preferences (e.g. two transposons instead of only 
one transposon) (Chaudhuri et al. 2009b), or by distinct distribution of insertion 
locations from random sampling of 50 mutants from the huge library (not shown 
preliminary data).  
 
Another more advanced technology, Transposon Directed Insertion-site Sequencing 
(TraDIS), became available in Sanger Institute to satisfy high-standard needs in high-
throughput functional studies (Langridge et al. 2009) just as our genomic DNA samples 
were prepared for TMDH. TraDIS is superior to TMDH in the accuracy of estimation of 
the transposon insertion sites, especially for those smaller genes which can be missed by 
chance in TMDH (Chauhuri et al. 2010). This method was used to map 370,000 unique 
transposon insertion sites in the Salmonella Typhi chromosome, using genomic DNA 
from a huge bacterial mutant pool of ~1.1 million transposon mutants and Illumina 
nucleotide sequencing, primed from the transposon in order to sequence into adjacent 
target DNA. Transposon insertion sites can be mapped more accurately by sequencing 
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(Langridge et al. 2009) than by microarrays (Chauhuri et al. 2010). This can facilitate 
semi quantitative analysis of the transposons inserted in every gene in the genome for 
identification of essential genes and non-essential genes in different laboratory 
conditions (Figure 5.2). TraDIS has also been used to analyse output pools of 8,550 
transposon mutants from Salmonella Typhimurium screened through infection of 
chickens, pigs, and calves to identify genes required for infection of these different 
hosts (Chauhuri et al. 2010). As the cost of sequencing continues to decrease, and the 
ability to multiplex massive amounts of biological samples in one sequencing run, it 
appears to be a trend for sequencing to replace microarrays in monitoring of mutants. 
Hence, we continued assessment of the genomic DNA samples after in vitro infections 
in HEP-2 cells as initially planned for TMDH, but we chose TraDIS as an approach 
instead of microarrays to identify virulence-associated genes involved in the early 
interactions of non-typhoidal Salmonella with human epithelium.  
 
 
Figure 5.2 TraDIS exploits Illumina sequencing to simultaneously assess the genotypes 
and relative fitness of thousands of transposon mutants. 
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In this study HEp-2 cells were infected with a small pool containing 96 transposon 
mutants to assess the overall rates of cell-association, invasion, and intracellular 
replication compared to those of the wild-type strain and one randomly selected mutant. 
Next, the wild-type isogenic tagged strains (WITS) of Salmonella Typhimurium (Grant 
et al. 2008) were applied in the same HEp-2 cell model for understanding of the pooling 
effects on individual tagged strains within one mixed pool (2.4.3. and 2.10.2.). Finally, 
a big pool of 1,440 transposon mutants in Salmonella Typhimurium SL1344 was used to 
infect HEp-2 cells, which were harvested at three different experimental conditions 
(Figure 2.5) as three output pools. These three output pools represent cell-associated 
mutants which adhered to and invaded cells (Output pool A), invading mutants which 
were internalised into cells (Output pool B), and intracellular replicating mutants which 
can not only invade cells but also proliferate inside cells with a longer time than Output 
pool B (Output pool C). The profiles of these output pools with significantly attenuated 
mutants are subjected to corresponding virulence genes under negative selection. Taking 
advantage of the huge library of mutants with transposon insertions throughout the 
genome and the accurate high-throughput sequencing in TraDIS, we aimed to identify 
novel virulence genes related to these specific cellular events during the first 10 hours of 
Salmonella infection of human epithelial cells, rather than late consequences of 
transposon mutants passing through the in vivo mice model (Chaudhuri et al. 2009b).  
 
5.2. Results 
5.2.1. Optimisation of a Salmonella infection model in HEp-2 cells for 
TMDH 
To understand how the effect of pooling isogenic mutants would impact individual 
mutants within the mixed populations in bacterial adhesion, invasion, and intracellular 
replication, an experiment was performed to compare differences in these three 
parameters between Salmonella Typnimurium wild-type strain SL1344, a single 
transposon mutant Mu864, and a pool of 96 Mu mutants after infection in the 
established HEp-2 cell culture model. The treatment protocol and the traditional 
invasion and intracellular replication assays for bacterial quantification were conducted 
as described in Chapter 2 (Figure 2.5 and section 2.4.3.). The 96 Mu mutants were 
randomly selected from the whole library (Chaudhuri et al. 2009b). Overnight cultures 
of these individual 96 Mu transposon mutants (serial ID from Mu 769 to Mu 864) were 
prepared and mixed thoroughly as described in 2.11.2. to form a small library, 
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immediately before inoculation of HEp-2 cells. After the appropriate incubation, cells 
from Output pool A, B, and C were individually lysed, serially diluted, and plated out 
for colony counts after overnight incubation to quantify viable bacterial numbers 
relative to the initial inoculums. Output pool A represents the pool of bacteria which can 
adhere to and invade HEp-2 cells, Output pool B represents the pool of bacteria which 
can invade HEp-2 cells, and Output pool C represents the pool of bacteria which can not 
only invade but also replicate within HEp-2 cells for further 7 hours (Figure 2.5).  
 
The three different Salmonella preparations showed a similar trend in the stage of 
bacterial invasion (Output pool B) but different patterns in the stages of bacterial 
adhesion/invasion (Output pool A) and bacterial intracellular replication (Output pool 
C). The viable bacterial numbers relative to the inoculums of Salmonella Typhimurium 
SL1344 from Output pools A, B, and C were 20.6 ± 4.6%, 8.8 ± 1.5%, and 76.7 ± 
20.2% (Figure 5.3A). Surprisingly, the randomly selected mutant strain Mu864 had a 
higher viable bacterial rate in Output pool A (87.9 ± 6.5%), a slightly lower invasion 
rate in Output pool B (6.3 ± 1.8%), and a lower intracellular bacterial rate in Output 
pool C (50.5 ± 19.9%) compared to the wild-type SL1344, indicative of its higher 
capability in bacterial adherence to HEp-2 cells and lower competence in intracellular 
replication. Compared to SL1344 and the mutant Mu864, the library of pooled 96 
mutants showed an intermediate average viable bacterial rate in Output pool A (40.3 ± 
2.0%), a similar invasion rate in Output pool B (8.1 ± 0.6 %) to SL1344, and a closer 
intracellular bacterial rate in Output pool C (44.6 ± 13.3%) to Mu864. This suggests that 
most of the pooled transposon mutants might allow individual strains a higher ability to 
adhere to HEp-2 cells, similar invasiveness, and a decreased capability of proliferating 
intracellularly compared to their parental wild-type strain (Figure 5.3B). On average, 
the 96 transposon mutants after pooling increased their adherence rates and decreased 
their intracellular replication rates compared to the wild-type strain, although most of 
the mutants behaved similarly to the wild-type strain and only a small portion of them 
might be deficient in certain bacterial functions after gene disruption by transposon 
insertion. However, the pooling effect itself might generate complex interactions 
between different transposon mutants which might affect individual strains in their 
behaviours within mixed populations.  
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Figure 5.3 Adherence, invasion and intracellular replication assays using Salmonella 
Typhimurium SL1344, Mu864, and the 96-mutant pool, shown in groups of different 
inoculations (A) and different conditions (B) (A+I: adhesion + invasion, I: invasion, IR: 
intracellular replication; results represent the mean + SEM, n = 3).  
 
5.2.2. Preliminary test for the pooling effect within a library of mixed 
Salmonella Typhimurium wild-type isogenic tagged strains (WITS)  
In order to individually quantify each single strain in a library of pooled tagged 
Salmonella Typhimurium strains, utilisation of 8 WITS for in vitro cell infection and 
real-time PCR detection of the inserted tags differently located within the bacterial 
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genomes of these strains (2.10.2.) provide a powerful tool for better understanding of 
the interactions between individual Salmonella Typhimurium WITS with their 
quantitative variations in the input pool and three output pools in the established HEp-2 
cell cultures. 
  
The total amounts of 8 WITS in 4 readouts of input/output pools were calculated from 
the sum of all the individual amounts of WITS in the Input pool, the Output pools A, B, 
and C. Then, the total amounts of 8 WITS in the three Output pools were converted into 
percentage relative to the Input pool (Figure 5.4), showing intermediate levels of the 
bacterial rates in Output pool A (26.1 ± 9.2%) and Output pool C (64.3 ± 13.5%) when 
compared with SL1344 (Output pool A: 20.6 ± 4.6%; Output pool C: 76.7 ± 20.2%) and 
the pooled 96 mutants (Output pool A: 40.3 ± 2.0%; Output pool C: 44.6 ± 13.3%), but 
a higher invasion rate in Output pool B (18.7 ± 4.6%) than those of SL1344 (8.8 ± 1.5%) 
and of the pooled 96 mutants (8.1 ± 0.6 %) (Figure 5.3A). The negative controls in the 
uninfected cells show extremely low DNA copies that can be reasonably ignored. The 
general pattern in the bacterial rates using WITS and real-time PCR (2.10.2.) is similar 
to the pattern obtained by plating out and colony counting using the traditional method 
(2.4.3.); however, the former can detect both live and dead bacteria whilst the latter can 
quantify only viable bacteria that may explain why the average invasion rate of WITS is 
higher than that of SL1344.  
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Figure 5.4 Percentage of total bacterial DNA copies by quantitative real-time PCR in 
three output pools (A: adhesion + invasion, B: invasion, C: intracellular replication) 
relative to Input pool of mixed 8 WITS after infection with the library of pooled 8 
WITS in the HEp-2 cells (results represent the mean + SEM, n = 3). 
 
Initially, 18-hour overnight cultures of 8 WTIS were prepared with equal volumes and 
equal aliquots of individual cultures were pooled into one library as the Input pool for 
inoculation in the HEp-2 cells. After lysis of the infected HEp-2 cells and subsequent 
quantitative real-time PCR of WITS, the DNA copies of individual WITS in each 
Input/Output pool were obtained (Figure 5.5B) and the percentage of DNA copies of 
individual WITS in their total DNA copies of mixed 8 WITS in each Input/Output pool 
was calculated (Figure 5.5A). Statistical comparison was performed in the percentage 
rates (DNA copies of single WITS relative to the sum of DNA copies from 8 WITS) 
between different Input/Output pools within each WITS group that showed no 
differences in seven WITS except for WITS 2 with its lower percentage rates in Output 
pools A, B, and C relative to Input pool (Figure 5.5A). In addition, higher percentage 
rates of WITS 11 were noticed in all Input/Output pools than those of the other seven 
WITS. Statistical analysis was also used to compare the DNA copies of individual 
WITS between different WITS within each Input/Output pool that demonstrated higher 
DNA copies of WITS 11 than the other seven WITS in the Input pool, but no differences 
in Output pools A, B, and C (Figure 5.5B). The real bacterial density in an 18-hour 
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culture of WITS might vary from each other. Therefore, it remains unknown if such 
unequal proportions of individual WITS in the Input pool, especially for those 
extremely high or low one(s), might influence the subsequent proportions of individual 
WITS in the output pools after HEp-2 cell infection.  
 
 
Figure 5.5 Percentage of DNA copies of individual WITS in the total DNA copies of 
mixed 8 WITS in each Input/Output pool (A) and DNA copies of 8 individual WITS in 
each Input/Output pool (B) by quantitative real-time PCR before (Input pool) and after 
infection with the pooled 18-hour cultures of 8 WITS in the HEp-2 cells at different 
conditions (Output pools A: adhesion + invasion, B: invasion, and C: intracellular 
replication) (one-way ANOVA, *P<0.05, #P<0.01, +P<0.001; results represent the mean 
+ SEM, n = 3). 
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In order to minimise the possible effect of major or minor predominance of any WITS 
strain(s) in the mixed population upon its proportion in the bacterial population after 
colonisation, invasion, and intracellular replication in the infected HEp-2 cells, further 
efforts were made to maximise equalisation of individual WITS in the Input pool. 
Although the OD600 values in 18-hour cultures of individual WITS had been adjusted to 
nearly the same (Figure 5.6A), the real viable bacterial concentrations obtained by 
plating out and colony counting still varied slightly (Figure 5.6B) because OD600 values 
by spectrophotometry can reflect the density of all live or dead bacteria. Equal OD600 
values may minimise variations in the amounts of viable bacteria, but can not guarantee 
equal density of viable bacteria in 18-hour cultures of individual WITS. 
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Figure 5.6 OD600 values (A) and viable bacterial concentrations (B) of 18-hour cultures 
of 8 WTIS and their mixed Input pool before with equal volumes (results represent the 
mean + SEM, n = 3). 
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Then, the HEp-2 cell infection experiments were repeated using the Input pool which 
was created by mixing equal aliquots of the OD600-adjusted 18-hour cultures of 8 WTIS 
(2.4.3.). After lysis of the infected HEp-2 cells and quantification of WITS by real-time 
PCR, the DNA copies of individual WITS in each Input/Output pool were obtained 
(Figure 5.7B) and the percentage of DNA copies of individual WITS in their total DNA 
copies of mixed 8 WITS in each Input/Output pool was calculated (Figure 5.7A). The 
DNA copies of 8 WITS showed no statistical difference in the Input pool despite the 
higher level of WITS 11 than the other WITS, whilst WITS 11 revealed higher DNA 
copies than the other seven WITS in the Output pools A, B, and C (Figure 5.7B). Lower 
percentage rates of WITS 2 in the Output pools A, B, and C, and higher percentage rates 
of WITS 11 in the Output pools B and C were statistically demonstrated when 
compared to their corresponding percentage in the Input pool (Figure 5.7A). The results 
of both tests using 18-hour cultures of WITS with and without OD600 adjustment hinted 
that WITS 2 and WITS 11 might not be stable in their proportion of the total mixed 
WITS pool in different Output pools. Such a phenomenon could be either a result of 
probability or affected phenotyping of WITS after tag insertion into the bacterial 
genome, although the insertion sites were acclaimed to be pseudogene regions.  
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Figure 5.7 Percentage of DNA copies of individual WITS in the total DNA copies of 
mixed 8 WITS in each Input/Output pool (A) and DNA copies of 8 individual WITS in 
each Input/Output pool (B) by quantitative real-time PCR before (Input pool) and after 
infection with the pooled OD600-adjusted 18-hour cultures of 8 WITS 8 WITS in the 
HEp-2 cells at different conditions (Output pools A: adhesion + invasion, B: invasion, 
and C: intracellular replication) (one-way ANOVA, *P<0.05, #P<0.01, +P<0.001; results 
represent the mean + SEM, n = 3). 
 
Next, the HEp-2 cell infection experiments were repeated using the Input pool which 
was created by mixing equal aliquots of the 18-hour cultures of 6 WTIS (WITS 1, 13, 
17 , 19, 20 , and 21) after exclusion of WITS 2 and WITS 11 (2.4.3.). The viable 
bacterial concentrations of the 18-hour cultures of 6 WITS without OD600 adjustment 
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were obtained by plating out and colony counting that showed mild variations when 
compared to the mixed Input pool (Figure 5.8). After lysis of the infected HEp-2 cells 
and quantification of WITS by real-time PCR, the DNA copies of individual WITS in 
each Input/Output pool were obtained (Figure 5.9B) and the percentage of DNA copies 
of individual WITS in their total DNA copies of mixed 8 WITS in each Input/Output 
pool was calculated (Figure 5.9A). WITS 13 was significantly higher in its DNA copies 
than WITS 19 and WITS 21 in the Input pool (P<0.05, Figure 5.9B) and its percentage 
of the total mixed 6 WITS in the Input pool was also significantly higher than those in 
the other three Output pools (Figure 5.9A). The percentage of WITS 19 of the total 
mixed 6 WITS in the Output pool C was significantly higher when compared to its 
percentage in the Input pool (Figure 5.9A). 
 
 
Figure 5.8 Viable bacterial concentrations of 18-hour cultures of 6 WTIS and their 
mixed Input pool before with equal volumes (results represent the mean + SEM, n = 3). 
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Figure 5.9 Percentage of DNA copies of individual WITS in the total DNA copies of 
mixed 6 WITS in each Input/Output pool (A) and DNA copies of 6 individual WITS in 
each Input/Output pool (B) by quantitative real-time PCR before (Input pool) and after 
infection with the pooled 18-hour cultures of 6 WITS in the HEp-2 cells at different 
conditions (Output pools A: adhesion + invasion, B: invasion, and C: intracellular 
replication) (one-way ANOVA, *P<0.05; results represent the mean + SEM, n = 3). 
 
Last, the HEp-2 cell infection experiments were repeated using the Input pool which 
was created by mixing equal aliquots of the OD600-adjusted 18-hour cultures of 6 WTIS 
(WITS 1, 13, 17, 19, 20, and 21) (2.4.3.). After OD600 normalisation by 
electrophotometry (Figure 5.10A), the viable bacterial concentrations of 6 WITS 
appeared to show minor variations (Figure 5.10B) than those 18-hour cultures without 
OD600 normalisation (Figure 5.8).  
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Figure 5.10 OD600 values (A) and viable bacterial concentrations (B) of 18-hour 
cultures of 6 WTIS and their mixed Input pool before with equal volumes (results 
represent the mean + SEM, n = 3).  
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The DNA copies of individual WITS in each Input/Output pool were obtained as earlier 
described using quantification of WITS by real-time PCR (Figure 5.11B) and the 
percentage of DNA copies of individual WITS in their total DNA copies of mixed 8 
WITS in each Input/Output pool was calculated (Figure 5.11A). This time, the data 
showed no statistical differences in either the percentage of each WITS in the total 
mixed 6 WITS between the Input/Output pools (Figure 5.11A), or the DNA copies of 
individual WTIS in the Input/Output pools (Figure 5.11B).  
 
 
 
Figure 5.11 Percentage of DNA copies of individual WITS in the total DNA copies of 
mixed 6 WITS in each Input/Output pool (A) and DNA copies of 6 individual WITS in 
each Input/Output pool (B) by quantitative real-time PCR before (Input pool) and after 
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infection with the pooled OD600-adjusted 18-hour cultures of 6 WITS in the HEp-2 cells 
at different conditions (Output pools A: adhesion + invasion, B: invasion, and C: 
intracellular replication) (one-way ANOVA; results represent the mean + SEM, n = 3). 
 
5.2.3. Validation of chromosomal DNA prepared from the input and output 
pools 
Prior to TraDIS for full sequencing of individual mutants in the 1,440-mutant pools, a 
series of experiments were undertaken to ensure the quality of extracted genomic DNA 
and the randomness of the transposon insertion sites within the bacterial genome of the 
pool mutants. 
 
First, extracted genomic DNA samples were examined on their degradation. Prepared 
from the Input pool of 1,440 Tn5 transposon mutants (2.11.2.), two inoculums were 
used to infect two sets of HEp-2 cells resulting in three output pools in duplicate. Such 
in vitro infection of the 1,440-mutant pool in HEp-2 cells was performed twice. 
Extraction of genomic DNA from Input/Output pools was individually processed as 
earlier described (2.11.3.) to generate four sets of Input/Output pools with two from 
each independent infection. After running on an agarose gel, all the DNA bands from 
these four sets of Input/Output pools and the untransposed wild-type SL1344 strain 
were visible above the top of the 10 kb marker in the ladder, indicating no DNA 
degradation (Figure 5.12). 
 
 
Figure 5.12 Extracted bacterial genomic DNA samples from four sets of Input pool and 
three Output pools on 0.8% agarose gel after running at 90 volts for 2.5 hours (I: Input, 
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A: Ouput pool A, B: Output pool B, C: Output pool C, U: untransposed control wild-
type SL1344 strain; I1–C1 and I2–C2: genomic DNA extracted from the first HEp-2 
cell infection, I3–C3 and I4–C4: genomic DNA extracted from the second HEp-2 cell 
infection). 
 
Next, the extracted genomic DNA samples were digested with the restriction enzyme 
RsaI before they were further used as PCR templates in linker PCR. After running on an 
agarose gel, all the RsaI digests from these four sets of Input/Output pools were visible 
in the range between <250 bp and 2.5 kb in size (Figure 5.13), showing successful 
digestion of all the DNA samples processed by this restriction enzyme (2.11.4.). 
 
 
Figure 5.13 RsaI digests of the DNA samples from 4 sets of Input pool and three 
Output pools in duplicate on 0.8% agarose gel after running at 90 volts for 2.5 hours (I: 
Input, A: Ouput pool A, B: Output pool B, C: Output pool C; I1–C1 and I2–C2: DNA 
digests from the first HEp-2 cell infection, I3–C3 and I4–C4: DNA digests from the 
second HEp-2 cell infection). 
 
Following DNA digest, linker PCR was conducted for comparison of the pool 
complexity between the input pools and output pools (2.11.5.). The gel profiles of the 
linker PCR products from four sets of Input/Output pools showed similarity of banding 
patterns in the second and fourth sets of pools (I2 vs A2–C2 and I4 vs A4–C4, Figure 
5.14). Instead of multiple bands, one predominant band was seen in the Output pool B 
of the first set pools (B1, Figure 5.14) and in the Output pool A of the third set pools 
(A3, Figure 5.14), suggesting possible dropout of mutants in these two pools. Therefore, 
the second and fourth sets of the bacterial genomic DNA samples from Input/Output 
pools were respectively selected from the two independent experiments for TraDIS.  
 275
 
 
Figure 5.14 Linker PCR samples using DNA RsaI digests as PCR templates from 4 sets 
of Input pool and three Output pools in duplicate on 1.2% agarose gel after running at 
80 volts for 4.5 hours (I: Input, A: Output pool A, B: Output pool B, C: Output pool C; 
I1–C1 and I2–C2: PCR products from the first HEp-2 cell infection, I3–C3 and I4–C4: 
PCR products from the second HEp-2 cell infection). 
 
5.2.4. Transposon directed insertion-site sequencing (TraDIS) to identify 
virulence genes using a HEp-2 cell model 
5.2.4.1. Identification of transposon mutants attenuated in bacteria-cell 
association 
For identifying Salmonella Typhimurium genes responsible for bacterial colonisation, 
invasion, and intracellular replication, 1,440 Tn5 transposon mutants of Salmonella 
Typhimurium SL1344 were randomly selected from one out of 6 sets in a huge library 
of totally 10,368 transposon mutants of Salmonella Typhimurium SL1344 (Chaudhuri et 
al. 2009b). The bacterial inoculum prepared from mixed overnight cultures of 
individually grown 1440 mutants as the Input pool was used to infect the HEp-2 cell 
monolayers in three different treatment protocols to generate three different Output 
pools A, B, and C (Figure 2.5). Output pool A represents the pool of bacteria which can 
adhere to and invade HEp-2 cells, Output pool B represents the pool of bacteria which 
can only invade HEp-2 cells, and Output pool C represents the pool of bacteria which 
can not only invade but also replicate within HEp-2 cells for further 7 hours. At the time 
points for harvest (Figure 2.5), the infected HEp-2 cells were collected. Genomic DNA 
was extracted from the Input pool of 1,440 transposon mutants of Salmonella 
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Typhimurium SL1344 grown overnight, and from the three Output pools obtained after 
infection of HEp-2 cells (2.11.3.). After a series of examinations for the extracted 
genomic DNA samples (2.11.4., 2.11.5., and 5.2.3.), TraDIS was performed at the 
Sanger Institute, Hinxton, Cambridge, in order to determine integration sites of the 
transposon Tn5 into the genomes of individual mutants from Input and three Output 
pools after passing through in vitro HEp-2 cells (2.11.6.). Individual integrations were 
compared in their relative abundance in the raw sequence counts. Datasets were 
converted into in the log2 fold change for statistical pairwise comparison using the 
analytic methods described in 2.11.7. and 2.12.. 
 
From the 1,440 transposon mutants from Input and three Output pools, a total of 1,371 
transposon mutants were identified by TraDIS. Integration read numbers of 47 mutants 
(3.4%) show differences between Output pool A and Input pool (Table 5.1) and are 
potentially involved in bacterial adhesion. The attenuation scores of these mutants range 
from –10 to –1.08 in Figure 5.16 (marked with a bracket).  
 
5.2.4.2. Genomic regions significant for bacterial adhesion and invasion 
Out of these 47 mutants, eight show significant differences between Output pools B and 
A (P<0.1 in B–A, Table 5.1), and 39 mutants without differences (P>0.1 in B–A, Table 
5.1). In the former group, the 5 representing genomic loci sucD-cydA, glyA, yqiC, wzxE, 
and rfaI were significant for bacteria-cell association, including bacterial adhesion and 
invasion, and there were no reads in Output pools of the mutants with disruption in the 
first 3 genomic loci (first 3 rows, Table 5.2). In the latter group, the mutant with Tn5 
insertion in rfaG (position number 3938496) also showed no reads in Output pools B 
and C (last row, Table 5.2). Therefore, it is not possible to judge whether these genomic 
loci correlate with Salmonella intracellular replication because of no different reads 
between Output pools B and C for statistical comparison. 
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Figure 5.15 Flow chart for the data analysis of the 1,440 transposon mutants from 
Input/Output pools using TraDIS. Genes/intergenic loci are listed starting with lowest P 
values from the top (*P<0.01, ~P>0.01).  
 
5.2.4.3. fimZ and fimF are required for bacterial adhesion 
The remaining 38 mutants without significant differences between Output pools C and 
B (P>0.1 in C–B, Figure 5.15 & Table 5.1) represented a total of 28 genes (parB, rfaG, 
glnG, rfaP, aroE, dcuS, acrB, yheO, SLP3_0003, udhA, rfaI, sucC, SLP3_0004, yrbH, 
pyrD, rfaQ, purH, fliI, purD, metL, fimZ, yihW, gor, fimF, trxB, SLP3_0007/8, and 
SL1344_4095) and 3 intergenic loci (imp-djlA, ntpA-aspS, and yaeT-ompH). These 
genes and intergenic regions are mainly involved in bacterial cell association. Most of 
them also correlate with bacterial invasion and/or persistent intracellular survival (P<0.1 
in B–Input and/or C–Input, Table 5.1), with two exceptions in fimZ and fimF that only 
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account for bacterial adhesion owing to no significant attenuation of their disruptive 
mutants in Output pools B and C (P>0.1 in both B–Input and C–Input, Table 5.1). In 
this group, the 7 mutants disrupted in pyrD, purH, SLP3_0003, purD, SLP3_0004, 
yihW, and SL1344_4095 were not only attenuated in Output pool A but also in Output 
pool C (P<0.1 in A-Input and C–Input, Table 5.1), suggesting the effects of these genes 
on bacterial attachment at 3 hours and sustained intracellular survival at 10 hours post 
infection. Three different Tn5 insertion sites (position numbers 4413986, 4414617, and 
4415376) in purH generated a similar phenotype. Nevertheless, different mutation 
points within the same bacterial gene might cause varied expression in their phenotypes. 
Two Tn5 insertion sites in rfaG resulted in two distinctive mutants, with one (position 
number 3938496) completely undetected in Output pools B and C (0 counts, Tables 5.1 
& 5.2) and the other one (position number 3938716) not (P>0.1 in C–B, Table 5.1). 
Another example is rfaI in which Tn5 transposon inserted at the 4 genomic positions 
(numbers 3934886, 3935520, 3935059, and 3935036) resulted in the mutants being 
significantly different between Output pools B and A (P<0.1 in B–A, Table 5.1), whilst 
Tn5 insertion at the genomic position number 3935538 had no significant difference 
(P>0.1 in B–A, Table 5.1). All the more, Tn5 insertions at another two genomic 
positions (numbers 2172367 and 2172279) in rfbI generated an additional phenotype of 
mutants (P>0.1 in A–Input and C–B; P<0.1 in B–A, Table 5.3). 
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Table 5.1 The 47 mutants with significant differences in their Tn5 sequence counts 
between Input pool and Output pool A (P<0.1 in pink backgrounds), expressed as log2 
fold change. The last 2 columns are the equivalent TraDIS attenuation scores obtained 
during an in vivo mouse systemic infection model (Chaudhuri et al. 2009b). 
+/–: direction of genes. Mouse logFC: log2 fold change; adj.P.Val: adjusted P value.  
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Table 5.2 The raw sequence counts by TraDIS for 9 representative mutants in each 
sample with two replicates each for Input pool, Output pools A, B and C. 
 +/–: direction of genes. L: 5' end data, R: 3' end data. 2: the 2nd set of DNA samples. 4: 
the 4th set of DNA samples. 
 
 
 
Figure 5.16 Curve showing the ordered attenuation scores for the 1,371 mutants 
identified by TraDIS. Each square red dot represents its attenuation score from the 
corrected log2 fold change in a comparison of Output pool A with Input pool.  
 
Gene’s name/code Input pool Output pool A Output pool B Output pool C Position +/- 
SL1344 LT2 I2L I4L A2L A4L B2L B4L C2L C4L 
    I2R I4R A2R A4R B2R B4R C2R C4R 
808848 - 1536 1886 0 0 0 0 0 0 
  
Intergenic: 
sucD-cydA 
Intergenic: 
sucD-cydA 471 661 0 0 0 0 0 0 
2692506 + glyA glyA 1748 1450 0 0 0 0 0 0 
    585 475 0 0 0 0 0 0 
3379778 + SL1344_3169 yqiC 458 478 0 0 0 0 0 0 
    643 564 0 0 0 0 0 0 
4157510 - SL1344_3885 wzxE 519 449 114 117 0 0 0 0 
    479 343 157 84 0 0 0 0 
3934886 + rfaI rfaI 8998 435 1530 111 237 0 568 0 
    1855 76 356 32 133 0 54 0 
3935520 + rfaI rfaI 5542 1694 1086 397 78 169 261 443 
    872 370 294 65 42 26 20 53 
3935059 - rfaI rfaI 12987 1616 2683 404 469 351 678 230 
    3097 390 812 75 252 62 79 33 
3935036 - rfaI rfaI 10919 5585 2197 1567 184 961 395 1357 
    1383 763 338 172 61 111 20 99 
3938496 + rfaG rfaG 1052 128 53 0 0 0 0 0 
    241 40 15 0 0 0 0 0 
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Table 5.3 The 4 mutants with no significant differences in their Tn5 sequence counts 
between Input pool and Output pool A, but with significant attenuation in Output pool B 
relative to Output pool A. The last 2 columns are the equivalent TraDIS attenuation 
scores obtained during an in vivo mouse systemic infection model (Chaudhuri et al. 
2009b). 
Each row represents a mutant. Data were corrected for multiple testing using Benjamini 
and Hochberg's False Discovery Rate. Values in pink backgrounds indicate P<0.1. 
 
5.2.4.4. The mutants with disruptions in rfbI, hilD, and invA are 
'adhesive but non-invasive' attenuated strains 
Among the 1,324 mutants not involved in bacterial adhesion (P>0.1 in A–Input, Figure 
5.15), four showed significant differences between Output pools B and A (P<0.1 in B–A, 
Figure 5.15). The 3 genes, rfbI, hilD, and invA, are required for bacterial invasion but 
not adhesion (P>0.1 in A–Input and C–B, Table 5.3). These 'adhesive but non-
internalised' mutant strains were significantly attenuated in bacterial invasion and 
sustained intracellular survival because of their significant differences in Output pools B 
and C relative to Input pool (P<0.1 in B–Input and C–Input, Table 5.3).  
 
5.2.4.5. speG is responsible for bacterial intracellular replication 
Among all the identified mutants, only the speG-disrupted mutant showed a significant 
difference between Output pools C and B (P<0.1 in C–B, Table 5.4), indicating that 
speG is responsible for intracellular replication. This mutant is an 'adhesive, invasive, 
but non-proliferative' attenuated strain.  
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Table 5.4 The mutant with no significant difference in itsTn5 sequence counts between 
Input pool and Output pools A/B, but with significant attenuation in Output pool C 
relative to Output pool B. The last 2 columns are the equivalent TraDIS fitness scores 
obtained during an in vivo mouse systemic infection model (Chaudhuri et al. 2009b).  
Each row represents a mutant. Data were corrected for multiple testing using Benjamini 
and Hochberg's False Discovery Rate. Values in pink backgrounds indicate P<0.1. 
 
5.2.4.6. Most identified genomic loci are outside SPIs with no 
involvement of SPI-2 in bacterial adhesion, invasion, or 
intracellular replication 
None of these mutations (Tables 5.1–5.3) are located within pathogenic islands 
including SPI-1, -2, -3, -4, -5, -6, and -9, except for hilD and invA which are in SPI-1.  
Intriguingly, mutants within the SPI-2 locus are not impaired in bacterial adhesion, 
invasion, or intracellular replication in this system. 
 
5.2.4.7. The majority of transposon mutants behave similarly to wild-
type Salmonella Typhimurium 
There were 1,258 mutants showing no significant changes in any pairwise comparisons 
among Input pool and three Output pools (Figure 5.15), suggesting that at least 87.4% 
of the transposon mutants in the library behaved similarly to their parental wild-type 
strain during Salmonella Typhimurium infection in the HEp-2 cells in the experimental 
conditions of this study. 
 
5.2.4.8. The 39 genomic loci unrelated to bacterial attachment but 
contributed to bacterial cellular internalisation due to small 
cumulative effects 
Although not being indentified by the earlier screening process (P>0.1 in A–Input, B–A, 
and C–B, Figure 5.15), the other 61 mutants were still somehow attenuated in Output 
pool B and/or Output pool C relative Input pool (P<0.1 in Input–B and/or Input–C, 
Figure 5.15), with their transposon insertions in the 36 genes (SLP3_0008, hepA, rfc, 
SL1344_1491, rfbK, rfbB, prgK, prgJ, prgH, hilA, sipC, invJ, invB, invA, invE, invG, 
invF, invH, SL1344_3112, yhdA, dam, feoB, rfaJ, rnpA, SL1344_3808, SL1344_3813, 
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tatC, fadB, metL, purD, siiC, siiD, siiE, siiF, SL1344_4247, and hflC) and the 3 
intergenic loci (SLP1_0041-SLP1_0042, xseB-SL1344_0419, and SL1344_3112-gsp). 
Many of these genomic loci belong to SPI-1 (prgK, prgJ, prgH, hilA, sipC, invJ, invB, 
invA, invE, invG, invF, and invH) or SPI-4 (siiC, siiD, siiE, and siiF). Because of no 
significant differences in comparisons between Output pool A and Input pool as well as 
Output pools B and A, these 36 genes/3 intergenic loci are not related to bacterial 
attachment. They may play a dynamic role in bacterial intracellular survival at different 
time points during the later period between 3–10 hours post Salmonella Typhimurium 
infection, which can be regarded as a time-dependently cumulative consequence of 
multiple bacteria-host interactions passing from initial bacterial adhesion through 
subsequent intracellular events. However, they are much less informative than the other 
identified genes to be determined as decisive genes in specific events during early 
interactions between non-typhoidal Salmonella and HEp-2 cells. 
 
5.2.4.9. Identified virulence loci can be genes or intergenic loci located 
on chromosome or plasmids 
Most of these genes/intergenic loci were discovered on the chromosome of Salmonella 
Typhimurium SL1344 whilst a few of them were detected on the plasmids such as parB 
(SLP1_0054) on SL1344P1 as well as SLP3_0003, SLP3_0004, and SLP3_0007/8 on 
SL1344P3. In some mutants, the transposon inserted in an intergenic region of the 
bacterial genome (e.g. sucD-cydA, imp-djlA, ntpA-aspS, and yaeT-ompH) that could still 
generate an significantly altered phenotype from their parental wild-type strain, 
probably due to polar effects on downstream gene expression, occasionally on upstream 
gene expression by producing interfering transcripts (Andrews-Polymenis et al. 2009), 
or disruption of an unannotated element such as a promoter or sRNA gene. In addition, 
the transposon disrupted two adjacent genes (e.g. SLP3_0007 and SLP3_0008) in their 
overlapping genomic region at one insertion site that might simultaneously affect the 
phenotypes of both genes. 
 
5.2.4.10. dcuS, SLP3_0004, fliI, fimZ, fimF, SL1344_4095, hilD, invA, 
and speG are only involved in early phases of Salmonella infection 
The identified genes/intergenic loci were compared with their equivalent TraDIS 
attenuation scores obtained during an in vivo mouse systemic infection model 
(Chaudhuri et al. 2009b). The mutants with transposon disruptions in dcuS, SLP3_0004, 
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fliI, fimZ, fimF, SL1344_4095 (Table 5.1), hilD, invA (Table 5.3), and speG (Table 5.4) 
were not significantly attenuated in the output pool after passing through the in vivo 
mice with septicaemia (Mouse adjusted P value>0.1), suggesting their importance 
primarily in early phases of Salmonella infection. The other recognised genes/intergenic 
loci are involved in both early interactions and late systemic phases during Salmonella 
Typhimurium infection (Mouse adjusted P value<0.1, Tables 5.1 & 5.3). 
 
5.2.4.11. Unreported functions of known or putative proteins encoded 
by the identified genes are discovered 
Their encoded proteins of the identified genes exert diverse functions covering a broad 
range, either known or hypothetical, and many of them still remain uncharacterised 
(Tables 5.1, 5.3, & 5.4) particularly in their roles in Salmonella virulence. In general, 
the protein products encoded by these genes can be divided into four categories: (i) the 
genes encoding known proteins with valid evidence in these three characteristics with 
knockout mutants, such as invA,  (ii) the genes encoding known proteins with indirect 
evidence in these three characteristics, such as fimZ and fimF involved in fimbria for 
bacterial attachment as well as fliI, hilD and rfa family (rfaG, rfaI, rfaP, and rfaQ) to 
regulate bacterial invasion, (iii) the genes encoding known proteins with little or no 
evidence in these three characteristics, such as speG without any report in intracellular 
replication, and (iv) the unnamed genes encoding unknown proteins with putative 
functions, such SLP3_0003, SLP3_0004, SLP3_0007, SLP3_0008, and SL1344_4095 
(Tables 5.1, 5.3, & 5.4). Because these are the results of a big-scale screening, 
characterisation of these identified genes using the equivalent mutants is necessary for 
validation of their precise phenotypes.  
 
5.3. Discussion 
Salmonella virulence genes involved in early interactions between non-typhoidal 
Salmonella and human epithelium have rarely been screened in a systemic and direct 
way. Regardless of positive or negative selection, almost all the currently known 
Salmonella virulence genes were identified using in vivo animals, which can be 
regarded as the end results of multiple-barrier filtering during complex bacteria-host 
interactions from early contact in the gastrointestinal tract to subsequent multiple organ 
involvement after systemic infections. Although HEp-2 or HeLa cells have been used in 
small scales to pre-screen TnphoA insertion mutants prior to screening of mutant library 
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in rabbit ligated ileal loops (Lodge et al. 1995) and in mice (Rubino et al. 1993), they 
have rarely been used as a main model to simultaneously screen a large numbers of 
transposon mutants for discovery of virulence genes in association with defined 
characteristics of Salmonella Typhimurium during early infection. In this study, some of 
the discovered genes are fully characterised and belong to SPI-1 or SPI-4, suggesting 
that in vitro TraDIS is efficient to identify genes which have been previously found in 
vivo. Moreover, many other uncharacterised genes were also identified outside SPIs that 
substantiates the methodology utilised in this study. 
 
Individual transposon mutant strains in a pooled library may behave similarly or 
differently from their parental wild-type strain in certain characteristic(s), depending on 
how the function of the gene has been affected by insertion of the transposon, how 
individual transposon mutants interact with each other within one mixed pool, and how 
these mutants interact with infected cells. Hence, two preliminary studies using small 
pools of mutants or tagged strains were undertaken for showing the possible trends and 
interactions of mutants in a huge library prior to the big-scale screening. 
 
The first preliminary study revealed a similar trend of a 96-mutant pool to Salmonella 
Typhimurium wild-type SL1344 in quantification on bacterial adhesion, invasion, and 
intracellular replication in HEp-2 cells. A biphasic pattern was exhibited in three Output 
pools that the quantities of bacteria associated with cells in Output pool A were higher 
than those of bacteria invading cells in Output pool B, and the amounts of invading 
bacteria climbed after a 7-hour period of intracellular growth in Output pool C (5.2.1.). 
However, their differences between the mixed pool and wild-type strain in three output 
pools might derive from the significantly altered phenotypes of a portion of disruptive 
mutants that could not be respectively quantified by the traditional plating-out method. 
 
The second preliminary study using a small pool of 6 or 8 WITS and quantitative real-
time PCR provides more information in their interactions within a pool between 
individual genome-tagged Salmonella strains which simulate transposon mutants 
despite no real mutation in their functional genes (5.2.2.). Unaffected by being pooled 
together, 75–100% of the individual strains in a library of 6 or 8 WITS maintained their 
equal distribution at different stages throughout the infection course in HEp-2 cells. In 
other word, 0–25% of the individual strains in a library of mixed genome-tagged 
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Salmonella strains might quantitatively vary in their proportion relative to the other 
strains in the same pool during the infection process. This could be presumably related 
to how equally the individual WITS were prepared from overnight cultures or whether 
the gene functions were disrupted or affected. Although not perfect, this method using 
real-time PCR detectable WITS is at least a feasible solution to quantitatively observe 
the alterations of individual WITS in their interactions within the pools, from inoculums 
prior to infection (Input pool) to different harvests post infection (Output pools A, B, 
and C). Such variations in the distribution of each single strain within a mixed pool 
seem unavoidable when overnight cultures of transposon mutants are prepared in a large 
scale. However, significantly attenuated mutant strains at different readouts can be 
identified by statistical comparison of the data, which mainly derive from comparison of 
significant changes in the individual mutant strain between different pools, may not be 
affected by slight variations of individual proportion with a pool, and may still be 
validated by compensation of repeated insertion of transposon in different sites within 
one gene. Subsequent re-confirmation in characterisation of the mutants with the 
identified genes can reinforce the authenticity of their phenotypes at different readouts. 
 
Ensuring the quality of the extracted genomic DNA samples from Input and Output 
pools of transposon mutants is crucial for validity and accuracy of TraDIS data. 
Random loss of mutants from the population is the major challenge when we use a huge 
pool containing very large numbers of mutants from random transposon mutagenesis, 
which is generated to complete coverage of the genome for negative selection. Due to 
such a 'founder effect' or 'bottleneck', a population of Salmonella in the input pool may 
fail to pass throughout the in vivo or in vitro models and drop out during the infection 
process, with only a small portion of the bacteria arriving in the new niche where the 
output pool is obtained (Andrews-Polymenis et al. 2009). Meanwhile, the dilution effect 
of pooling created by the size of the mutant library should be considered because the 
bigger the mutant pool is, the smaller the multiplicity of infection (MOI) will be for 
individual mutant. This might lead to insufficient interactions between Salmonella 
mutants and infected cells that could further affect the capability of individual 
transposon mutants to fully express their phenotypes of virulence during the infections. 
In this study, 1,440 mutants were pooled into one library as Input pools and finally only 
some Output pools were satisfactory in their complexity patterns of linker PCR (5.2.3.). 
If the remaining strains of the 10,368-mutant library are further screened, the in vitro 
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infections may be conducted in several batches in a similar scale with subsequent 
pooling of their extracted genomic DNA samples to minimise random loss of mutants. 
 
Salmonella genes on the bacterial genome transcribe mRNA and then translate into a 
wide range of protein products that exert important functions in basic cellular 
metabolism, bacterial virulence, and interrelated regulation. Generally, housekeeping 
genes involved in basic cellular metabolism are not regarded as virulence genes (Kim 
and Choy 2010) and the mutants disrupted in these essential genes cannot grow in 
overnight cultures whilst only those mutants with disruption insertions in non-essential 
genes can be present in the prepared input pool for inoculation in the in vitro or in vivo 
models. In general, every gene involved in pathogenicity is called a virulence gene 
regardless of its function in the complex process of virulence. More precisely, virulence 
genes are defined as genes that encode factors or enzyme-producing factors involved in 
interaction with the host and that are directly responsible for pathology during infection 
(Wassenaar and Gaastra 2001). Virulence-associated genes regulate the expression of 
virulence genes, activate virulence factors via translational modification, processing or 
secretion, or are required for the activity of true virulence factors (Kim and Choy 2010). 
In contrast to the systemic effects of the genes identified by negative selections in the in 
vivo mice model, this study investigated Salmonella virulence factors that allow bacteria 
to break through merely the first several barriers of host defence in the human epithelial 
cell monolayer: adhesion, invasion, and intracellular replication. 
 
In this study, we identified four genes (glyA, yqiC, wzxE, and rfaI) and one intergenic 
locus (sucD-cydA) that have not been reported before to be responsible for Salmonella 
adhesion and invasion in human epithelial cells. The metabolic gene glyA encodes 
serine hydroxymethyltransferase which catalyses the reversible, simultaneous 
conversions of L-serine to glycine via retro-aldol cleavage and 5,6,7,8-tetrahydrofolate 
to 5,10-methylenetetrahydrofolate via hydrolysis in cellular one-carbon pathways to 
generate the largest part of the one-carbon fragments available to the cell (Appaji et al. 
2003;Stover and Schirch 1990). A study using IVET demonstrated induced expression 
of glyA in the reproductive tract tissues of laying hens after intravenous inoculation of 
Salmonella Enteritidis (Gantois et al. 2008). Upregulation of glyA by CsgD in E. coli is 
an integral response to signals that elicit synthesis of curli (thin aggregative fimbria) 
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(Chirwa and Herrington 2003). Curli promote biofilm formation, binding to host 
proteins such as fibronectin, and increase bacterial internalisation in eukaryotic cells 
(Brombacher et al. 2006;Gophna et al. 2001;Olsen et al. 1989). The homologous CsgD 
and AgfD proteins are members of the FixJ/UhpA/LuxR family and are reported to 
regulate curli, and cellulose production by Escherichia coli and Salmonella 
Typhimurium, respectively (Chirwa and Herrington 2003). The agf genes in Salmonella 
enterica are organised in two adjacent divergently transcribed operons: the agfBAC 
operon and the agfDEFG operon. The former contains agfB for a nucleator protein and 
agfA for fimbrin, the major protein component of the curli fibre with more glycine than 
other normal proteins; and the latter contains a regulatory gene agfD, a gene agfE 
encoding a chaperone-like protein, a gene agfF encoding a second nucleator protein, 
and a gene agfG encoding a lipoprotein involved in secretion of fimbrin and AgfB  
(Brombacher et al. 2006;Collinson et al. 1996;Collinson et al. 1997;Hammar et al. 
1995;Romling et al. 1998;Romling et al. 2000). Although changes in the agfD  promoter 
region can influence expression of glyA and curli formation with subsequent bacterial 
attachment or internalisation, it is reported for the first time that only disruption in glyA 
can attenuate adhesion and invasion of Salmonella Typhimurium in human epithelial 
cells. Whether its protein function is completed via blockage in curli formation requires 
further confirmation. 
 
The gene yqiC encodes a conserved hypothetical protein, whilst another gene wzxE 
encodes a putative lipopolysaccharide biosynthesis protein (Table 5.1). The bacterial 
wzx genes encode integral membrane proteins called translocases or 'flippases' to 
mediate the transbilayer movement of polyisoprenoid lipid-linked oligosaccharide 
intermediates across the cytoplasmic membrane for the assembly of many bacterial cell 
surface polysaccharides (Rick et al. 2003). In the biosynthesis of enterobacterial 
common antigen (ECA), the translocase WzxE, its corresponding polymerase WzyE, 
and the O-antigen chain-length regulator WzzE presumably form a multiprotein 
complex. Their interactions facilitate translocation of O-antigen and ECA subunits 
across the plasma membrane and the subsequent assembly of periplasmic O-antigen and 
ECA undecaprenyl-phosphate-linked polymers (Marolda et al. 2006). A genetic analysis 
of Salmonella Enteritidis identified wzxE with involvement in biofilm formation 
(Solano et al. 2002). However, no previous reports but this study showed direct 
evidence that this gene is indispensible for Salmonella adhesion and invasion. 
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Single disruption in the intergenic region of sucD-cydA significantly disables 
Salmonella Typhimurium SL1344 in bacterial adhesion and invasion, suggesting that its 
polar effects on either of both genes may alter the phenotype of the wild-type strain. The 
gene sucD encodes succinyl-CoA synthetase alpha chain as one component of succinyl 
coenzyme A synthetase which catalyses the formation of succinate and coenzyme A 
from succinyl-CoA with simultaneous generation of guanosine triphosphate (GTP) from 
guanosine diphosphate (GDP). This is a reversible step in the tricarboxylic acid (TCA) 
cycle, which is a series of enzyme-catalysed chemical reactions using oxygen in cellular 
respiration to convert carbohydrates into carbon dioxide and water for generation of 
usable energy and metabolic precursors in organisms (Tchawa et al. 2006). The Cra 
protein (catabolite repressor/activator) of enteric bacteria regulates central carbon 
metabolism by enhancing expression of genes in the gluconeogenic pathway, the 
glyoxylate bypass, the TCA cycle, and electron transport and suppressing genes 
encoding glycolytic enzymes (Saier, Jr. and Ramseier 1996). The TCA cycle functions 
as a full cycle because a sucCD mutant with impaired conversion of succinyl coenzyme 
A to succinate was attenuated for virulence of Salmonella Typhimurium in survival of 
mice (Tchawa et al. 2006). However, bacterial disruption of fatty acid degradation and 
the glyoxylate bypass does not affect virulence of Salmonella Typhimurium (Tchawa et 
al. 2006). Unlike the late impact on survival of mice in vivo, our in vitro study showed a 
novel potential phenotype of sucD via a polar effect on early Salmonella adhesion and 
invasion in human epithelial cells. In addition, sucD also plays a similar role to wzxE in 
the pathways leading to the synthesis of polysaccharides involved in the biofilm 
phenotype of Salmonella Enteritidis (Solano et al. 2002).  
 
The gene cydA encodes aerobic respiratory chain cytochrome d ubiquinol oxidase 
subunit I that comprises cytochrome d ubiquinol oxidase. Cytochrome d is preferably 
expressed in microaerobic growth conditions and plays a role in an electron transport 
chain for extracting energy from redox reactions such as the oxidation of sugars 
(Alvarez et al. 2010). The Arc (anoxic redox control) two-component system comprises 
the ArcA response regulator and the ArcB sensor kinase, and renders E. coli 
appropriately responsive to alterations of oxygen availability (Alvarez et al. 2010). The 
arcA gene was initially found as the dye gene because the arcA-deleted mutant was 
susceptible to dyes such as toluidine blue O (TBO) and methylene blue (Buxton et al. 
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1983). Afterwards, mutants with mutations in the cytochrome d-encoding operon, 
cydAB, and in arcB show a similar TBO-sensitive phenotype (Delaney et al. 1993;Iuchi 
et al. 1989) that links these two genetic systems to bacterial regulation of oxygen 
utilisation. Mutation in cydA attenuated Salmonella Typhimurium not only in their 
relevant virulence assays of typhoid-like infections, but also compromised their 
persistence and multiplication in the reticuloendothelial system and macrophages of 
chickens, whilst mutation of cydA reduced in vitro invasiveness into cultured chicken 
kidney cells only transiently at 1 hour postinfection (Turner et al. 2003). Our 
identification of a mutation in sucD-cydA unveiled the close relationships between 
utilisation of oxygen as cellular respiration for generation of energy and Salmonella 
virulence during early infections in human epithelial cells.  
 
Our study indicates that rfaI is significant for bacterial adhesion and invasion (Table 1). 
The rfa locus consists of three distinct blocks of genes according to the direction of 
transcription (Figure 5.17). At the left end is a block of genes rfaDFCL which are 
transcribed rightward without evidence of being a single operon. In the middle of the 
locus is a large block of genes rfaQGP–BIJYZK which are transcribed leftwards and 
some or all of these genes consitute a complex operon with internal promoters. At the 
right end, the kdtA gene involved in attachment of ketodeoxyoctulosonic acid and the 
18-kDa polypeptide gene are transcribed rightwards and are organised into another 
operon (Schnaitman et al. 1991). Lipopolysaccharide 1,3-galactosyltransferase encoded 
by rfaI is one of a series of glycosyltransferases that catalyse the stepwise transfer of 
sugars from their nucleotide-linked precursors to synthesize a similar LPS core region 
in all gram-negative bacteria. This core LPS provides the attachment site for O-
antigenic polysaccharide which is the major determinant of bacterial virulence. The 
genes encoding these glycosyltrasferases are located in the rfaGBIJ gene cluster within 
the largest block rfaQGP–BIJYZK, with an operon (rfaG-rfaB-rfaI) transcribed from 
one or more promoters that lie within the upstream of rfaG (Brazas et al. 1991), a 
complex promoter region in the AT-rich gap of about 400 bp between rfaQ and kdtA 
(Figure 5.17) (Schnaitman CA 1991). The product of the rfaH (homologous sfrB in E. 
coli) gene is a positive regulator for transcription of the whole rfaGBIJ cluster and at 
least one genomic locus regulated by RfaH lies within or very close to the upstream 
promoter region (Brazas et al. 1991). Therefore, there is no wonder that disruptions of 
the other genetic sites (rfaI, rfaP, rfaG, and rfaQ) within the gene block rfaQGP–
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BIJYZK also similarly generate significant attenuation in Salmonella invasion and 
persistent intracellular survival in this study (Table 5.1), as well as in dissemination to 
spleen and liver in mice with septicaemia (Chaudhuri et al. 2009b). Independent on host 
protein synthesis, gene expression was downregulated during the initial 2 hours but later 
upregulated to a new steady state for the rfa promoter during Salmonella Typhimurium 
invasion in response to signals present within intestinal epithelial cells (Maurer et al. 
2000). Our study further confirmed the importance of the rfa genes during early 
interactions of Salmonella Typhimurium with human epithelial cells. 
 
 
Figure 5.17 Physical map of the rfa loci of Salmonella Typhimurium; adapted from 
(Schnaitman et al. 1991). 
 
The only 3 genes rfbI, hilD, and invA are exclusively significant for bacterial invasion 
but not for adhesion in this study. The hilD and invA genes respectively encode an 
AraC-family transcriptional regulator (Boddicker et al. 2003) and secretory apparatus of 
T3SS (Galan et al. 1992;Steele-Mortimer et al. 2002), both of which are within SPI-1 
and well known in how their products affect bacterial invasion. Moreover, the fimYZ-
encoded regulatory proteins are important activators of hilE expression (Baxter and 
Jones 2005). Because HilE acts as a negative regulator of hilA through protein-protein 
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interactions with HilD which is required for activation of hilA transcription (1.5.1.), 
FimYZ can overexpress hilE to indirectly suppress expression of hilA and the invasive 
phenotype. In addition, FimYZ are implicated in type 1 fimbrial gene expression and 
motility gene regulation therefore invasion gene expression is coregulated with 
adherence and motility, and the expression of these virulence phenotypes coordinately 
contributes to bacterial pathophysiology (Baxter and Jones 2005). The other gene rfbI 
was identified in a big screening during Salmonella Enteritidis infection in chicken 
macrophages, with its encoded putative reductase RfbI involved in LPS side chain 
biosynthesis (Zhao et al. 2002). However, we identified this gene in human non-
phagocytic HEp-2 cells, indicating the importance of rfbI in bacterial invasion within 
different cell types and species.  
 
To our knowledge, this is the first study to report the significance of speG in Salmonella 
intracellular replication in human non-phagocytic cells. The speG gene encodes 
spermidine N1-acetyltransferase (SAT) which regulates and is highly regulated by 
cellular polyamine content to maintain polyamine homeostasis (Pegg 2008). Polyamines, 
polycationic compounds present in all living organisms, have been implicated in a wide 
diversity of biological reactions, including synthesis of nucleic acids and proteins. SAT 
activity not only links polyamine metabolism to other parts of cell physiology such as 
lipid and carbohydrate metabolism by alterations in the content of acetyl-CoA and ATP, 
but is also induced via the oxidation of acetylated polyamines by various stimuli such as 
toxins, hormones, cytokines, nonsteroidal anti-inflammatory agents, natural products, 
stress pathways, and ischaemia-reperfusion injury (Pegg 2008). Extracted from whole 
cells of Salmonella Typhimurium and E. coli, total polyamines including putrescine, 
cadaverine, and spermidine are bound to the cell envelope and mainly constitute the 
bacterial outer membranes (Koski and Vaara 1991). Polyamines are required for optimal 
growth in most cells, but polyamine accumulation leads to inhibition of cellular growth. 
Spermidine is monoacetylated by SAT in both prokaryotes and eukaryotes. Such 
spermidine acetylation can reduce intracellular polyamine levels to prevent spermidine 
toxicity under stressful growth conditions in E. coli (Limsuwun and Jones 2000). The 
accumulation of spermidine starts to inhibit synthesis of proteins, but not DNA and 
RNA, at the late stationary phase of growth and decreases cell viability of speG-
deficient mutant of E. coli due to its disruption in spermidine acetylation. These affected 
proteins include the ribosome modulation factor and OmpC protein and the former is 
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essential for cell viability at the stationary phase of growth (Fukuchi et al. 1995). Taken 
together, it is reasonable to assume that speG plays an important role in intracellular 
replication of Salmonella Typhimurium within HEp-2 cells.  
 
Presumably, the 'adhesive but non-internalised' attenuated mutants with disruptions in 
rfbI, hilD, and invA (Table 5.3) or the 'adhesive, invasive, but non-proliferative' (Table 
5.4) speG-impaired mutant strain might be potential candidates as targeted vectors or 
oral vaccines due to their capability of adhesion but inability of intracellular replication 
in human epithelial cells. Among the 5 strains with mutations in 4 genes, only two rfbI-
disrupted mutants (Table 5.3) were also attenuated in the typhoidal mice (Chaudhuri et 
al. 2009b), showing their persistent, rather than transient, expression of genetic 
phenotype throughout the in vivo infection process as tolA and trxA genes (Paterson et 
al. 2009;Peters et al. 2010). Because these mutants were already attenuated in human 
epithelial epithelium on the host front barrier, they might be unable to spread to 
lymphoid tissues, blood streams, or other organs such as livers or spleens and might be 
supposed as safer strains than those screened out in vivo. Recombinant attenuated 
Salmonella vaccines have been constructed to deliver antigens from other pathogens to 
induce immunity to those pathogens in vaccinated hosts (Curtiss, III et al. 2010). 
However, most of the attenuated strains were screened in vivo, indicating their survival 
following vaccination to colonise lymphoid tissues or to disseminate into livers/spleens 
without causing significant diseases. Whether our attenuated mutants identified in vitro 
could induce less severe pathology but more efficient immunity in hosts than those 
vaccine strains identified in vivo warrants further characterisation. 
 
Among the 28 genes and 3 intergenic loci which correlate with bacterial cell association, 
their involvement in bacterial adhesion can not be excluded. Most of them also correlate 
with bacterial invasion and/or persistent intracellular survival (Figure 5.15; Table 5.1), 
except for two fimbriae-encoding genes fimZ and fimF. The mutants with disruptions in 
these two genes were only impaired in cell association but not bacterial invasion and/or 
prolonged intracellular survival. fimZ encodes FimZ which regulates expression of type 
1 fimbriae (Figure 5.18); whilst fimF encodes FimF which is one subunit of type 1 
fimbriae to connect tip fibrillum to pilus rod (Figure 5.19). Motile strains of 
Enterobacteriaceae including Salmonella Typhimurium swim using flagella and adhere 
to mannose-containing glycoconjugates of eukaryotic cells using type 1 fimbriae (Clegg 
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and Hughes 2002), which is assembled via the chaperone-usher pathway related to those 
described for E. coli fimbrial biogenesis (Vetsch et al. 2004). Different from that 
described in other bacteria, expression of the fim gene cluster in Salmonella 
Typhimurium is regulated by integrated circuits containing three proteins FimZ, FimY, 
and FimW which involve a combination of positive and negative feedback to affect the 
expression of fimA, the major fimbrial subunit (Figure 5.19) (Vetsch et al. 2004;Yeh et 
al. 1995). FimZ and FimY independently activate the PfimA promoter which controls 
the expression of the fim structural genes, with FimZ found to be the dominant activator. 
FimZ and FimY strongly activate each other’s expression and weakly activate their own 
expression. FimW negatively regulates fim gene expression by repressing transcription 
from the PfimY promoter. Furthermore, FimW and FimY interact in a negative feedback 
loop, whilst FimY activates the PfimW promoter (Figure 5.18). FimZ alone can enhance 
the expression of hilE (Figure 1.7), a known repressor of SPI-1 gene expression (Saini 
et al. 2009). Moreover, over-expressed FimZ creates hyperfimbriated but nonmotile 
Salmonella Typhimurium in soft agar. Such non-motility correlates with downregulation 
of the flhDC master flagellar operon (Clegg and Hughes 2002). FliZ, a flagellar 
regulator, represses type 1 fimbrial gene expression through the posttranscriptional 
regulation of FimZ (Saini et al. 2010). Therefore, FimZ represents a molecular bridging 
flagellar and fimbrial formation in Salmonella Typhimurium, suggesting that the 
synthesis of flagella and fimbriae are oppositely controlled. 
 
Figure 5.18 Model for the type 1 fimbriae gene circuit in Salmonella Typhimurium; 
adapted from (Saini et al. 2009).  
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The subunits of type 1 fimbriae FimA, FimF, FimG, and FimH enter the periplasm in an 
unfolded conformation and then form 1:1 complexes with the chaperone FimC (Vetsch 
et al. 2004). The interaction of these complexes with the usher FimD forms a pore in the 
outer membrane and dissociation of the chaperone–subunit complexes ensues. The 
subunits cross the outer membrane and become incorporated into the growing pilus, 
with the chaperone remaining in the periplasm (Figure 5.19). Our results confirm that 
both fimZ and fimF are indispensible for efficient bacterial attachment. Not only is fimZ 
proved to dominantly affect the function of type 1 fimbriae, but also fimF plays a 
decisive role in completely fulfilling the fimbraie assembly.   
 
 
Figure 5.19 Schematic illustration of type 1 fimbriae assembly according to the 
chaperone–usher pathway; adapted from (Vetsch et al. 2004). OM, outer membrane; IM, 
inner membrane. 
 
The 36 genes and the 3 intergenic loci are significantly associated with bacterial 
internalisation despite of no correlation with bacterial adhesion (Figure 5.15), 
suggesting their cumulative small effects. Many of these genomic loci are known within 
SPI-1 (prgK, prgJ, prgH, hilA, sipC, invJ, invB, invA, invE, invG, invF, and invH) or 
SPI-4 (siiC, siiD, siiE, and siiF), both of which can coordinate with each other (1.5.1.). 
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Meanwhile, most of them were also identified by the in vivo TMDH screening as the 
outcome of cumulative small effects through systemic infections. In other word, our 
screen study using an in vitro model and TraDIS has identified mutants in dcuS, 
SLP3_0004, fliI, fimZ, fimF, SL1344_4095 (Table 5.1), hilD, invA (Table 5.3), and 
speG (Table 5.4), which are attenuated only in early stages of Salmonella Typhimurium 
infection and therefore can not be directly identified by an in vivo model.  
 
In this study, all the identified genes/intergenic loci significant for bacterial cell 
association are located outside SPI-1. This finding indicates that the genes which are not 
located within pathogenicity islands also play an important role during early Salmonella 
infection in human epithelium. In addition to those genes in SPI-1, SPI-3, SPI-4, 
virulence plasmids (1.5.1.), and adhesion-encoding fimbrial operons (van der Velden et 
al. 1998), a number of novel genes in the other locations of bacterial genome were 
found to be decisive in the intimate attachment of Salmonella to human non-phagocytic 
cells. Although the principal role of SPI-2 is to facilitate the replication of intracellular 
bacteria within SCV (Waterman and Holden 2003), only one non-SPI gene speG is 
found to be responsible for intracellular replication in this study. A possible explanation 
is that the 10-hour incubation period may be too short to statistically reveal significant 
replication of intracellular Salmonella in our HEp-2 cell model. Intriguingly, no SPI-2 
locus is found to correlate with bacterial adhesion, invasion, or intracellular replication 
in this system, implying that SPI-2 does not associate with these characters of 
Salmonella virulence and the role of SPI-2 is mainly confined in the late stages of 
Salmonella infection. 
 
In conclusion, this study identified novel virulence-associated genes/intergenic loci in 
the bacterial genome of Salmonella Typhimurium SL1344 which are responsible for 
bacterial adhesion, invasion, and intracellular replication in human epithelial cells. SPI-
2 appeared not involved in the early interactions during the initial 10 hours post 
infection, including intracellular growth in non-phagocytic cells. Further investigations 
in various models are required for better understanding of how these novel genes and 
their encoded proteins contribute to Salmonella virulence and host immune responses 
during pathogen–host interactions.  
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6.1.  Introduction 
This thesis is aimed to investigate the early interaction of non-typhoidal Salmonella 
with human epithelium in several aspects, from cellular microbiology to virulence gene 
determination. How early is early? In this study, such early interactions are basically 
defined as any events of pathogen–host interplays occurring at an infection stage when 
the invasive bacteria have not broken through the basal membranes of the intestinal 
epithelial barrier into the subepithelial space regardless of the position of Salmonella 
above, on, or within the epithelium. Salmonella may also encounter other specific cells 
in vivo, ex vivo, or in human when the infected epithelial layers still remain intact during 
early stages. These cells can be goblet cells, M cells, or even dendritic cells in addition 
to absorptive intestinal cells. Once if the intestinal epithelial barrier is breached, 
Salmonella may be preferentially internalised by some highly specialised phagocytic 
cells such as macrophages and neutrophils that can migrate from the lamina propria to 
the intestinal epithelium or into the intestinal lumen.  
 
Another important emphasis of this thesis is 'human', as the host for interaction with 
non-typhoidal Salmonella. The majority of the currently available knowledge 
concerning early interactions of non-typhoidal Salmonella derives from animal studies 
with extrapolation to the human situation. However, in vivo animal studies can not 
completely reflect the genuine situations in human non-typhoidal Salmonella infection, 
at least partly due to the possible presence of host specificity in some virulence genes 
and their dependent responses (Morgan et al. 2004;Zhang et al. 2003a). It is better to use 
human tissues/cells to study human Salmonella infection. Therefore, we selected three 
studying materials which are all human derived, including in vitro human epithelial 
carcinoma cells (Chapter 3), in vivo human biopsied explants from clinical cases 
(Chapter 4a), and polarised ex vivo human intestinal organ cultures (Chapter 4b) to 
investigate human non-typhoidal Salmonella infection based on their individual 
characteristics.  
 
There are drawbacks for using in vitro cell lines because they can not fully reflect the 
actual situations in human intestinal epithelium because of their abnormal nature as 
cancer cells, the lack of commensal flora and mucus secretion, and the deficiency in 
responses and systemic reactions from subepithelial or other tissues such as blood 
circulation, regional lymph nodes, and remote lymphoid tissues in spleen or liver. After 
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optimisation as described in Chapter 3, the two selected in vitro cell culture models 
using HEp-2 cells and polarised Caco-2 cells were applied for different specific 
purposes, with the former mainly for assessment of bacterial adhesion, invasion, and 
intracellular replication in host cells, and the latter primarily focusing on evaluation of 
intestinal epithelial integrity and host innate immune responses.  
 
Helpfully, polarised ex vivo human intestinal organ cultures, as discussed in Chapter 4b, 
can compensate for the aforementioned drawbacks of in vitro cell culture models when 
used to study human Salmonella infection, particularly early infection due to the short 
life span of its maintenance ex vivo. This short incubation duration, approximately 5–8 
hours post Salmonella infection, allows the polarised ex vivo human intestinal organ 
cultures to informatively answer key questions regarding early human Salmonella 
infection.  
 
Furthermore, in vivo human biopsied explants from clinical cases of non-typhoidal 
salmonellosis, as described in Chapter 4a, explored another route for obtaining direct 
evidence of bacterial interactions with human host cells, although they were not 
harvested as early as those samples infected in vitro or ex vivo. 
 
It is just a beginning to understand at a molecular level how non-typhoidal Salmonella 
interacts with its host cells to cause human diseases, although many facts regarding the 
three studied virulence characters of non-typhoidal Salmonella including bacterial 
attachment (McCormick et al. 1993), invasion (Douce et al. 1991), and intracellular 
replication (Leung and Finlay 1991) have been documented at a cellular level. A number 
of Salmonella virulence genes have been discovered to be responsible for these three 
virulence characteristics.  
 
So far fimbrial proteins, including type 1 fimbriae (Fim), are well known to play an 
important role during intestinal colonisation of Salmonella Typhimurium (Humphries et 
al. 2001). The fimZ-encoded regulator protein FliZ can significantly control type 1 
fimbrial gene expression and bridging flagellar and fimbrial formation in Salmonella 
Typhimurium (Saini et al. 2009). However, it remain little known whether the fimF-
encoded protein FimF, one subunit of type 1 fimbria (Vetsch et al. 2004), alone could 
affect the phenotypic function of type 1 fimbria. This study not only re-confirmed that 
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fimZ can dominantly affect bacterial adhesion, but also showed a novel finding that 
single disruption of fimF can significantly impair bacterial attachment, probably due to 
its decisive role in the completion of the fimbraie assembly. 
 
In general, SPI-1 is thought to contain genes required for bacterial invasion of non-
typhoidal Salmonella into host cells (Galan 1996), whist SPI-2 is necessary for 
intracellular survival (Shea et al. 1996). The SPI-1 genes encoding the secretion 
apparatus are located in two clusters inv–spa and prg–org, both of which are separated 
by the other genes encoding the secreted proteins Sip/SptP and an essential regulator 
HilA (Darwin and Miller 1999). Moreover, the other T3SS machinery encoded by SPI-2 
is activated after bacterial entry into eukaryotic cells and facilitates bacterial 
proliferation in all cell types, which is linked to systemic growth in the host because of 
profound attenuation of SPI-2 null mutants in vivo (Waterman and Holden 2003). 
Although intracellular replication is essential for the virulence of Salmonella 
Typhimurium in the mouse typhoidal model (Leung and Finlay 1991), it can occur in 
vitro within the vacuolar compartment of both macrophages and non-phagocytic 
epithelial cells (Gahring et al. 1990). However, this study overthrew such a stereotypical 
impression on Salmonella virulence genes by identification of the genomic loci which 
are mostly located outside SPI-1, with the only exception of hilD and invA. We also 
discovered an intriguing finding that SPI-2 is not involved in bacterial adhesion, 
invasion, or intracellular replication in this system. 
 
Altogether, we adopted three different models in vitro, ex vivo, or 'in vivo' using human 
cells/tissues to study early interactions of non-typhoidal Salmonella with human 
epithelial cells, which is based on their characteristics and limitations in the short-
duration incubations. After optimisation of the in vitro models, validation in evidence of 
early Salmonella Typhimurium invasion in the human intestinal explants ex vivo, and 
acquirement of the firsthand clues as to the pathogen–host cell interactions in the 
biopsied 'in vivo' tissues from the patients with non-typhoidal salmonellosis, a big-scale 
screening was conducted for narrowing down the occurrence of Salmonella infection 
with 1,440 transposon mutants to the three initial events in vitro: bacterial adhesion, 
invasion, and intracellular replication. These virulence characters occur at much earlier 
stages than those in an in vivo mouse typhoidal model, which is mainly designed for 
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systemic infection. With introduction of the appropriately optimised in vitro HEp-2 cell 
culture model and the high throughput genomic technologies including a big library of 
transposon mutants and TraDIS, novel or uncharacterised genes significant for the three 
highlighted virulence factors of Salmonella Typhimurium in human epithelial cells have 
been discovered in this study. 
 
6.2.  In vitro 
The first in vitro model using HEp-2 cell cultures was validated by time-course SEM 
assessment of bacterial colonisation, immunofluorescence assessment of bacterial 
internalisation, and gentamicin protection assays for selection of the most proficient 
Salmonella Typhimurium strain in bacterial invasion. Then, probiotic modulation of IL-
1β- and Salmonella Typhimurium-induced host responses by lactobacilli were further 
clarified. Lactobacillus rhamnosus GG or Lactobacillus plantarum 299v can dose-
dependently and transiently inhibit IL-1β-induced IL-8 responses which are independent 
on degradation of IκBα and phosphorylation of NF-κB p65 and do not block nuclear 
NF-κB p65 translocation. Both lactobacilli can suppress pathogen-induced cellular IL-8 
responses only upon early and simultaneous co-treatment with Salmonella 
Typhimurium. However, HEp-2 cells are human epithelial cancer cells, neither intestinal 
nor polarised cells, which might be unable to fully simulate the genuine human 
intestinal epithelium in vivo. Therefore, we need more adjuvant models for 
characterisation of Salmonella strains and the assessment of host responses. 
 
The second in vitro model using polarised differentiated Caco-2 cells, which are human 
colonic epithelial cancer cells and behave as small intestinal enterocytes, reconfirmed 
the importance of flagellin and exhibited the potential role of bacterial CpG DNA in 
eliciting epithelial pro-inflammatory responses. In the past, TLR9 was thought to be 
located within endosomes in the cytosol (Ewaschuk et al. 2007) and CpG DNA was 
supposed to enter the cytosol for binding with subcellular localised TLR9 in the early 
endosomes after infection (Takeshita et al. 2004). However, a recent review indicated 
that TLR9 can be expressed on the apical cellular membrane (Wells et al. 2010). Our 
study demonstrated that extracellular exposure of Salmonella DNA to the basolateral 
sides of cell monolayers appears to be an important stimulator to hBD-2 in relative to 
IL-8, hinting that basolateral expression of TLR9 in the intestinal epithelium cannot be 
excluded. 
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Another ex vivo model using polarised human intestinal organ cultures in transwells is 
indeed a variant of the in vitro model providing a delicate approach to simulate human 
intestinal epithelium on the mucosal explants, which are genuine normal tissues rather 
than cancer cells. To our knowledge, it was the first time to use this polarised ex vivo 
model in studying non-typhoidal Salmonella following its successful trials in EPEC 
(Schuller et al. 2009) and in the non-polarised model for Salmonella Typhimurium 
infection (Haque et al. 2004) from our team. This study established a reproducible 
polarised ex vivo human intestinal organ culture model which is able to show direct 
evidence of intimate interactions of Salmonella Typhimurium with host cells, 
particularly internalisation of bacteria into epithelial cells and non-epithelial cells such 
as neutrophils and macrophages. Additionally, in this model the known fact was 
reconfirmed pertaining to the predominant distribution of Paneth cell antimicrobial 
peptides HD5 and HD6 in small intestines (Wehkamp et al. 2006). With the first use of 
this model, our study exhibited a novel finding in the significant downregulation of 
wild-type Salmonella Typhimurium on hBD-3 mRNA expression in the human 
duodenum. This finding coincides with a recent in vivo study showing that 
neutralisation of IL-17A by Salmonella Typhimurium can suppress constitutive 
localisation of IL-17A-induced β-defensin-3 at the apical side of the intestinal mucosa 
to assist Salmonella Typhimurium to evade host innate immunity in mice during early 
Salmonella infection (Mayuzumi et al. 2010). This finding urges further studies of 
interest for clarification of its mechanism(s). 
 
There should be more space for improving the in vitro cell culture models used in this 
study. The well-differentiated human colon carcinoma cell line, LS174T cells, shows 
great potential for prospective works after our ex vivo studies revealed information such 
as downregulation of hBD-3 mRNA expression by Salmonella and intimacy between 
Salmonella and mucus/goblet cells. LS174T cells can be cultured with polarity in vitro 
(Gum et al. 1987) and can express significant levels of hBD-3 that cannot be expressed 
in Caco-2 cells (Fahlgren et al. 2004;Ou et al. 2009). Meanwhile, there are goblet cell-
like mucin-secreting cells expressing MUC2 and MUC6 mRNAs which are virtually 
absent in Caco-2 cells (van Klinken et al. 1996). At the protein level LS174T cells 
express the goblet cell specific mucin protein precursors MUC2, MUC5A/C, and 
MUC6 as well as synthesize and secret the goblet cell specific mature MUC2 and 
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MUC5A/C. In addition, there is a pro-inflammatory cytokine IFN-γ that can induce 
increased hBD-3 mRNA expression in LS174T cells but not in T-84 cells or Caco-2 
cells (Fahlgren et al. 2004;Ou et al. 2009) so as to be a good stimulator for creating 
positive controls. Since Salmonella Typhimurium was found in close contact with 
goblet cells and their secreted mucin lakes, and was able to suppress hBD-3 expression 
by intestinal epithelium in the polarised ex vivo human intestinal organ cultures, 
LS174T cell cultures provide an alternative in vitro model to Caco-2 cells for 
elucidation of the cell-type specific mechanisms responsible for human β-defensin-3 
and mucin expression in vitro (van Klinken et al. 1996).  
 
6.3.  In vivo   
No single one in vivo animal model can perfectly simulate human non-typhoidal 
salmonellosis in all aspects. In this study, we used neither in vivo human volunteers nor 
any in vivo animal models. The only in vivo data we obtained originated from post-
biopsy processing of the formalin-fixed paraffin-embedded endoscopic intestinal tissues 
from three paediatric patients who were naturally infected 'in vivo'. These patients were 
initially thought to have IBD but later then were confirmed to have acquired non-
typhoidal salmonellosis. These firsthand clues as to the pathogen–host cell interactions 
were not at very early stages of Salmonella infection. However, they provide an 
overview in human non-typhoidal salmonellosis that most of the invasive Salmonella 
bacteria were trapped in the mucus layers, whilst a number of the bacteria invaded or 
attached to the absorptive enterocytes or goblet cells in the epithelium and sporadic 
bacteria were associated with inflammatory cells such as macrophages from the lamina 
propria underneath a breached epithelium. Although such 'in vivo' human intestinal 
infection does not infer any systemic infection from in vivo which is usually referred to 
as a conception of septicaemia in a typhoidal mice model, these findings facilitate 
further research design for our experiments of ex vivo human intestinal organ cultures or 
future studies in non-typhoidal Salmonella enterocolitis.  
 
An in vivo typhoidal mice model had been applied to a TMDH gene screen in the library 
of 10,368 transposon mutants for Salmonella Typhimurium SL1344 at the Cambridge 
Veterinary School (Chaudhuri et al. 2009b) before a portion of the same library 
comprising 1,440 mutants was employed in our gene screen using in vitro HEp-2 cells 
and TraDIS. Basically, those attenuated mutant strains after passing through in vivo 
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typhoidal mice are incompetent in their systemic spread from the first niche in gut to 
extra-intestinal organs such as liver and spleen. However, it is unknown whether these 
selected strains were also incompetent in the three studied virulence characteristics 
during early stages of non-typhoidal Salmonella enterocolitis. 
 
Since non-typhoidal Salmonella serotypes mostly cause enterocolitis rather than 
systemic infection in human, an appropriate in vivo animal model for non-typhoidal 
salmonellosis is required to validate the roles of in vitro TraDIS-identified genes in the 
early interactions of Salmonella Typhimurium with human intestinal epithelium. Cattle 
infected with Salmonella Typhimurium and Salmonella Dublin have been established as 
an in vivo model for studying human Salmonella enterocolitis (Tsolis et al. 1999a). 
However, cattle are outbred and usually genetically diverse so genetic or immunological 
manipulation for the bovine host is technically limited when compared with murine 
models (Hapfelmeier and Hardt 2005). Meanwhile, the costs and logistics involved in 
bovine experiments are also considerable.  
 
When orally infected with Salmonella Typhimurium, mice usually develop septicaemia 
with poor intestinal colonisation and cause only modest mucosal inflammation with 
mononuclear infiltrate as the typhoidal model. However, streptomycin-pretreated mice 
develop neutrophil-dominated colitis that is accompanied by both intestinal pathology 
and pathophysiology resulting in watery stools (Hapfelmeier and Hardt 2005;Woo et al. 
2008). This colitis model develops these changes closely resembling the features of 
enterocolitis in humans and has been used to study both bacteria and host components 
important for human Salmonella enterocolitis. The organised gut-associated lymphoid 
tissues (GALT) are dispensable for the initiation of murine colitis (Barthel et al. 2003). 
Streptomycin-pretreated mice provide a unique in vivo infection model that allows both 
the pathogen and the host amenable to genetic manipulation using knockout mutants of 
both to study specific cellular signalling pathways of the host in response to Salmonella 
virulence factors for connecting cellular microbiology to disease. Thus, these two mice 
models are candidate in vivo models for the prospective studies which can facilitate 
characterisation of the identified Salmonella Typhimurium virulence-associated genes 
and their contribution to the host responses during enteric and systemic phases of 
human salmonellosis. 
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6.4.  Selection of important virulence genes during early interactions of 
Salmonella Typhimurium with epithelium 
Gene expression of Salmonella Typhimurium varies with time at different stages of 
infection in human epithelial cells and involves more than one T3SS, which has been 
acknowledged by a microarray study (Hautefort et al. 2008). Such transcriptional 
adaptation assists pathogens in coping with the rapidly changeable milieu during the 
infection process and appears to be a result of reciprocal reactions between the pathogen 
and the infected host. Therefore, this observation vindicates that some genes represented 
by individual transposon mutants in the huge library might not be identified by TMDH 
after passing the mutant strains through an in vivo mice model (Chaudhuri et al. 2009b), 
particularly for those genes only slightly and transiently involved in the early stages of 
Salmonella infection without cumulative effects throughout the entire infection course. 
 
Our proposed gene-screening strategy, combining in vitro infection of transposon 
mutants in HEp-2 cell monolayers and semiquantitative detection of the transposon 
mutants using TraDIS, confined the infection process to the very early three events 
which are bacterial colonisation, invasion, and intracellular replication. This in vitro 
procedure allows the competition among huge amounts of transposon mutants in 
passing through only the first defence barriers of the infected human epithelial cell 
monolayers rather than through multiple defence barriers and immune systems during 
systemic infection in vivo. Since this in vitro system is much simpler than the complex 
systems in vivo, it can more specifically identify the decisive genes which 
predominantly affect the three virulence characters we focus on. Whether these 
identified genes are exclusively significant for these three characters or exert lasting 
effects throughout the systemic infection can be shown by comparison of the data 
between in vitro and in vivo TraDIS using the same library of transposon mutants. 
 
It is important to validate this in vitro TraDIS system for identification of Salmonella 
virulence genes. First, a number of well known SPI-1 genes (prgK, prgJ, prgH, hilA, 
sipC, invJ, invB, invA, invE, invG, invF, and invH) or SPI-4 genes (siiC, siiD, siiE, and 
siiF) were found to be associated with bacterial internalisation at 3 hours and/or 10 
hours after infection to HEp-2 cells by detecting their significant attenuation of their 
disruptive transposon mutants in the last two output pools representing bacterial 
invasion and intracellular replication (Output pools B & C, Figure 2.5). All of these 
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genes are not related to bacterial attachment to HEp-2 cells, indicating the small 
cumulative effects of their phenotypes on significant attenuation not in early bacterial 
adhesion but in subsequent bacterial internalisation. These genes have been well 
documented for their contribution to bacterial invasion (Behlau and Miller 
1993;Hayward and Koronakis 1999;Main-Hester et al. 2008;Park et al. 2000). 
Meanwhile, SPI-1 and SPI-4 play complementary roles in the interaction of Salmonella 
Typhimurium with the intestinal mucosa (Main-Hester et al. 2008). Second, another two 
genes fimZ and fimF were identified in this study to be required for bacterial attachment. 
Both genes have been clearly known for their importance in regulation and biosynthesis 
of type 1 fimbriae which mediates adherence to tissues and cells via receptor-specific 
interactions (Clegg and Hughes 2002;Saini et al. 2009;Vetsch et al. 2004). Hence, it can 
be confirmed that our proposed in vitro TraDIS system is as efficient as other means for 
identification of these virulence genes. 
 
In addition to the above known genes, it is highly desirable to see if this proposed study 
could identify novel genes which had not been previously linked to the three targeted 
virulence characteristics of Salmonella Typhimurium. Altogether, the intergenic loci 
sucD-cydA as well as the 5 genes glyA, yqiC, wzxE, rfaI, and speG have been selected as 
important Salmonella virulence-associated genes according to their significant P values 
and characteristic phenotypes of their transposon mutants in the interactions with human 
epithelial cells.  
 
The present in vitro TraDIS study identified the 5 genomic loci sucD-cydA, glyA, yqiC, 
wzxE, and rfaI that had never been reported to be responsible for Salmonella adhesion 
and invasion since the first 3 disruptive mutants were absolutely impaired in bacteria-
cell association and the last 2 disruptive strains were significantly attenuated in both 
bacterial attachment and internalisation (Tables 5.1 & 5.2). As discussed in 5.3., almost 
all of these genes are related to cellular metabolism. The sucD and cydA genes are 
implicated in utilisation of oxygen as cellular respiration for generation of energy. The 
expression of glyA is relevant to cellular one-carbon pathways to provide largest one-
carbon fragments available to cells, whist wzxE and rfaI are involved in 
lipopolysaccharide biosynthesis. The yqiC gene is completely a novel gene with 
unknown protein function. The phenotypic effects of these single gene disruptions are 
not transient but robustly persistent because their mutant strains were also found to be 
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significantly attenuated in the output pools of in vivo TraDIS (last two columns, Table 
5.1). Intriguingly, none of these genes are located within known SPIs, indicating that 
genomic loci outside SPIs also play a crucial role in bacterial adhesion and invasion.  
 
Meanwhile, we discovered the novel significance of speG in intracellular replication of 
Salmonella Typhimurium within human epithelial cells despite its insignificance in the 
systemic effect on the in vivo mice with septicaemia (last two columns, Table 5.4). This 
indicates that the effect of speG on growth of intracellular bacteria is limited to the first 
10-hour early stage prior to the establishment of the systemic infection. The speG gene 
correlates with regulation of cellular polyamine content for synthesis of nucleic 
acids/proteins and prevents polyamine accumulation that leads to inhibition of cellular 
growth (Limsuwun and Jones 2000;Pegg 2008), from which it can be extrapolated why 
this gene is important for bacterial intracellular replication.  
 
Moreover, the 'adhesive but internalisation-attenuated' mutants with disruptions in rfbI, 
hilD, and invA (Table 5.3) and/or the 'adhesive, invasive, but proliferation-attenuated' 
speG-impaired mutant strain (Table 5.4) have been chosen to be potential candidates as 
targeted vectors or oral vaccines, relying on their discovered capability of adhesion but 
inability of invasion and/or intracellular replication in human epithelial cells. Because 
HEp-2 cells are cancer cells not of intestinal origin, some bias might accordingly 
develop. It remains little known if these strains selected by this in vitro HEp-2 cell 
culture model would behave similarly when the infections of these strains were 
alternatively established in the in vivo animal model and ex vivo human organ culture 
model. The in vivo and ex vivo models can respectively fulfil the involvement of 
adaptive immunity and the employment of human non-cancer intestinal mucosal tissues 
for acquiring more information in studying human non-typhoidal salmonellosis.  
 
Genetically engineered and/or live attenuated Salmonella has been exploited as a 
delivery vector for targeted therapy or vaccination, with its promising properties such as 
inherent anti-tumour virulence, targeting of multiple tumours from a distant inoculation 
site, selective replication within tumours, the ability to express heterologous proteins by 
genetic engineering, delivery of therapeutic and/or prophylactic proteins in vivo, and 
simultaneous stimulation of mucosal and systemic immune protection following oral 
administration (Garmory et al. 2003;Loessner et al. 2008;Pawelek et al. 1997). For 
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example, wild-type Salmonella bacteria were found to proliferate rapidly within the 
tumour leading to death of the melanoma-bearing mice. However, their attenuated 
hyperinvasive auxotrophic mutants can exhibit limited pathogenicity by retaining the 
characteristics of the tumour-targeting and amplification phenomena, but can suppress 
tumour growth and survival of the treated mice after intraperitoneal inoculation. With 
the expression of a plasmid comprising the herpes simplex virus thymidine kinase (HSV 
TK) gene, the prodrug ganciclovir can be phosphorylated and translocated to the 
periplasm. Inoculation with HSV TK-expressing Salmonella in melanoma-bearing 
animals allows ganciclovir-mediated, dose-dependent suppression of tumour growth 
and prolonged survival (Pawelek et al. 1997). Salmonella Typhimurium can grow under 
aerobic and anaerobic conditions, can invade diverse host cells including epithelial cells, 
macrophages and dendritic cells, can colonise large established tumours (Leschner and 
Weiss 2010), and can even invade and affect metastases (Yam et al. 2010). Our 
identified Salmonella mutants with disruptions in rfbI, hilD, invA, and speG carrying the 
character of bacterial attachment and/or invasion to cervical epithelial carcinoma cells 
warrant further studies to confirm if these strains could be useful to the anticancer 
therapy for tumours of intestinal origins when introduced with targeted recombinant 
chemotherapy drugs within the carriers. 
 
Salmonella is one of the most extensively explored pathogenic microorganisms which 
can be genetically engineered into recombinant or attenuated strains as natural delivery 
vehicles for mucosal vaccines (Mestecky et al. 2008). Unlike the selected attenuated 
strains with disruptions in tolA and trxA which had passed through multiple host 
defence systems of the mice with septicaemia in the in vivo TMDH model (Chaudhuri et 
al. 2009b), the identified 'adhesive but non-invasive' rfbI-, hilD-, and invA-disrupted 
mutants or the 'invasive but non-proliferative' speG-disrupted mutant by in vitro TraDIS 
exhibited various attenuation effects during different infection stages, with only two 
rfbI-disrupted mutants attenuated in the typhoidal mice but hilD-, invA-, and speG-
impaired strains transiently attenuated in the infected HEp-2 cells during the first 10 
hours. Seeing that non-typhoidal salmonellosis rarely develop into septicaemia, the 
questions arise whether it is necessary for these candidate strains as oral vaccines to 
survive for long durations in vivo until they disseminate into other organs, and when is 
the best timing before significant attenuation for eliciting satisfactory protective 
immunity. Since dendritic cells are potent antigen-presenting cells to initiate and 
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modulate immune responses and can penetrate gut epithelial monolayers for sampling 
of bacteria (Dietrich et al. 2001;Rescigno et al. 2001), invasion of non-typhoidal 
Salmonella attenuated mutants into immunologically relevant organs (e.g. liver and 
spleen) far away from gut may be not required for induction of both mucosal and 
systemic immunity after oral vaccination. In addition, the whole solitary intestinal 
lymphoid tissue (SILT) in the gut with a spectrum from small lymphoid aggregations to 
larger groups of lymphoid follicles such as in Peyer’s patches (Halle et al. 2007) 
accompanied by M cells can serve as an immune organ which plays an important role in 
mediation of antigens and stimulation of host immunity. These GALT can promote 
antigen-specific immunoglobulin production in response to Salmonella infection and 
oral immunisation that requires appropriate maintenance of mesenteric lymph nodes in 
their microenvironment including a follicular dendritic cell network (Lorenz and 
Newberry 2004;Yamamoto et al. 2004).  
 
Therefore, there is a good chance that the attenuated mutants identified in this thesis 
could minimise the adverse effects which might occur during passing throughout 
systemic infections. Whether they could trigger protective immunity necessitates further 
characterisation of these strains in various models. The aims of research will be focused 
on whether these mutants could selectively or inclusively induce mucosal secretory 
immunoglobulin A, serum immunoglobulin G antibodies, and cell-mediated immune 
responses. Meanwhile, it is worthwhile to investigate how gut innate immunity interacts 
with stimulation of adaptive immunity, how mucosal activated and mature dendritic 
cells imprint specific homing patterns on T and B lymphocytes, and how mucosal 
immunologic memory is elicited (Pasetti et al. 2011). 
 
6.5.  Limitations to the study 
The potential weakness in this study directly derives from the unavoidable limitations of 
the models used and requires more than one model to answer a question. Although HEp-
2 cells are cancerous and non-intestinal in origin (Gey et al. 1952), they have been 
validated in their advantage of testing bacterial attachment (Boddicker et al. 
2002;Hancox et al. 1997), invasion (Douce et al. 1991;Lee et al. 1992), and intracellular 
replication (Leung and Finlay 1991;Small et al. 1987) of Salmonella Typhimurium in 
the previous studies and ours. Fortunately, this in vitro model is mainly utilised for the 
screen of bacterial transcriptome with regard to their interactions with human epithelial 
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cells (Hautefort et al. 2008), but not for the confirmation in characterisation of bacterial 
transposon mutant strains. In comparison to genuine human intestinal epithelium, HEp-
2 cells lack cell polarity, and are comprised of a single cell type. This rationalises the 
utilisation of alternative models for a comprehensive interpretation of phenotypic 
expression of Salmonella virulence-associated genes in human intestinal epithelium. 
 
Another limitation of this study is the availability of human isolates of Salmonella 
Typhimurium strains with complete genome sequences. In this study, the parental strain 
of the utilised transposon mutants is Salmonella Typhimurium SL1344. This is not a 
wild-type strain in human but in mice and cattle, and was originally derived from 
bovine dysentery (Hoiseth and Stocker 1981). Because a complete sequence of the 
bacterial genome is mandatory for molecular biological approaches to identify bacterial 
genes, we adopted this completely sequenced strain and verified its competency in the 
three highlighted characteristics (i.e. bacterial adhesion, invasion, and intracellular 
replication) after comparison to the other human and animal isolates of Salmonella 
Typhimurium strains without accessible complete genome sequences. 
 
The most difficult part of this study is the insufficiency of human intestinal tissue 
samples for ex vivo organ cultures. Due to the limited availability and the pathological 
consideration of the biopsy tissues, it was only possible to investigate the optimisation 
of the model for Salmonella Typhimurium infection, to carry out preliminary 
experiments for seeking evidence of bacterial invasion, and to initiate studies 
concerning host innate immune responses in human defensins. Fortunately, useful 
information in mRNA expression of antimicrobial peptides has been obtained from our 
study using the ex vivo polarised human intestinal organ culture model despite the 
limited number of endoscopy biopsies. However, the antimicrobial gene expression has 
not been substantially confirmed at the protein level due to the limitation of protein 
assays for β-defensin-3 in very low concentration and the possible localisation of 
secreted antimicrobial activities to the mucus surface layer over the intestinal mucosa 
(Meyer-Hoffert et al. 2008). This requires further reinforced works for clarification, 
including the collection of mucus from human intestinal explants and to concentrate the 
harvested protein solution before quantification of the target protein levels. 
 
We adopted the reproducible in vitro HEp-2 cell culture model for identification of 
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Salmonella virulence-associated genes because it is quite suitable for the three 
highlighted virulence factors (bacterial adhesion, invasion, and intracellular replication) 
which are less dependent on the influences from the host systemic effects. Importantly, 
this is a screen not the final result. It will be necessary to combine the use of several 
models using human cells/tissues for further characterisation of the identified genes.  
 
6.6.  Future works 
6.6.1. Completion of the screen for the whole library of 10,368 transposon 
mutants of Salmonella Typhimurium SL1344 
In the proposed in vitro TraDIS study, only 1,440 transposon mutants of Salmonella 
Typhimurium SL1344, comprising approximately one sixth of the total library, were 
investigated for Salmonella virulence-associated genes during early stage of infection. It 
is worthwhile to complete the screen in the rest of this huge library containing totally 
10,368 transposon mutants (Chaudhuri et al. 2009b) for identification of any more novel 
virulence-associated genes. Such a prospective work can facilitate a comprehensive 
overview of Salmonella virulence-associated genes involving early interactions of 
Salmonella Typhimurium with human epithelial cells. None of the identified Salmonella 
virulence-associated genes (i.e. sucD-cydA, glyA, yqiC, wzxE, rfaI, and speG) is located 
within SPIs, including SPI-1 and SPI-2. These genetic loci are involved in early specific 
event of salmonellosis without cumulative effects. This finding is somehow compatible 
with those of a recent report utilising the Rotating-Wall Vessel-generated organotypic 3-
D model derived from the colon epithelial cell line, HT-29 (Radtke et al. 2010), 
indicating that SPI-1/SPI-2 are dispensable for Salmonella invasion into highly 
differentiated human intestinal epithelial cells. Intriguingly, no SPI-2 locus is found to 
correlate with bacterial adhesion, invasion, or intracellular replication in our study. 
Hence, completion of the screen in the whole library of transposon mutants can draw a 
final conclusion in these observations. 
 
6.6.2. Mutagenesis of Salmonella Typhimurium SL1344 based on the 
virulence-associated genes identified by in vitro TraDIS 
The next goal of the ongoing research is to complete mutagenesis of Salmonella 
Typhimurium SL1344 based on the in vitro TraDIS-selected genes (i.e. sucD-cydA, glyA, 
yqiC, wzxE, rfaI, and speG) into their matching mutants and complementation of 
plasmid in these mutants as complete sets of gene-specific mutants and plasmid-
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complemented strains for further studies in characterisation of these genes, because we 
can not directly select any specific gene-disrupted strain from the library of transposon 
mutants. Therefore, a series of molecular biological procedures should be performed for 
reconstruction of the gene-targeted mutant strains. 
 
According to the genomic blueprint of the TraDIS-selected transposon mutants, 
Salmonella Typhimurium wild-type SL1344 can be transformed into the site-directed 
mutants with disruption of allocated genes/genetic loci which have been mapped on the 
bacterial genome using the same method as previously detailed (Buckley et al. 2010). 
Meanwhile, the corresponding plasmid-complemented strain of the gene-deficient 
mutant can be generated to study if the impaired gene function could be restored after 
reimplantation of the lost gene into the mutant by a plasmid. For those genes that are 
mutually and closely correlated with each other, it may be necessary to create single, 
double, or triple deletion mutants to investigate if there is any presence of gene 
predominance or synergism as previously studied in certain genes (Mo et al. 2006). 
Simultaneous comparison can be made between the gene-disrupted mutants, the 
plasmid-complemented strains, and their parental wild-type for further characterisation 
in their phenotypes. 
 
6.6.3. Characterisation of the identified virulence-associated genes using 
various infection models 
Upon availability of the gene-deficient mutants and their corresponding plasmid-
complemented strains, characterisation of these genes becomes feasible when 
Salmonella infections are conducted with these genetically engineered strains and their 
parental wild-type strain in various infection models for assessment of bacterial 
virulence and host responses.  
 
First, the Salmonella virulence will be reconfirmed for the responsibility of the 
identified genes in the three studied characters including bacterial adhesion, invasion, 
and intracellular replication in vitro. Correlations of these virulence characters with the 
identified genes will be validated in the in vitro HEp-2 cell culture model which was 
originally designed for gene screening, then followed by confirmation tests in the in 
vitro polarised Caco-2 cell and LS174T cell culture models to see if there are consistent 
results in different cell lines.  
 313
 
Second, the host responses during early salmonellosis will be evaluated in vitro and ex 
vivo for their relationships with the identified Salmonella virulence-associated genes. 
Based on the nature of intestinal cell culture lines and our finding in the downregulation 
of hBD-3 expression in the human small intestine by Salmonella Typhimurium SL1344, 
the expression of antimicrobial hBD-1 and hBD-2 will be evaluated in the in vitro 
polarised Caco-2 cell culture model, whilst the expression of hBD-3 will be further 
investigated in the in vitro polarised LS174T cell culture model and the ex vivo 
polarised human intestinal organ culture model. The ex vivo model can be improved by 
reinforcement of the tissue viability and by postinfectious isolation of the intestinal 
epithelium from the whole biopsy explants for precise mRNA expression and image 
studies of the human intestinal epithelial cells. The underlying mechanism and cell 
signalling in hBD-3 regulation by Salmonella Typhimurium and its potential link to the 
identified virulence-associated genes will be highlighted in the prospective studies. 
 
Third, the interactions between pathogen and host cells, particularly direct links 
between PAMPs and PRRs, with the subsequent cellular responses will be evaluated by 
taking advantage of the bidirectional approaches across the transwells in the in vitro 
polarised Caco-2/LS174T cell culture models and the ex vivo polarised human intestinal 
organ culture model. Since we have discovered that Salmonella CpG DNA is an 
additional PAMP to flagellin for eliciting epithelial pro-inflammatory reactions such as 
IL-8 and hBD-2 mRNA expression in the in vitro polarised Caco-2 cells, it is worth 
investigating hBD-3 mRNA expression induced by Salmonella CpG DNA in the in vitro 
polarised LS174T cells and the ex vivo polarised human intestinal mucosa. The 
corresponding PRRs of pathogenic CpG DNA, particular TLR9, will be highlighted for 
its time-course expression and polar distribution in the human epithelium after ex vivo 
Salmonella infection.  
 
Last but not least, host responses involving adaptive immunity or other systemic 
tissues/organs than intestinal epithelium after Salmonella infection will be evaluated in 
both streptomycin-pretreated Salmonella colitis and septicaemia in vivo mice models. 
Although some of the Salmonella Typhimurium mutants (e.g. tolA and trxA) identified 
by in vivo TMDH (Chaudhuri et al. 2009b) showed protection against virulent 
challenges in the BALB/c mice model (Paterson et al. 2009;Peters et al. 2010), it could 
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be criticised that this is a main model for typhoidal salmonellosis which can not reflect 
the real situation of non-typhoidal salmonellosis caused by Salmonella Typhimurium. 
This rationalises the utilisation of both colitis and septicaemia mice models for 
characterisation of the mutants identified by in vitro TraDIS. The 6 selected mutants 
with disruptions in sucD-cydA, glyA, yqiC, wzxE, rfaI, and speG as well as the potential 
candidates as targeted vectors or oral vaccines derived from 'adhesive but non-invasive' 
or 'invasive but non-proliferative' attenuated mutants from the in vitro TraDIS study will 
be used to infect the mice with colitis and septicaemia in both in vivo models. These 
works can hopefully answer key questions with regard to involvement of systemic and 
intestinal Salmonella Typhimurium infections, and can compare the phenotypes of 
different Salmonella virulence-associated genes and the host responses induced by their 
representative deficient mutants in both mice models. Furthermore, if the knockout mice 
lacking specific chemokine receptors (e.g. IL-8 receptor) (Hang et al. 2000), immune 
cells (e.g. macrophages and dendritic cells) (Qualls et al. 2006;Qualls et al. 2009), TLRs 
(e.g. TLR9), or inhibition of specific mediator in signalling pathways (e.g. MyD88 
knockout) (Heimesaat et al. 2010) are available, they can provide a more powerful 
approach for elucidating the complex network of bacteria-host interactions in the 
infected animal down to the subcellular and the molecular levels. 
 
After the genes identified by in vitro TraDIS are comprehensively studied in their 
phenotypes and characteristics, their representative attenuated mutants are promising 
candidates to use as tools to improve our understanding of the pathophysiology of non-
typhoidal salmonellosis and to develop novel strategies for its prevention and treatment. 
 
6.7.  Conclusions 
This thesis has advanced the currently available knowledge in early interactions of non-
typhoidal Salmonella with epithelium, not only from animals to humans but also from 
cells to genes. The robust HEp-2 cell culture model was established to investigate three 
important early virulence characters of human non-typhoidal Salmonella, which are 
bacterial adhesion, invasion, and intracellular replication in the epithelium. This allows 
an extension of the in vivo methods for screening Salmonella virulence genes to an in 
vitro model that can more specifically focus on the cellular events occurring in the early 
interactions of Salmonella Typhimurium with human epithelium. This advantage 
together with the intervention of the innovative technology TraDIS enabled the 
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discovery of novel Salmonella virulence-associated intergenic locus/genes sucD-cydA, 
glyA, yqiC, wzxE, rfaI, and speG that appear to be virulence factors involved in early 
non-typhoidal salmonellosis. Interestingly, all the identified genes are outside SPI-2 and 
are unable to be recognised by the previous in vivo gene screens because of their host 
systemic effects. Although the full gene screen in the entire library of Salmonella 
Typhimurium SL1344 transposon mutants has not been completed, this finding 
indicates the importance of SPI-2 genes at late stages rather than in early process of 
Salmonella infection within human epithelium.  
 
Furthermore, the second in vitro model using polarised Caco-2 cells demonstrated the 
potential significance of Salmonella CpG DNA in triggering the host pro-inflammatory 
and innate responses. This model also creates a feasible platform for future 
characterisation of the mutants deficient in the genes identified by in vitro TraDIS.  
 
In addition, the human intestinal endoscopy biopsies incidentally obtained from patients 
with Salmonella gastroenteritis mimicking onset of IBD provided useful information in 
the real 'in vivo' non-typhoidal salmonellosis in humans although the tissues were not 
collected at the early stages.  
 
For the first time, this study utilised the ex vivo polarised human intestinal organ culture 
model to study Salmonella Typhimurium infection, and demonstrated valid evidence of 
bacterial invasion into human intestinal epithelial cells, macrophages, and neutrophils. It 
also manifested considerable downregulation of hBD-3 mRNA expression in the human 
duodenum by wild-type Salmonella Typhimurium. This ex vivo model reveals the clues 
as to the direction of prospective studies and offers more opportunities for 
characterisation of the gene-disrupted mutants in human tissues. Importantly, it would 
be challengeable to validate if the 'adhesive but non-invasive' or 'invasive but non-
proliferative' attenuated mutants selected by in vitro TraDIS could significantly trigger 
persistent and sufficient adaptive host immunity without causing detrimental effects. 
Such potential candidates as targeted vectors or oral vaccines offer hope to the 
prevention and treatment in not only non-typhoidal salmonellosis but also other 
infectious diseases. 
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Identification Of Virulence-Associated Genes Of Salmonella Typhimurium Responsible 
For Bacterial Adhesion, Invasion, And Intracellular Replication In Human Epithelial Cells 
Using Transposon Directed Insertion-Site Sequencing 
 
S.-B. Fang 1,*, R. R. Chaudhuri 2, S. E. Peters 2, J. Wang 2, S. J. Pleasance 2, D. J. Maskell 2, I. 
G. Charles 3, J. Parkhill 4, S. Eckert 4, N. J. Klein 5, A. D. Phillips 1 
 
1Centre For Paediatric Gastroenterology, UCL Medical School, London, 2Department of 
Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom, 3The ithree institute, 
University of Technology, Sydney, Australia, 4The Wellcome Trust Sanger Institute, Wellcome 
Trust Genome Campus, Hinxton, Cambridge, 5Infectious Diseases and 
Immunology Unit, Institute of Child Health, London, United Kingdom 
 
Objectives and Study: To identify virulence-associated genes responsible for Salmonella 
adhesion, invasion, and intracellular replication in human epithelial cells using a high throughput 
screening model based on Transposon Directed Insertion-site Sequencing (TraDIS). 
 
Methods: HEp-2 cells were infected (MOI = 50) with 1,440 Tn5 transposon mutants of 
Salmonella Typhimurium SL1344 (Input pool) for 2 hours, then the cells were: (i) treated with 
plain medium for 1 hour and washed to remove non-adherent bacteria (Output pool A; cell-
associated mutants which adhere to and invade cells), (ii) gentamicin-treated for 1 hour to kill 
extracellular bacteria (Output pool B; cell-invading mutants), or (iii) infected for a further 7 hours 
(Output pool C; mutants which invade and proliferate within cells). Genomic DNA was then 
extracted from the Input/Output pools. TraDIS was used to determine Tn5 integration sites in 
the genomes of individual mutants from Input/Output pools. Individual integrations among the 4 
pools were pairwise compared in their relative abundance expressed as a log2 fold change. P 
<0.01 was considered statistically significant from 2 independent biological replicates. 
 
Results: TraDIS identified 1,371 transposon mutants with 47 mutants involved in bacterial 
adhesion. The 5 genomic loci sucD-cydA, glyA, yqiC, wzxE, and rfaI were significant for 
adhesion and invasion. The 31 genes/intergenic loci (parB, rfaG, glnG, rfaP, aroE, dcuS, acrB, 
yheO, SLP3_0003, udhA, rfaI, sucC, SLP3_0004, yrbH, pyrD, rfaQ, purH, fliI, purD, metL, fimZ, 
yihW, gor, fimF, trxB, SLP3_0007/8, SL1344_4095, imp-djlA, ntpA-aspS, and yaeT-ompH) were 
involved in bacterial cell-association, with fimZ and fimF only transiently responsible for 
adhesion. rfbI, hilD, and invA were required for invasion but not adhesion, whilst speG was 
required for intracellular replication but not adhesion or invasion. Interestingly, SPI-2 mutants 
were not impaired in adhesion, invasion, or intracellular replication in this system. 
 
Conclusion: We identified novel Salmonella virulence-associated genomic loci responsible for 
adhesion, invasion, and intracellular replication. The 'adhesive but non-invasive' or 'invasive but 
non-proliferative' attenuated mutants are potential candidates as targeted vectors or oral 
vaccines. 
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STIMULATION OF IL-8 AND BETA-DEFENSIN-2 BY PATHOGEN-ASSOCIATED 
MOLECULAR PATTERNS OF SALMONELLA ENTERICA SEROVAR TYPHIMURIUM IN 
POLARISED HUMAN INTESTINAL EPITHELIAL CELLS   
 
Gut infection  
S. Fang*1, M. Lucas1, D. J. Maskell2, A. D. Phillips1 
1Centre for Paediatric Gastroenterology, Royal Free Campus, University College London 
Medical School, London, 2Department of Veterinary Medicine, University of Cambridge, 
Cambridge, United Kingdom  
Objectives and Study: To investigate which pathogen-associated molecular patterns (PAMPs) 
of Salmonella enterica serovar Typhimurium (S. Typhimurium) stimulate epithelial IL-8 and beta-
defensin-2 (hBD-2) mRNA expression and protein secretion in human intestinal epithelial cells.  
Methods: Polarised 14-day-old Caco-2 cells grown on transwells were stimulated with apical 
application of three Salmonella PAMPs for 2 hours (lipopolysaccharide [LPS, 10 mug/ml], 
flagellin [FliC, 2 mug/ml] or S. Typhimurium SL1344 DNA [25 mug/ml]). Monolayers were also 
apically infected with S. Typhimurium strains for 2 hours (wild-type SL1344, invasion-
incompetent SPI-1 mutant ∆spaS, and FliC-deficient mutant ∆fliM) at a multiplicity of infection of 
20:1 before infections were stopped with 1-hour gentamicin treatment (100 mug/ml). At 7 hours 
post infection IL-8 and hBD-2 mRNA expression were measured using quantitative real-time 
PCR; at 21 hours post infection basolateral and apical supernatants were respectively collected 
to measure protein levels of IL-8 and hBD-2 using ELISA. Statistical significance (P <0.05) was 
tested using one-way ANOVA.  
Results: Stimulation of Caco-2 cells with FliC, or S. Typhimurium DNA induced mRNA 
expression of IL-8 (62.4×104 and 10.5×104 copies of mRNA transcripts/mug total RNA) and 
hBD-2 (11.5×105 and 1.6×104 copies of mRNA transcripts/mug total RNA). IL-8 and hBD-2 
transcriptional activity was not detectable in LPS-stimulated and non-treated cells. Stimulation 
with FliC induced the highest level of IL-8 and hBD-2 gene expression among three PAMPs. S. 
Typhimurium SL1344, ∆spaS, and ∆fliM induced IL-8 mRNA levels (93.2×104, 45.5×104, 
20.3×104 copies of mRNA transcripts/mug total RNA, respectively), whilst only S. Typhimurium 
SL1344 and ∆spaS, but not S. Typhimurium ∆fliM, induced hBD-2 mRNA levels (62.2×104, 
38.0×104 copies of mRNA transcripts/mug total RNA, respectively). S. Typhimurium SL1344 
and ∆spaS, but not S. Typhimurium ∆fliM, induced basolateral secretion of IL-8 (SL1344: 
98.0±10.4 pg/ml, ∆spaS: 75.5±19.7 pg/ml, P <0.05; ∆fliM: 43.5±9.4 pg/ml, P >0.05; vs non-
infected controls: 51.4±17.9 pg/ml) and apical secretion of hBD-2 (SL1344: 12.1±2.7 pg/ml, 
∆spaS: 10.1±3.6 pg/ml, P <0.05; ∆fliM: 4.4±0.2 pg/ml, P >0.05; vs non-infected controls: 4.6±0.8 
pg/ml).  
Conclusion: FliC is the principle S. Typhimurium PAMP that elicits IL-8 and hBD-2 gene 
transcription and protein secretion. However, exposure to S. Typhimurium DNA triggers IL-
8/hBD-2 mRNA expression and infection with a FliC-deficient mutant strain S. Typhimurium 
∆fliM stimulates IL-8 mRNA expression, indicating that additional PAMPs may play a role in 
eliciting epithelial pro-inflammatory responses.  
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Inhibition of intracellular replication of Salmonella enterica serovar Typhimurium SL1344 
and IL-8 secretion in HEp-2 cells by postinfectious administration of Lactobacillus GG 
and Lactobacillus plantarum 299v 
 
Shiuh-Bin Fang, Mark Lucas, Arunon Sivananthan, Stephanie Schüller, Alan Phillips 
 
Centre for Paediatric Gastroenterology, Royal Free & University College Medical School, 
London, UK 
 
Objective: The ability of probiotics to ameliorate existing infections would be a high desirable 
characteristic. The aim of this study was to investigate if Lactobacillus GG (LGG) or 
Lactobacillus plantarum 299v (Lp299v) could reduce IL-8 secretion and/or intracellular non-
typhoidal Salmonella replication following infection of HEp-2 cells. 
 
Methods: HEp-2 cells were infected with Salmonella enterica serovar Typhimurium SL1344 
(MOI = 20) for one hour, treated with gentamycin for one hour to kill extracellular bacteria, and 
the infections were allowed to continue for 5 and 7 hours (positive controls). At these times 
intracellular bacterial cell numbers were calculated, and supernatants were collected to 
measure IL-8 protein with a commercially available ELISA. To determine the effect of probiotics 
on these parameters, low (MOI = 4) or high (MOI = 40) dose overnight cultures of LGG or 
Lp299v were added after gentamycin treatment and incubated with the cells. Statistical 
significance (p< 0.05) was tested using One-Way ANOVA. 
 
Results: Intracellular replication of SL1344 was not inhibited by 5 hours probiotic exposure. At 7 
hours, high dose LGG (22%, p = 0.029), and either low (22%, p = 0.028) or high dose Lp299v 
(33%, p = 0.002) inhibited SL1344 replication. High, but not low, dose probiotic treatment 
lowered IL-8 production at 5 hours (LGG 104 ± 14 pg/ml [p = 0.0001], Lp299v 90 ± 8 pg/ml [p = 
0.0001] vs positive control 255 ± 75 pg/ml). At 7 hours, both low and high dose probiotics 
reduced IL-8 levels (LGG low 171 ± 47 pg/ml [p = 0.0001], high 87 ± 42 pg/ml [p = 0.0001]; 
Lp299v low 171 ± 58 pg/ml [p = 0.0001], high 52 ± 40 pg/ml [p = 0.0001] vs positive control 288 
± 56 pg/ml). High dose probiotics reduced IL-8 more than low dose treatment at 7 hours (LGG p 
= 0.003, Lp299v p = 0.0001). 
 
Conclusion: The application of LGG and Lp299v to Salmonella enterica serovar Typhimurium 
SL1344 infected HEp-2 cells can reduce intraepithelial bacterial replication and can dose-
dependently reduce IL-8 secretion. 
 
 
 
 
 
 
 363
 
 
 
 
 
 
 364
 
 
